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CHAPTER 1A 
 
ION MOBILITY-HIGH RESOLUTION MASS SPECTROMETRY BASED 
METABOLOMICS 
 
1.1 Introduction 
 
Metabolite analysis is a demanding initiative for analytical technologies. It is 
estimated that between 4,000 and 20,000 distinct metabolites are expressed in 
eukaryotic organisms, spanning between 7-9 orders of magnitude in 
concentration range,1, 2 which necessitates highly sensitive and broad dynamic 
range analyses. This is particularly true when considering xenobiotic metabolites, 
in which all feasible biotransformations an administered drug may undergo must 
also be considered. These may occur over a large dynamic range of possible 
concentrations, and depending on the dose administered, may require highly 
sensitive analytical techniques.3 Metabolism is a dynamic process, requiring 
measurement strategies that provide high sample throughput and instrument 
duty cycle. A further challenge is that metabolites represent a diverse set of 
chemical classes possessing disparate polarities, such that there is no single 
extraction or separation technique which can handle most, much less all, 
metabolites present. Because of the shortcoming of current technologies, 
contemporary profiling strategies are necessarily focused on a relatively small 
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number of known metabolites and thus are noncomprehensive. Nevertheless, 
targeted analysis and low complexity metabolite profiling approaches have been 
highly successful in drug discovery and development.4, 5 
 Established bioanalytical methods for studying metabolites are 
predominately based on nuclear magnetic resonance (NMR) and mass 
spectrometry (MS). MS methods are widely used and are routinely combined 
with additional separations (e.g., gas and liquid chromatography prior to MS 
identification), to improve instrument sensitivity and dynamic range to detect 
lower abundance analytes. In parallel with advances in MS has been the 
development of post-ionization gas-phase separations based on ion mobility 
(IM).6-8 IM is a compartmentalized technology which offers a combined 
separation and analysis that is ca. 4 to 6 orders of magnitude faster than gas 
chromatography (GC) and liquid chromatography (LC), respectively.9 Since gas-
phase ionization is a prerequisite for both IM and MS, the two methods are 
commonly coupled into a single analysis technique referred to as ion mobility-
mass spectrometry (IM-MS), which allows separations on the basis of two 
physical properties: ion mobility (size) and ion mass (weight). IM-MS is still an 
emerging technology and one major challenge associated with using IM-MS for 
metabolite profiling is the limited amount of validation that can be drawn from the 
literature. Another challenge is the limited orthogonality between IM and MS 
separation dimensions, since analyte size and mass are two closely correlated 
physical properties.10 Nevertheless, the extremely high speeds of the separation 
(micro- to milliseconds) and the potential for enhancing existing MS 
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methodologies offers great promise for IM-MS to become a complimentary 
bioanalytical technique for dynamic metabolic and metabolomics analyses. 
 This introductory chapter provides an overview of the ion mobility 
technique and a review of the various analytical approaches that utilize ion 
mobility for metabolomics. The coupling of IM and MS is discussed in light of the 
herein utilized analytical advantages and the additional information gained in 
these 2-dimensional analyses. In recent years, high resolution mass 
spectrometers have allowed for the determination of metabolite identity based 
upon high mass accuracy measurements which allow the determination of 
metabolic transformations based upon mass defect filtering, which is further 
enhanced in combination with IM. Tandem MS experiments (MS/MS) are 
important methods for elucidating analyte identity, and the common methods of 
operation will be outlined. The addition of IM capabilities to MS instrumentation 
permits several useful combinations of tandem experiments (e.g., IM-MS/MS, 
MS/IM-MS, MS-IM-MS/MS, etc.) which enhance the current commercial MS/MS 
capabilities, and these will be discussed in detail at the end of this chapter.  
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1.2 An Overview of Ion Mobility Techniques 
 
1.2.1 Fundamental Aspects of Ion Mobility 
Ion mobility can be broadly defined as the kinetic behavior (velocity) of 
ions in a neutral gas. Differences in the velocity of two ions, even those that are 
isobaric (i.e. same mass), can be used to differentiate the two ions 
experimentally. The analytical technique which utilizes the property of ion mobility 
to separate ions is often called ion mobility spectrometry, to draw parallels with 
mass spectrometry. Other names such as gas-phase electrophoresis11 and 
plasma chromatography12 have also been used. In terms of the technology, ion 
mobility spectrometry closely resembles mass spectrometry, however, the 
separation mechanism is very similar to chromatography, which can cause 
confusion if the fundamentals of the ion mobility method are described from 
either a spectrometric or chromatographic perspective.13 Here, we will refer to the 
analytical technique simply as ion mobility (IM) and will make important 
distinctions where necessary. 
From a pedagogical perspective, all IM techniques can be conceptualized 
as a series of opposing vector forces: (i) the electric field force which directs ions 
across a defined region and (ii) the opposing force of ion-neutral collisions which 
impedes this forward motion. In the simplest IM experiment, ions are pulled by an 
electric field through a chamber filled with a constant pressure of gas and 
disperse in time based on differences in their mobility. The number of ion-neutral 
collisions is related to the size of the ion. Thus, for two ions of equal mass but 
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different sizes, the smaller of the two will have a higher ionic mobility (velocity) 
and traverse the region the fastest, arriving on the other side of the region first. 
This kind of ion mobility experiment is known as the drift tube IM technique and is 
the most commonly encountered IM method in the literature.  
The term ion mobility does not refer to any single experimental method but 
rather it encompasses a family of different analytical techniques, all of which 
utilize the same basic concept of an ion’s gas-phase mobility to generate an 
analytically useful separation. As with mass spectrometry, ion mobility techniques 
can be broadly divided into two categories: (i) temporally dispersive methods 
which separate all ions in time but along the same spatial path, and (ii) spatially 
dispersive methods which separate ions along different trajectories. The 
conceptual differences between temporal and spatial dispersion are depicted in 
Figure 1.1. Temporally dispersive IM methods can obtain a complete IM 
spectrum in a single measurement cycle while spatially dispersive IM techniques 
are almost always configured to transmit only a narrow IM range of ions at a 
time. Members of the spatially dispersive IM category are considered scanning 
methods which filter ions based on their mobilities and require that a parameter 
(typically a voltage) be scanned in order to generate the broadband spectrum. 
Table 1.1 contains a listing of several different ion mobility methods along with 
their defining attributes. The distinction between any two IM techniques can be 
most easily made by comparing the relative direction of the various field forces 
(electric field and gas flow) with respect to the motion of the ion. Note here that 
the ion motion will preferentially follow one of the forces such that the ion velocity 
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vector is aligned with one of the force vectors. A listing of the analogous MS 
method for each IM technique is also provided in Table 1.1.  
 
 
 
 
Figure 1.1. Conceptual schematic of the two types of separation schemes for ion 
mobility techniques. (A) Temporally dispersive separation methods partition a 
pulse of ions into different mobility values along the same spatial trajectory. Ions 
of different mobilities arrive at different times during each measurement pulse. 
(B) Spatially dispersive separation methods partition a continuous beam of ions 
into different mobility values along different spatial trajectories, with each 
trajectory representing ions possessing common gas-phase mobilities.  
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The following sections will describe each of the specific IM techniques in 
more detail. We will start with a qualitative description of the drift tube ion mobility 
method, and will use concepts discussed there as the foundation for 
understanding other IM techniques. These methods will initially be discussed in 
the absence of MS, however, the IM techniques will be framed as modular rather 
than stand-alone or end detection technologies. Governing equations, though 
important for each technique, will be avoided in this chapter in order to convey 
the qualitative operational principles clearly. The reader is directed towards 
specific references given in Table 1.1 if a more thorough understanding of each 
technique is sought. 
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Table 1. 1. The different ion mobility techniques, defining features and currently 
achieved resolving powers reported in the literature. Also included are the 
analogous mass spectrometry methods for each ion mobility technique. 
References are provided directing the reader to comprehensive reviews on the 
separation described. 
 
 
Ion Mobility 
Technique 
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a
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Differential High-Low 
Field IM 
High Field 
Asymmetric 
Waveform IMS 
(FAIMS) 
Differential Mobility 
Spectrometry 
(DMS) 
→ → ↑ 200
d
 Quadrupole 15, 16 
Differential Mobility 
Analyzer (DMA) 
Gas-phase 
Electrophoretic 
Molecular Mass 
Analyzer 
(GEMMA) 
→ ↑ → 50
e 
to 80
f
 Magnetic Sector 17, 18 
   
* It should be noted that resolving power does not adequately represent the separation 
efficiency of certain ion mobility methods, particularly the spatially dispersive IM 
techniques. For these methods, peak capacity is a more representative metric of 
separation ability (refer to Section 3.2). 
a. [19]. A resolving power >300 has been observed for a special circular path drift tube which 
operates in a narrow bandpass mode. 
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b. Experimentally observed on the Synapt Generation 2 (G2) for data obtained in the author’s 
laboratory. 
c. [21] 
d. [22] 
e. [23] 
f. Performance specifications for the SEADM DMA interface. 
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1.2.2 Drift Tube Ion Mobility Spectrometry 
 The drift tube ion mobility technique is the most familiar IM method and 
has been a commercial technology since the 1970s, though it has primarily been 
used as a stand-alone technology for chemical screening in security 
applications.24 Drift tube instruments can operate either at ambient pressure (ca. 
760 Torr) or reduced pressure (ca. 1-10 Torr), the latter more amendable to 
coupling with vacuum MS techniques. Ambient pressure drift tubes do not need 
bulky vacuum systems and, owing to the high gas number densities, the IM 
separation occurs in a relatively short distance, so these instruments are often 
preferred as low-cost, portable chemical detectors. Reduced pressure drift tubes 
are more costly and technically complex due to the added vacuum hardware, but 
offer very high measurement precision and accuracy and are readily coupled to 
mass spectrometers. Complicating ion chemistry is often avoided at reduced 
pressures where ions experience fewer interactions with trace gas impurities 
inherently present in the drift gases used. Reduced pressure drift tubes are 
generally preferred in research applications where high quality ion 
measurements are desired, but one major disadvantage has traditionally been 
that these instruments were not readily available commercially. This situation has 
changed in the last five years or so as several commercial vendors have begun 
offering high performance drift tube ion mobility-mass spectrometers (IM-MS). 
10 
 
 
 
Figure 1.2. The operation principles governing the four ion mobility techniques. 
(A) The drift tube ion mobility method disperses ions of differing mobilities 
temporally along the same trajectory by utilizing a continuous declining potential 
across a gas-filled region. (B) The traveling wave ion mobility method achieves 
temporally dispersive mobility separations through the use of a traveling wave 
potential across a gas-filled region. (C) The high field asymmetric waveform ion 
mobility method disperses ions spatially along different trajectories through the 
use of an orthogonally applied asymmetric waveform as ions are entrained in a 
gas flow. (D) The differential mobility analyzer disperses ions spatially by mobility 
through the use of a flow of gas and an orthogonally applied uniform electric field. 
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 The basic components and operational principle of the drift tube IM 
technique is depicted in Figure 1.2(A). A uniform electric field is defined along 
the length of a tube by a series of stacked ring electrodes. The tube is filled with 
an inert gas, usually helium or nitrogen, which is maintained at a constant 
pressure and low flow conditions. A pulse of ions is introduced at one end and 
allowed to drift down the length of the tube by the influence of the electric field via 
electrophoretic migration. During the ion’s drift, it collides many times with the 
drift gas (greater than 104 collisions at 1 Torr) which slows the ion’s forward 
motion. The amount of time any given ion spends in the drift tube is directly 
related to the number of collisions it experiences, which in turn depends on its 
collision cross section, or nominal gas-phase size and shape. This is analogous 
in principle to gas chromatography where the less volatile (lower vapor pressure) 
analyte will spend more time in the column. The measured drift times in the IM 
experiment are essentially the same in principle as retention times measured in 
chromatography, but it is important to note that IM is not chromatography in the 
strictest sense as there is no stationary phase (and thus no phase partitioning), 
but rather a constantly moving density of gas.  
Because the electric field, gas pressure (number density), temperature 
and tube length are (ideally) all kept constant in the drift tube IM experiment, the 
relationship between the measured ion drift time and the collision cross section is 
direct and can be determined from first principle kinetic equations.25 The 
measure of absolute gas-phase collision cross sections of ions is an important 
feature of the drift tube experiment. The interpretation of the collision cross 
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section value is, however, not straightforward since effects such as neutral gas 
polarization can contribute to nonideal (inelastic) ion-gas interactions.26 This is 
particularly significant for small molecules such as metabolites, where the analyte 
polarity can contribute to a more attractive ion-gas interaction (a “sticky” collision) 
which will make the collision cross section appear larger than the physical size of 
the gas-phase analyte ion. Thus, it is difficult to assign any physical meaning to 
the collision cross sections measured for small molecules in the IM experiment. 
For larger analyte ions, greater than about 500 mass-to-charge, the size effects 
become the significant contributor to the measured drift times, and collision cross 
section in this case is a close representation of the physical size and shape of 
the gas-phase ion. The use of nonpolar drift gases also improves the accuracy of 
the collision cross section measurement, which is why helium is often preferred 
in research drift tube instruments. One prevailing advantage of drift tube 
instruments over the other IM techniques described in this chapter is the very 
high resolving powers which can be achieved (greater than 200) ,19 which makes 
drift tubes the preferred IM instrumentation for core research and development. 
 
1.2.3 Traveling Wave Ion Mobility Spectrometry 
 Traveling wave is a relatively new IM technique, but already has shown 
great promise to become a routine method for chemical analysis. This is largely 
due to the rapid commercialization of the technology, which is now widely 
available integrated into a high-end mass spectrometer platform.14 The first 
commercial traveling wave instrument was released in 2006 (Synapt HDMS, 
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Waters) and has since seen a major revision (Synapt G2, 2009) which has 
improved the ion mobility resolving power by about a factor of four (currently ca. 
40-50) and offers mass resolving powers up to ca. 50,000. The traveling wave 
concept itself can be traced back to early accelerator physics applications,27 and 
early work with using RF fields to determine ionic mobilities,28, 29 but until recently 
there have been no attempts made at translating this technology to separating 
ions by mobility on an analytical scale. 
 The basic components of the traveling wave IM device is shown in Figure 
1.2(B) and are essentially the same as what can be found in a drift tube IM 
instrument. The drift region consists of a stacked ring ion guide and is filled with a 
low static pressure (1-5 Torr) of nitrogen. The rings serve two purposes: (i) a 
sinusoidal radio-frequency potential is applied to confine ions to the center axis of 
the device to improve instrument sensitivity, while (ii) a pulsed voltage is applied 
on sets of rings and rapidly switched from one end of the device to the other to 
generate the traveling wave potential for ion mobility separation. Ions which are 
introduced to the device in narrow pulses will be picked up by the wave and 
pushed down the length of the drift region where they experience many collisions 
with the nitrogen gas. Some ions experience more collisions with the drift gas 
and are pushed against the wave until they fall behind it and wait for the next 
wave to carry them forward again. The number of times any given ion will tumble 
behind the wave is directly related to its ionic mobility—larger ions are inherently 
more difficult to push forward than light ions. Thus, the device disperses ions 
based on their mobilities in much the same way as the drift tube experiment, 
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though fundamentally this is achieved in a very different manner. Because the 
wave travels at a fixed velocity, only ions which fall behind the wave will 
separate—those ions which are pushed along by a single wave will arrive at the 
same drift time and result in no useful mobility separation. Factors such as the 
wave velocity and voltage amplitude must be tuned in order to obtain a good 
mobility separation. The current second generation traveling wave instrument 
(Synapt G2) can achieve ion mobility resolving powers of ca. 45 (author’s 
laboratory). 
Because of the complex potentials utilized in the traveling wave IM 
instrument, there is no direct first principle correlation between measured drift 
times and collision cross sections. For those interested in obtaining structural 
information from the IM experiment, this is seen as a disadvantage when using 
the traveling wave IM technique, though methods have been proposed. By 
preparing a calibration curve with standards of known collision cross section, 
structural values have been extracted using traveling wave IM. This method is 
limited to the range of the calibration curve, which typically limits this method to 
the analysis of a particular biomolecular class. Additionally, methods of 
dynamically changing the traveling wave velocity for the determination of mobility 
have been presented as well, though this method is not commercially available 
and not particularly feasible for complex sample analysis. However, there are two 
distinct advantages that traveling wave IM offers over traditional drift tube IM. 
First, the axially confining electric fields results in very little ion loss and thus very 
good analyte sensitivity. Second, the traveling wave device is much easier to 
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couple to other instrumentation due to the fact that the potential at the start and 
exit of the device remains the same. In contrast, coupling instrumentation such 
as MS to a drift tube IM device requires either the front or back component be 
biased to a nonzero electric potential, increasing technical complexity. A third 
advantage might be that traveling wave instruments are becoming much more 
accessible to mainstream analytical research and will no doubt see some exciting 
applications in the near future, particularly in the area of drug research and 
discovery. Both the drift tube and traveling wave IM techniques disperse ions 
temporally along the same space, which permits an entire broadband mobility 
spectrum to be generated in each experimental measurement cycle. This has the 
obvious advantage of allowing one to obtain data on several analyte peaks at the 
same time. One limitation of temporally dispersive approaches is that ions are 
introduced in pulses, requiring that each measurement be complete before 
another pulse is admitted (a duty cycle) which reduces the overall sample 
throughput of the technique. In some cases, it is desirable to only monitor a few 
select analyte signals continuously, and so the next two IM techniques we will 
discuss act as narrow bandpass mobility filters and are particularly well suited for 
analyte monitoring applications. 
 
16 
1.2.4 High-Field Asymmetric Waveform Ion Mobility & Differential Mobility 
Spectrometry  
 
  Consider now a continuous stream of ions entrained in a gas flow that 
passes between two parallel plates as shown in Figure 1.2(C). One plate is kept 
at a constant potential, usually ground, and on the other plate is applied an 
alternating (AC) voltage. This AC voltage is kept at the same average potential 
as the opposite plate but alternates between a short duration, high amplitude and 
a longer duration, low amplitude (an asymmetric waveform) as shown in Figure 
1(c). The total magnitude of each push/pull potential is the same, such that the 
ions experience the same average electric field for each cycle, but in opposite 
directions. If the mobility of the ion during the push cycle is the same as during 
the pull cycle, then the ion’s average displacement will be zero. However, the 
gas-phase mobility of an ion has an electric field dependence such that it 
changes between going from high field (ca. 20,000 V cm-1) to low field (ca. 1000 
V cm-1).30 This results in a different net displacement of the ion when subjected to 
the short duration, high field wave cycle than when it experiences the longer 
duration, lower field wave cycle. Ultimately this results in ions which are not 
balanced by the asymmetric waveform to be neutralized onto one of the plates. 
This device will transmit a narrow bandpass of ions whose high field and low field 
ion mobility is exactly matched by the waveform. An additional compensation 
voltage is applied to either plate to allow the device to be scanned, thus filtering 
ions possessing different changes in high/low field ion mobilities.  
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Devices which utilize this principle of ion mobility separation have been 
described by several names, the two most popular being high-field asymmetric 
waveform ion mobility spectrometry (FAIMS) and differential mobility 
spectrometry (DMS). In Table 1.1, we refer to both techniques as differential 
high-low field IM. Both terms describe the same general technique with defining 
differences being in the geometry of the electrodes used and how ions are 
detected in stand-alone applications. FAIMS and DMS devices do not separate 
purely by ion mobility, but rather separate by the difference in high/low field ion 
mobility (the first derivative) so the observed separations are often subtly 
different than those derived from the other IM methods. In many cases, these 
devices can resolve ion species which are difficult to separate by traditional IM, 
such as leucine and isoleucine.31 Additionally, one can couple FAIMS or DMS 
with a temporally dispersive IM method (i.e., drift tube or traveling wave IM 
spectrometry) and achieve excellent orthogonality between the two 
separations,32 which is analogous in principle to 2-dimensional gas 
chromatography using polar and nonpolar columns. FAIMS and DMS have been 
successfully used to separate a variety of small molecules and both technologies 
are commercially available as front-end separators for mass spectrometers 
(FAIMS, Thermo Scientific, and DMS, Sionex). Because these devices operate at 
or near ambient pressure, they are readily compatible with atmospheric pressure 
ionization sources. 
The high field/low field ion mobility behavior and transition between 
differential behaviors is still poorly understood. Because there is no first principle 
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correlation between the change in ion mobility and the low field collision cross 
section, analyte size information is difficult to obtain with any accuracy using the 
differential high-low field IM technique. Gas-phase collision cross sections can be 
determined in differential high-low field IM through special energy loss 
experiments using triple quadrupole mass spectrometry.33 
 
1.2.5 Differential Mobility Analyzer 
 
 Differential mobility analyzers are a special class of ion mobility 
instruments used primarily for measuring the size of aerosol particles greater 
than 5 nm in diameter. These instruments are not commonly used for small 
molecules due to high diffusive ion losses; however, the method is included here 
to complete the discussion of IM technologies. The reader may skip to the next 
section if more relevant discussion regarding IM techniques for metabolite 
analysis is preferred. 
 Building on the differential high-low field IM technique described in the 
previous section, consider now a similar experimental setup whereby ions are 
entrained in a flowing gas and allowed to pass between two parallel plates as 
shown in Figure 2(D). Instead of an alternating voltage, a direct voltage is 
applied across the two plates creating a uniform electric potential gradient 
perpendicular to the ion transit. This will cause ions to migrate from one plate to 
the other as they are being pulled along by the gas flow. All ions of the same 
charge will experience the same force of the electric field, but because of 
differences in their ion mobilities, smaller ions will be displaced a shorter distance 
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than larger ions. This results in a spatial dispersion of ions based on their ionic 
mobilities. Practical designs of this type of transverse field IM instrument utilize 
small apertures or slits on the parallel plates which are offset some defined 
distance from one another, as depicted in Figure 1(D). Ions are introduced to the 
gas stream through one slit and the voltage is tuned to allow ions with different 
mobilities to pass through the second slit, in much the same way as tuning the 
m/z of a magnetic sector MS instrument. With the exit slit design, the instrument 
operates in a scanning mode. The exit slit can also be replaced by an array 
detector, which allows for broadband ion mobility spectrum to be measured,34 
however this design cannot be coupled as a front-end to MS (e.g., IM-MS).  
These instruments are sometimes called aspirator mobility analyzers due 
to the aspiration effect of introducing ions into the gas stream. More commonly 
they are referred to as differential mobility analyzer (DMA) and by the trade name 
gas-phase electrophoretic molecular mobility analyzer (GEMMA), the latter now 
referred to as macroIMS (TSI Incorporated). The DMA nomenclature is 
oftentimes confused with the DMS technique described in the previous section, 
but it should be noted that these two IM techniques separate ions by two very 
distinct mechanisms, specifically the DMA differentiates ions based on 
aerodynamic ionic mobility (IM in the presence of a gas flow) whereas DMS 
exploits ion mobility differences between high and low electric field conditions. 
DMA and GEMMA have been highly successful in measuring particle sizes down 
to the nanometer range.17 Smaller ions are more difficult to transmit due to 
diffusive losses and the instrument performance is inherently tied to the size of 
20 
the slits used—larger slits improve sensitivity at a cost of resolution and vice 
versa. Recent technological improvements show promise for extending the 
usable size range down to small molecular ions with high sensitivity and ion 
mobility resolution.23 
 As with drift tube IM instruments, DMA measurements can be used to 
determine the ion’s effective size since there is a direct relationship between the 
experimental conditions (transmission voltage and gas flow rate) and the 
experimentally measured gas-phase ion mobility. A hard sphere model is used to 
relate the measured ion mobility value to an effective size. As mentioned 
previously, DMA instruments are currently limited to the analysis of relatively 
large ions (10s of nanometers or greater in diameter), requiring that effects such 
as surface roughness be accounted for in the size calculation.35 Nonetheless, 
because the DMA experimental separation parameters (voltage, drift length and 
gas flow) are well characterized, the resulting measurement precision of the DMA 
technique is high. 
 
1.3 Integrated Ion Mobility-Mass Spectrometry 
 
 All of the IM methods described previously can operate as a stand-alone 
chemical analysis technology (i.e., an ion mobility spectrometer). One 
shortcoming of ion mobility analysis alone is that the measured ionic mobility is a 
relative property of the analyte and will change with respect to different 
experimental conditions (e.g., drift gas pressure, temperature and composition). 
Consequently, confident analyte identification using IM spectrometry information 
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alone (via the reduced mobility) relies on rigorous method validation and even 
then is subject to specific constraints on the system being studied.36-38 In 
contrast, mass spectrometry measures an inherent physical property of the 
analyte (mass or more specifically, the mass-to-charge ratio) which can be used 
for analyte identification purposes, as the property of ion mass is readily 
comparable across instrument platforms. MS and tandem MS methods are the 
cornerstone technology of many analyte characterization initiatives, a fact which 
is reflected in the numerous contributions to this volume. Due to the requirement 
that the analyte be ionized, IM is particularly suited for coupling with mass 
spectrometry. The first IM-MS instruments appeared in the 1960s in response to 
the need to better characterize the ion chemistry observed in drift tubes.39, 40 
Bioanalytical drift tube mass spectrometers emerged in the 1990s owing to the 
development of soft ionization methods (MALDI and ESI which are discussed in 
other chapters).6 Ion mobility-mass spectrometry (IM-MS) is now widely utilized 
and regarded as a technique in and of itself,41 much like the integration of liquid 
chromatography to mass spectrometry (LC-MS). Most of the technical challenges 
associated with coupling the elevated pressure IM stage to a vacuum MS have 
been solved, largely due to parallel initiatives in improving the transfer efficiency 
of ions from atmospheric ionization sources to MS.42 As mentioned previously, 
commercially available IM-MS instruments are now emerging and offer little to no 
compromise in performance as compared with the familiar MS platforms in which 
they are coupled. Thus, researchers familiar with existing commercial MS 
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technologies will find that IM capabilities enhance existing methodologies built 
upon MS analysis. 
 
1.3.1 Ion Mobility-Mass Spectrometry Instrumentation 
Figure 1.3(A) illustrates the basic components of an IM-MS instrument. 
Sample introduction can include direct infusion, GC or LC. Virtually every 
ionization source which has been used in MS has been coupled to an IM-MS 
instrument,41 including all of the ionization techniques covered in this volume. 
Likewise, virtually every combination of IM and MS has been attempted. 
Temporally dispersive IM (drift tube and traveling wave) combined with 
temporally dispersive MS (time-of-flight) is a particularly useful combination since 
both techniques offer broadband analysis for each experimental cycle.43 Another 
useful combination is coupling a scanning IM (e.g., FAIMS or DMS) to a scanning 
MS (an ion trap), which allows selective monitoring and analysis experiments.44 
Instruments based on bracketing an IM between two mass spectrometer stages 
(MS-IM-MS) have also been developed,45 allowing several useful stages of 
tandem ion experiment to be conducted.46 We will discuss various combinations 
of tandem IM/MS in later sections. Commonality between all of these instrument 
configurations is the back-end mass analysis, which provides a comprehensive 
characterization of the sample by mass, or specifically, the mass-to-charge ratio. 
For the purposes of this chapter, we will focus primarily on IM-MS instruments 
which incorporate a first stage of mass selection and tandem capabilities with a 
high resolution mass spectrometer (so-called “high performance” IM-MS, Figure 
1.3(B)). Though the literature defines high resolution mass spectrometers with a 
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degree of disparity, we will consider high resolution the ability to obtain part-per-
million mass precision (e.g., 1000 ± 0.015 Da, or 20,000 resolving power) within 
the mass-to-charge range of interest. 
 
 
 
 
Figure 1.3. (A) A schematic of the basic components of an ion mobility-mass 
spectrometer. From left to right, sample is introduced, ionized, then separated 
first by ion mobility then by mass and finally detected. (B) A “high performance” 
ion mobility-mass spectrometer can include a mass spectrometer before the ion 
mobility spectrometer and several stages of ion activation located between each 
spectrometer component. Additionally, the spectrometers operate with high 
precision (resolving power) and sensitivity, enabling high quality measurements 
of mobility and mass to be made. 
 
 
1.3.2 Orthogonality and Peak Capacity in Ion Mobility-Mass Spectrometry 
Analyses 
 The observed mobility-mass correlation in IM-MS data limits the 
orthogonality of the two separations. Completely orthogonal measurements 
would distribute data throughout two dimensional separation space with no 
correlation between the data sets, as each separation is contingent upon 
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chemical or physical properties that are independent of one another.47 In other 
words, data projected on a two-dimensional separation plot would occupy all of 
separations space, as illustrated conceptually in Figure 1.4(A), where analyte 
signals distribute themselves across the full 2-dimensional area. This high 
orthogonality is often observed, for example, in 2D gel electrophoresis 48, 49 
where the two dimensions of separation are analyte mass and isoelectric point—
two unrelated analyte parameters. The degree of orthogonality of IM-MS 
separations is low due to the correlation of mass and size.50 This is apparent 
when considering an ion of increasing mass, which will inherently possess a 
larger volume, and therefore occupy an established region of separations space, 
a mobility-mass correlation termed “conformational space”.51 Low orthogonality 
inherently limits the peak capacity (φ) of the IM separation, which is the 
maximum number of resolvable peaks within the separation window, as 
illustrated in Figure 1.4(B) for a hypothetical IM-MS spectrum.52 Here, the narrow 
distribution of data requires that the analysis window be narrowed accordingly, 
depicted with the dotted lines in Figure 4(B). Previous IM studies have reported 
a peak capacity of approximately 5 for the IM dimension alone, which is low as 
compared with other separation methods.10 However, the strength of IM is that, 
when combined with MS, the overall peak capacity of the MS dimension is 
increased multiplicatively (specifically, five-fold). As there is virtually no 
compromise in analytical performance when IM is added to MS, this represents a 
significant improvement in analytical performance. For example, IM-MS has 
recently demonstrated a peak capacity of 103 for metabolites in a single IM-MS 
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spectrum, which is comparable to that of highly orthogonal methods, such as 
reverse phase LC-MS (φ=1000-1500, Shewanella oneidensis lysate),53 two 
dimensional gas chromatography-mass spectrometry (GCxGC-MS, φ=1200, lean 
C57BL/6 mice spleen extract, φ=1800 human serum),54, 55 and capillary 
electrophoresis-mass spectrometry (CE-MS, φ=1692, Bacillus subtilis extract).56 
These examples represent general separation benchmarks for each analytical 
platform, and while useful for qualitative comparative purposes, it should be 
noted that the samples, conditions, and mass spectrometers are not consistent 
across each study.  
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Figure 1.4. Shown in (A) is a theoretical distribution of peaks (represented in 
black in grid space) in two-dimensional space for completely orthogonal 
separations. Each axis corresponds to a theoretical separation parameter. The 
high orthogonality allows for the occupancy of all two dimensional space, thus 
having a peak capacity equivalent to the product of the two peak capacities. 
Illustrated in (B) are two separations with low orthogonality. The region of two-
dimensional separations space that peaks occupy is limited to a fraction of all 
separations space. The region of analysis space is narrowed to that shown in the 
overlapping regions, for example. This limits peak capacity, as the total peak 
capacity is no longer the product of the two peak capacities, but a corrected 
value that is a fraction of the maximum. The grey areas are regions of separation 
space in which no signal appears. 
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1.3.3 Ion Mobility-Mass Spectrometry Analysis Speed 
The main strength ion mobility holds over conventional separations 
techniques is that it occurs post ionization, which means separations are 
performed entirely in the gas phase. This results in a separation that occurs on 
the order of hundreds of microseconds to milliseconds. As a result, thousands of 
ion mobility spectra can be acquired each second. When compared with 
previously presented separation methods which are utilized prior to ionization 
(e.g., LC, CE and GC), the time required for a mobility separation to occur is 
several orders of magnitude faster. An analysis speed comparison of several 
separation techniques is provided in Figure 1.5. For a typical metabolomics 
study, high performance liquid chromatography, two dimensional gas 
chromatography, and capillary electrophoresis separations occur on the order of 
minutes to hours. Additionally, gas chromatography separations often require 
analyte derivatization to promote volatility, which adds multiple hours in addition 
to the separation.55, 57-61 While the orthogonality and peak capacity of IM-MS 
remains comparable to other 2-dimensional methods, it is the high speed of IM-
MS which affords a great analytical advantage in terms of the peak production 
rate, as illustrated in Table 1.2.9 
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Table 1. 2. Several single dimensional separation methods and the parameter for 
separation, peak capacity (φ) and peak production rate (φ/s) associated with 
each. 
Separation Method 
(Single Dimension) 
Separation 
Parameter 
Peak 
Capacity 
(φ) 
Signal 
Peak 
Production 
Rate (φ/s) 
Ref. 
Capillary 
Electrophoresis (CE) 
electrophoretic 
mobility 
1000 0.5 62 
Gas Chromatography 
(GC) 
vapor pressure 75 6 63 
Liquid Chromatography 
(LC) 
Ultrahigh Pressure LC 
hydrophobicity 
60 
300 
0.06 
0.2 
64, 65 
1D Slab Gel 
Electrophoresis 
isoelectric point, 
mass 
100 0.03 66 
Field Flow 
Fractionation (FFF) 
hydrodynamic 
radius 
10 0.005 66, 67 
Ion Mobility 
(IM) 
gas phase cross 
section 
5 500 10 
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Figure 1.5. Speeds for separation techniques commonly applied to metabolite 
analysis. Note the logarithmic scaling on the abscissa.  
 
 
 
 
In addition to the high data production rate of IM-MS, another key 
advantage of coupling time dispersive IM and MS is the complimentary nature of 
the timescales for each dimension of analysis. Because time dispersive IM 
separations (ms) occur 2-3 orders-of-magnitude slower than time dispersive MS 
(μs), hundreds of mass spectra can be acquired for each ion mobility spectrum, 
which benefits the sampling resolution across the IM dimension.68 This temporal 
sampling benefit is commonly exploited in LC-MS where each LC trace is 
sampled numerous times by the MS. One criticism of LC-MS has been that the 
immensely disparate timescales (6 to 8 orders of magnitude) ineffectively utilizes 
the throughput of the mass spectrometer. IM readily bridges this time disparity 
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between LC and MS, which has been demonstrated for the three-dimensional 
analysis of complex biological samples.69 CE-IM-MS has also been 
demonstrated to improve the sensitivity of the MS for low abundance analytes in 
complex biological samples.70 Combining front end separation techniques with 
IM-MS is still an emerging area that holds great promise for improving the 
chemical analysis for both contemporary and future applications. 
 
1.4 Information Content of Ion Mobility-Mass Spectrometry Analyses 
One favorable consequence of the data correlation between ion mobility 
and mass is the potential for extracting additional information regarding specific 
analytes within the sample. This complimentary information can be used in a 
number of ways for more confident identification and characterization of analyte 
signals within the sample. Figure 1.6(A) contains a 2-dimensional projection of 
ion mobility-mass data for a nano-electrosprayed sample of a methanol extract of 
rat blood. This data was obtained in less than 1 minute in the author’s laboratory 
using a traveling wave IM-MS instrument. The spectrum displays mass-to-charge 
(Da) on the abscissa and drift time (ms) on the ordinate. The spectrum is false 
colored (heat mapped) to represent relative signal abundances and is comprised 
of almost exclusively singly charged ions due to the nano-electrospray ionization 
conditions utilized. Immediately obvious is the close correlation between the 
mobility and mass, which manifests as a clustering of data along a mobility-mass 
correlation line.71 This results from the intuitive scaling of the analyte size with its 
weight. Figure 1.6(B) illustrates the advantage of selective interrogation of data 
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corresponding to the mobility-mass correlation for lipids, peptides, and small 
molecules. The individual mass spectra are extracted directly from the combined 
mobility-mass spectrum (Figure 1.6(A)). The result is the extraction of relevant 
analyte signals, based upon the distillation of chemical noise, which greatly 
improves the amount of information which can be gleamed from the data. This 
strategy has recently been shown to be applicable to metabolite identification for 
the IM-MS analysis of human blood,72 rat lymph fluid,73 and Escherichia coli 
extracts.74 
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Figure 1.6. (A) Shown is a nano-electrospray ionization-ion mobility-mass 
spectrum of a methanol extract of rat blood. Mass-to-charge is depicted on the 
abscissa, with mobility drift time represented on the ordinate (ms). Peaks are 
false colored to illustrate relative abundance, with the scale displayed in the 
inset. Shown above the IM-MS plot is the corresponding mass spectrum for the 
entire sample. Regions corresponding to various mobility-mass correlation lines 
are highlighted and labeled, with the extracted mass spectra displayed in (B). 
Preliminary identifications are assigned based upon conformational space 
occupation. 
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 One of the challenges of metabolite studies is the diverse representation 
of chemical species classified as metabolites. These include both large (e.g., 
peptides, lipids and glycosides) and small (e.g., alkaloids, terpenes and phenols) 
biomolecules, but traditionally focused on the latter due to available technologies 
for small molecule analysis (e.g., GC-MS). As described previously, the IM-MS 
analysis provides an advantageous dimension of information in the form of 
molecular class-specific mobility-mass correlation lines which can be used for 
identification purposes, but also for isolation and extraction of certain chemical 
signals. From a global analysis perspective, this has the advantage of 
interrogating a large amount of chemical data simultaneously, which is 
particularly advantageous for whole systems approaches.75 As an example of the 
utility of IM-MS for whole systems studies, Figure 1.7(A) depicts a mapping of 
ion collision cross section (ion mobility) versus ion mass for a large sample 
number (n=951) representing four biomolecular chemical classes: lipids, 
carbohydrates, peptides and nucleotides. Figure 1.7(B) contains logarithmic 
regression fits of the datasets in Figure 7(A) and illustrates the average mobility-
mass correlation for each biomolecular class. Note that the ion mobility data 
normally projected as drift time has been converted to collision cross section (in 
square angstroms). What is immediately obvious is that the average mobility-
mass correlation is different for each class, with notable disparity between 
peptides and carbohydrates. The data projections in Figure 6 represent an initial 
attempt at mapping mobility-mass data space for a large dataset representative 
of several molecular classes. The ultimate goal of such a project is to generate a 
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reliable “atlas” of conformational space of biologically relevant molecules and 
apply this a priori knowledge towards an integrated “omics” approach.76 
 
 
 
 
Figure 1.7. Shown are the mass-to-charges and calculated collision cross 
sections (in Å2) obtained using a drift tube ion mobility-mass spectrometer for 53 
lipids, 610 peptides, 192 carbohydrates, and 96 oligonucleotides, illustrating the 
separation of biomolecular classes in two-dimensional space using IM-MS. (B) 
Logarithmic regression fits applied to the biomolecular class distributions in (A). 
Adapted with permission from 77. 
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1.4.1 Tandem Methods for Ion Mobility-Mass Spectrometry 
Ion mobility has so far been discussed with regards to the analytical merit 
of performing fast separation of mixtures and using the resulting separation to 
locate relevant chemical signals which may otherwise be disregarded in a single 
dimension of mass analysis, such as the case of structural isomers. While the 
identification of significant analyte signals (markers) in the spectrometric analysis 
is certainly important, it is more challenging to then assign these signals a 
chemical identity.78 Tandem MS experiments (MS/MS) are a critical aspect of MS 
approaches to metabolite identification. MS/MS involves two mass separation 
steps with ion fragmentation occurring between. The first MS is used to isolate 
one mass-to-charge, which is then subjected to a fragmentation step (most 
commonly through energetic gas collisions in a pressurized chamber), causing 
decomposition of the selected precursor ion into fragments. The fragment ions 
are then analyzed in a second MS stage to generate a fragment ion mass 
spectrum. Fragmentation data is used to determine the precursor ion’s identity 
based upon predicted fragmentation pathways.79 Additionally, there are several 
useful “scans” which can be utilized with MS/MS in order to monitor, for example, 
specific product ions which are known metabolic markers for a particular drug. 
These tandem strategies will be briefly outlined later in the chapter. Tandem MS 
experiments are performed either using serial stages of MS instrumentation 
(tandem in space) or an ion trap instrument (tandem in time). When we discuss 
tandem experiments in IM-MS, we will only deal with tandem in space 
arrangements (primarily as a result of the lack of development of ion trapping 
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based IM technologies, though it is noted that such a device has been suggested 
theoretically).80 
 
1.4.2 Scanning Modes for Tandem Mass Spectrometry 
 There are several “scan modes” which are useful in multi-stage tandem 
MS for metabolite screening applications. These modes differ only in whether 
each MS stage is operated in narrow (selected MS) or broadband (full MS) 
mode. With two MS stages (including a fragmentation stage in between), there 
are 4 possible combinations of scan modes which can be utilized. Figure 1.8 
illustrates these four scan modes, which are (A) precursor ion scan (full-
selected), (B) neutral loss scan (full-full), (C) product ion scan (selected-full), and 
(D) selected reaction monitoring (selected-selected). Traditionally these modes 
were applied to triple quadrupole instruments, but the general methodology has 
since carried over to other MS/MS instrumentation, such as Q-TOF, TOF-TOF, 
and, to some extent, various ion trap platforms. The underlying difference in 
applying these scan modes to different instrument platforms is in the resulting 
performance: TOF instruments generally sacrifice sensitivity and broad range 
linear response (e.g., quantitative ability) for high speed and high resolution/mass 
accuracy. Ion traps trade some degree of performance (speed and mass 
resolution) for experimental versatility, most notably the capability to do multiple 
stages of tandem experiments (MSn, where n>2). Because TOF instruments 
obtain a broadband mass spectrum, the precursor and selective reaction 
monitoring experiments are performed post-data acquisition. What will follow is a 
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brief description of each scan mode as they are applied in tandem MS/MS 
experimentation.  
 The precursor ion scan (Figure 1.8(A)) and neutral loss scan (Figure 
1.8(B)) modes are the first tandem MS experiments which are utilized in a 
metabolite study. These MS/MS experiments are considered reasonable 
preliminary methods since the information gained is broadly encompassing and 
requires very little a priori knowledge regarding the system under investigation. In 
a precursor ion scan, an expected product ion is selected with the second MS 
stage and the first MS stage is scanned through a range of m/z values until the 
expected product ion signal appears. The product ions of interest represent 
common metabolic alterations, such as glucuronidation (M+176). Additionally, the 
second MS stage can be set to monitor the m/z of the parent compound itself in 
order to discover metabolites which consist of an unaltered portion of the parent 
compound, such as oxidation (M+16). Because the fragmentation step in an 
MS/MS experiment results in both fragment ions and fragment neutrals, the mass 
spectrometer is blind to the latter. To overcome this fundamental limitation, the 
two MS stages can be set to transmit a fixed m/z difference from one another 
representing a characteristic neutral loss. For example, to locate an oxidation 
product metabolite, the first MS stage is scanned through a range of m/z values 
and the fragment ion, M-16, is monitored by the second MS stage. This will find 
all precursor ions which have been oxidized. 
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Figure 1.8. Illustrations of the various MS/MS scanning methods for two tandem 
MS stages. Fragmentation occurs between the two mass analyzers, as depicted. 
(A) A precursor ion scan, where the first mass analyzer performs a full scan, 
while the second mass analyzer is fixed to a given m/z that corresponds to an 
expected product ion. (B) A neutral loss scan, where both mass analyzers 
perform a full scan, with the second mass analyzer set to a fixed mass-to-charge 
difference from the first. Commonly, the analyzer offset corresponds to a known 
biotransformation. (D) A product ion scan in which the first mass analyzer 
isolates a particular mass-to-charge and the second mass analyzer performs a 
full scan to obtain all resulting fragments. (D) A reaction monitoring scan in which 
the first mass analyzer selects a specific mass-to-charge and the second mass 
analyzer is set to selectively monitor for the appearance of a particular product 
ion. 
 
 
 The product ion scan (Figure 1.8(C)) is the conventional mode for MS/MS 
experiments. In a product ion scan, a precursor ion m/z is isolated and 
transmitted by the first MS stage, fragmented and the entire fragment ion 
spectrum is obtained in the second MS stage. The product ion scan is useful for 
characterizing a precursor ion once it has been identified as being of interest. 
Finally, the reaction monitoring experiment (Figure 1.8(D)) is a powerful and 
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specific mode of MS/MS operation used primarily when quantitative information 
is sought. In this mode, an m/z of interest is selected by the first MS, fragmented, 
and a specific m/z is monitored by the second MS. Prior knowledge regarding the 
expected product ions is necessary. A single or multiple set of fragment ion m/z 
values can be monitored for each precursor ion transmitted by the first MS. 
 As mentioned previously, these scanning modes were originally 
developed for triple quadrupole instrumentation, but recent advances in hybrid 
MS instrumentation has expanded their usage to other platforms. The Q-TOF 
configuration is a particularly important instrument platform which replaces the 
final MS stage of a triple quadrupole with a broadband time-of-flight MS. This has 
the significant advantage that TOF MS performs with greater analyte sensitivity in 
its conventional broadband MS mode than a quadrupole operating in a full scan 
MS mode. The other important analytical advantage that Q-TOF instruments hold 
over a triple quadrupole platform is higher speed and consequently, higher 
sample throughput. Finally, the high mass resolving power capabilities of TOF 
greatly improve the mass measurement accuracy. Contemporary Q-TOF 
instruments are capable of resolving powers in excess of 40,000 with a 
theoretically unlimited mass range. Macromolecules in the MDa (106 mass units) 
range have recently been studied using QTOF instruments.81 
 
1.5 High-Performance Tandem Ion Mobility-Mass Spectrometry Modes 
The addition of ion mobility to multi-stage MS instruments offers greater 
experimental flexibility with regards to tandem experiments. For example, the use 
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of a FAIMS device at the front-end of an MS instrument introduces an added 
dimension of chemical noise discrimination which serves to enhance important 
ion signals which appear at low abundance 82. A more versatile example is the 
addition of an IM dispersive stage into a hybrid quadrupole time-of-flight 
instrument (Q-TOF), which creates the useful MS-IM-MS configuration 
(specifically, a Q-IM-TOF). Because of the necessary transition between the two 
vacuum MS stages into the pressurized IM, elevated pressure ion guides are 
utilized between each stage to efficiently transfer ions into and out of the IM 
device, which creates an advantageous addition of two collision cells in the MS-
IM-MS instrument configuration. Thus, collisional activation of ions can be 
accomplished before or after the IM separation, which creates a number of useful 
tandem arrangements. The next section will deal with the various tandem 
configurations afforded by the MS-IM-MS configuration and we will consider 
some of the added information which can be gleamed from each stage of tandem 
analysis. Regarding nomenclature, the hyphen designates two coupled analyzers 
(e.g., IM-MS) while the forward slash designation (e.g., MS/MS) denotes tandem 
capabilities (i.e., a collision cell between the two components). 
When considering an analytical configuration which brackets a mobility 
separation between two mass analyzers (MS-IM-MS), the first possibility is to 
select an m/z window with the first MS stage and immediately induce 
fragmentation prior to the IM-MS analysis (i.e., MS/IM-MS). This will generate a 
comprehensive 2D IM-MS spectrum of resulting fragment ions, as illustrated in 
Figure 1.9(A). This strategy is identical to performing a product ion scan but with 
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the added dimensionality of the ion mobility separation, resulting in separation of 
product peaks based upon both mobility and mass-to-charge. The practical 
benefit is the separation of product ions in chemical space, allowing for the 
distillation of the fragmentation spectrum. However, isobaric species will not be 
separated prior to fragmentation, and the resulting product ion spectrum may 
reflect multiple isobaric species not easily differentiated.  
An alternative mode of operation is to first select a mass-to-charge of 
interest, mobility separate and then fragment the ions following the IM region 
(i.e., MS-IM/MS). As a result, a particular mass of interest is dispersed based 
upon mobility prior to fragmentation and secondary mass analysis. An example 
spectrum is contained in Figure 1.9(B). Because ion fragmentation follows the 
IM separation, resulting fragment ions will have mobility drift times correlated to 
their precursor ion signal. Thus, this method allows for the initial separation of 
isobaric ions based upon their different mobilities, while simultaneously 
correlating the product ions to their precursors. Thus, both chemical noise and 
isobaric signal overlap are attenuated through this fragmentation method. The 
MS-IM/MS method can greatly simplify analyte identification based upon the 
removal of contaminating product peaks contributed by isobaric ions. 
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Figure 1.9. Three different tandem modes for MS-IM-MS instrumentation. Each 
2-dimensional spectrum corresponds to a single m/z value isolated by the first 
MS stage. (A) MS/IM-MS mode in which fragmentation precedes the IM-MS 
analysis. (B) MS-IM/MS mode in which the mobility spectrum is generated prior 
to ion fragmentation, resulting in alignment of the fragment ions to respective 
precursor ion measured mobility value. As illustrated, this tandem mode is 
particularly useful for isobaric ions which cannot be differentiated by MS alone. 
(C) MS/IM/MS mode in which an isolated m/z value is fragmented both before 
and after the ion mobility analysis, resulting in parallel fragment ion alignment 
correlating to their respective precursor ion signals. In these examples, only 
singly charged ions are considered. 
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 A third mode of operation which can be utilized in the MS-IM-MS 
configuration is to isolate a mass-to-charge in the first MS stage, induce 
dissociation and mobility separate the resulting fragments, and finally fragmented 
once again prior to the secondary mass analysis (e.g., MS/IM/MS). This mode of 
operation (illustrated in Figure 1.9(C)) results in mobility correlated secondary 
product ions in a quasi- MS3 experiment. Figure 1.10 contains tandem data for 
the IM-MS analysis of the small carbohydrate, lacto-N-fucopentaose 1 and 
illustrates two modes of tandem IM-MS. In Figure 1.10(A) the ion fragmentation 
occurs before the IM-MS analysis which results in a 2-dimensional spectrum of 
fragment ions separated in both mobility and mass space. In Figure 1.10(B), 
ions are induced to fragment both before and immediately following the IM 
analysis, resulting in a second stage of fragmentation (a pseudo MS3 
experiment). In this latter example, the secondary fragments align themselves to 
the precursor ion signals in which they originated since the ion mobility 
separation occurs prior to their formation. The novel aspect of this mode of 
tandem experimentation (MS/IM/MS) is that simultaneous ion activation can be 
achieved, generating a complete precursor and fragment ion spectrum during 
each experimental measurement cycle.   
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Figure 1.10. Ion mobility-mass spectra of the small carbohydrate, lacto-N-
fucopentaose 1, illustrating two tandem IM-MS modes. (A) Spectra from 
fragmentation prior to IM-MS analysis, which results in dispersion of fragment ion 
signal across both dimensions of data analysis. (B) Spectra resulting from two 
stages of fragmentation, one before the IM analysis and one immediately 
following the IM. In this latter case, fragment ion signal is dispersed across the 
mobility dimension and secondary fragment ion signals align isobaric in mobility, 
resulting in simultaneous fragmentation of all ions resulting from the first stage of 
activation. For the mass spectra (above in both panels), the carbohydrate 
nomenclature used is from Domon and Costello.83 Adapted with permission from 
84. 
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1.5.1 Advantages of High Mass Accuracy and High Resolution in 
Metabolite Identification 
In drug metabolism studies, the molecular formula of a metabolite of 
interest is a key piece of information. This information is most easily obtained by 
measuring the exact mass of the ion to high accuracy. High resolution MS can 
obtain a mass measurement with high precision which factors directly into the 
accuracy of the mass measurement. By obtaining an accurate mass 
measurement with high confidence, one can narrow down the number of possible 
molecular formulas pertaining to the measured mass. In many cases, sufficiently 
high mass accuracy can narrow down the possibilities to a single molecular 
formula and provide an unambiguous result. 
 When utilizing high resolution MS, an approach has been applied to 
metabolite identification that relies primarily on high mass accuracy to query the 
entire sample, post separation.85 This method is termed MSE, and functions by 
initially acquiring data over a large mass range (ca. 100-1000 Da). Subsequently, 
collision energy is imparted to the same range of ions in a ramped method from 
low to high energy. This results in data that combines both a full scan with 
corresponding fragments. Using the high mass accuracy of the instrument, 
product ions can be correlated back to their respective precursor ions based 
upon mass defect. This resolves the issue of discarding ions based upon 
selective fragmentation, as this method allows for the fragmentation of all ions 
within a time given range. High mass accuracy is maintained through the use of 
an internal standard for proper calibration. What results is the ability to perform 
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broadband fragmentation and monitor product ion transitions, as commonly done 
in scanning experiments, over an entire mass range. A fundamental limitation lies 
in the fragmentation of isobaric species which are inherently present in complex 
samples, as product ions for both isobars will be present in the fragmentation 
spectrum, resulting in convoluted data sets. This is commonly addressed by 
performing a pre-ionization separation. Fortunately, the IM separation can 
distinguish isobars in the mobility dimension. As a result, an additional degree of 
discrimination is present for compiling a list of product ions for a given precursor. 
Currently IM information is not used to deconvolute MSE data, though the only 
apparent limitation is the potential to generate extremely large data files, which is 
becoming increasingly trivial with current data storage. 
 Tandem mass spectrometry inherently has limitations. Most notably, this 
method is insensitive to low intensity precursor ions, as these are often 
overlooked by automated systems if a particular peak is transient in nature. 
Selected precursor ions must be well above the limits of detection for a given 
tandem platform in order to generate meaningful tandem spectra. Isobaric 
species which would commonly convolute tandem spectra may be separated 
using IM post ionization separations to resolve isobars. While IM-MS enhances 
tandem experiments, currently IM separations are insufficient for the routine 
resolution of structurally similar isobars, e.g. compounds that differ by a single 
chiral center. This is where high resolution structural measurements, such as 
NMR, are required. However, these methods allow for the relatively rapid 
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interrogation of complex samples, allowing distillation of robust data sets to 
significant analytes. 
We began this chapter by stating the technological challenges of 
metabolite analysis are substantial. While this is accurate, the number of 
metabolites expressed by eukaryotes is small in comparison to the number of 
proteins, which is estimated somewhere at ca. 200,000 for humans. If IM-MS and 
related technologies are to be commissioned into the global “omics” initiatives, 
then there is perhaps no greater potential for impact than in metabolite analysis. 
Future work should seek to implement the real time acquisition of metabolic 
information to better represent the dynamic nature of the metabolome. The 
temporal resolution necessary to understand transient biological responses will 
likely require the ability to acquire spectra at a rate that exceeds our current 
analytical capacity using pre-ionization separations. This conundrum lends itself 
strongly to the case for ion mobility-mass spectrometry as a means of rapid 
analysis of drug metabolism. By coupling ion mobility-mass spectrometry with 
microfluidics that allow for the trapping and maintenance of cell colonies, a global 
profile of a microenvironment can be acquired with high temporal resolution. This 
permits a more complete understanding of the underlying metabolic processes 
that preclude particular metabolites, while potentially circumventing the dilution 
issue commonly associated with bulk cultures. Though many technical issues 
exist with coupling microfluidic environments directly to ion mobility-mass 
spectrometers (e.g. ion suppression by non-informative, high abundance 
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metabolites and salts), these are surmountable, and have been addressed in a 
modular fashion. 
 
1.6 Summary and Perspectives 
Ion mobility spectrometry is the separation of gas phase ions based upon 
differential velocities through an inert buffer gas under the influence of an electric 
field, this rate being termed mobility. Four main ion mobility separations methods 
exist (drift tube ion mobility spectrometry, traveling wave ion mobility 
spectrometry, high-field asymmetric waveform ion mobility or differential mobility 
spectrometry, and differential mobility analyzer), each utilizing a different 
approach for separations of gas phase ions. These methods, though present in 
various geometries and grounded in disparate physical principles, have the 
common thread of performing a post-ionization separation based upon mobility. 
Drift tube and traveling wave ion mobility temporally separate ions along the 
same space, which has the advantage of generating a broadband spectrum for 
each measurement cycle, while limited to separating discontinuous ion pulses. 
High-field asymmetric waveform ion mobility and differential mobility analyzers 
separate ions along different spatial trajectories, allowing for a continuous beam 
of ions to be transmitted which possess a narrow band of mobilities. The latter 
techniques must be scanned across an instrument parameter (a voltage) to 
generate a broadband ion mobility spectrum. 
Each ion mobility separation method has been integrated with mass 
spectrometry for two dimensional separations based upon both mobility and 
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mass-to-charge. These two analytical methods are readily coupled (IM-MS), as 
both separations occur post ionization, and result in rapid separations occurring 
on the order of milliseconds and microseconds, respectively. This temporal 
disparity allows for hundreds of mass spectra to be obtained for each mobility 
spectrum. For high performance mass spectrometry applications, broadband 
dispersion mobility separations are commonly implemented, which allow for 
global metabolome profiles to be obtained. Because the ionic mobility is a 
function of gas phase size and size a function of mass, a 2-dimensional IM-MS 
analysis results in a clustering of data along a narrow region of mobility and mass 
separation space. Thus, the degree of orthogonality between ion mobility and 
mass spectrometry is low, however the rate at which information is generated is 
very high, with signal peak production rates ca. 2 orders of magnitude greater 
than other analytical separations. The correlation between mobility and mass 
data exhibits a dependence upon intramolecular forces, monomer subunit 
composition, and degree of branching, which allows for the preliminary 
determination of biomolecular and metabolite class based upon mobility. Ion 
mobility-mass spectrometry allows spectra acquisition temporal resolution on the 
order of milliseconds, dispersion of chemical noise in two dimensions, separation 
of isobaric species based upon structural differences, and preliminary 
determination of molecular class based upon mobility. Ion mobility-mass 
spectrometry is also readily coupled to any liquid phase pre-ionization separation 
through electrospray ionization. 
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The ability to perform fragmentation between separations in an ion 
mobility-mass spectrometer allows for identification studies (tandem 
experiments) that enhance precursor ion identification confidence. Fragmentation 
is commonly prefaced with a mass selection step using a scanning mass 
analyzer (e.g. a quadrupole MS) in order to isolate a single mass-to-charge 
window. Fragmentation can occur either before (MS/IM-MS) or after (MS-IM/MS) 
the ion mobility separation, resulting in product ions or isobaric precursor ions 
separated in mobility space, respectively. Fragmentation prior to mobility 
separation results in mobility-resolved product ions, and these product ions can 
be further fragmented after mobility separation (MS/IM/MS), resulting in 
secondary product ions that can be correlated to primary product ions based 
upon the congruent mobilities. Broadband fragmentation can also be performed 
on relatively simple samples using a large mass window (ca. 100-1000 Da), a 
ramped fragmentation energy profile, and a high performance mass 
spectrometer. In this latter example, product ions are correlated to precursor ions 
based upon mass defect. Increased confidence is obtained through the use of 
mobility correlation to this broadband fragmentation method, as isobaric ions will 
convolute data otherwise.  
Processing and prioritizing the extensive data that acquired during a 
typical high resolution mass spectrometry based metabolomics experiment is 
nontrivial. The focus of the work described herein seeks to utilize these 
multidimensional separations in conjunction with statistical workflows to prioritize 
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and identify meaningful analytes, assigning biological significance to features and 
extending the utility of ion mobility measurements.  
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CHAPTER 2B 
 
CONFORMATION BASED PRIORITIZATION OF SECONDARY MICROBIAL 
METABOLITES 
 
2.1 Introduction 
 
A significant challenge in natural product discovery is the initial 
discrimination of discrete secondary metabolites alongside functionally similar 
primary metabolic cellular components within complex biological samples. A 
property that has yet to be fully exploited for natural product identification and 
characterization is the gas phase collision cross section, or, more generally, the 
mobility-mass correlation. Peptide natural products possess many of the 
properties that distinguish natural products, as they are frequently characterized 
by a high degree of intramolecular bonding, and possess extended and compact 
conformations among other structural modifications. Herein, a rapid structural 
mass spectrometry technique based on ion mobility-mass spectrometry for the 
comparison of cyclic peptide natural products to their primary metabolic 
congeners using mobility-mass correlation is described. This property is 
empirically determined using ion mobility-mass spectrometry, applied to the 
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analysis of linear versus cyclic peptides, and used to discriminate cyclic peptides 
in a crude microbial extract. Complementary computational approaches are 
utilized to understand the structural basis for the separation of primary metabolite 
linear peptides from secondary metabolite cyclic and modified cyclic species. 
These findings provide a platform for enhancing the identification of secondary 
metabolic peptides with distinct mobility-mass ratios within complex biological 
samples. 
Further, this method was extended to commercially available traveling 
wave ion mobility instruments through the conceptualization of the “inherent 
trendline”, which represents the common mobility-mass correlation for a given 
microbial extract. For this study, an actinomycete was isolated from Lechugilla 
cave in New Mexico at a depth of 1250 feet by dilution plating of pulverized wall 
rock sample. This organism, designated Streptomyces cunninghamii, was 
screened for secondary metabolic potential by chemical screening under multiple 
growth conditions, and features were prioritized for isolation by structural mass 
spectrometry using ion mobility-mass spectrometry.  A new series of C-
glycosylangucyclines designated Lechacyclines A–C were isolated from 
Streptomyces cunninghamii and the structures of these compounds were 
determined by a series of 1D and 2D NMR experiments and mass spectrometry 
fragmentation analysis.  
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2.2 A Basis for Peptide Natural Product Discrimination 
 
The diverse activities of peptide natural products are partially a function of 
their unique structural attributes, which are defined by incorporation of 
nonproteinogenic amino acids and by extensive ‘post-translational’ modifications 
including macrocyclization, heterocyclization, and oxidation/elimination reactions. 
These modifications are responsible for the diversity of reported cyclic and 
heterocyclic scaffolds. Additionally, conformational restraints introduced through 
these modifications have been implicated in the biological activity of these 
secondary metabolites, as the entropic loss is less significant upon active site 
binding compared to non-constrained analogues.86 Some microbial peptide 
secondary metabolites with medical relevance include cyclosporin 
(immunosuppressive), bialaphos (herbicide), vancomycin and penicillin 
(antibiotic), to name a few, and their activities have inspired the continuing 
search for new peptide natural products from microbial sources. This search has 
been reinvigorated in recent years by the discovery of a large reservoir of cryptic 
peptide gene clusters, both ribosomally encoded and nonribosomally encoded, in 
microbial genomes, potentially expressing new peptide natural products.87, 88 
Correspondingly, the conditions under which these gene clusters are expressed 
as well as the identity of their products are a matter of significant interest to the 
natural product biosynthesis and discovery communities, respectively. However, 
these discovery endeavors are challenged by low secondary metabolite 
abundance and the peptide rich background of biological extracts from which 
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they must be isolated. In this report we describe a structural mass spectrometry 
technique, ion mobility-mass spectrometry (IM-MS), to rapidly distinguish cyclic 
peptides from other species present in complex mixtures. This method of 
discrimination is then applied to a crude extract for cyclic peptide prioritization. 
Additionally, a simulated annealing computational approach provides a model to 
understand the structural differences characteristic of linear and cyclic peptides 
in the gas phase. 
 Briefly, IM-MS is a two-dimensional separation technique that first 
separates ions in a dimension related to structure (charge-to-surface area ratio) 
based on their collision cross section (CCS), which represents the area of the ion 
available for collisions with neutral molecules in the gas phase, and in a second 
dimension by mass-to-charge. Many forms of ion mobility exist: high-field 
asymmetric waveform ion mobility (FAIMS), differential mobility, traveling wave 
ion mobility (TWIM) and uniform field ion mobility (IM). However, for CCS 
measurements uniform field ion mobility is the only of these methods that 
presently allows for calculation of absolute CCS using the kinetic theory of 
gases.89 For that reason, we choose to focus on this instrument as the foundation 
of this study.  
Importantly, by using IM-MS, biomolecular classes can be separated in a 
complex mixture by their structure due to their different gas phase packing 
efficiencies dictated by the prevailing intermolecular folding forces.77, 90 The 
average correlation for each biomolecular class is referred to as a mobility-mass 
correlation, or trendline , and significant deviation, i.e., > 7% in CCS for linear 
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peptides (as it has been shown that ~94% of linear peptides fall within this 
range), from this correlation are observed for modifications and conserved 
secondary structure in the gas phase.77, 90 A previous study found that the cyclic 
peptide gramicidin S (cyclo-VOLFPVOLFP) adopted a more compact structure 
than linear analogs.9, 91 To understand the full potential for IM-MS to distinguish 
cyclic from linear peptides in complex samples, we have evaluated the general 
utility of structural separations for a suite of microbially produced cyclic peptide 
natural products in comparison to linear peptide congeners. Moreover, we have 
applied this method to the detection of the known macrocyclic peptide siamycin 
II, expressed in an extract from a recently isolated cave actinomycete, 
demonstrating the potential of IM-MS for distinguishing modified peptides in 
crude extracts.  
 
2.3 Materials and Methods 
 
2.3.1 MALDI sample preparation and analysis 
The cyclic peptides, thiostrepton, vancomycin, ampicillin, valinomycin, 
phleomycin, cyclosporine A, polymyxin B, actinomycin D, and bacitracin, were 
obtained from Sigma and used without further purification. Crude extract was 
reconstituted in 50:50 MeOH:H2O at a concentration of ~5mg/mL. To determine 
collision cross sections, MALDI ionization was performed by mixing analytes in a 
200:1 molar ratio of saturated 2,5-dihydroxybenzoic acid in 20% methanol or 25 
mg/mL α-cyano-4-hydroxycinnamic acid in 50% methanol with analyte. Samples 
were spotted onto a stainless steel plate, and allowed to dry before IM-MS 
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analysis. The MALDI-IM-TOFMS is equipped with a 13.9 cm ion mobility drift cell 
that is maintained at a pressure of ca. 3 Torr helium and an orthogonal reflectron 
TOFMS with a 1 m flight path maintained at 5 x 10-8 Torr. Further instrumental 
details have been published previously.92  
 
2.3.2 Collision cross section calculations 
The ion-neutral collision cross section (CCS, Ω) was calculated by 
determining the drift time (td) of the ions across the cell under low-field conditions. 
Drift time values were obtained at multiple field strengths of between 69 and 91 
Townsend (Td), to ensure that measurements were performed under the low-
field limit. Collision cross sections were calculated by the following: 
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where L is the length of the drift cell, E is the electrostatic-field strength (~90-120 
V cm-1), z is the charge state of the ion, e is elementary charge, mi and mn are 
the masses of the ion and the neutral drift gas, respectively, N0 is the gas 
number density at standard temperature and pressure, kB is the Boltzmann 
constant, and p and T are the pressure (~3 Torr) and temperature (~293 K), 
respectively.89  
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2.3.3 Computational modeling charge derivation protocol  
All molecules were first built in ChemBioDraw Ultra. Molecules were 
broken into fragments for charge derivation of feasible size for quantum based 
energy minimization and charge calculations (i.e. ~120 atoms or less). An initial 
energy minimization was performed using a B3LYP/HF 6-31G* level of quantum 
theory in Gaussian03.93 After determining the calculation had converged upon a 
local minimum, the frequency values were interrogated to ensure the calculation 
had not rested upon a saddle point. These energy minimized structures were 
then subjected to further ab initio optimization and electrostatic potential 
calculations using Gaussian03, mimicking the protocol derived for the general 
Amber force field, applying a HF/6-31G* basis set and the Merz-Singh-Kollman 
scheme for charge parameterization. 
 
2.3.4 Computational modeling molecular dynamics protocol  
All molecular dynamics simulations were generated using the Amber 11 
Molecular Dynamics Package.94 Charge densities were converted to restrained 
electrostatic potential (RESP) values and prep files using antechamber.  
Intact molecules were assembled and coordinated with sodium in LeAP 
using prep files. GAFF 95(general AMBER force field) was used for atom type 
descriptions. To define the sodium cation, AMBER99SB force field was used.96, 97 
Topology and coordinate files were generated for molecular dynamic simulations 
in sander. Initially, restraint files were generated for the sodium cation such that 
full exploration of the assembled molecule was possible, but if the cation began 
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to leave the molecule, a force would be applied to return the sodium within 
reasonable distance constraints of sodium-peptide interaction. Upon inspection 
of trajectory files, this restraint was not necessary, as the cation remained 
proximal to the molecule, yet was still able to fully explore all regions of the 
molecule. Prior to simulation, an energy minimization was performed using 
sander to ensure a stable starting structure. The simulated annealing protocol 
was carried out in three steps. First, the structure was heated to ~1200-1500K 
over 10 picoseconds using 0.25 femtosecond time steps. The structure was then 
held at this temperature for 9 nanoseconds using 0.25 femtosecond time steps, 
extracting a conformation every 3 picoseconds, resulting in 3000 conformational 
snapshots. These snapshots were cooled to ~320K over 15 picoseconds to allow 
the conformation to find a local minima. To generate the desired 24,000 
conformations, this protocol was performed 8 times, using unique starting 
conformations for each to promote enhanced sampling of conformational space. 
Each conformation was then converted to a collision cross section using 
MOBCAL.26, 98 The collision cross section and potential energy for each 
conformation was then extracted and visualized using a scatter plot. Data were 
then discriminated using the measured collision cross sections, with the sampling 
window ± 2 sigma of the IM CCS measurement. 
 
2.3.5 Computational modeling clustering protocol  
The extracted conformations were then aligned using super-positioning 
software, suppose, written by Jarrod Smith (Vanderbilt Center for Structural 
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Biology). These structures were then clustered based upon their root mean 
square distance (RMSD) over all atoms. A cutoff was then determined based 
upon the RMSD which resulted in approximately 19-21 conformations. This value 
was then imposed, and the most representative conformation from each branch 
of the cluster was extracted. This in effect distilled the data from ~400-2000 
conformations to 20 which could be interrogated (see Supplementary Material). 
PDB files for each were generated and interrogated using Molecular Operating 
Environment (MOE).99 
 
2.3.6 Fermentation and extraction conditions 
  BBBLUE19 was cultivated in a 1-L Erlenmeyer flask containing 500 mL 
of medium EA ( 5% lactose, 0.5% corn steep solids, 0.5% glucose, 1.5% 
glycerol, 1% soybean flour, 0.5% bacto-peptone, 0.3% CaCO3, 0.2% (NH4)2 SO4, 
0.01% FeSO4 · 7H2O, 0.01% ZnCl2, 0.01% MnCl2, 0.05% MgSO4 · 7H2O ) for 7 
days at 30 °C on rotary shaker 170 rpm. The 25 g of Diaion HP-20 resin was 
added to the 500 mL culture and resin/culture mixture was agitated on a rotary 
shaker at 170 rpm for 1 hour. The mixture was separated by centrifugation and 
resin/cells layer was extracted separately with 300 mL of methanol and 300 mL 
of acetone. Combined organic fractions were evaporated to dryness to produce 
crude extracts. The closest relative by 16S RNA sequencing was Streptomyces 
mirabilis NBRC 13450 (99.9 % identity). 
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2.4 Results and Discussion 
 
2.4.1 Measurements of Collision Cross Sections of Peptide Secondary 
Metabolites 
Collision cross sections for a series of cyclic peptides including 
thiostrepton, vancomycin, ampicillin, valinomycin, phleomycin, cyclosporin A, 
polymyxin B, actinomycin D, bacitracin, and siamycin, are determined and 
compared to the values for a large suite of collision cross sections for linear 
peptides. Cyclic peptide CCS measurements are reported in Table 2.1. The 
cyclic peptides are prepared and analyzed using a MALDI-IM-MS instrument 
which is described previously,92 and further information about the sample 
preparation and collision cross section calculations can be found in the 
experimental section above and in Appendix 1. The collision cross sections for all 
of the quasimolecular ions present (i.e., [M+H]+, [M+Na]+, [M+K]+, and [M+Cu]+) 
in the IM-MS plot are compared to the mobility-mass correlation for the relevant 
280 of 607 reported linear peptides which occur within the m/z range reported 
(see Table 2.1, Figure 2.1).90 A power-fit line of regression is used to best 
describe the linear peptide data over this region (y=2.8269x0.6475 R2=0.8926). 
Notably, 76% of cyclic peptide signals fall below the peptide trendline consistent 
with cyclic peptide compact structure.  
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Table 2. 1. Cyclic peptides analysed in the present studies. Quasi-
molecular ion types are shown with their associated CCS values. Ion 
deviation from expected linear peptide conformation is depicted in Figure  
2.1. Number of measurements for each CCS is shown in parentheses. 
 
Cyclic Peptide  Ion Adduct m/z (Da) Ω (Å2)  
ampicillin [M+Na]+ 372.1 110.1±1.3(20) 
valinomycin [M+H]+ 1111.6 271.9±1.4(19) 
valinomycin [M+Na]+ 1133.6 269.7±0.8(19) 
valinomycin [M+K]+ 1149.6 274.5±0.6(19) 
cyclosporine [M+H]+ 1202.8 296.6±1.2(19) 
polymyxin [M+H]+ 1203.8 285.6±1.0(19) 
cyclosporine [M+Na]+ 1224.8 289.9±1.2(19) 
polymyxin [M+Na]+ 1225.7 279.4±0.9(19) 
polymyxin [M+K]+ 1241.7 284.4±4.9(19) 
actinomycin  [M+H]+ 1255.6 280.1±1.9(18) 
actinomycin  [M+Na]+ 1277.6 284.2±0.7(19) 
actinomycin  [M+K]+ 1293.6 280.8±4.1(17) 
bacitracin [M+H]+ 1422.8 301.2±0.8(19) 
phleomycin  [M+H]+ 1427.7 275.7±1.3(13) 
bacitracin  [M+Na]+ 1444.7 305.3±1.0(19) 
phleomycin  [M+Na]+ 1448.4 276.7±1.2(19) 
vancomycin [M+H]+ 1448.4 299.4±0.9(20) 
bacitracin [M+K]+ 1460.7 303.6±2.3(10) 
vancomycin  [M+Na]+ 1470.4 296.0±3.7(20) 
vancomycin  [M+K]+ 1486.4 299.4±3.8(15) 
phleomycin  [M+Cu]+ 1489.5 276.8±2.7(19) 
thiostrepton  [M+H]+ 1664.5 310.0±1.6(20) 
thiostrepton [M+Na]+ 1686.5 315.5±1.0(20) 
thiostrepton [M+K]+ 1702.5 314.8±3.0(10) 
siamycin I  [M+Na]+ 2185.8 373.2±0.8(15) 
siamycin I  [M+K]+ 2201.8 375.2±1.7(14) 
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Figure 2.1. Conformational space plot depicting the relative increased gas-phase 
density of cyclic peptides when compared to linear peptides. IM-MS plot 
comparison of the collision cross sections of cyclic peptides compared to a 
trendline best representative of linear peptides for the mass range of 1100-2300 
Da (y=2.8269x0.6475 R2=0.8926). The collision cross section values and 
associated error of measurements can be found in Table 2.1. Symbols are as 
follows: ●-[M+H]+; ■-[M+Na]+; ▲-[M+K]+; and ♦-[M+Cu]+. 
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2.4.2 Computational Modeling of Peptide Natural Products in the Gas 
Phase 
To interpret the theoretical basis of these results, a molecular dynamics 
model was developed. For conformational analysis, a protocol analogous to 
simulated annealing was used in which snapshots of conformations were taken 
periodically during the heating procedure and these conformations were 
subsequently cooled to allow for energy minimization, generating 24,000 unique 
low-energy conformations. This method was performed for representative cyclic 
peptides based upon their chemical and structural diversity, as illustrated in 
Figure 2.2.100 Further details regarding the modeling protocol can be found in the 
experimental section and in APPENDIX 2. Valinomycin is a macrocyclic 
depsipeptide comprised of a mixture of D- and L-Val. Vancomycin is a highly 
cross-linked tricyclic peptide compacted and rigidified by aromatic C-C and C-O 
(ether) cross links. Cyclosporin A is a nonribosomally synthesized macrocyclic 
molecule containing D-Ala along with a butenyl-N-methyl-L-threonine residue. 
Finally, polymyxin B is a lariat macrolactam with a hydrophobic tail and 
hydrophilic macrocyclic core. Shown in Figure 2.2 are the most representative 
conformations describing the data discriminated using experimentally derived 
CCS values, which were extracted from the aforementioned 24,000 unique 
structures generated for each modeled structure. For structural analyses, larger 
sets (ca. 18-22 representative conformations) were generated using clustering 
analyses and interrogated to determine prevalent structural motifs (see 
APPENDIX 2). 
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Figure 2.2. Representative structures for cyclic peptides. From left to right: 
sodiated cyclosporin A (24000 , 807), valinomycin (24000, 302), polymyxin B 
(24000, 891), and vancomycin (24000, 2010) conformations which are most 
representative (top row) of the extracted conformers discriminated based upon 
experimentally derived CCS values. The number of unique structures initially 
calculated and the number that correspond with the IM-MS empirical collision 
cross section are shown in parenthesis, respectively. The percent deviation of 
each calculated CCS value from predicted CCS values for isobaric linear 
peptides are 2.69%±0.43%, 0.43%±0.30%, -1.08%±0.32%, -6.88%±1.16%, 
respectively. Sodium coordination distances are labeled. Carbon atoms are 
shown in grey, hydrogen white, nitrogen blue, oxygen red, chlorine green, and 
sodium yellow. Shown below are the associated chemical structures.  
 
 
 
These molecular dynamics calculations provide a model for rationalizing 
conformational differences for cyclic versus linear peptides. The primary features 
that influence gas phase conformational density are: (1) the loss of degrees of 
freedom due to macrocyclization, (2) the presence of highly coordinated metal 
atoms, and (3) the presence of atoms with intrinsically higher density, such as 
halides.101 While it is expected that torsional freedom is significantly reduced for 
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cyclic peptides compared to linear peptides, this effect was visualized in these 
models. Notably, the degree of cyclization and the number of residues per ring 
has a large influence on trendline deviation. For example, valinomycin (a 12 
residue macrocycle) and cyclosporin (an 11 residue macrocycle), each adopt 
CCS values greater than that predicted by the linear peptide trendline, while 
polymyxin B (a lariat compound with 7 residues present in the macrocycle) falls 
below the trendline. However, vancomycin (a tricyclic peptide with 3 - 4 amino 
acids per ring) falls significantly below the linear peptide trendline. Modeling 
indicates extensive coordination of sodium within the ring of cyclosporin and 
valinomycin, likely resulting in the less dense conformations, as this extends the 
ring. This is supported by the increased collision cross section of valinomycin 
when coordinated to potassium, which likely results in an extended ring 
conformation, as reported in the literature (as valinomycin is a potassium specific 
ionophore). Sodium coordination distances and proximities in cyclic peptides are 
consistent with those from quantum mechanical calculations previously reported 
for gas phase linear peptides.102, 103 The observed high degree of coordination to 
sodium appears to be facilitated by the more constrained orientation of 
carbonyls, esters, ethers, amines, and other functional groups (e.g., chlorine), but 
should not be considered an exclusive product of cyclization. It should be noted 
that post-translational modifications and the addition of atoms such as chlorine 
increase the density of the compounds, resulting in further deviation from the 
linear peptide trendline. Therefore, although cyclization provides increased 
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density, glycosylation and halide inclusion can further enhance the deviation from 
linear peptides in ion mobility based separations.  
In individual cases, these models aid in rationalizing deviations. For 
example, the relatively low collision cross section deviation of polymyxin B is 
attributed to coordinating sodium by both the ring and tail portions of the lariat 
peptide. The small number of residues present in the ring allows for increased 
density due to this constraint, as well. The extended butenyl-methyl-L-threonine 
group of cyclosporin A likely expands its conformation relative to other peptides, 
while the large number of residues present in the ring structure preclude adopting 
a dense gas phase conformation. Vancomycin is an example of a molecule 
possessing both deoxysugars and halides present in addition to three small 
macrocyclic structures, factors that apparently contribute to the higher gas-phase 
packing efficiency.  
 
2.4.3 Discriminating Cyclic from Linear Peptides 
Intuitively, the apparent decreased mobility-mass correlation of structurally 
constrained peptides relative to linear peptides can potentially aid in 
discriminating peptide natural products from linear peptide ions. As previously 
noted, a line of regression best describing the mobility-mass correlation for a 
large number of linear peptides was generated. This creates a baseline of 
comparison, in which we explored the utility of analyzing percent deviation from 
this line of regression as a discriminator for cyclic peptides, termed the threshold. 
Figure 2.3 displays the percentage of cyclic peptides (white fill) versus linear 
peptides (black fill) that fall beyond the applied threshold (i.e., have a CCS value 
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smaller than the applied threshold). Using this threshold analysis, the enrichment 
of cyclic peptides is evident. For instance, 80% of peptide natural products 
possess CSS-mass ratios beneath a -3% deviation, whereas only 20% of linear 
peptides are observed. Using a more stringent analysis, beneath a 6.0% 
deviation threshold, 95% of linear peptides are excluded from analysis, while 
40% of the cyclic peptides in the dataset remain. Beyond an -8% deviation 
threshold, ~99% of linear peptides are removed from analysis, at the expense of 
excluding ~2/3 of cyclic peptides. Therefore, while not an absolute discriminator 
of cyclic from linear peptides; we propose that the deviation of observed mobility-
mass measurements from the linear trendline is a useful metric for enhancing the 
identification of peptide natural products in extracts containing competitive 
background levels of linear peptide signals. 
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Figure 2.3. Percentage of analyzed linear (black fill) and cyclic (white fill) 
peptides that deviate from the linear peptide mobility-mass correlation greater 
than an applied threshold. As a function of percent deviation from the linear 
peptide trendline, the percentages of analyzed species that occupy a more dense 
CCS value are indicated. Notably, with a threshold of -6.0%, 95% of linear 
peptides are excluded from analysis, while 40% of cyclic peptides have more 
dense CCS values. 
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2.4.4 Cyclic Peptide Discrimination in a Crude Extract 
To demonstrate the potential of IM-MS to discriminate peptide natural 
products within a crude microbial extract, we analyzed an extract derived from 
actinomycete “BBBLUE19”, an organism recently isolated from a hypogean 
ecosystem (Blue Springs Cave, Sparta, TN). This organism was fermented and 
extracted under conditions typical for natural product discovery and a total 
hydrophobic extract of BBBLUE19 was analyzed using the aforementioned 
MALDI-IM-MS methodology. Correspondingly, the linear peptide mobility-mass 
correlation was superimposed on the IM-MS snapshot of the crude extract 
(Figure 2.4(A)). A threshold of -6.0% was applied to enrich for potential peptide 
natural products, and peaks were prioritized upon this basis. A series of high 
abundance peaks with significant trendline deviation were thus selected for 
further identification, one of which (accurate mass = 2175.88Da, CCS value 
360.8±4.5Å2) possessed > 11% deviation (predicted linear peptide CCS at this 
mass = 409.7Å2, Figure 2.4(B)), which corresponds to a <1% probability of being 
a linear peptide. The observed mass was most consistent with Siamycin II (within 
5 ppm mass error), previously isolated from Streptomyces sp. AA3891.104-106 
Subsequently, the isolated compound was dereplicatively identified and validated 
as siamycin II by comparison to the reported 1H NMR spectrum. As a result, the 
tricyclic peptide natural product siamycin II was successfully prioritized from a 
crude extract using the unique CCS value adopted in gas phase. 
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Figure 2.4. Shown are the analyses of crude BBBLUE19 streptomycete extract 
using IM-MS methodologies for the determination of cyclic peptide compound 
presence. (A) 2-dimensional MALDI-IM-MS spectrum of crude extract using drift 
tube mobility separations. The red-boxed in region is expanded in (B). In (B), the 
red-circled region annotates a peak that, upon initial inspection, has dense gas 
phase packing efficiency. Collision cross section measurements were performed, 
resulting in a CCS value of 360.8 ± 4.5 Å2, a deviation of 11.9% below the linear 
peptide trendline for this m/z (predicted CCS value of 409.7Å2). The sample was 
then analyzed using ESI-IM-high resolution MS (not shown). This compound was 
identified to be siamycin II, a cyclic peptide, using high mass accuracy 
measurements obtained from an IM-high resolution MS. The structure is shown 
as an inset in (B). 
 
 
2.5 Uniform Field Perspectives 
 
Uniform field IM-MS instruments as described herein remain an 
uncommon instrument in drug discovery laboratories. Commercially available IM-
MS instruments typically use an alternative mobility separation paradigm termed 
a traveling wave, which is distinct from uniform field instruments and not 
amenable to absolute CSS determination using the kinetic theory of gases.89 As 
72 
such, the utility of using the mobility-mass correlation as a means for 
discrimination of natural products using the commercially available traveling 
wave IM-MS were explored. The primary difficulty in comparing the two 
separations is the inability to extract CCS values from first principles using 
travelling wave IM separations, as the electric field gradient experienced by ions 
is time dependent, although CCS calibrants can be used to obtain relative CCS 
measurements.14, 107 To address this, and extend the utility of ion mobility 
measurements beyond uniform field instruments, we have devised a method of 
assigning a “structural uniqueness” attribute to compounds through ion mobility 
measurements on a commercially available traveling wave instrument. This 
method utilizes the background signals present in crude extracts as a 
comparison. 
 
2.6 Extension of Mobility Based Discrimination to Traveling Wave Ion 
Mobility 
 
2.6.1 Overview of Biological Source
The organism interrogated for this study was again of hypogean origin. 
Caves possess properties favorable for microbial growth including extensive 
oxygen and water saturated aerobic surface areas supporting biofilm formation, 
in addition to a relatively constant temperature and humidity. However, the 
nutrient deprived nature of caves, with a common total organic content of less 
than 0.5mg per liter, results in the adaptation of cave microorganisms to these 
hypercompetitive environments.108 Previously surveys of cave microbiotica have 
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revealed the presence of genera known to produce secondary metabolites 
including actinomycetes and myxobacteria.109 Herein we describe the isolation of 
a cave actinomycete from a remote and deep cave system and the isolation and 
structural elucidation of a secondary metabolite from this strain using mobility 
guided prioritization. To facilitate identification of secondary metabolites within 
crude extracts we describe a new method using structural mass spectrometry to 
identify conformationally divergent mass features in order to prioritize compound 
discovery. 
The strain LC30 was isolated from one of the most remote locations within 
Lechuguilla Cave, approximately 400m underground.  The Lechuguilla cave is a 
deep and isolated cave found within Carlsbad Caverns National Park (USA). The 
cave was formed by hypogenic (ascending) sulfuric acid-rich water throughout 
the last 7 million years.110-112 Due to the lack of surface inorganic flux and 
absence of sunlight, microbial community subsistence in this cave system is 
likely driven by chemolithotrophic activity.116, 117 Visitation records available from 
Carlsbad Caverns National Park demonstrated that the sample site had only 
been visited once before, while the absence of scuff marks and boot prints 
indicated that no humans had accessed the actual sample site. The site itself 
was a wall without obvious signs of organic input, such as dripping water or 
condensation. It was also away from main airflow routes, limiting the likelihood 
that airflow had transported microorganisms from the surface to this location. 
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2.6.2 Interrogation of Hypogean Streptomycete Secondary Metabolites 
Cultivation from the site sample on HC media revealed the presence of 
over 100 colonies, a number of which had the characteristic powdery appearance 
of Actinomycetes. Purification of these colonies revealed the presence of a 
number of Streptomycetes, including strain LC30, which demonstrated 100% 
identity with Streptomyces anulatus by comparative BLAST alignment. Strain 
LC30 was subsequently selected for secondary metabolome analysis, cultured in 
various fermentation media, and analyzed by liquid chromatography-mass spectrometry 
(LC-MS) and ion mobility-mass spectrometry (IM-MS). 
In this chapter, we have demonstrated the ability to prioritize secondary 
metabolites in crude extracts using deviations from predicted mobility values.119 
Significantly, this study focused on analyte deviation from predicted peptide ion 
mobilities obtained on a drift tube style instrument.120 However, to provide 
applicability of these methods across mobility platforms, ion mobility analysis was 
performed on a commercially available travelling wave instrument (SYNAPT G2 
HDMS, Waters, Milford, MA). To determine unique mobility values, and thus 
prioritize metabolites accordingly, we devised the concept of the ‘inherent 
trendline’. Essentially, this concept relies on the correlated nature of mass and 
size, and uses an empirically derived line of regression to determine what an 
expected mobility is for a given mass, as only singly charged species are 
considered.9 In this regard, all extracted species are used to establish a common 
mobility value trend. Natural products commonly possess cyclization, rigid 
scaffolds, halogens, sugar moieties, or chelated metals, for example, all of which 
will produce a deviation from the predicted mobility.90, 91, 121-124 
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2.6.3 Inherent Trendline Analysis 
Crude LC30 extracts were analyzed using IM-MS and revealed the 
presence of abundant features with high deviation from inherent trendline 
(Figure 2.5).To establish perspective, a deviation of greater than 17.3% was 
observed in 8.8% (141 of 1601) detected features with m/z  values greater than 
400Da. When the additional criterion of intensity is applied, Lechacycline C is 
prioritized in the top 5 compounds of 1601. When the structural deviation criterion 
is relaxed to 10.3%, 36% of detected features are prioritized, and when further 
relaxed to 5.5%, nearly two-thirds of all features possess this deviation. However, 
as abundance is critical to isolation, when intensity is factored as a secondary 
filtering variable, Lechacycline A-C are all found in the top 20 prioritized 
compounds, even at 5.5% deviation, with Lechacycline A and C found in the top 
5 (top 0.31%). When based upon intensity alone, this falls to the top 30 
compounds.  
We consider the Lechacycline family an exemplary example of the added 
benefit provided by ion mobility. The rigid angucycline scaffold provides a basis 
for separation, as the planar structure results in inherently extended gas phase 
packing efficiency, as demonstrated by the large positive deviation of 
Lechacycline C. The addition of the A2 group likely provides a mechanism for 
Lechacycline B to self-solvate in the gas phase, resulting in increased packing 
efficiency. The addition of the mycothiol moiety found in Lechacycline A 
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represents a bulky substituent that is demonstrated by the positive deviation from 
the inherent trendline.  
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Figure 2.5. (A) Ion mobility-mass spectrum of crude LC30 extract. Singly 
charged species analyzed are indicated by inset black region. Lechacyclines A-C 
are annotated and percent deviation from the inherent trendline, indicated by 
yellow line, is reported. (B-D) depict drift time chromatograms for Lechacyclines 
A-C, respectively, with the inherent trendline and 6% deviation labeled for 
comparative purposes. 
 
 
78 
 
 
Figure 2.6. Structures of Lechacyclines A-C. 
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2.6.4 Isolation and Identification of Lechacyclines 
 Medium BA was selected for production scale up based on the highest 
abundance of compounds of interest. Solid phase extraction of broth and 
mycelium with Diaion HP-20 resin followed by extraction of mycelium and resin 
with methanol and acetone captured the targeted compounds. Prefractionation 
on LH20 size exclusion column followed by purification with reversed phase 
HPLC yielded three pure compounds of interest (Figure 2.6). Compound 1 was 
isolated with a high resolution mass spectrum yielding an m/z of 1200.46. [M+H]+ 
and combined with UV and NMR data indicated a chemical formula of 
C54H77N3O25S, that does not correlate with known entries in natural product 
databases (Dictionary of Natural Products, PubChem).  
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Figure 2.7. (A) Major substructures of Lechacycline A (1) assembled from 
COSY, HSQC and HMBC spectral data. (B) Substructures were linked via HMBC 
correlations. 
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Briefly, four partial structures (I-IV) (Figure 2.7(A)) were proposed based 
on COSY, HSQC and HMBC spectral data (Table A2.3-5) with ring assembly of 
tetracyclic aglycone core (I) closely resembling Aquayamycin-Type angucycline 
natural products.125 HMBC correlations from H1’ proton to C9 quaternary carbon 
determined the connectivity of disaccharide fragment II and aglycone I (Figure 
2.7(B)). The chemical shifts of carbons C1’ and C9 were characteristic to C-
glycosidic linkage. We were able to assign relative stereochemistry of II based on 
coupling constants present in 1H NMR experiment. HMBC from H1’’’ anomeric 
proton to C5 carbon established the relationship between fragments III and I 
(Figure 2.7(B)). Again we were able to assign relative stereochemistry of III, that 
turned out to be an unusual amino sugar, based on coupling constants present in 
1H NMR. Finally, we were able to link partial structures IV and I based on HMBC 
correlation from H13 methylene protons to C6a quaternary carbon. The chemical 
shift of carbon C6a  indicates sulfur substituent in this position.This compound, 
that we named Lechacycline A (1) was isolated along with two analogs, 
Lechacyclines B (2) and C (3) that differ in substitution in position C6a (Figure 
2.6). 
A particularly interesting substituent in this position was fragment IV of 
Lechacycline A (1) called mycothiol, that has been previously reported in the 
literature.126-128 We were able to assign relative stereochemistry of this moiety 
based on coupling constants of 1H NMR but its absolute stereochemistry was 
established by Bewley and coworkers as 1-D-myo-inosityl2-deoxy-2(N-
acetamido-L-cysteinamido)-α-D-glucopyranoside and was in agreement with our 
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assignment.129 It has been reported that mycothiol in bacterial cells of 
actinomycetes is involved in detoxification pathway where it forms S-conjugate 
with alkylating agent, which is then cleaved to release mercapturic acid that is 
excreted outside the cell.130 We can speculate that compounds 1 and 2, that we 
captured are as well the products of detoxification pathway performed by our 
bacteria.  
 
2.7 Conclusions and Perspectives 
 
Herein we describe the application of ion mobility as an additional attribute 
for secondary metabolite prioritization. Through a suite of standards, a motif was 
established to prioritize cyclized and decorated natural products peptidic in 
nature. Additionally, this method was extended beyond a uniform field ion 
mobility instrument to the commercially available traveling wave ion mobility 
instrument. This extension considers structural uniqueness as a means of 
prioritization, as compared to the extract background. These methods resulted in 
the prioritization and isolation of the tricyclic peptide Siamycin II and a new class 
of molecules, termed Lechacyclines. The addition of ion mobility exhibits little to 
no negative consequences in extract interrogation, as the minor decrease in 
sensitivity is negligible, as analytes in abundance near the limits of detection are 
not optimal for natural product discovery. This provides an attribute orthogonal to 
conventional lead compound prioritization criteria.  
In addition to prioritizing lead compounds, ion mobility allows 
comprehensive analysis of microbial extracts in one pass through the expansion 
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of peak capacity. Coupling this technique to liquid chromatography allows the 
acquisition of fragmentation spectra in a non-discriminant manner, as shown in 
the following chapter. 
 
2.8 Supporting Information 
 
Structures, clustering trees and representative structures from 
computational studies are available in APPENDIX 2. Additionally, all procedures 
for both studies and NMR assignments can be found in APPENDIX 2. 
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CHAPTER 3C 
 
MULTIVARIATE STATISTICAL ANALYSIS METHODS FOR MICROBIAL 
EXTRACT INTERROGATION 
 
3.1 Introduction 
 
Bacteria develop resistance to many classes of antibiotics vertically, by 
engendering mutations in genes encoding transcriptional and translational 
apparatus. These severe adaptations affect global transcription, translation, and 
the correspondingly effected metabolism. Here we characterize metabolome 
scale changes in transcriptional and translational mutants in a genomically 
characterized Nocardiopsis in stationary phase. Analysis of UPLC-IM-MS 
metabolomic features from a cohort of streptomycin and rifampicin resistant 
mutants grown in the absence of antibiotics exhibit clear metabolomic speciation 
and loadings analysis catalog a marked change in metabolic phenotype. 
Consistent with derepression, up to 311 new features are observed in antibiotic 
resistant mutants that are not present in their progenitors. Mutants demonstrate 
changes in primary metabolism, such as modulation of fatty acid composition, 
and the increased production of the osmoprotectant ectoine, in addition to the 
presence of abundant emergent potential secondary metabolites. Isolation of 
three of these metabolites followed by structure elucidation demonstrates them to 
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be an unusual polyketide family with a previously uncharacterized xanthene 
framework resulting from sequential oxidative carbon skeletal rearrangements. 
Designated as ‘mutaxanthenes’, this family can be correlated to a type-II 
polyketide gene cluster in the producing organism. Taken together, these data 
suggest that biosynthetic pathway derepression is a general consequence of 
some antibiotic resistance mutations.  
Increasing evidence is accumulating that a large fraction of antibiotic 
resistance may be elicited via horizontal transfer of resistance elements from the 
reservoir of microbial diversity found in soil. 131, 132 Additionally, bacterial 
resistance towards a significant subset of antibiotics is rapidly generated 
vertically by mutations in central housekeeping genes encoding polymerases and 
ribosomal subunits. For example, bacterial resistance to rifampicin is afforded by 
mutations in the RNA polymerase β-subunit, encoded by rpoB, while resistance 
to streptomycin results from mutations in the ribosomal 30S subunit and/or 
ribosomal methyltransferases. 133-135 Notably in these adaptive strategies, a small 
number of mutations ultimately result in complex and significant global changes 
in gene expression and protein synthesis. For instance, rpoB mutations foster the 
up-regulation of proteins involved in central metabolism (including nucleoside 
and nucleotide, amino acid, carbohydrate, lipid and phospholipid biosynthesis), 
detoxification, signal transduction, protein synthesis, and cell envelope 
processes, to name a few, while cell division proteins are generally down-
regulated. 136, 137 Streptomycin resistance, via rpsL mutation (encoding for 
ribosomal protein S12, a subunit of the 30S ribosome), leads to increased 
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translational accuracy, slower overall translation and has demonstrated late 
growth phase protein synthesis increases in comparison to the wild type.138 It 
follows causally that these changes are predicted to result in wholesale 
alterations in metabolism. Indeed, recent studies describe an apparent 
connection between vertically acquired antibiotic resistance and secondary 
metabolic fecundity in antibiotic producing soil organisms such as the 
actinomycetes. The acquisition of resistance to antibiotics in these strains results 
in enhanced levels of antibiotic production for both known 138-140 and previously 
unknown 141, 142 compounds. These data suggest that vertically selected 
antibiotic resistance may be a general strategy for eliciting secondary 
metabolism, but the scope of metabolic changes resulting from these mutations 
remains to be systematically described. 
Herein we describe an assessment of the consequences of antibiotic 
resistance mutations on a comprehensive metabolome scale. Comparative 
analysis of metabolomic data is greatly facilitated by employing multivariate 
statistical analysis methods (e.g. principal component analysis, orthogonal 
projection to latent structures-discriminant analysis), which convert 
multidimensional microbial extract UPLC-MS data into lower-dimensional plots of 
maximally distinguishing eigenvectors.143 Critical loadings evaluation 144 
efficiently validates the observed changes and identifies subsets of metabolites 
that are unique or shared within the data sets of a given antibiotic-resistant 
mutant and its progenitor strain. With these tools, we endeavor to describe and 
discriminate how antibiotic induced mutations affect global metabolite pools and 
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how PCA-based comparative analysis can identify secondary metabolite 
derepression in an unbiased fashion. Using a genomically characterized soil 
actinomycete of the Nocardiopsis genus as an example, we demonstrate the 
degree of metabolomic speciation afforded by antibiotic resistance mutations in 
the RNA polymerase β-subunit and the ribosome. Additionally, this analysis 
facilitates the rapid identification of upregulated secondary metabolites. Isolations 
of several upregulated features, followed by structure elucidation by 2D-NMR 
and isotopic incorporation experiments, reveal a new polyketide carbon 
framework that may be correlated to a formerly unexpressed type-II polyketide 
gene cluster present in the producing strain. Methods described herein will 
enable future studies to determine if this derepression is an adaptive or 
coincidental trait, in the context of the evolutionary benefits of antibiotic 
resistance. 
 
3.2 Materials and Methods 
 
3.2.1 General Experimental 
All reagents were purchased from Sigma/Aldrich Inc. Strains and primers 
used are listed in APPENDIX 2. NMR analyses were performed using a Bruker 
600 MHz instrument equipped with 5mm Z-gradient TCI Cryo-probe. All strains 
were maintained on GYM agar (0.4% glucose, 0.4% yeast extract, 1% malt 
extract, 0.1% peptone NZ amine, 0.2% NaCl, 2% agar) containing 50 ug/ml 
apramycin. Seed cultures were generated by transferring a loop full of inoculum 
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into GYM broth and incubating for 7 days at 30°C. Fermentation cultures of 
strains were performed for 7 days at 30°C in R4 medium (1% glucose, 0.1% 
yeast extract, 0.01% casamino acids, 0.3% proline, 1% MgCl2·6H2O, 0.4% 
CaCl2·2H20, 0.02% K2SO4, 0.56 TES, 0.2% (v/v) trace elements. 
 
3.2.2 Preparation of Antibiotic Resistant Mutants 
Spore suspensions of Nocardiopsis sp. FU40 ΔApoS8 were inoculated 
onto GYM agar plates containing 50 ug/ml apramycin,400 ug/ml streptomycin 
and 50 ug/ml apramycin, 100 ug/ml rifampicin.. Agar plates were incubated for 10 
– 14 days at 30 °C to select for antibiotic resistant colonies. Individual 
streptomycin and rifampicin resistant colonies were selected and inoculated onto 
GYM agar containing the appropriate antibiotic for validation of resistance 
phenotype and to prepare of glycerol stock solution for cryopreservation. 
 
3.2.3 General Extraction Procedure and Analysis  
Polystyrene solid phase extraction resin (HP-20, Diaion Inc) was added to 
500 mL seven day fermentation cultures. Cells and resin were separated from 
the broth by centrifugation and extracted sequentially 250 mL with methanol and 
acetone. Combined extracts were dried in vacuo and analyzed by HPLC-IM-MS 
using a SYNAPT G2 HDMS (Waters, Milford, MA) as described in Appendix II.  
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3.2.4 Mass Spectrometry based Feature Identification 
Features prioritized using the methods described herein were subjected to 
putative identification using both accurate mass (<10ppm) and fragmentation 
spectra (accurate mass < 20ppm). Liquid chromatography and ion mobility 
retention times were used to isolate features in separations space. This provided 
enhanced subtraction of concomitant peaks present in the analyzed 
fragmentation spectra. These spectra were then subjected to manual 
interpretation to determine the type of parent ion (e.g. protonated, sodiated, in-
source fragment, etc.). In source fragmentation can be determined by 
determining if the ion in question occurs at multiple drift times. After 
determination of ion type, and isolation of fragmentation spectra, accurate mass 
was used for database searching from multiple sources. Databases queried 
include KEGG, Metlin, ChemSpider, PubChem, Human Metabolome Database, 
Dictionary of Natural Products, and MetaCyc. These databases were searched 
with a mass tolerance of 0.01Da. If the accurate mass deviated by more than 
20ppm, the compound was excluded from further investigation from the 
database. Fragmentation spectra were subjected to both manual interpretation, 
and MetFrag evaluation, an in silico interpreter. High energy peak lists were 
imported into MetFrag using centroided data with an intensity cutoff of ~1%. To 
utilize MetFrag with the Dictionary of Natural Products and MetaCyc, .sdf files 
were prepared with all matching compounds within a tolerance of 0.01Da and 
scored accordingly. Congruency between retention time and ClogP was also 
considered when assigning identifications. 
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3.2.5 Mutaxanthene Purification  
Crude extract, generated as above, was dissolved in water, acidified to pH 
3 with trifluoroacetic acid and extracted with chloroform. The chloroform fraction 
was dried in vacuo, resuspended in methanol, and applied on a Sephadex LH20 
size exclusion column (100 cm). The LH20 fraction containing mutaxanthenes 
was purified by RP-HPLC using a linear gradient of water/acetonitrile containing 
0.1% trifluoroacetic acid.  
 
3.2.6 Isotopic Incorporation Experiment 
Modified media R4 was used to optimize compound production with 
variable pH (6, 7.2 or 8.2), glucose concentration (1% or 2%) and MgCl2·6H2O 
concentration (1% or 2%). Fermentation cultures were extracted following 
method described above and analyzed with HPLC/MS for the most improved 
production. A seed culture of R4 mutant was inoculated into 500 ml Erlenmeyer 
flask containing modified mediumR4 with pH 6 and incubated at 30°C in rotary 
shaker. After 36h the pulse feeding of [1, 2-13C]sodium acetate was started and 
continued for a total of four 1 ml feedings and 0.5 g of labeled sodium acetate in 
12h intervals. Culture was then incubated for another 72 h. Extraction and 
compound purification methods were as described above (General extraction 
procedure and analysis), yielding 7 mg of pure compound. 
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3.2.7 Data Processing and Multivariate Statistical Analysis  
Data were centroided post-acquisition. Peaks were deisotoped, peak 
picked, and normalized using MarkerLynx data processing software (Waters, 
Milford, MA). Peak detection was performed on low energy data across the mass 
range of 100-2000 Da with retention times between 0.0 and 20.0 min, peak 
widths automatically detected, an intensity threshold of 2000, mass window of 
0.08, retention time window of 0.60, noise elimination of 4.00. Multivariate 
statistical analyses were performed using Umetrics extended statistics software 
EZinfo version 2.0.0.0. (Umetrics AB, Umeå, Sweden). All data were pareto 
scaled. 
 
3.3 Results and Discussion 
 
3.3.1 Generation of a Cohort of Antibiotic-Resistance Mutants.  
Nocardiopsis sp. FU40 ΔApoS8 was selected as a case study as it has 
been sequenced to high coverage, contains at least 19 identified secondary 
metabolic gene clusters, including several putative polyketides, and because the 
only secondary metabolite family identified from this organism to date are the 
pro-apoptotic macrolide polyketide apoptolidins A – H.145 We have previously 
disabled the biosynthetic genes for the production of apoptolidins via gene 
replacement of the terminal polyketide synthase ApoS8 with an apramycin 
resistance cassette, yielding a clean background for secondary metabolite 
analysis.146 Antibiotic resistant mutants of this strain, Nocardiopsis sp. FU40 
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ΔApoS8, were generated by dilution plating of spore preparations on antibiotic 
containing media followed by selection of several rifampicin (R1 – R5) or 
streptomycin (S1 – S6) resistant colonies with and without obvious morphological 
phenotypic differences.  
Resistant and progenitor strains were then grown in an antibiotic free 
vegetative medium and in production cultures from which total culture metabolite 
extracts were generated. Solid phase extraction of combined broth and mycelium 
with Diaion HP-20 resin followed by extraction of mycelium and resin with 
increasingly nonpolar solvents captured a wide subset of moderate to highly 
hydrophobic excreted and cell-associated components. Genetic analyses of rpoB 
and ribosomal mutations were performed by PCR amplification and re-
sequencing of the corresponding genes (summarized in Table A3.1(B)). 
Sequencing of rpoB in resistant colonies demonstrated that all genes possessed 
a single G⬌A transition at position 3280, a mutation not previously reported in 
antibiotic resistant Streptomyces.139 Similarly, among streptomycin resistant 
clones, a handful of new resistance mutations were observed in S3,4,6 whereas 
in S1,2,5 no mutations were present in the amplified rpsL gene, suggesting that 
resistance to streptomycin in Nocardiopsis may occur outside of previously 
reported regions.  
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3.3.2 Analysis of Changes in Extracted Metabolomes in Antibiotic 
Resistant Mutants  
The challenges to identifying mutation-induced changes in metabolism 
include detection/identification of discrete metabolites and ascertaining changes 
in generated metabolomes. We utilized unsupervised PCA of UPLC-IM-MS data 
followed by loadings-plot evaluation, reasoning that linking metabolomics 
changes to a biological phenomenon would be facilitated by identifying metabolic 
species that are unique and/or shared to mutational phenotype. UPLC-MS data 
were peak deconvoluted and deisotoped to provide discrete features 
corresponding to a specific retention time and m/z pair. These data were 
normalized to total ion count, and each feature was used as a dimension for 
subsequent PCA. This results in relatively smaller changes being attenuated less 
than large-fold changes. 147 Data compression occurs through the determination 
of the highest eigenvalue eigenvectors of the covariance matrix. The largest 
eigenvalue eigenvector is considered the principal component and describes the 
greatest variation in the data, with each subsequent eigenvector being 
orthogonal and describing progressively less variation. This provides sample 
grouping and separation based on patterns in the most significant detected 
features. 
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Figure 3.1. (A) Global PCA of five induced rifampicin (R1 – R5, red) and six 
streptomycin (S1 – S6, blue) mutants compared to the wild type Nocardiopsis sp. 
FU40 ΔApoS8 (black). Technical replicates are represented with the same 
symbols. (B) A loadings plot indicating features which contribute to group 
separation for a comparison of select mutants. Features upregulated in R4, for 
example, fall in the center of the red shaded region, while the features that fall 
near region boundaries are shared. Labeled metabolites correspond to Table 
3.1. (C) The inset PCA scores plot demonstrates mutant separations and 
indicates sample specificity of feature loadings. (D) Bar graph depicting 
normalized intensity of features as labeled in loadings plot for select rifampicin 
induced mutant (red), streptomycin induced mutant (blue), and wild type (black). 
Error bars include 1 standard deviation. 
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As shown in Figure 3.1(A), PCA effectively clusters technical replicates of 
UPLC-MS analyzed metabolomes from various antibiotic-resistance mutants 
selected by streptomycin and rifampicin plating. Each data point represents 1065 
feature/intensities, generated by UPLC-IM-MS and peak identification using 
MarkerLynx (Waters, Milford, MA). Plotting selected mutants in this manner 
reveals, without manual analysis of chromatograms or other visual phenotypic 
bias, which members are the most metabolically distinct from the progenitor 
strain. Interestingly, there is a marked metabolomic differentiation between 
antibiotic resistant clones selected using the same antibiotic. In the case of 
rifampicin induced mutations for example, which possess identical mutations in 
rpoB, these data suggest that additional mutations are responsible for 
transcriptional variation. This likelihood is in accordance with observations from 
compensatory mutations found in streptomycin and rifampicin resistant 
organisms 148, 149, which have been demonstrated to reverse the fitness costs of 
ribosomal and polymerase mutations. The PCA plots also demonstrate that 
different antibiotic induced mutations inducing transcriptional or translational 
variation can result in apparently similar global changes in metabolism.  
 
3.3.3 Analysis of Metabolic Features  
Interpretation of the significance of groupings determined via PCA require 
that the individual variance components be identified and, if possible, validated. 
Correspondingly, we endeavored to identify strain-specific metabolic features to 
develop an understanding of the lasting metabolic perturbations resulting from 
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the acquisition of antibiotic resistance. Aiding in these identifications, the addition 
of ion mobility 150 provided sufficient analyte separation to acquire untargeted 
fragmentation data of all detected species. Using both chromatography and 
mobility dimensions, high energy fragmentation data for analytes of interest were 
extracted by correlating both retention and drift times of product ions to 
precursors. This depletion of coeluting species and chemical noise increases the 
confidence of identification. In-source fragmentation can be discerned from 
retention and drift time correlations. 
Loadings analysis is a tool used for identifying the contribution of 
individual peaks to the PCA dispersion. The cosine of the angle between a 
component and a feature describes the weight of that particular feature for that 
component. For example, Figure 3.1(B) shows three-way loadings analysis for 
selected strains shown in Figure 3.1(C). To interpret these plots, the features in 
Figure 3.1(B) aligned along the vector of the strains in the inset PCA plot in 
Figure 3.1(C) represent those species that contribute most to the dispersion in 
the PCA analysis. Features with greater magnitudes describe more group 
variation, through both uniqueness and intensity in the UPLC-MS. The three-way 
loadings analysis is useful for illuminating clone-specific biosynthesis shared 
amongst cohorts. An analogous pairwise comparison (Figure A3.2) of a mutant 
to its progenitor stain is also useful for identifying new features in a single 
mutant.144 Figure 3.1(D) demonstrates how loadings analysis successfully 
identifies and deconvolutes clone-specific metabolites from UPLC-IM-MS data 
without manual chromatrogram analysis. Table 3.1 summizes a selection of the 
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most abundant metabolites unique to R4, S5 and the progenitor strains, 
respectively. A complete list of the 280 mutation upregulated metabolites in this 
pair, along with extracted ion chromatograms and MS/MS analyses, is found in 
APPENDIX 3 (Figures A3.37-99).  
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Table 3. 1.  Putative identities of metabolites identified for strains 
 
ID 
   
m/z*      Mass error** Putative Identification*** 
1 443.101 8.35 Mutaxanthene A 
2 457.115 4.38 Mutaxanthene C 
3 429.085 7.92 Mutaxanthene B 
4 454.085 -6.61 Mutaxanthene A [2M+H+Na]
+2
 
5 465.081 4.30 Mutaxanthene A [M+Na]
+1
 
6 462.071 -8.66 Mutaxanthene A [2M+H+K]
+2
 
7 683.120 0.00 Mutaxanthene A [3M+H+K]
+2
 
8 360.217 0.00 C21H29O4N1  
9 387.324 5.16 C21H42O4N2 
10 296.222 - No match in DNP, KEGG, METLIN 
11 261.144 -3.82 Glu-Leu/Ile 
12 297.169 -3.37 C16H24O5 
13 298.097 0.00 5’-deoxy-5’-(methylthio)adenosine 
14 143.084 13.98 Ectoine 
15 162.094 18.51 Salsolinol Variant (Water loss) 
16 191.158 20.9 C12H18N2 
17 
1161.15
9 - 5796.72 MW Peptide/Protein 
18 230.113 -4.35 N-(5-Iminoprolyl)threonine 
19 515.275 0.00 C28H38N2O7 
20 384.217 0.00 C5H9NO3 loss of 19 
21 203.180 4.92 1,4(15),5,10(14)-germacratetraene 
22 205.195 0.00 1(10),4(15),5-germacratriene 
23 415.358 2.41 C28H46O2 
24 401.340 -4.98 C27H44O2 
25 399.324 - [M+2H]
+2
 
26 407.314 - [M+2H]
+2
 
27 443.388 -2.26 C30H50O2 
*  Measured mass 
** Mass error represents ppm deviation from the theoretical mass of the putative 
identification 
***[M+H]
+
 species are presented unless otherwise indicated 
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Figure 3.2. Feature production comparison for mutants and wild type as 
generated through binary comparisons using OPLS-DA. (A) A standard Venn-
diagram depicting the number of unique and shared features for select mutants 
and wild type via the 3-way comparison. (B) Comparison of unique features 
specific to bottom-row organism when compared to left-column organism. (C) 
Features unique to right-column organism when compared to bottom-row 
organism. Values from tables in (B) and (C) were generated via pairwise 
comparison and hence cannot be compared to those of the tripartite comparison 
in (A). 
 
 
Figure 3.2(A) depicts a summary of the global effects of acquiring 
antibiotic resistance on the metabolomes for R4, S5 mutants and WT via the 
tripartite analysis of Figure 3.2(B). These values were obtained by permuting the 
three groups in binary comparisons using orthogonal projections to latent 
structures-discriminate analysis, a supervised multivariate statistical method that 
defines the first component (abscissa) as the eigenvector describing the greatest 
inter-group variation, with the second component (ordinate) defined as the 
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eigenvector describing the greatest intra-group separation.151 A large portion of 
the features are present in all groups. In addition to new metabolites specific to a 
clonal metabolome, this also includes unmetabolized media components and 
other sample background peaks. Of the 993 total features identified as exclusive 
to S5 and R4 mutants, and the wild type Nocardiopsis sp. FU40 ΔApoS8, 56 
features are exclusively expressed in the wild type Nocardiopsis sp. FU40 
ΔApoS8, 641 are shared between the wild type and at least one mutant, and 280 
of all features are produced as a result of rpoB or rpsL mutation. The resulting 
model was used to generate a plot of loadings contribution vs. correlation value. 
To generate group specific features, a correlation threshold of > 0.9 was applied.  
 Half-matrix representations of these comparisons are displayed in Figure 
3.2(B) and Figure 3.2(C). Figure 3.2(B) can be interpreted as the number of 
unique features specific to the metabolomic extract of the organism indicated on 
the bottom row when compared specifically to the organism on the left column. 
Conversely, the half-matrix in Figure 3.2(C) represents the number of unique 
features specific to the organisms indicated on the right column, when compared 
specifically to the organisms on the bottom row. For perspective, a similar 
comparison of Escherichia coli, Micrococcus luteus, and Bacillus subtilis yield 
feature differences on the order of as little as 13 specific features, and a 
maximum of 166 unique features, when compared in a binary fashion (Figure 
A3.1). This suggests that the metabolic phenotypes of the mutant organisms are 
on the scale of inter-phylogenic differences. Of note, the biosynthesis of new 
features not detected, or at low levels, in the progenitor strain is often found to be 
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increased in multiple distinct mutants. The number of new features found in the 
resistant mutants range from 100 to over 300 (237 on average) in comparison to 
the nonresistant Nocardopsis progenitor, whereas the number of features unique 
to the progenitor strain in comparison to the mutants average 80. For example, 
an increase in feature 14, putatively identified as ectoine, is observed in multiple 
antibiotic resistance mutants. Likewise, features 11-15, in addition to many 
others, are shared by mutant groups. This includes the upregulation of the 
putatively identified quorum-sensing molecule (feature 13), dipeptides (feature 
11) and features with no known match (feature 10, for example). Interestingly, 
lipid-like features in the progenitor Nocardopsis (e.g. 23, 24, and 27) appear 
attenuated in all antibiotic resistant strains. Together, these trends and specific 
analyses are consistent with generalized gene derepression as a consequence 
of mutations in the rpsL and rpoB genes. Normalized heat maps of features 
described as unique in Figure 3.2(A-C) are found in APPENDIX 2, Tables 
A3.10-23). 
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Figure 3.3. (A) Major substructures I – III were inferred from COSY, HSQC, 
HMBC, and ADEQUATE experiments. (B) Substructures were putatively linked 
via HMBC and ADEQUATE correlations. The xanthene frame work was 
confirmed by 13C J-coupling measurements in the amino congeners of 
mutaxathenes (D 4, E 5), generated serendipitously by treatment with ammonium 
acetate, which were sharper than the A – C and afforded confirmation of the 
complete carbon framework of mutaxathenes. (C) Proposed biosynthesis of 
mutaxanthenes. 
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3.3.4 Isolation and Identification of Selected Secondary Metabolic 
Features 
Many of the metabolic features corresponding to upregulated species in 
antibiotic resistant mutants (207 of ca. 650) possess high molecular weights 
(>400 Da), and are found to be upregulated in more than one mutant. To 
investigate whether these species correspond to secondary metabolites we 
isolated a subset of the most abundant features in rifampicin resistant mutant R4. 
Feature 1 (Figure 3.1(B), Table 3.1) was isolated with UV spectrum 
showing absorption maxima at 225, 252, 279 and 409 nm. The high resolution 
mass spectrum yields an apparent m/z of 443.101 [M+H]+ and, along with a UV 
and NMR data, yields a chemical formula of C22H18O10 that does not correlate 
with known entries in the aforementioned chemical databases. Challenges to 
structural elucidation of feature 1 include the large number of quaternary 
carbons, a high degree of unsaturation, and rapid dynamic chemical exchange 
properties of several resonances over the timescale of the NMR experiments. 
Briefly, three partial structures (I - III, Figure 3.3(A)) were proposed on the basis 
COSY, HSQC, HMBC and ADEQUATE NMR correlations. HMBC correlations 
from C14 methylene protons to C3 quaternary carbon determine the relationship 
of fragment II with fragment III and crucial HMBC and 1,1-ADEQUATE 
correlations from protons H12 to carbon C11a and from proton C4a to carbon C5 
determine the connectivity between fragments I and II and permit the closure of 
the last ring, which revealed that the compound contains an unusual xanthene 
scaffold (Fig. 17B). This compound, which we named mutaxanthene A 1, 
contained two minor variants, mutaxanthenes B 2 and C 3, which correlate to 
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features 2 and 3 from the loadings analysis in Figure 3.1(B). The remaining 4 
most abundant features in this plot correspond to adducts of the mutaxanthenes. 
As less abundant features, they further validate the utility of loadings analysis in 
comparing metabolomic perturbations in antibiotic resistant mutants.  
A notable property of mutaxanthenes A – C, is their ready conversion in 
pH ~ 6.6 ammonium acetate buffer into mutaxanthenes D (4) and E (5), which 
are tautomeric eneamine congeners of their parent compounds (Fig 17B). 
Notably, substantial line broadening of 13C resonances of C1, C2 and C4 in 
mutaxanthenes A – C, ostensibly due to dynamic chemical exchange of the enol 
tautomers, appear as sharp singlets in D and E (Figure A3.35). This line width 
improvement in the amino congeners permits J-coupling values to be obtained 
for these atoms from 1,2-13C sodium acetate incorporation experiments (Figure 
A3.36). Correspondingly, the structures of mutaxthenes A – E are supported by 
these incorporation experiments, which confirm the substructures and correct 
assembly of the xanthene scaffold and support the likely type II polyketide 
synthase origins of this family of compounds. A detailed description of NMR 
studies can be found in Appendix 3. 
 
3.3.5 Analysis of Biosynthetic Gene Cluster and Proposed Biosynthetic 
Pathway 
 The 12,12a-dihydro-1H-benzo[b]xanth-ene-based carbon framework of 
the mutaxathenes has, to our knowledge, never before been reported in 
polyketide natural products. This unusual scaffold requires multiple skeletal 
rearrangements of an unreduced decaketide precursor. While the process for 
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generating the xanthene scaffold remains highly speculative, we can propose a 
pathway (Figure 3.3(C)) consistent with the following features: (a) acetate 
incorporation reveals that the two carbons at positions C-16 and C4a are 
uncoupled, suggesting that these carbons were once an intact acetate unit in the 
decaketide chain; (b) the ether and carboxylate moieties together with the 
position of the uncoupled acetate-derived carbons formally imply oxidative 
cleavage, but not cleavage between the aforementioned acetate unit; (c) the 
position of the acetate derived carboxylate in the middle of the polyketide chain 
suggests an additional carbon skeletal rearrangement involving a ring 
contraction. In the proposed pathway, the intermediate precursor 6 is common to 
several polyketide families including polyketomycin 152, and mithramycin 153. The 
first oxidative cleavage resulting in 7 is a regiochemical variant of the Baeyer-
Villiger oxidation found in mithramycin biosynthesis 154. The ring contraction 
rearrangement may occur in analogy to the Favorskii-like reaction proven in the 
biosynthesis of the enterocins 155 and implied in okadaic acids 156, in which an 
oxidative carbonylation sequence via 8 precedes the formation of a 
cylopropanone intermediate 9, which upon hydration may rearrange to the 
internally situated carboxylate 11. An intramolecular Michael addition may be 
proposed to complete the xanthene framework. The previously reported genome 
sequence of Nocardiopsis sp. FU 40 ΔApoS8 contains one typical type II 
polyketide gene cluster. Analysis of this gene cluster (Table A3.7) reveals 
hypothetical polyketide synthase proteins consistent with the generation of the 
common precursor 6 and genes encoding translated sequence similarity to flavin-
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dependent oxidases (Mtx O1, O2 O3) consistent with the proposed oxidative 
rearrangement biotransformations. Future studies will define the relationship of 
these oxidases to the skeletal rearrangements implied in the proposed 
biosynthesis mutaxanthenes A -C. 
 
3.4 Conclusions and Perspectives 
 
We are broadly interested in detecting and identifying metabolome-scale 
changes in microorganisms and understanding their roles in cellular processes. 
As the end-product of the central dogma, metabolites and their dynamics may be 
used to complete our understanding of the molecular basis for biological 
phenomenon such as cell signaling, antibiotic resistance, pathogenicity, and 
metabolic fitness. The subject of this work, antibiotic resistance-induced changes 
in the transcriptional and translational apparatus of bacteria, has multiple aspects 
of interest. Investigating metabolome scale changes resulting from these 
adaptations may provide insight into these widespread modes of vertically 
acquired bacterial resistance in the clinic. Additionally, due to the established 
connection between acquired resistance adaptations and secondary metabolism, 
unbiased analytical methods to assess new features engendered by resistance 
can potentially accelerate natural product discovery.  
To address these subjects, we describe here metabolome scale changes 
from resistance mutations in a secondary metabolite producing nonpathogenic 
soil organism. Notably, similarly drastic regulatory adaptations, engendered by 
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mutations in the S12 ribosomal subunit and rpoB polymerase, are stably 
maintained in some, but not all clinically resistance strains (e.g. Mycobacterium 
tuberculosis, Streptococcus pyogenes, Staphylococcus aureus, Neisseria 
gonorrhoeae). 157-159 However, despite the importance of antibiotic-selected 
mutations in both pathogenic and antibiotic-producing microorganisms, the 
downstream effects of a modified transcriptome and/or proteome on global 
metabolism have not been broadly investigated in a systematic manner. Here we 
quantify the metabolic feature differences in stationary phase between cohorts of 
mutants revealing the scope of changes in metabolomic phenotype. Notably, the 
number of new features found in resistant mutants is, on average, three-fold 
greater than the number of features identified as unique to wild-type using the 
same comparison. Together with the results that these new features number in 
the hundreds and that the majority of the new features are not found in the 
progenitor Nocardiopsis are shared throughout the diverse mutant cohort, 
suggest that one means by which S12/rpoB mutations affect survival may be by 
a strategy of general derepression of biosynthetic processes.  
In the case of secondary metabolite producing actinomycetes, antibiotic 
induced S12 ribosomal subunit and rpoB polymerase mutants have been 
demonstrated to modulate the production of specific secondary metabolites 
resulting in increased production of poorly expressed or ‘silent’ gene clusters. 135, 
138 However, it is not known if secondary metabolite production is simply a 
symptom of broader transcriptional and translational derepression, or a specific 
adaptive response to antibiotic challenge. The results described here measure 
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metabolomic changes in bacteria in the contexts of the phenomenon of vertically 
acquired antibiotic resistance and secondary metabolism. The observation that a 
large fraction of accumulated metabolites are of high molecular weight, are not 
identifiable in primary metabolism databases, and are demonstrated to be 
secondary metabolites, corroborates the hypothesis that generalized secondary 
metabolic derepression may be an important byproduct of antibiotic resistance to 
transcription/translation targeting antibiotics. It is conceivable that metabolic 
plasticity may be an evolutionary ‘save all ships’ response to antibiotic challenge. 
However, whether or not general metabolic derepression is an adaptive or 
coincident trait is unknown at this time. Future studies linking the quantification of 
identified accumulated metabolites to gene transcription and translation 
quantification data will define the relationship between primary and secondary 
metabolism, derepression, survival, and the mechanism of resistance in 
microorganisms. 
 
3.5 Supporting Information 
 
 Supporting information, including metabolic heat maps, extracted ion 
chromatograms, fragmentation spectra, and all NMR spectra, can be found in 
APPENDIX 3. 
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CHAPTER 4D 
 
DEVELOPMENT OF A SELF-ORGANIZED MAP DRIVEN WORKFLOW FOR 
METABOLOMIC DATA PROCESSING AND INTERROGATION 
 
4.1 Introduction 
 
Currently, we seek to enhance the interpretation of metabolomics data 
through the application of self-organizing maps to provide an additional 
dimension of data analysis: feature intensity profile correlation. The generation of 
these “metabolic profiles” allows for Gestalt comparison of samples, providing a 
global snapshot of metabolite production. 
Metabolomics endeavors to interrogate the global metabolite profile of a 
particular biological system of interest, with the intent of gaining insight into the 
system phenotype or endotype, or how the system is interacting with the 
surrounding environment.160 In metabolomics studies, the complexity of 
metabolic profiles is often distilled to a fundamental comparison of small 
molecule inventories derived from differing physiological states of interest at a 
single time point (e.g. “normal” vs. “diseased”). Up- and downregulated 
metabolites are then used to infer metabolic perturbations. Multivariate statistical 
methods are used frequently to distill the large dimensional datasets which 
commonly result from mass spectrometry based metabolomics experiments into 
 110 
relevant features (i.e., up- and downregulated metabolites),161 with a feature 
defined as any detected molecular species, metabolite or other.162 The wide-
spread application of principal component analysis (PCA) to metabolomic studies 
has provided a means of visualizing sample groupings, and determining 
significant metabolite contributions through loadings plot interpretation. Other 
metabolomic based workflows utilize a univariate statistical approach and 
consider fold change differences in features.163 Unfortunately, the interrelated 
nature of the metabolic fluctuations and underlying feature patterns through 
biological variation are often ignored in conventional feature prioritization 
workflows.  
We have implemented a self-organizing map algorithm to visualize 
metabolic phenotype and feature patterns that is complimentary to traditional 
metabolomics approaches. Gene Expression Dynamics Investigator (GEDI) 
utilizes an algorithm intended for the organization of genes based upon 
underlying patterns in static or dynamic expression profiles using a self-
organizing map based approach.164 This has been applied to the visualization of 
metabolic profiles in a handful of studies, but never as a metabolite prioritization 
method.165, 166 In this study, self-organizing maps group discrete features, which 
are defined by both retention time and mass-to-charge ratio, based upon 
similarities in signal intensity profiles across biological sample sets. In-other-
words, features that change in similar trends across sample sets are grouped, 
whereas those that change differently group into separate neighborhoods, in an 
iterative fashion. As a result, metabolites cluster based upon underlying trends in 
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the biological samples. These maps may then be averaged across experimental 
groups and compared to provide a heat map of up-regulated and down-regulated 
metabolites as a function of experimental group. This added dimension of 
feature-feature correlation provides valuable insight into recognizing 
experimental subpopulations and relevant biomolecules, as well as allowing for 
the removal of biologically insignificant background features.  
We have termed this workflow, which consists of studying MS based 
metabolic profiles using self-organizing maps, Metabolic Expression Dynamics 
Investigator (MEDI). Though we apply this method to static samples, this method 
is also well-suited for comparison of temporal dynamic samples, as the name 
implies. For the purpose of this work, however, we endeavor to describe this 
method on temporally pooled samples. Specifically, the MEDI workflow begins 
with data acquisition and ends with the identification of biologically significant up- 
and down-regulated mass spectrometry signals. To the authors’ knowledge, no 
instructive tutorial on the use of self-organizing map algorithms for analyzing 
metabolomics based data exists. This manuscript describes the MEDI workflow 
method in detail, and subsequently applies MEDI to determine the metabolic 
effects of long term cocaine exposure upon rat populations. Currently, we display 
the application of self-organizing maps to a mass spectrometry based 
metabolomic analysis of static sera samples from cocaine-naïve rats and 
behaviorally distinct cocaine-exposed rat models (behaviorally addicted and non-
addicted).167 Though these sera samples were taken two weeks after the last 
administration of cocaine, clear distinction between cocaine naïve and 
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experienced sera profiles are distinguished using MEDI. This work describes an 
alternative and complimentary method for metabolomic data processing and 
visualization. 
 
4.2 Materials and Methods 
 
4.2.1 Rat Cocaine Addiction Behavioral Model 
Addiction models were prepared using a long-term exposure self-
administration protocol.167 Briefly, rats were conditioned to become addicted to 
cocaine injections administered upon the completion of a task (i.e. depression of 
a stimulus specific paddle). This behavior was subsequently extinguished 
through the replacement of cocaine injections with saline injections upon task 
completion. For addiction class determination, a reinstatement injection was 
administered to rats that contained cocaine, and the rats were again given 
access to cocaine injections upon task completion. Based upon the recurrence 
and magnitude of cocaine seeking behavior, rats were classified as addicted or 
recreational drug users. Two weeks following the completion of the behavioral 
study, rats were sacrificed and their blood used for analyses. 
 
4.2.2 Rat Serum Sample Preparation for UPLC-IM-MS Analysis 
Frozen whole blood samples from “addicted”, “non-addicted” and naïve 
rats were thawed at 4°C, and then centrifuged at 14k rpm for two minutes. 60µL 
of serum was removed and metabolites isolated by precipitating the proteins with 
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3:1 v:v cold methanol kept on dry ice. Samples were vortexed for 10 seconds 
and centrifuged at 14k rpm for 10 minutes at 4°C. 150uL of supernatant was 
extracted and dried down in a SpeedVac, after which the samples was 
reconstituted in 100uL of solvent A.  
 
4.2.3 Liquid Chromatography-Ion Mobility-Mass Spectrometry Conditions  
UPLC-IMS-MS and UPLC-IMS-MSE analyses were performed on a 
SYNAPT G2 HDMS (Waters, Milford, MA) mass spectrometer equipped with a 
nanoAcquity UPLC and autosampler (Waters, Milford, MA). Metabolites were 
separated on a 75 μm x 100 mm HSS C18 (1.7 μm particle size) column and 180 
μm x 20 mm HSS C18  (5μm particle size) trap column. Column temperature was 
maintained at 45°C to minimize chromatographic drift, and the auto-injector 
sample tray held at 4°C to minimize sample degradation. A double-loop injection 
volume of 10 μL was injected in a 5 μL loop. Chromatographic separations were 
performed by using a 20 min method at a flow rate of 450 nL/min using a 
gradient mixer of 0.1% formic acid in H2O (mobile phase A) and 0.1% formic acid 
in ACN (mobile phase B). Briefly, a 3 min wash period at a flow rate of 15 μL/min, 
during which the eluent was diverted to waste prior to analytical separation. 
Following removal of residual salts and trapping of analytes on the trap column, 
flow was redirected to flow through the analytical column with an initial 99% 
mobile phase A for 0.5 min. Mobile phase B was increased to 60% over 6.5 mins 
and up to 99% in 4 min, and then held at 99% for 3 minutes. The column was re-
equilibrated to 99% mobile phase A over 0.5 minutes and held for 5.5 min after 
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each run. All analytes were analyzed using positive mode nanoelectrospray 
ionization. Typical parameters include a capillary voltage of 3.5kV, sampling cone 
setting of 25.0 and extraction cone setting of 4.0, source temperature of 80°C, 
desolvation gas (N2) flow of 600 L/hr, and a cone gas flow of 20 L/hr. Data were 
acquired in MSE mode, which acquires both a low energy spectrum and a high 
energy spectrum. Collision induced dissociation (CID) was performed post 
mobility separation with a ramped energy profile from 20-60 V in the high CID 
acquisition. Traveling wave velocity was held constant at 550 m/s and a height of 
40.0 V. Data was acquired at a sampling rate of 2 Hz over the mass range 50-
1400 m/z. Sodium formate (10 μg/mL) in 90:10 propan-2-ol:water (v:v) was used 
to calibrate over this range with < 1 ppm mass accuracy. Leucine enkephalin in 
50:50 H2O:ACN with 0.1% formic acid (v:v) was used as a lock mass compound 
(accurate mass 556.2771 Da) at a flow rate of 0.6 μL/min and a concentration of 
2 ng/mL every 10 seconds. Data acquisition was performed from 0 to 20 minutes 
of the liquid chromatography separation. Triplicate technical analysis was 
performed in a randomized fashion; with quality control samples analyzed every 
5 injections. Quality control samples contained equal volume aliquots of each 
sample mixed together. 
 
4.2.4 Data Processing and Multivariate Statistical Analysis 
Data were mass corrected post-acquisition and centroided. Peaks were 
deisotoped and normalized using MarkerLynx data processing software (Waters, 
Milford, MA). Peak-picking using chromatographic profiles were also performed 
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using MarkerLynx. Peak detection was performed on low energy data across the 
mass range of 50-2000 Da with retention times between 1-20 min with peak 
widths ≤ 30 seconds (no applied smoothing), intensity threshold of 1000, mass 
window of 0.03 Da and retention time window of 0.1 min. Data were deisotoped 
and areas normalized to 10,000/sample.  
Multivariate statistical analyses were performed using Umetrics extended 
statistics software EZinfo version 2.0.0.0 (Waters, Milford, MA). Principal 
component analysis (PCA) and orthogonal partial least squares-discriminate 
analysis (OPLS-DA) were performed on all data acquired and pareto scaled.  
 
4.2.5 GEDI Parameters 
A grid of 50X51 was defined and trained using 80 first phase and 160 
second phase iterations. A neighborhood radius of 4.0 was used during the first 
phase, and 1.0 during the second. The first phase learning factor was 0.5 and 
0.05 for the second phase. The neighborhood block size applied for the first and 
second phases were 4 and 2, respectively. A conscience of 3.0 was used for 
both phases. A random seed value of 1 was used, and Euclidean distance was 
applied for the distance metric. A linear initialization method was applied. 
Samples were average across technical and biological replicates, and subtracted 
across experimental groups within the GEDI software. GEDI maps were exported 
through the software, in addition to “Gene Assignment Lists”, which indicate node 
location of features, and “Map Centroids” which were used for the generation of 
intensity values for regions of interest. 
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4.2.6 Statistical Analysis of Regions in MEDI heat maps 
The cocaine-experienced MEDI self-organized heat map (Figure 4.4(C) 
shows the summed ion signal intensities for specific regions across sample types 
(cocaine-naïve, cocaine-addicted and cocaine-non-addicted)). This MEDI heat 
map has allowed us to quantify and determine the statistical significant regions, 
labeled A-F, using a one-way ANOVA test among sample types. A one-way 
ANOVA compares the effect of cocaine use using the grouped ’neighborhoods’ 
of signal ion intensities for non-addicted, addicted, experienced (average of non-
addicted and addicted samples) and naïve rats (see Figure 4.6). We observed a 
significant effect (p<0.01) based on cocaine exposure for all regions, and for 
those regions with unequal variance between groups, a Kruskal Wallis one-way 
ANOVA was conducted (regions a, d, e, and f). [a: H(3,37)=22.03, p<0.0001; b: 
F(3,37)=4.99, p=0.0052; c: H(3,37)=21.83, p<0.0001; d: F(3, 37)=7.24, 
p=0.0006; e: H(3,37)=18.9, p=0.0003; f: H(3,37)=25.6, p<0.0001], indicating that 
post hoc comparisons were appropriate. Post hoc comparisons using a 
Bonferroni-Holm’s test show statistical significant differences (p≤0.01) for all 
regions (A-F) when comparing cocaine experienced, addicted, non-addicted and 
cocaine-naïve sample types. Additionally, region F showed a statistically 
significantly difference (p<0.01) between addicted and non-addicted rat models 
(see F in Figure 4). Region C, however, does not show a statistically significant 
difference (p=0.06) between non-addicted and addicted sample groups, which 
indicates that there are ’neighborhoods’ that further discriminate cocaine non-
addicted and addicted models. 
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4.2.7 Feature Identification 
Putative identifications were performed using the monoisotopic accurate 
mass and raw data to determine molecular ion type. Monoisotopic masses were 
searched against the Human Metabolome Database (HMDB)168, 169, METLIN170, 
and LIPID MAPS171 databases for putative identifications. When possible, 
fragmentation data were used to support identifications, utilizing mobility 
separation prior to fragmentation to isolate parent ions in separations space. 
 
4.3 Overview of the Data Analysis Approach, Metabolite Expression 
Dynamics Inspection (MEDI) 
 
For mass spectrometry based metabolomic data analysis, our Metabolite 
Expression Dynamics Inspection (MEDI) adapts the Gene Expression Dynamics 
Inspector (GEDI) software. Figure 4.1 outlines the general workflow for the 
analysis of metabolomics data using a self-organizing map algorithm to sort 
detected features in an unsupervised, data-driven manner. This workflow 
facilitates the identification of unique expression profiles across samples based 
on feature patterns detected in the metabolomic analysis. Briefly, this workflow 
consist of six steps: (1) initial data acquisition, (2) data preprocessing which 
incorporates peak detection, alignment, and normalization, (3) the use of GEDI 
software to generate self-organizing maps, (4) differential analysis in GEDI of 
sample intensity maps generated in step (3) to determine relevant feature 
clusters, (5) interrogation of metabolite feature assignment maps to determine 
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unique features/analytes of interest, and lastly (6) identification of peaks of 
interest. The MEDI workflow is applicable across platforms, with the exception of 
peak identification, which will be technique/detector dependent. The generalized 
MEDI workflow is now described in greater detail.  
 
4.3.1 Data Acquisition and Preprocessing (MEDI workflow – steps 1 and 2) 
The first step in the proposed workflow is the initial data acquisition. It is 
important to note that no one sample preparation or mass spectrometry analysis 
technique will give a global metabolomic view, simply based on the chemical 
diversity associated with metabolites. It is therefore important to plan 
experiments, extractions, and analysis techniques accordingly. It is beyond the 
scope of this article to discuss all metabolite extraction and analysis protocols, 
but it is important to understand the limitations of each sample preparation and 
analytical method. We suggest a few relevant reviews.161, 172, 173  
After data acquisition, raw data must be described as discrete features. 
This involves centroiding and aligning retention time and mass spectral profiles, 
in addition to deisotoping data to ensure monoisotopic peak comparison. 
Subsequent normalization scales data to reduce the impact of technical variation. 
Publically available software (e.g., XCMS) can be used to filter, detect and align 
peaks; therefore this workflow is compatible across numerous mass 
spectrometry platforms (e.g., LC-MS/MS, LC-IM-MS/MS, GC-MS) and vendors, 
in addition to 1-D data (e.g., direct infusion, matrix assisted laser 
desorption/ionization MS), assuming relative quantitation applies.163 After initial 
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peak filtering, detecting, aligning, and normalization, features are exported in a 
tab-delimited file congruent with GEDI (found at http://www.childrenshospital.org/ 
research/ingber/GEDI/GEDI_InputDataFormat.pdf). Normalized metabolomics 
data is then appropriate for feature organization through the self-organizing map 
algorithm. 
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Figure 4.1. Data processing workflow for metabolomics based analyses. The 
generic process of data mining using self-organizing maps to sort data is shown. 
This begins with experimental data acquisition (A), and subsequent processing 
and formatting (not shown). Features are then used to generate heat maps for 
each sample, using the GEDI self-organizing map algorithm (B). The relative 
density of features per node can be seen in (C), with white indicating no features, 
blue indicating one features, scaling to red, indicating many features.  Differential 
analyses of samples generates feature clusters of varied intensity (D). The 
feature assignment map is then used to determine the retention time and m/z 
identity of the features of interest (E). This prioritizes analytes for further 
identification (F). 
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4.3.2 Feature Organization and Analysis (MEDI workflow – steps 3 and 4) 
In these MEDI workflow steps, a self-organizing map algorithm is used to 
assign detected features to a grid of user-defined dimensions. Specifically, the 
algorithm arranges features in an iterative manner based upon similarity in 
intensity profiles across samples. Initially, the grid is populated with randomly 
generated intensity profiles. Randomly selected features from the input data are 
placed in the grid location, or node, which best matches the intensity profile of 
that feature. This profile of this node is then adjusted to more closely resemble 
the profile of the matched feature. Surrounding nodes are also adjusted to more 
closely resemble the matched feature, but to a lesser extent. This process is then 
performed iteratively with a different, randomly selected input feature. Features 
that behave similarly across samples are assigned to a particular 
“neighborhood”, or in nodes adjacent to like-features, as seen in the trend plots in 
Figure 4.2. The assignment of features to specific nodes is then iterated as node 
profiles evolve. After features are assigned to specific node coordinates, intensity 
maps are generated for each sample using the summed intensity for each node. 
These profile the metabolic phenotype for each sample (see Figure 4.1(B)), 
displaying all detected features in a heat map fashion. The relative number of 
features that contribute to a neighborhood is shown in the feature density map 
(Figure 4.1(C)). Subsequently, samples can be averaged and subtracted based 
on sample group and experimental specifics, as seen in Figure 4.1(D). 
Differential profile maps show clusters/regions of up- or downregulated features, 
which are potential metabolites of interest. This specific analysis reveals regions 
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(red-boxed areas), which should be prioritized and compared across samples. 
Importantly, the feature density map indicates that many of these regions of 
interest are resultant of a small number of metabolites. 
 
 
 
 
Figure 4.2. Illustrative MEDI heat map indicating trend plots that correspond to 
seeded features. Features that behave similarly across the samples or 
experimental conditions (81 total samples), which are depicted on the x-axis of 
the bracketing trend plots, are grouped into close regions. This results in the 
organization of features based upon similarities in relative intensity profiles. 
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4.3.3 Cluster Decryption (MEDI workflow step 5) 
To extract which metabolomic features contribute to neighborhoods of 
interest, clusters must be decrypted into constituent features. Each node has a 
finite number of features associated (Figure 4.1(C) and 4.1(E)), which determine 
the images shown in Figure 4.1(B) and 4.1(D). Multiple features can contribute 
to a single coordinate intensity, thus images need to be ‘decrypted’ by 
determining which features contribute to specific ‘neighborhoods’. The 
descriptive data for a feature indicates the chemical properties of the feature and 
the location in the raw data.  
 
4.3.4 Feature Identification (MEDI workflow step 6) 
The final step in the proposed workflow includes the identification of 
significant features described in Figure 4.1(E). These identifications will be 
platform specific, thus the tools used for analyte identification will also be 
platform specific. There are a number of tools available for fragmentation 
prediction and matching of spectra for metabolomic based studies, as well as 
databases (e.g., Human Metabolome Database, Lipid Maps Structure Database, 
METLIN, Kyto Encyclopedia of Genes and Genomes).168-171, 174, 175 The 
metabolites detected provide the basis for inferences on metabolic perturbations 
between sample groups. Figure 4.1(F) depicts a fragmentation spectrum used to 
identify a metabolite of interest. Guidelines for metabolite identification 
confidence have been outlined by the Metabolomics Standards Initiative. 
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Figure 4.3. Representative UPLC-MS and MEDI heat maps indicating relative 
analyte intensity. For each of the two behavioral groups of cocaine use (addicted 
and non-addicted) and cocaine naïve rat sera metabolomes, corresponding heat 
maps for single UPLC-MS analyses (A) and average MEDI heat maps (B) are 
presented. Though differences may be seen in the UPLC-MS profiles, the static 
metabolite phenotypes displayed through self-organizing maps indicate gross 
differences between each group. 
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4.4 MEDI Analysis of Rat Sera Samples 
 
4.4.1 Applying MEDI to Explore the Effects of Long-Term Cocaine 
Exposure 
To display the utility of this workflow, we applied the MEDI process to 
liquid chromatography-mass spectral (LC-MS) sera profiles from cocaine-naïve 
rats and behaviorally distinct cocaine-addicted and non-addicted rats. Figure 
4.3(A) illustrates a 2D retention time (RT) vs. mass-to-charge ratio heat maps for 
each sample type (cocaine-naïve, behaviorally non-addicted, and addicted rats). 
This is representative of raw data from selected samples from each group. In 
these 2D heat maps, we observed ~2266 unique features (RT – m/z pairs) 
across all samples after peak picking, alignment, and normalization using 
MarkerLynx software (Waters Corporation, Milford, MA). A visual investigation 
reveals that little, if any, information is gleaned from a casual viewing of these 
metabolic profiles. These same features were formatted for further analysis in the 
MEDI workflow. 
Detected features were self-organized using the GEDI software, and 
average group heat maps are seen in Figure 4.3(B). This function simply 
averages node intensities across a selected group of samples, which, in this 
case, is determined by behavioral class. For comparison of the generalized 
effects of cocaine exposure, the two behavioral classes were pooled and are 
classified “cocaine-experienced”. These individual self-organizing heat maps 
clearly show distinct differences among groups. The density of metabolites for 
given nodes can be seen in Figure A3.1.  
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Visual inspection of the metabolite heat maps demonstrates that the sera 
profiles for the three groups have both shared and distinct characteristics. This 
displays a significant advantage to using GEDI for metabolic phenotype 
investigation. By virtue of the feature organization process, the groupings that 
result from the self-organizing algorithm are driven by hierarchical specificity. As 
a result, if experimental groups have significant differences, groups will emerge 
that concentrate these differences. Additionally, background, or ubiquitous, 
signals will be organized together and essentially eliminated from the analysis. 
Features that are specific to a particular sample will then occupy separate 
regions. To gain perspective on how the MEDI process compares to multivariate 
statistical analysis methods, we performed principal component analysis and 
orthogonal projection to latent structures-discriminant analysis on detected 
features. 
 
4.4.2  Multivariate Statistical Analyses  
The use of multivariate statistical analysis methods is a common 
informatics approach for metabolomics data. This enables researchers to 
determine significant features in complex datasets, interrogate sample grouping, 
investigate data acquisition reproducibility, and classify unknown samples based 
on example training sets. Figure 4.4(A) is a principal component analysis (PCA) 
of the three sample groups analyzed. In PCA, the intensity of each feature 
(considered a dimension) is used to describe a given sample. Briefly, PCA 
determines the largest eigenvalue eigenvector of the covariance matrix of the 
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data, which is principal component one. This eigenvector describes the largest 
differences in the samples, by definition. The second principal component is 
orthogonal to the first principal component and describes the next largest 
differences in the data. The result is sample grouping based upon similarity, and 
separation based upon the largest global feature differences in principal 
component one, and the next largest differences in principal component two. 
Principal components one and two are plotted in Figure 4.4(A) as the abscissa 
and ordinate, respectively. This displays the samples in maximally distinguishing 
2-dimensional space, based upon feature intensity. Subsequent principal 
components are all orthogonal and describe progressively less variation (i.e. 
lower eigenvalue eigenvectors of the covariance matrix). The PCA plot in Figure 
4.4(A) illustrates the ability for MS based metabolic profiles from cocaine-naïve 
and experienced rat sera to separate in the first principal component (see x-axis 
Figure 4.4(A)). This also shows a separation in the second principal component 
(see y-axis); cocaine-experienced rats further separate into two main groups. 
The top group (quadrant I) consist of data from both behaviorally addicted (black) 
and non-addicted rats (red), while the other group (quadrant IV) were data 
generated from biological duplicates of a behaviorally non-addicted rat (multiple 
points due to technical replicates). The grouping consistency in the biological 
duplicates indicates biological variation from the other cocaine exposed rats. It is 
unclear if this secondary separation is a result of behavioral class, or simply 
specific to the rat. Importantly, principal component one separates metabolomic 
profiles based upon cocaine history, independent of behavioral class. In these 
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experiments, rat serum was obtained 2 weeks after cocaine administration, 
therefore cocaine and its metabolites were not detected in these analyses. 
Though the PCA plot indicates separation based upon exposure, it describes 
only 24% of the variation with the first two principal components. For the 
purposes of subsequent binary comparisons, the samples are grouped as either 
cocaine- naïve or cocaine-experienced.  
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Figure 4. 4. Rat sera metabolome depictions for cocaine-experienced versus 
naïve classes. (A) Principal component analysis (PCA) of cocaine experienced 
(block markers) rat sera metabolomes plotted with cocaine-naïve (diamond 
markers). Behavioral sub-classes are indicated by color. (B) S-plot comparing 
cocaine-experienced (-) to cocaine-naïve (+) metabolomes. Marker color 
corresponds to the boxes in (C) (inset shows a magnified sub-image). (C) 
Differential MEDI heat map of average cocaine-experienced metabolic profiles 
with average cocaine-naïve profiles subtracted. Boxed in regions are then 
delineated in (D), which is an annotated representative UPLC-MS heat map 
marking feature location on the cocaine-experienced UPLC-MS plot. The colored 
dots correspond to the different feature islands in (C). [Box dimensions: 
a(39,38:50,51); b(46,33:50,37); c(28,34:38,46); d (39,28:45,36); e (36,20:42,27); 
f (46,20:50,32)] 
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Orthogonal partial least squares-discriminant analysis (OPLS-DA) can 
also be used to compare cocaine-naïve to cocaine-experienced rat sera profiles 
(Figure A3.2).176 OPLS-DA is similar to partial least squares to latent structures 
(PLS), which, in this case, finds the relationship between the UPLC-MS data and 
cocaine history, and is a supervised method. However, OPLS-DA orients the 
model such that the abscissa is the predictive component, or between-group 
variation. The orthogonal ordinate then describes intragroup variation. 
Specifically, this model explains 98% of the data variation between groups. 
Figure 4.4(B) shows a corresponding S-plot used to determine metabolites of 
significance. This S-plot graphs features based upon group specificity or 
correlation (ordinate) and covariance (abscissa). Features with a high group 
correlation, or specific to either cocaine-exposed or naïve, in this case, have a 
large magnitude in the y-dimension. Features with a large loadings contribution 
to the predictive component possess large magnitudes in the x-dimension. Those 
features of interest have been colored in Figure 4.4(B), which will subsequently 
be explained. In this manner, we are able to determine the features that are 
specific to long term cocaine exposure. 
 
4.4.3 MEDI Heat Map Interpretation 
The self-organizing map approach to feature organization places features 
with similar sample intensity profiles proximal in the coordinate grid, as afore 
mentioned. This generates regions of features that are up- and downregulated 
(e.g. Figure 4.4(C), red and blue, respectively) consistently across samples, in 
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addition to regions that are specific to a subset of samples. This provides 
additional flexibility to data organization beyond the convention dimensions of 
loadings analyses of MVSA methods. Shown in Figure 4.4(C) is an average 
GEDI heat map of cocaine-experienced serum profiles (i.e. both behavioral 
classes) with the average naïve heat map subtracted to display metabolites that 
are either upregulated (yellow to red), or downregulated (blue to dark blue) as a 
general result of prolonged cocaine exposure. This differential analysis subtracts 
the average node intensities of cocaine-naïve rat sera profiles from the averaged 
experimental group. Though many islands exist, the more intense regions of 
upregulation are outlined for comparative purposes. These regions are both 
annotated and outlined with a colored box in Figures 4.4(C). The colored boxes 
are for comparative purposes, which indicate the feature location in other data 
representations (Figure 4.4(B) and 4.4(C)) [Box coordinates: a(39,38:50,51); 
b(46,33:50,37); c(28,34:38,46); d(39,28:45,36); e(36,20:42,27); f(46,20:50,32)]. It 
should be noted that these boxes are consistent across sample groups and 
determined by group perimeter. Thresholding and image recognition software is 
being implemented for future applications. 
Correlating the regions of interest in Figure 4.4(C) with a raw LC-MS plot 
(Figure 4.4(D)) illustrates the concept that grouped features display a large 
range of chemical properties, as they occupy different regions of separations 
space. The marker color in Figure 4.4(D) corresponds to the location in the heat 
map in Figure 4.4(C). The S-plot in Figure 4.4(B), described above as a 
common method to extract meaningful features from OPLS-DA binary analyses, 
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has been modified so the color of the markers correspond to the regions of 
interest in Figure 4.3(C). All the features that would be prioritized through OPLS-
DA are encapsulated in the regions of interest. These features occupy disperse 
regions of the S-plot. 
 
 
 
 
 
 
 
Figure 4.5. Loadings contribution of nodes to PCA. The contributions of each 
node to (A) principal component 1 and (B) principal component 2 are indicated 
by color intensity. Red indicates a negative contribution and blue indicates a 
positive contribution. 
A B 
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4.4.4 Loadings Contributions of MEDI Coordinates 
Correlations between the MEDI feature assignment location and the 
loadings contributions to PCA are seen in Figures 4.5(A) and 4.5(B). The 
loadings contribution of a feature to a particular principal component indicates the 
weight of that feature regarding sample magnitude in that dimension. In other 
words, a feature with a large negative loadings value in principal component one 
will influence a sample containing that feature to have a negative value in that 
component. Representing the loadings in this medium provides insight into 
neighborhood formation. The static nature of these samples means any 
clustering that occurs is sample-group-specific, assuming technical 
reproducibility. As such, what occurs in all cocaine-experienced sera profiles will 
group, and subsequent neighborhoods will form based upon sample specificity. 
Figures 4.5(A) and 4.5(B) should be considered with both Figures 4.4(A) and 
4.4(C), as the loadings contributions link the MEDI heat map to the PCA scores 
plot. The largest trends are resultant of cocaine experience, and have been 
organized into two main regions of the map accordingly. The upper portion of the 
map corresponds to features that are down-regulated, generally, in the cocaine-
experienced. This is indicated by the dominantly blue upper portion. Features are 
initially partitioning based upon the global group differences. Considering the 
second principal component loadings, there is very little contribution from the 
features that are found in elevated intensities in the cocaine-naïve samples, 
which is seen by the relatively small contribution of the red region in Figure 
4.5(A). The second principal component loadings map offers more insight into 
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the formation of feature islands in the cocaine-experienced group. The significant 
feature loadings are those describing intra-experienced separations, which as 
indicated by the scores plot. The nodes that contribute greatly to principal 
component 2 form regions in the MEDI plot. This demonstrates the finer 
clustering effects of the feature sorting algorithm. Subpopulations of samples, 
such as the biologically distinct cocaine exposed rat, produce regions 
representing features that are unique to that subgroup. The grouping in principal 
component analysis, in addition to individual sample MEDI heat map 
investigation, provides insight into the interpretation of these underlying features.  
Specifically, coordinate (50,51), or the extreme bottom right node, has the 
greatest contribution to a positive loading in principal component 1 and 2. This 
feature group, consisting of putatively identified 6-methyltetrahydopterin, 
deoxyuridine, and two other features, contains the most distinguishing features to 
cocaine experience in PCA. This group is also prioritized during the MEDI 
process. Other contributing signals are listed based upon their group occupation, 
feature descriptors, and, when applicable, a putative identification in Table 4.1. 
The greatest negative contributors to principal component 2 are found within 
region “c”, in addition to more peripheral regions. These are features are 
upregulated in the distinct cocaine-exposed rat sera. As a result, these features 
provide insight into the difference between this rat and other cocaine-exposed 
models, whether biological or other. Additionally, region “f” has a positive 
contribution to principal component 2, and thus is upregulated in most cocaine 
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exposed rats. As a result, this region may provide alternative insight into the 
intra-group separation. 
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Table 4. 1. Putative metabolite identification. Metabolites were given preliminary 
identifications based upon accurate mass, ion type, and database searching.  
Retention Time 
(min) 
m/z 
MEDI 
Region 
Putative Identification 
11.76 130.066 a 1: 3-Methylene-indolenine 
12.83 616.179 a 2 
13.22 158.154 a 3 
9.92 182.192 a 4: 6-Methyltetrahydropterin 
10.82 185.116 a 
5: (3-Methoxy-4-hydroxyphenyl) ethylene 
glycol 
11.78 190.086 a 6: Kynurenic acid 
9.98 211.143 a 7 
9.60 215.125 a 8 
9.85 229.069 a 9: Deoxyuridine 
10.53 229.142 a 10: Protein degradation dipeptide 
10.77 243.104 a 11: Thymidine 
10.85 257.136 a 12 
12.63 261.109 a 13 
10.34 273.168 a 14: Estradiol 
9.09 279.688 a 15 
10.19 308.091 a 16: Glutathione 
9.49 338.087 a 17: 3-Indole carboxylic acid glucuronide 
9.74 340.104 a 18: 5-Hydroxy-6-methoxyindole glucuronide 
10.55 361.138 a 19: Dityrosine 
14.09 500.277 a 20: LPE 
9.72 520.313 a 21: LPC 
9.58 432.280 b 31 
9.09 201.072 b 32: Bilirubin oxidation product 
12.87 614.174 c 22 
12.62 225.110 c 23: 3-Hydroxykynurenine 
9.22 305.159 c 24: Steroid-like molecule 
10.58 392.138 c 25 
9.60 406.164 c 26 
12.18 430.296 c 27: Met 30-2H2O 
9.96 431.090 c 28 
12.18 448.306 c 29: Met 30 –H2O 
12.19 466.318 c 30 
10.19 162.056 d 33: 4,6-Dihydroxyquinoline 
9.55 269.129 d 
34: 3-Carboxy-4-methyl-5-pentyl-2-
furanpropionic acid 
9.48 371.227 d 35: 6-Keto-prostaglandin F1a 
9.86 547.334 d 36 
9.93 608.387 d 37 
10.46 186.223 e 38 
9.54 399.625 e 39: [M+2H]
2+
 
1.20 203.054 f 40: Succinylacetoacetate 
11.94 223.066 f 41: Salsolinol 1-carboxylate
 
10.71 383.113 f 42 
14.11 542.327 f 43: LPC 
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4.4.5 Region Interpretation and Comparison 
Further heat map interpretation prioritizes regions of interest, which 
consist of grouped features. Figure 4.6 compares the summed node intensities 
for outlined regions of the MEDI heat map. This provides insight into the 
significance of regions, in addition to the intragroup differences that occur. The 
summed intensities corroborate the loadings analysis, as the regions selected 
have significant differences in intensities between cocaine-experienced and 
naïve groups, and each have positive contributions to principal component 1. The 
regions that show differences within the experienced group (i.e. regions c and f) 
have varied intensities between behavioral classes, and also hold negative and 
positive contributions to principal component 2, respectively. The significance of 
the displayed differences was subsequently determined. 
 
4.4.6 Determination of Contributing Features 
Extracting relevant biological information is paramount in metabolomic 
experiments. Following regional analysis of MEDI heat maps, the extraction of 
contributing features is performed through the interface of GEDI by selecting a 
node, or through an exported “Gene Assignments List” (Metabolite Assignment 
List, in MEDI). Table 4.1 lists relevant feature identifiers, region located, and, 
when available, putative identifications. The organization of features is a function 
of whether the feature is present in the same permutation of samples at relatively 
similar intensities. As a result, the subpopulations that arise indicate biological 
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subtleties that exist among groups. The putatively identified features in disparate 
regions provide insight into these biological differences. 
 
 
 
 
Figure 4.6. Histogram depicting total area in enclosed regions of MEDI heat 
map, as indicated in Figure 4.3(C). Rats with a history of cocaine exposure (white 
fill) had mean intensities significantly higher than cocaine-naïve rats (blue fill) in 
all regions tested (p<0.05). Additionally, the mean intensity of region “f” was 
significantly higher in cocaine-addicted rats (black) than non-addicted (red) 
(p<0.01). 
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Regions a-f all show distinct upregulation as a result of prolonged cocaine 
exposure, as seen in both Figure 4.6 and the loadings representation in Figure 
4.5(A). Region “a” contains metabolites that occur in a majority of the cocaine 
exposed group. These include metabolite indicative of compensatory 
mechanisms of the biochemical effects of prolonged cocaine exposure. The most 
significant metabolite that is upregulated is 6-methyltetrahydropterin, which is a 
cofactor for tyrosine hydroxylase in the pathway to dopamine synthesis.177 
Elevated (3-methoxy-4-hydroxyphenyl)ethylene glycol, which is the primary 
serum metabolite of norepinephrine, has been found to be dysregulated following 
cocaine withdrawal.178 Kynurenic acid is a naturally occurring metabolite resulting 
from tryptophan metabolism and has displayed protective effects against cocaine 
toxicity.179 The inhibitory effects of cocaine exposure on glial cell growth have 
also been shown, significantly decreasing incorporation of thymidine in DNA 
synthesis, inhibiting growth.180 The marked increase in serum thymidine 
concentrations is perhaps a compensatory result of cocaine exposure, or 
perhaps a result of metabolite pooling resulting from lack of incorporation. This 
could be the reason for upregulation of deoxyuridine as well. Alterations in 
estradiol concentrations have been seen in response to cocaine exposure, 
though why upregulation occurs in male rats following cocaine extinction is 
unclear. The presence of 3-Carboxy-4-methyl-5-pentyl-2-furanpropionic acid 
could speak to renal health as a result of the prolonged cocaine exposure.181, 182 
Region “c” concentrates the biological differences that exist within the 
cocaine exposed group. The increased 3-hydroxykynurenine that appears to 
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exist implicates further tryptophan perturbations.183 This metabolite has been 
associated with oxidative stress and neuronal cell death. Unidentified features 
that exist in this region may ultimately provide more insight into the biological 
variation that exists. 
The other distinct region of difference within the cocaine-experienced 
group is region “f”. The presence of succinylacetoacetate is a unique metabolite 
resulting from tyrosinemia, which has been shown to result from long term 
cocaine exposure.184 Additionally, the presence of salsolinol 1-carboxylate, an 
intermediate toward the production of the endogenous neurotoxin salsolinol, is 
upregulated in region “f”, which has been linked to stimulated dopamine 
production.185, 186 
The current study focuses entirely on the upregulated features found in 
the cocaine-experienced group. There is a wealth of information that is present in 
the regions of down-regulation. However, considering the pedagogical nature of 
this dataset, we have chosen to demonstrate the relevance of the MEDI method 
using a subset of the prioritized features.  
 
4.7 Conclusion and Perspectives 
 
We have proposed and described the MEDI workflow, in detail, and 
applied this method to a static set of samples. We have demonstrated the utility 
of self-organizing maps to distinguish underlying feature motifs. Features that 
contributed to these regions were putatively identified and metabolic connections 
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that have been well described as consequential of cocaine exposure were 
established.  
Though this method was applied to data acquired using mass 
spectrometry based detection, it is easily be applied to other metabolomics 
platforms (i.e., NMR), in addition to further degrees of separation. We have also 
only indicated the application of the MEDI workflow on s:-tatic samples, though 
the GEDI core software is ideal to determine underlying temporal dynamics. 
MEDI is a method that provides a medium to express metabolic phenotype and 
prioritize features based upon underlying sample patterns.  
 
4.8 Supporting Information 
 
 Supporting information, including statistical summaries, can be found in 
APPENDIX 4. 
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Chapter 5 
 
PERSPECTIVES AND PROPOSED IMPROVEMENTS ON THE APPLICATION 
OF MVSA AND MEDI WORKFLOWS TO MULTIDIMENSIONAL SEPARATION 
METABOLOMICS 
 
5.1 Introduction 
 
In this work, we sought to expand and apply the capabilities of multi-
dimensional data collection and analysis to relevant systems, focusing on the 
interrogation of metabolites. This regards not only multi-dimensional separations, 
but also temporally defined data, which should be expanded upon in future work. 
A multitude of advancing integrations, applications, and modifications to enhance 
the applicability and functionality of these methods exist. Presented are 
meaningful endeavors that will advance metabolomic studies, and ameliorate the 
data processing bottleneck.  
A large portion of the presented research advances the field of natural 
product discovery and the interrogation of metabolite profiles of microbial 
systems (Chapters 2 & 3). The structural properties of natural products allow ion 
mobility to be considered an attribute for lead prioritization. Additionally, the 
presented methods allow the organization of the large data associated with 
microbial extracts in an unbiased manner, providing a method for rapidly 
discriminating distinct features from a large cohort of extracts. Further 
development of these methods will only serve to expedite discovery methods. 
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It should not be overlooked that recent scientific momentum has mounted 
for the integration of other broad-scope, hypothesis generating studies, such as 
genomics, transcriptomics, proteomics, and lipidomics.187 The integration of all 
these data into analyses provides connectivity in often isolated areas of research. 
This work has established a means for the comprehensive analysis of 
metabolites, a necessary framework for the establishment of more holistic 
studies. 
 
5.2 Microbial Metabolite Interrogation 
 
5.2.1 Extract Prioritization 
 The pursuit of new therapeutics from natural sources may require 
researchers to either approach discovery from the standpoint of analyzing 
extracts from many organisms in a high throughput fashion, screening for 
compounds based upon attributes (i.e. bioassay guided fractionation)188, or 
comprehensively mining a single organism.189 The implementation of the data 
acquisition and analysis methods described herein to either drug discovery 
approach allows unbiased prioritization of compounds, comparison of many 
extracts simultaneously, organization of analytes into unique feature regions 
using the MEDI process, and the addition of a structural attribute to detected 
analytes. 
For the initial comparison of many extracts to determine unique metabolic 
profiles, such as that described in Chapter 3, principal component analysis or 
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other multivariate statistical analysis methods are appropriate. Applying 
multivariate statistical analysis methods provides a global perspective of sample 
clustering, and can be used to prioritize extracts and lead compounds for further 
analysis through loadings interrogation.  
 
 
 
 
Figure 5.1. Principal component analysis of Streptomyces coelicolor extracts 
from various growth conditions. A global analysis of metabolic profiles reveals 
that the various methods for altering secondary metabolite production yield 
distinct differences. Region A is expanded in the callout, and principal 
components recalculated considering only mixed fermentation data. Regions B 
and C correspond to altered metabolism based upon transcription/translational 
mutations (as described in Chapter 3) and exposure to rare earth elements, 
respectively.  
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 Figures 5.1 and 5.2 demonstrate the approach of growing an organism 
under a larger array of conditions to change metabolic expression.189 The 
included data represent Streptomyces coelicolor extracts grown in the presence 
of the rare earth elements scandium and lanthanum (in varied concentrations), 
grown in mixed fermentation conditions with Micrococcus luteus, Bacillus subtilis, 
Escherichia coli, and Tsukamurella pulmonis, and mutated through conferring 
resistance to streptomycin and rifampicin (as described in Chapter 3). In Figure 
5.1, distinct metabolic differences exist dependent upon the growth conditions. 
The density of the data is observed in the expansion of the compressed region A, 
which, when isolated and principal components are recalculated, reveals 
metabolic profile differences amongst mixed fermentation conditions.  
The selected heat map in Figure 5.2 corresponds to a mixed fermentation 
condition with Tsukamurella pulmonis, a mycolic acid-containing organism that 
has been demonstrated to change Streptomycete secondary metabolism 
expression.190 The heat map represents features organized based upon all 
growth conditions with monoclonal cultures subtracted, leaving persisting regions 
of increased abundance representative of aberrant metabolism. This prioritized 
two regions of interest that corresponded to increased production of geosmin and 
3,8-dihydroxy-1-methylanthraquinone-2-carboxylic acid (DMAC), known 
secondary metabolites of Streptomyces coelicolor.191 This proof-of-principal 
demonstrates the application of the MEDI workflow to natural product discovery 
and, more generally, the interrogation of microbial extracts. However, this does 
not address the true bottleneck. 
 146 
 
 
Figure 5.2. MEDI heat map of a select Streptomyces coelicolor extract grown in 
competition with Tsukamurella pulmonis. Using the MEDI process, one of a 
number of potential growth conditions (shown above) is selected and analyzed to 
determine compounds specific to the growth condition. The highlighted 
metabolites are upregulated in mixed fermentation conditions, and are known 
Streptomycete coelicolor secondary metabolites. 
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5.2.2 Feature Dereplication 
An automated means of interrogating the acquired fragmentation data for 
a prioritized lead would aid in dereplication. The presented study in Chapter 3 
was performed on a single, untargeted analysis, demonstrating the density of 
data acquired using multi-dimensional separations. Through the addition of ion 
mobility, high energy data were acquired for essentially all analytes of moderately 
high abundance that were isolated in separations space. Through commonly 
occurring in-source fragmentation of certain analytes, often labile molecular 
decorations such as glycosylation or phosphorylation, higher order fragmentation 
data can be acquired. These data can be confidently correlated through drift time 
chromatogram consistencies. For example, if a particular mass possesses two 
distinct drift times in a high energy spectrum, one corresponding to a longer drift 
time, and the other a shorter, and this peak is the precursor ion for the shorter 
drift time, it follows that insource fragmentation has likely occurred, and tandem 
information found corresponding to the shorter drift time is exclusive to the 
insource fragment ion. By extracting drift time specific fragmentation information, 
and subsequently performing accurate mass discriminated in silico comparisons 
of compounds present in the Dictionary of Natural Products, LIPID MAPS171, 
MetaCyc192, 193, the Human Metabolome Database168, 169, and METLIN170 using 
MetFrag194 or MassFragment (Waters, Milford, MA), confident dereplication can 
be automated. Additionally, a feature flagged as an insource fragment can be 
searched against a database of biotransformations. This higher order 
fragmentation data acquired from insource fragmentation can be used to 
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disambiguate structure. Additionally, analogous peak assignments for new 
compounds can be performed, providing insight into the moieties present. 
Features prioritized using initial filtering criteria, whether through 
multivariate statistical analysis and MEDI methods, or attribute analysis, such as 
molecular weight, relative elution time, and structural uniqueness, would be 
dereplicated through retention time and drift time correlated high energy data 
extraction and comparison to the aforementioned database in silico predictions. 
A modified threshold would be empirically established corresponding to the 
number of matched fragment peaks, fragmentation feasibility, and mass 
accuracy of matching peaks. The incorporation of higher order fragmentation, 
which is available through insource fragmentation, can be incorporated to 
increase peak assignment and overall molecule matching confidence.  
 
5.2.3 Lead Compound Mechanism of Action Determination 
A final addition to the proposed drug discovery pipeline is the ability to 
determine an unknown compounds mechanism of action through the 
metabolomic analysis of a bioactivity assay. Preliminary data, shown in Figure 
5.3, suggest metabolic indicators of mechanism of action exist which may be 
used to predict the mode of action for unknown compounds. The data shown 
represent biological duplicates of Escherichia coli cultures grown for 12 hours in 
the presence of lethal doses of apramycin, kanamycin, ampicillin, and 
vancomycin. These extracts were generated and analyzed in a similar fashion to 
 149 
those described in Chapter 3. Global analysis reveals biologically reproducible 
clustering based upon metabolic profiles, and warrant further investigation. 
 
 
 
 
Figure 5.3. Principal component analysis of Escherichia coli extracts after 12 
hours of treatment with various antibiotics with known mechanisms of action.  
Biological replicates indicate a reproducible clustering of extracts based upon 
treatment. Through analyzing antibiotics with known mechanisms of action, 
diagnostic metabolites can be determined to discern the mechanism of action of 
an unknown compound. 
 
Initially, the metabolic ramifications treating a model organism (such as 
Escherichia coli) with a library of antibiotics with known mechanisms of action will 
be analyzed to determine metabolic indicators. In this manner, a forensic 
approach can be taken to determine the mechanism of action for an unknown 
bioactive compound. The biological insight gained through comprehensive 
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analyses of metabolic perturbations resultant from antibiotic treatments should 
not be overlooked, which expands beyond target prediction of an unknown 
compound. Conceptually, bioactive fractions from extracts collected through split-
flow following LC can be extracted and analyzed for metabolic indicators of 
mechanism of action. Predictions of biological targets of bioactive fractions can 
be determined through comparisons to the training set.   
 
5.3 Metabolite Organization Enhancement 
 
 The use of self-organizing map based analysis of metabolic profiles has 
been demonstrated in Chapter 4. There exist a number of additions and 
modifications to the MEDI workflow that would aid in ease-of-use, and enhance 
the utility and comprehensiveness of analysis. Through adding additional 
functionality, modifying the MEDI interface, and expanding analysis beyond 
feature prioritization, the cumbersome nature of the current implementation will 
be ameliorated, in addition to providing significance to features and aiding in 
feature identification. 
 
5.3.1 MEDI Interface and Extension Modifications 
 The current MEDI process requires a significant amount of external 
processing and formatting. This generates a bottleneck at the manual stages of 
data analysis. Through interfacing peak-picking software and an mzXML viewer 
with the self-organizing map software, raw data can be accessed that 
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corresponds to a particular feature located at a node of interest. As mobility data 
becomes more ubiquitous amongst mass spectrometry laboratories, three-
dimensional peak picking software will allow for the full utilization of the acquired 
data. As a result, peaks with isobaric retention and mobility times found in high 
energy data, as routinely acquired in the MSE function (Chapter 1.5.1), can be 
called upon as well, providing automated return of fragmentation data for a 
particular node. It follows that these data be compared to publically available 
databases corresponding to the biological system in question, as described in 
Chapter 5.2.3.  
 Additionally, the ability to group samples prior to analysis, and later 
compare automatically detected regions of interest using univariate statistical 
methods, such as Welch’s t test (which accounts for unequal variances), ANOVA 
testing and subsequent post hoc analyses would provide significance to selected 
regions and prioritize groups of features. Selecting specific features from a region 
and performing these analyses is also useful for obtaining the significance of a 
specific feature, though multiple hypothesis testing correction, such as Bonferroni 
correction, may be necessary. Regions detection should be automated through a 
thresholding method195, which will first a region of interest, allowing the extraction 
of the features within, the statistics of the region across groups, and the 
contribution of features to the overall region intensity. 
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5.3.2 Inverse Feature Organization 
Currently, MEDI processing occurs through a self-organizing map 
algorithm that arranges features based upon relative similarities in intensity 
profiles across a time series or samples using Pearson’s correlation as the 
comparison metric.164 As a result, intensity profiles of features that are similar are 
grouped. However, there is utility in analyzing inverse correlations amongst 
features. When considering a dynamic profile, it is extremely useful to monitor 
and group features that behave in a relatively inverse fashion. It should be noted, 
however, that this method is not relevant when considering binary comparisons, 
as all discriminating features will be grouped into one region. 
 
5.3.3 High-Energy Data Comparison 
A final proposed addition is the ability to compare high energy data within 
regions of interest. Transitions found within high energy data for selected 
features would first be compared for descriptive fragmentation, such as the loss 
of a lipid head group, phosphorylation, or glycosylation, as well as common 
transitions such as b and y ions in peptides. This provides an initial discrimination 
of the broad biomolecular class the feature occupies in an automated manner. A 
second layer of comparison would investigate similarities amongst features within 
a region, to determine chemical relation between features. Existing high energy 
transitions for a feature would be compared to those present in grouped features. 
When considering features that demonstrate inverse intensity profiles, it is 
feasible that the depletion of one feature supplies the generation of another. 
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Feature correlations can be surmised with increased confidence through 
comparison of high energy data, and the assumption that similar transitions will 
exist between related but biotransformed molecules. Additionally, a filter for 
common biotransformations and adducts would allow for the distillation of 
features, and would require simple comparison of mass differences in features 
with similar retention time and mobility values. These methods would be 
particularly valuable for metabonomics experiments in the identification of drug 
metabolites. 
 
5.4. Integration into Trans-omics Studies 
  
The described work fits neatly into a larger agenda, which aligns with a 
recent thrust in the scientific community approach biological problems from a 
holistic standpoint.187 The visualization of metabolic profiles has significantly 
lagged behind the development of analysis methods.196 As a result, the MEDI 
process provides a means for visualizing metabolomic data, though 
advancements in the interface and functionalities are necessary, as 
aforementioned. Additionally, ion mobility separations were used in this work for 
both structural discrimination and as a means of analyte isolation in separation 
space, but the full capabilities of these measurements should be utilized for 
metabolite identification. 
Briefly, with advancements to MEDI, as described in the previous section, 
comparative metabolomics visualization and feature identification will be 
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enhanced to provide increased fragmentation confidence through the additional 
dimension of mobility separation in an untargeted manner, database searching 
using accurate masses and fragmentation spectra to discriminate matches, and 
correlation of features based upon up- or down-regulation trends. Through the 
addition of a mobility measurement discriminator, such as defined in previous 
works demonstrating biomolecular class separation in ion mobility76, additional 
scores can be incorporated into feature identification. With the extraction of 
absolute collision cross sections, which may be done using a uniform field 
instrument89 or through calibration profiles in traveling wave ion mobility107, 197 (as 
described in Chapter 1), assumptions of biomolecule class can be made, and 
through the development of a database with collision cross section values for 
metabolites, an additional parameter is available for metabolite identification. By 
enhancing the accessibility of metabolomics data through a more integrated 
interface, the potential of multi-dimensional separations data can be accessed. It 
should be noted, as well, that simultaneous metabolomics and lipidomics may be 
performed through the parsing of features based upon mobility-mass correlation, 
or predicted biomolecular class. 
When considering the integration of metabolomics data into a systems 
biology approach, the correlation of regions of interest to metabolic pathways is 
necessary. The ability to assign identifications to features and map regions of 
interest within MEDI to KEGG pathways174 allows for a direct comparison of 
metabolic ramifications. Furthermore, clustering of metabolic pathways based 
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upon self-organizing maps allows for organization of subgroups arising from 
potential biological variation.  
 
5.4 Conclusions and Perspectives 
 
 This work has significantly advanced the fields of metabolite analysis by 
applying established multivariate statistical analysis methods to microbial 
metabolome analysis, developing a metric utilizing gas phase structure for lead 
compound prioritization, and integrating self-organizing map based algorithms for 
metabolite analysis. As a result, new advancements are present that build upon 
the herein-established framework. By integrating the necessary components for a 
metabolomics study into a central interface, feature determination, prioritization, 
and identification can be performed in the same suite, with the subsequent 
options of retrieving higher order data and performing automated analyses of 
experimental groups based upon regions of interest. Additionally, mobility 
correlation can be further implemented as a metric for lead compound 
prioritization, and established as an attribute for feature scoring in drug discovery 
endeavors. The interrogation of many growth conditions or strains can be 
performed through combining multivariate statistical analysis methods with the 
MEDI approach, with subsequent dereplication aided by automated database 
searching and fragmentation analysis. 
The utility of the methods described herein is dependent upon the modification of 
the interface to incorporate feature detection, self-organizing map analysis along 
with multivariate statistical analysis methods, mobility and retention time 
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correlated feature high energy extraction, database searching using accurate 
mass and predicted fragmentation profiles in a central location. This package 
would provide a tool for secondary metabolite prioritization and dereplication for 
natural product discovery, along with primary metabolism insight and correlation 
to metabolic pathways.  
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Table A2.1. Cyclic peptide collision cross sections reported in Chapter 2. 
 
Cyclic Peptide Name  Species m/z (Da) Ω (Å
2
) σ (# of 
measurements) 
ampicillin [M+Na]
+
 373.6 110.1 1.3(20) 
valinomycin [M+H]
+
 1110.5 271.9 1.4(19) 
valinomycin [M+Na]
+
 1133.3 269.7 0.8(19) 
valinomycin [M+K]
+
 1149.5 274.5 0.6(19) 
cyclosporin [M+H]
+
 1202.6 296.6 1.2(19) 
polymyxin [M+H]
+
 1203.6 285.6 1.0(19) 
cyclosporin [M+Na]
+
 1224.4 289.9 1.2(19) 
polymyxin [M+Na]
+
 1225.3 279.4 0.9(19) 
polymyxin [M+K]
+
 1240.2 284.4 4.9(19) 
actinomycin [M+H]
+
 1255.9 280.1 1.9(18) 
actinomycin [M+Na]
+
 1277.9 284.2 0.7(19) 
actinomycin [M+K]
+
 1293.8 280.8 4.1(17) 
bacitracin [M+H]
+
 1421.6 301.2 0.8(19) 
phleomycin [M+H]
+
 1427.7 275.7 1.3(13) 
bacitracin [M+Na]
+
 1444.6 305.3 1.0(19) 
phleomycin [M+Na]
+
 1448.4 276.7 1.2(19) 
vancomycin [M+H]
+
 1449.2 299.4 0.9(20) 
bacitracin [M+K]
+
 1466.6 303.6 2.3(10) 
vancomycin [M+Na]
+
 1470.6 296.0 3.7(20) 
vancomycin [M+K]
+
 1485.3 299.4 3.8(15) 
phleomycin [M+Cu]
+
 1489.5 276.8 2.7(19) 
thiostrepton [M+H]
+
 1668.6 310.0 1.6(20) 
thiostrepton [M+Na]
+
 1686.1 315.5 1.0(20) 
thiostrepton [M+K]
+
 1702.6 314.8 3.0(10) 
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Procedures used in Chapter 2.3. 
 
Charge Derivation Protocol 
All molecules were first build in ChemBioDraw Ultra. Molecules were 
broken into fragments for charge derivation of feasible size for quantum based 
energy minimization and charge calculations (i.e. ~120 atoms or less). An initial 
energy minimization was performed using a B3LYP/HF 6-31G* level of quantum 
theory in Gaussian03.198 After determining the calculation had converged upon a 
local minimum, the frequency values were interrogated to ensure the calculation 
had not rested upon a saddle point. These energy minimized structures were 
then subjected to further ab initio optimization and electrostatic potential 
calculations using Gaussian03, mimicking the protocol derived for the general 
Amber force field, applying a HF/6-31G* basis set and the Merz-Singh-Kollman 
scheme for charge parameterization. 
 
Molecular Dynamics Protocol 
All molecular dynamics simulations were generated using the Amber 11 
Molecular Dynamics Package.199 Charge densities were converted to restrained 
electrostatic potential (RESP) values and prep files using antechamber.  
 Intact molecules were assembled and sodiated in LeAP using prep files. 
GAFF95 (general AMBER force field) was used for atom type descriptions. To 
define the sodium cation, AMBER99SB97, 200 force field was used. Topology and 
coordinate files were generated for molecular dynamic simulations in sander. 
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Restraint files were generated for the sodium cation such that full exploration of 
the assembled molecule was possible, but if the cation began to stray into space, 
a force would be applied to facilitate return. Upon inspection of trajectory files, 
this restraint was not necessary, as the cation remained proximal to the 
molecule, yet was still able to fully explore all regions of the molecule. Prior to 
simulation, an energy minimization was performed using sander to ensure a 
stable starting structure. The simulated annealing protocol was carried out in 
three steps. First, the structure was heated to ~1200-1500K over 10 picoseconds 
using 0.25 femptosecond time steps. The structure was then held at this 
temperature for 9 nanoseconds using 0.25 femptosecond time steps, extracting a 
conformation every 3 picoseconds, resulting in 3000 conformational snapshots. 
These snapshots were cooled to ~320K over 15 picoseconds to allow the 
conformation to find a local minima. To generate the desired 24,000 
conformations, this protocol was performed 8 times, using unique starting 
conformations for each to promote enhanced sampling of conformational space. 
Each conformation was then converted to a collision cross section using 
MOBCAL.26, 98 The collision cross section and potential energy for each 
conformation was then extracted and visualized using a scatter plot. Data were 
then discriminated using the measured collision cross sections, with the sampling 
window ± 2 times the error of the measurement.  
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Clustering Protocol 
The extracted conformations were then aligned using superpositioning 
software, suppose, written by Jarrod Smith (Vanderbilt Center for Structural 
Biology). These structures were then clustered based upon their root mean 
square distance (RMSD) over all atoms. A cutoff was then determined based 
upon the RMSD which resulted in approximately 19-21 conformations. This value 
was then imposed, and the most representative conformation from each branch 
of the cluster was extracted. This in effect distilled the data from ~400-2000 
conformations to 20 which could be interrogated. PDB files for each were 
generated and interrogated using Molecular Operating Environment (MOE).201 
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Figure A2.1. Chemical structure of sodiated vancomycin. Monoisotopic mass 
was measured to be 1470.42 Da. The calculated collision cross section used for 
conformation discrimination is 293.41 ± 7.22 Å2, which is a window two times the 
error of the measurement. 
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Figure A2.2. Scatter plot representative of 24,000 sodiated vancomycin 
conformations. Plotted on the abscissa is collision cross section in Å2, while the 
ordinate displays the relative potential energy of the conformation in kcal/mol. 
Each circle is representative of a unique conformation. The dashed blue lines 
indicate the region corresponding to experimentally measured CCS values. The 
width of the window corresponds to two times the standard deviation of the 
measurement. The data falling within the defined region were extracted for 
clustering analysis. Similar scatter plots were generated for all data to ensure 
proper sampling (not shown). It should be noted that this method of data 
projection does not express the data density with respect to conformational 
space occupation. 
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Figure A2.3. Clustering analysis of 2010 sodiated vancomycin conformations 
extracted from a set of 24,000 based upon collision cross section correlation. As 
the tree progresses from right to left, the clustering tolerance is increased. 
Clustering was done on the basis of root mean square distance of atoms after 
superimposing structures. The red dashed line indicates the cutoff for the 
generation of representative conformations. The green circles correspond to 
each branch that represents the entire dataset. In the end, all conformations 
were distilled into 20 representative structures. A clustering cutoff of 5.23 
Angstroms was implemented. 
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Vancomycin Conformation 1. n=140 
 
 
 
Vancomycin Conformation 2. n=116 
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Vancomycin Conformation 3. n=159 
 
 
 
Vancomycin Conformation 4. n=275 
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Vancomycin Conformation 5. n=122 
 
  
 
Vancomycin Conformation 6. n=101 
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Vancomycin Conformation 7. n=69 
 
  
 
Vancomycin Conformation 8. n=132 
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Vancomycin Conformation 9. n=103 
 
  
 
Vancomycin Conformation 10. n=119 
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Vancomycin Conformation 11. n=131 
 
  
 
Vancomycin Conformation 12. n=35 
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Vancomycin Conformation 13. n=45 
 
  
 
Vancomycin Conformation 14. n=58 
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Vancomycin Conformation 15. n=44 
 
  
 
Vancomycin Conformation 16. n=90 
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Vancomycin Conformation 17. n=45 
 
 
 
Vancomycin Conformation 18. n=29 
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Vancomycin Conformation 19. n=154 
 
 
 
Vancomycin Conformation 20. n=43 
 
Figure A2.4. Shown above are the 20 representative conformations of sodiated 
vancomycin generated from the simulated annealing molecular dynamics 
protocol. Each conformation represents between 30 and 300 structures, as 
indicated by n. Distances in Angstroms are annotated to indicate proximity of 
sodium cation. Carbon atoms are shown in grey, hydrogen in white, nitrogen in 
blue, oxygen in red, chlorine in green, and sodium in yellow. 
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Figure A2.5. Chemical structure of sodiated valinomycin. Monoisotopic mass 
was measured to be 1133.34Da. The calculated collision cross section used for 
conformation discrimination is 269.72 ± 1.65 Å2, which is a window two times the 
error of the measurement. 
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 Figure A2.6. Clustering analysis of 302 sodiated valinomycin conformations 
extracted from a set of 24,000 based upon collision cross section correlation. As 
the tree progresses from right to left, the clustering tolerance is increased. 
Clustering was done on the basis of root mean square distance of atoms after 
superimposing structures. The red dashed line indicates the cutoff for the 
generation of representative conformations. The green circles correspond to 
each branch that represents the entire dataset. In the end, all conformations 
were distilled into 21 representative structures. A clustering cutoff of 5.09 
Angstroms was implemented. 
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Valinomycin Conformation 1. n=7 
 
 
 
Valinomycin Conformation 2. n=6 
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 Valinomycin Conformation 3. n=12 
 
 
 
 Valinomycin Conformation 4. n=6 
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 Valinomycin Conformation 5. n=12 
 
 
 
 Valinomycin Conformation 6. n=14 
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 Valinomycin Conformation 7. n=7 
 
 
 
 Valinomycin Conformation 8. n=5 
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 Valinomycin Conformation 9. n=14 
 
 
 
 Valinomycin Conformation 10. n=25 
 
 183 
 
 
 Valinomycin Conformation 11. n=15 
 
 
 
 Valinomycin Conformation 12. n=21 
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 Valinomycin Conformation 13. n=18 
 
 
 
 Valinomycin Conformation 14. n=9 
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 Valinomycin Conformation 15. n=20 
 
 
 
 Valinomycin Conformation 16. n=18 
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 Valinomycin Conformation 17. n=11 
 
 
 
 Valinomycin Conformation 18. n=10 
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 Valinomycin Conformation 19. n=30 
 
 
 
 Valinomycin Conformation 20. n=16 
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 Valinomycin Conformation 21. n=26 
 
Figure A2.7. Shown above are the 21 representative conformations of sodiated 
valinomycin generated from the simulated annealing molecular dynamics 
protocol. Each conformation represents between 5 and 30 structures, as 
indicated by n. Distances in Angstroms are annotated to indicate proximity of 
sodium cation. Carbon atoms are shown in grey, hydrogen in white, nitrogen in 
blue, oxygen in red, and sodium in yellow. 
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Figure A2.8. Chemical structure of sodiated cyclosporin A. Monoisotopic mass 
was measured to be 1224.40 Da. The calculated collision cross section used for 
conformation discrimination is 289.87 ± 2.37 Å2, which is a window two times the 
error of the measurement. 
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Figure A2.9. Clustering analysis of 807 sodiated cyclosporin A conformations 
extracted from a set of 24,000 based upon collision cross section correlation. As 
the tree progresses from right to left, the clustering tolerance is increased. 
Clustering was done on the basis of root mean square distance of atoms after 
superimposing structures. The red dashed line indicates the cutoff for the 
generation of representative conformations. The green circles correspond to 
each branch that represents the entire dataset. In the end, all conformations 
were distilled into 19 representative structures. A clustering cutoff of 5.67 
Angstroms was implemented. 
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 Cyclosporin A Structure 1. n=76 
 
 
 
 Cyclosporin A Structure 2. n=59 
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 Cyclosporin A Structure 3. n=49 
 
 
 
 Cyclosporin A Structure 4. n=24 
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 Cyclosporin A Structure 5. n=48 
 
  
 
Cyclosporin A Structure 6. n=39 
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Cyclosporin A Structure 7. n=46 
 
 
 
 Cyclosporin A Structure 8. n=38 
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Cyclosporin A Structure 9. n=62  
 
  
 
Cyclosporin A Structure 10. n=23  
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Cyclosporin A Structure 11. n=63 
 
  
 
Cyclosporin A Structure 12. n=33  
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Cyclosporin A Structure 13. n=41 
 
  
 
Cyclosporin A Structure 14. n=46 
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Cyclosporin A Structure 15. n=19 
 
  
 
Cyclosporin A Structure 16. n=23 
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Cyclosporin A Structure 17. n=63 
 
  
 
Cyclosporin A Structure 18. n=30 
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Cyclosporin A Structure 19. n=25 
 
Figure A2.10. Shown above are the 21 representative conformations of sodiated 
cyclosporin A generated from the simulated annealing molecular dynamics 
protocol. Each conformation represents between 10 and 80 structures, as 
indicated by n. Distances in Angstroms are annotated to indicate proximity of 
sodium cation. Carbon atoms are shown in grey, hydrogen in white, nitrogen in 
blue, oxygen in red, and sodium in yellow. 
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Figure A2.11. Chemical structure of sodiated polymyxin B. Monoisotopic mass 
was measured to be 1225.74 Da. The calculated collision cross section used for 
conformation discrimination is 275.65 ± 4.03Å2, which is a window two times the 
error of the measurement. 
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Figure A2.12. Clustering analysis of 891 sodiated polymyxin B conformations 
extracted from a set of 24,000 based upon collision cross section correlation. As 
the tree progresses from right to left, the clustering tolerance is increased. 
Clustering was done on the basis of root mean square distance of atoms after 
superimposing structures. The red dashed line indicates the cutoff for the 
generation of representative conformations. The green circles correspond to 
each branch that represents the entire dataset. In the end, all conformations 
were distilled into 20 representative structures. A clustering cutoff of 5.45 
Angstroms was implemented. 
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Polymyxin B Conformation 1. n= 66 
 
  
 
Polymyxin B Conformation 2. n= 84 
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Polymyxin B Conformation 3. n= 66 
 
  
 
Polymyxin B Conformation 4. n= 66 
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Polymyxin B Conformation 5. n= 91 
 
  
 
Polymyxin B Conformation 6. n= 45 
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Polymyxin B Conformation 7. n= 33 
 
  
 
Polymyxin B Conformation 8. n= 50 
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Polymyxin B Conformation 9. n= 61 
 
  
 
Polymyxin B Conformation 10. n= 21 
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Polymyxin B Conformation 11. n= 36 
 
  
 
Polymyxin B Conformation 12. n= 23 
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Polymyxin B Conformation 13. n= 27 
 
  
 
Polymyxin B Conformation 14. n=32 
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Polymyxin B Conformation 15. n= 24 
 
  
 
Polymyxin B Conformation 16. n= 52 
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Polymyxin B Conformation 17. n= 38 
 
  
 
Polymyxin B Conformation 18. n= 12 
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Polymyxin B Conformation 19. n= 30 
 
 
 
Polymyxin B Conformation 20. n=17 
 
Figure A2.13. Shown above are the 20 representative conformations of sodiated 
polymyxin B generated from the simulated annealing molecular dynamics 
protocol. Each conformation represents between 10 and 100 structures, as 
indicated by n. Distances in Angstroms are annotated to indicate proximity of 
sodium cation. Carbon atoms are shown in grey, hydrogen in white, nitrogen in 
blue, oxygen in red, and sodium in yellow. 
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Procedures used in Chapter 2.6 
 
General experimental procedures 
All chemicals and drugs were purchased from Sigma manufacturer. All 
strains and primers used are listed in Table S1. 1H, 13C and 2D NMR spectra of 
pure compounds were recorded with a Bruker 600 MHz instrument equipped with 
5mm Z-gradient TCI Cryo-probe. IMMS were performed on a SYNAPT G2 
HDMS (Waters, Milford, MA) mass spectrometer equipped with a nanoAcquity 
UPLC and autosampler (Waters, Milford, MA). 
 
Cultivation 
Water was collected from a pool within travel distance of the sample site 
and filter-sterilized using a 0.22 mm nitrocellulose filter. A sterile Dremel tool was 
used to cut ~ 5 g piece of wall rock at each sample site, which was crushed in 
situ using a sterile steel pestle and mortar. Approximately 1 g of this material was 
then placed in 2 ml of the sterile cave water and mixed by shaking. The 
supernatant was used to inoculate the culture media.  An uninoculated plate was 
used as a sampling control, to confirm that any growth was not the result of 
human contamination (either through preparation or during sample collection). 
The culture was carried out of the cave and shipped to the laboratory at 4°C (2 
days), before incubating in the dark at 21°C (the temperature of Lechuguilla 
Cave) for approximately 4 weeks.  All unique colonies were isolated in pure 
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culture and transferred to a 50% concentration of trypticase soy agar (TSA; 
(Difco™, Becton Dickinson, Franklin Lakes, NJ). 
 
Strain Identification 
To identify all the isolates, genomic DNA was extracted from each colony 
using a ZR Fungal/Bacterial DNA Kit (Zymo Research, Orange, CA) and the 16S 
ribosomal RNA gene sequences isolated as via PCR as previously described 
(Banks et al., 2010).  Sequencing was carried out at the University of Kentucky 
Advanced Genetic Technologies Center (http://www.uky.edu/Centers/AGTC) and 
each species was identified by comparison with the NCBI Genbank database, 
with phylogenetic placement was confirmed via maximum likelihood analyses as 
described (Bhullar et al., 2012). 16S sequence of LC30 was deposited in 
Genbank database under accession number JN863449. 
 
Growth and production conditions 
The growth media contained a soil-extract of 40 mg/L humic acids, 4 g/L 
CaCO3 light-powder (Sigma Chemical) and 1.5 g/L agarose (Difco™, Becton 
Dickinson, Franklin Lakes, NJ).  The humic acids were extracted from 
commercially available potting soil as follows: 100 g of soil was mixed with 400 
ml of water and the pH was adjusted to 7.0 using 1 M NaOH, this slurry was 
allowed to stir for 4 hours, after which the supernatant was collected by settling of 
the particulate matter followed by decanting of the supernatant. This supernatant 
was then successively filtered, first through cheesecloth and then through 
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increasingly fine Whatman (grade 6) filter papers.  The pH of the clarified 
supernatant was dropped to 1.0 using 1 M HCl and stirred gently for 4 hours, 
allowing the humic acids to precipitate.  Centrifugation at 10,000 x g was then 
used to separate the humic acid pellet, which was resuspended in approximately 
100 mL of dH2O and adjusted to pH 7.0 using NaOH.  The total organic carbon 
(TOC) content of the humic acid solution was measured as 2 mg/mL using the 
persulfate-ultraviolet method on a Shimadzu TOC analyzer by WATERS testing 
services, KY (waters.waterky.org).LC30 spore suspension was inoculated on 
ISP2 agar ( 0.4% glucose, 0.4% yeast extract, 1% malt extract, 2% agar) and 
incubated for 7 days at 30°C.A loop full spore sample was transferred into seed 
culture ( 0.4% glucose, 0.4% yeast extract, 1% malt extract) for another 7 days of 
incubation at 30°C. For fermentation, four 500 mL flask containing BA medium ( 
1.5% soybean powder, 1% glucose, 1% soluble starch, 0.3% NaCl, 0.1% 
MgSO4·7H2O, 0.1% K2HPO4 ) were inoculated with 25 mL of seed culture each 
and incubated at 30°C for 7 days. 
 
Extraction and compound purification 
HP-20 Diaion resin was added into 7 days fermentation cultures. Cells and 
resin were separated from the broth and extracted with methanol and acetone. 
Extracts were dried and analyzed by HPLC/MS with TSQ Triple quantum mass 
spectrometer equipped with ESI and Surveyor PDA detector with a linear 
gradient of water/acetonitrile containing 10 mM ammonium acetate using Thermo 
Fisher Xcalibur 2.1.0 as data analysis software and IMMS on a SYNAPT G2 
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HDMS (Waters, Milford, MA) mass spectrometer equipped with a nanoAcquity 
UPLC and autosampler(Waters, Milford, MA). For compound purification, crude 
extract was dissolved in methanol and applied on Sephadex LH20 size exclusion 
column for prefractionation. LH20 fraction was injected into RP-HPLC and 
separated with linear gradient of water/acetonitrile containing 10mM ammonium 
acetate. Finally, the HPLC fraction containing mixture of lechamycins was 
applied on Sephadex LH20 size exclusion column yielding X mg of Lechamycin 
A, X mg of Lechamycin B and X mg of Lechamycin C. 
 
Ion mobility-mass spectrometry 
MeOH extracts were diluted in 100% H2O w/ 0.1% formic acid at a 
concentration of 10μg/mL and infused at a constant flow of 7.0 μL/min for 3 min. 
Ion mobility-mass spectrometry analysis was performed on a Synapt G2 HDMS 
(Waters, Milford, MA). Calibration was performed on date of acquisition with 
sodium formate clusters with a range of 50-1400 Da with a tolerance of 1ppm. 
Data were acquired at 2 Hz in resolution continuum mode. The capillary voltage 
was set at 4.00 kV, source temperature held constant at 80°C, the sampling cone 
was held at a setting of 40, with the extraction cone at a setting of 3.0. The 
nitrogen desolvation gas flow was held at a temperature of 150°C and a flow rate 
of 600.0 L/hr. The nitrogen cone gas flow was set to 20.0 L/hr. The helium cell 
prior to the mobility chamber had a gas flow setting of 180.0, and the ion mobility 
nitrogen gas flow was set to 90.0 mL/min. The ion mobility wave velocity was 
held constant at 550 m/s at a wave height of 40.0V. Data were peak-picked 
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within DriftScope (Waters, Milford, MA) with a threshold of 500 counts, a TOF 
resolution parameter of 10,000, and a mobility peak width parameter of 14 scans. 
These data were exported for further analysis in Excel (Microsoft, Redmond, 
WA). 
Exported peaks were used to generate a mobility-mass correlation using 
regression analysis. The subsequent line of regression was used to predict the 
mobility for a given mass, and the percent deviation for detected peaks was 
generated for prioritization. 
 
Structure elucidation of Lechacyclines 
Lechacycline A (1) was isolated as pale yellow solid with the UV spectrum 
showing absorption maxima at 205, 238 and 359 nm. The HR-MS of m/z 
1200.4713 [M+H]+ combined with 1H and 13C NMR spectral data (Table S1) 
determined the molecular formula of C54H77N3O25S. The 13C NMR and HMBC 
spectra indicated the presence of 54 carbons including 5 methyl groups, 10 
methylenes, 25 methines and 14 quaternary carbons. The 2D NMR signals 
allowed establishing partial structures (I-IV) with I being aglycone fragment, II 
and III being disaccharide and monosaccharide respectively and IV being an 
unusual mycothiol moiety. The HSQC data suggested the presence of four 
monosaccharide fragments within the molecule, including three O-glycosides and 
one C-glycoside. The COSY, HSQC and HMBC correlations indicated that the 
aromatic ring of aglycone (I) is tetrasubstituted with the hydroxyl group in C-8 
position and C-glycoside in C-9 position. The HMBC correlations from proton H-
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11 to carbons C-12 and C-7 suggested the presence of another ring adjacent to 
the aromatic ring with two carbonyls in positions C-12 (δ=191.8) and C-7 
(δ=197.9) with 13C NMR chemical shifts typical for a quinone-type ring that lacks 
double bonds. The COSY correlations between protons H-6 and H-5 and the 
HMBC correlations from methylene protons H-6 to carbons C4a, C-6a and C-12a 
allowed assembling another ring of aglycone fragment (I). The chemical shifts of 
carbons C-12a, C-12b and C-4a suggested that they all have hydroxyl groups 
attached, whereas quaternary carbon C-6a was shifted significantly upfield with 
chemical shift (δ= 60.5) typical for sulfur substituent. This was supported by 
chemical formula of 1. The last ring was assembled based on 1H proton and 13C 
carbon chemical shifts and HMBC correlations from proton H-2 to carbon C-12b, 
from methyl protons to carbon C-3 and from methylene protons H-4 to carbons 
C-4a and C-12b. The partial structure I turned out to be tetracyclic aglycone with 
ring assembly characteristic for angucycline family compounds. The COSY and 
TOCSY NMR spectral data allowed establishing carbon backbone of two 
monosaccharide fragments of partial structure II. The HMBC correlation from 
proton H-4’ to carbon C-1’’ allowed assembling two monosaccharide fragments 
into disaccharide. Finally we were able to assign relative stereochemistry of 
partial structure II based on coupling constants present in 1H NMR spectrum and 
comparison of 13C NMR chemical shifts of fragment II and monosaccharides 
present in other, known anucyclines. The partial structure III was established 
based on 1H proton and 13C carbon chemical shifts and also COSY and HMBC 
spectral data. The presence of anomeric proton (δ = 5.25) attached to anomeric 
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carbon (δ= 94.9) in HSQC spectrum indicated that fragment III is a 
monosaccharide. The carbon C-4’’’ was shifted upfield significantly (δ = 50.0) 
suggesting the presence of amine in this position. The coupling constants 
present in 1H proton spectrum allowed assigning the relative stereochemistry of 
partial structure III which turned out to be unusual amino sugar tolyposamin that 
was previously observed for some angucyclines. The last partial structure (IV) 
was assembled based on 1H proton and 13C carbon chemical shifts and HMBC 
spectral data. HMBC correlations from proton H-14 to carbons C-15 and C-16 
and from methyl protons H-16 to carbon C-16 allowed toassemble the first 
component of IV that turned out to be acetylcysteine. COSY and HMBC 
correlations allowed assembling two other components: monosaccharide 
glucosamine and another 6-membered ring that turned out to be inositol. The 
HMBC correlation from proton H-1’’’’ to carbon C-1’’’’’ established the 
connectivity between glucosamine and inositol moieties and HMBC from proton 
H-2’’’’ to carbon C-15 suggested that the glucosamine-inositol fragment and 
acetylcysteine moiety are connected through N-glycoside bond. Finally, the 
coupling constants present in proton spectrum of 1 indicated the relative 
stereochemistry of 6-membered rings in partial structure IV. The whole fragment 
consisted of glucosamine, inositol and acetylcysteine  called mycothiol was 
previously reported in literature (citation) as bacterial analog of glutathione. The 
absolute stereochemistry of mycothiol was established as 1-D-myo-inosityl 2-
deoxy-2-(N-acetamido-L-cystein-α-D-glucopyranoside (citation) which further 
supported our assignment of relative stereochemistry.  
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The key HMBC correlations allowed assembling all partial structures 
(Figure A2.3). The HMBC from proton H-1’ to carbon C-9 established 
connectivity between fragments I and II. The chemical shift of carbon C-1’ was 
characteristic to C-glycoside bond connection. Fragment III was connected to 
aglycone (I) based on HMBC from proton H-1’’’ to carbon C-6 and the attachment 
of fragment IV was established based on HMBC correlation from methylene 
protons H-13 to carbon C-6a. 
Lechacycline B (2) was isolated as a pale yellow solid with the UV 
spectrum showing absorption maxima at 205, 238 and 359 nm. The HR-MS of 
m/z 877.3457 [M+H] combined with 1H and 13C NMR spectral data (Table A2.4) 
determined the molecular formula of C42H56N2O16S. The 
13C NMR and HMBC 
spectral data indicated the presence of 42 carbons including 5 methyl groups, 9 
methylenes, 14 methines and 14 quaternary carbons. The 2D NMR signals 
allowed establishing partial structures (I-IV) with I being aglycone fragment, II 
and III being disaccharide and monosaccharide respectively and IV being 
acetylcysteine moiety. Comparative analysis of NMR data suggested that 
fragments I, II and III of 2 are the same as corresponding fragments of 1 but 
fragment IV lacked two 6-membered ring components and 13C NMR chamical 
shift of carbon C-15 (δ=175.6) of 2 was shifted downfield suggesting hydroxyl 
group in this position. The whole fragment turned out to be acetylcysteine. Again, 
the key HMBC correlations allowed establishing connectivity between fragments 
(Figure 2.7). 
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 Lechacycline C (3) was isolated as pale yellow solid with UV spectrum 
showing absorption maxima at 199, 238 and 360 nm. The HR-MS of m/z 
732.3223 [M+H]+ combined with 1H and 13C NMR spectral data (Table A2.5) 
determined the molecular formula of C37H49NO14. The 13C NMR and HMBC 
spectra indicated the presence 37 carbons including 4 methyl groups, 8 
methylenes, 13 methines and 12 quaternary carbons. The 2D NMR signals 
allowed assembling partial structures (I-III) and the comparative analysis of NMR 
data of Lechacycline C (3) and Lechacycline A (1) and B (2) indicated that 
fragments II and III of 3 are identical as corresponding fragments of 1 and 2, 
however the aglycone partial structure I was modified in 3. The downfield shift of 
carbon C-6a (δ= 78) suggested the replacement of acetylcysteine with hydroxyl 
group in 3. This was supported by molecular formula that is missing sulfur 
element. 
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Table A2.2. Regression statistics used for the generation of the inherent 
trendline in Figure 2.5. Percent deviations for lechamycin compounds are 
reported. 
 
Coefficients Standard Error 
Intercept 2.105241 0.289343 
X Variable 1 0.124053 0.000547 
 
Regression Statistics Compound m/z Measured Mobility 
Predicted 
Mobility 
Percent 
Deviation 
Multiple R 0.972964 Lechamycin C 733.322 109.01 93.11 17.08% 
R Square 0.946659 Lechamycin B 877.346 117.10 110.99 5.51% 
Adjusted R Square 0.94664 Lechamycin A 1200.470 166.68 151.10 10.31% 
Standard Error 7.026161 
Observations 2902 
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Table A2.3. NMR spectroscopic data for compound lechamycin A in CD3OD. 
 
Pos. 
13
C 
1
H HMBC 
1 195.4   
2 125 5.92, 1H, br s 3-Me, 12b 
3 160.8 
  
3-Me 24 2.04, 3H, br s 2, 3, 4 
4 37.1 2.90, 2H, br s, 13 Hz 2, 3, 3-Me, 4a, 5, 12b 
4a 80.3   
5 71.4 4.16, 1H, dd, 4 Hz, 12 Hz 1’’’ 
6 24.6 2.40, 1H, dd, 4 Hz, 13 Hz, 2.47, 1H, dd, 4 Hz, 13 Hz 4a, 5, 6a, 12a 
6a 60.7 
  
7 197.9 
  
7a 115.8   
8 159   
9 140.2   
10 133.9 7.84, 1H, d, 8 Hz 8, 11, 11a, 1’ 
11 120.5 7.66, 1H, d, 8 Hz 7, 7a, 9, 10, 12 
11a 131.6 
  
12 191.8   
12a 79.9 
  
12b 77.7 
  
13 33.6 2.56, 1H, dd, 6 Hz, 13 Hz 2.77, 1H, dd, 6 Hz, 13 Hz 6a, 14, 15 
14 54.3 4.36, 1H, dd, 6 Hz, 13 Hz 13, 15, 16 
15 171.8 
  
16 173.7 
  
16-Me 22.9 1.92, 3H, s 16 
1’ 65.9 5.08, 1H, br d 11 Hz 2’, 3’, 8, 9, 10 
2’ 32.4 1.53, 1H, 2.19, 1H, m 1’, 4’ 
3’ 26.4 1.94, 2H 1’, 2’, 4’, 5’ 
4’ 74.1 3.95, 1H 1’’, 5’-Me 
5’ 72.3 4.37, 1H 3’, 4’, 5’-Me 
5’-Me 11.7 1.33, 3H, d, 7 Hz 4’, 5’ 
1’’ 97.6 4.94, 1H, br d 3’’, 4’, 4’’ 
2’’ 24.9 1.43, 1H, 2.01, 1H, br dd, 11 Hz 1’’, 4’’ 
3’’ 26.4 1.68, 1H, 2.02, 1H, br dd, 12 Hz 1’’, 5’’ 
4’’ 67.9 3.54, 1H, br  2’’ 
5’’ 68 3.99, 1H, 
 
5’’-Me 17.9 1.15, 3H, d, 7 Hz 5’’ 
1’’’ 94.9 5.25, 1H, d, 3.5 Hz 5, 3’’’, 5’’’ 
2’’’ 24.2 1.69, 1H, m, 2.24, 1H, m 4’’’ 
3’’’ 24.5 1.84, 1H, 1.99, 1H 1’’’ 
4’’’ 50 3.18, 1H 2’’’ 
5’’’ 66.2 3.97, 1H, dq, 7 Hz 5’’’-Me 
5’’’-Me 17.5 1.15, 3H, d, 7 Hz 4’’’, 5’’’ 
 224 
1’’’’ 100.3 4.96, 1H, d, 4 Hz 1’’’’’,  
2’’’’ 55.7 3.82, 1H, dd, 4 Hz, 11 Hz 15, 4’’’’ 
3’’’’ 72.9 3.68, 1H, dd, 10 Hz, 11 Hz 2’’’’, 4’’’’ 
4’’’’ 72.3 3.25, 1H, t, 10 Hz 3’’’’, 5’’’’, 5’’’’-CH2OH 
5’’’’ 74.4 3.82, 1H, m 3’’’’ 
5’’’’-
CH2OH 
62.8 3.62, 1H, dd, 6 Hz, 12 Hz, 3.85, 1H, dd, 2 Hz, 12 Hz 5’’’’ 
1’’’’’ 81 3.46, 1H, dd, 3 Hz, 10 Hz 1’’’’, 2’’’’’ 
2’’’’’ 74 3.72, 1H, t, 10 Hz 1’’’’’, 3’’’’’ 
3’’’’’ 76.4 3.17, 1H, t, 10 Hz 4’’’’’ 
4’’’’’ 74.1 3.58, 1H, t, 10 Hz 3’’’’’, 5’’’’’ 
5’’’’’ 73.1 3.36, 1H, dd, 3 Hz, 10 Hz 4’’’’’ 
6’’’’’ 73.3 4.13, 1H, t, 3 Hz 1’’’’’, 4’’’’’ 
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Table A2.4. NMR spectroscopic data for lechamycin B in CD3OD. 
 
Pos. 
13
C 
1
H HMBC 
1 194.9   
2 125.1 5.87, 1H, br s 3-Me, 4, 12b 
3 160.1 
  
3-Me 24.1 2.00, 3H, br s 2, 3, 4 
4 37 2.86, 2H, br  3, 4a, 12b 
4a 80.2   
5 71.3 4.21, 1H, dd, 2 Hz 6, 1’’’ 
6 24.9 2.44, 1H, br dd 2 Hz, 2.47, 1H, brdd 2 Hz 5, 6a, 7, 12a 
6a 60.5 
  
7 197.8 
  
7a 115.9 
  
8 158.9   
9 140   
10 133.7 7.82, 1H, d, 8 Hz 8, 11, 11a, 1’ 
11 120.2 7.65, 1H, d, 8 Hz 7a, 9, 12 
11a 131.7 
  
12 192.4 
  
12a 79.6   
12b 77.8 
  
13 35.2 2.67, 1H, dd, 6 Hz, 12 Hz, 2.79, 1H, dd, 6 Hz, 12 Hz 14, 15 
14 55.2 4.22, 1H, dd, 6 Hz 15, 16 
15 175.6   
16 172.4 
  
16-Me 22.8 1.83, 3H, s 16 
1’ 65.8 5.09, 1H, dd, 2 Hz, 12 Hz 8, 9, 10 
2’ 32.4 
1.54, 1H, ddd, 2 Hz, 9 Hz, 12 Hz, 2.19, 1H, ddd, 2 Hz, 9 Hz, 
12 Hz 
1’, 4’ 
3’ 26.4 1.94, 2H, dd, 9 Hz 2’, 4’ 
4’ 74.1 3.95, 1H, dd, 6.5 Hz 3’, 5’, 5’-Me, 1’’ 
5’ 72.3 4.37, 1H, dq, 6.5 Hz 
 
5’-Me 11.7 1.32, 3H, d, 6.5 Hz 4’, 5’ 
1’’ 97.2 4.93, 1H, br 4’, 3’’, 4’’ 
2’’ 25.1 1.45, 1H, m, 2.01, 1H, m 1’’, 4’’ 
3’’ 26.7 1.67, 1H, m, 2.02, 1H, m 1’’, 4’’ 
4’’ 67.9 3.54, 1H, br 2’’ 
5’’ 68 3.99, 1H, dq, 6.8 Hz 4’’, 5’’-Me 
5’’-Me 17.7 1.13, 3H, d, 6.8 Hz 5’’ 
1’’’ 95.6 5.22, 1H, d, 3 Hz 5, 3’’’, 5’’’ 
2’’’ 24.8 1.78, 1H, m, 2.19, 1H, m 
 
3’’’ 24.5 1.68, 1H, m, 1.97, 1H, m 4’’’ 
4’’’ 50 3.08, 1H, br 3’’’ 
5’’’ 66.5 3.97, 1H, dq, 5.7 Hz 4’’’ 
5’’’-Me 17.5 1.13, 3H, d, 5.7 Hz 4’’’, 5’’’ 
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Table A2.5. NMR spectroscopic data for lechamycin A in CD3OD. 
 
Pos. 
13
C 
1
H HMBC 
1 196   
2 125.1 5.88, 1H, br 3-Me, 4, 12b 
3 160 
  
3-Me 24 2.00, 3H, br s 3, 4 
4 37 2.86, 2H, br 4a, 5, 12b 
4a 80.1   
5 70.1 4.06, 1H, dd 4.5 Hz, 12 Hz 
 
6 27.3 2.30, 1H, br, 2.42, 1H, br 6a 
6a 78.5 
  
7 201.3 
  
7a 116.1 
  
8 159   
9 139.8   
10 134.1 7.88, 1H, d, 8 Hz 8, 11, 11a, 1’ 
11 120.5 7.72, 1H, d, 8 Hz 7, 7a, 9, 10, 12 
11a 132.7 
  
12 194.5 
  
12a 78.4   
12b 78.2 
  
1’ 65.9 5.09, 1H, d, 2 Hz 9, 10, 2’ 
2’ 32.4 1.46, 1H, 2.14, 1H, ddd, 2.5 Hz, 13 Hz 
 
3’ 26.4 1.91, 2H, br 2’, 4’, 5’ 
4’ 74.1 3.94, 1H, m 5’-Me, 1’’ 
5’ 72.2 4.37, 1H, dq, 6.7 Hz 1’, 3’, 4’, 5’-Me 
5’-Me 11.7 1.33, 3H, d, 6.7 Hz 4’, 5’ 
1’’ 97.6 4.93, 1H 4’, 3’’, 5’’ 
2’’ 25.5 1.43, 1H, br, 2.00, 1H, br 1’’, 3’’, 4’’ 
3’’ 26.7 1.67, 1H, br, 2.01, 1H, br 1’’, 4’’ 
4’’ 67.9 3.53, 1H, br 2’’ 
5’’ 68 3.97, 1H, dq, 6.7 Hz 4’’, 5’’-Me 
5’’-Me 17.5 1.13, 3H, d, 6.7 Hz 5’’ 
1’’’ 94.5 5.12, 1H, br 2’’’, 5’’’ 
2’’’ 23.5 1.89, 1H, 2.30, 1H, m 
 
3’’’ 24.3 1.72, 1H, br, 1.95, 1H, br 
 
4’’’ 50.2 3.33, 1H, br 2’’’ 
5’’’ 65.4 4.01, 1H, br 4’’’, 5’’’-Me 
5’’’-Me 17.4 1.13, 3H, d, 6.7 Hz 4’’’, 5’’’ 
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APPENDIX 3 
 
SUPPORTING INFORMATION FOR CHAPTER 3 
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 Metabolomic analysis of microbial extracts 
 
Mutational analysis of antibiotic resistant mutants  
PCR of antibiotic resistance genes was performed using Taq DNA 
polymerase (Roche) and the primers listed in table A3.1. PCR products were 
purified and sequenced using BigDye Terminator chemistry and resolved on the 
ABI 3730xl or 3730 DNA analyzers.  
Table A3.1. Primers used in this study. 
Gene Primer name Sequence 
rpsL 
rpslf 5’-rtgccwacsatycagcag-3’ 
rpslr 5’-yccytcttvgcgccgtar-3’ 
rpoB 
rpobb1f 5’-ttggcagtctctcccgcgaa-3’ 
rpobb1r 5’-gacacgtccatgtagtcg-3’ 
rpobb2f 5’-ccgttcggcttcatcgag-3’ 
rpobb2r 5’-tgcacgacgtcgtccaccga-3’ 
 
Table A3.1(B). Mutations in rifampicin (R1-R5) and streptomycin (S1-S6) cohort 
Organism gene mutation 
R1 rpoB G3280A 
R2 rpoB G3280A 
R3 rpoB G3280A 
R4 rpoB G3280A 
R5 rpoB G3280A 
S1 rpsl No mutation 
S2 rpsl No mutation 
S3 rpsl A43G, C9G, G10C 
S4 rpsl C9G, G10C, G129C 
S5 rpsl No mutation 
S6 rpsl C9G, G10C 
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Liquid chromatography-ion mobility-mass spectrometry conditions 
 LC-IM-MS and LC-IM-MSE analyses were performed on a SYNAPT G2 
HDMS (Waters, Milford, MA) mass spectrometer equipped with a nanoAcquity 
UPLC and autosampler (Waters, Milford, MA). Metabolites were separated on a 
1 mm X 100 mm HSS C18 (1.8μm particle size) column and 1 mm X 20 mm HSS 
C18  (5μm particle size) guard column. Column temperature was maintained at 
40°C to minimize chromatographic drift, and the auto-injector sample tray held at 
4°C to minimize sample degradation. A double-loop injection volume of 10μL was 
injected in a 5μL loop. Chromatographic separations were performed by using a 
20 min gradient at a flow rate of 60 uL/min using a gradient mixer of 0.1% formic 
acid in H2O (mobile phase A) and 0.1% formic acid in ACN (mobile phase B). 
Briefly, the mobile phase was held constant at 100% A for 1 min, then ramped 
linearly to 100% B over 11 minutes, held for 2 minutes at 100%B, then returned 
to 100%A over 0.1min for a 5.9 min reequilibration period. All analytes were 
analyzed using positive mode electrospray ionization. Typical parameters include 
a capillary voltage of 3.0kV, sampling cone setting of 30.0 and extraction cone 
setting of 2.0, source temperature of 110°C, desolvation gas (N2) flow of 700 
L/hr, and a cone gas flow of 10 L/hr. Data were acquired in MSE mode, which 
acquires both a low energy spectrum and a high energy spectrum. Collision 
induced dissociation (CID) was performed post mobility separation with a ramped 
energy profile from 15-40 V in the high CID acquisition. Traveling wave velocity 
was held constant at 550 m/s and a height of 40.0 V. Data was acquired at a 
sampling rate of 2 Hz over the mass range 50-2000 m/z. Sodium formate (10 
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μg/mL) in 90:10 propan-2-ol:water (v:v) was used to calibrate over this range with 
< 1 ppm mass accuracy. Leucine enkephalin in 50:50 H2O:ACN with 0.1% formic 
acid (v:v) was used as a lock mass compound (accurate mass 278.1141, 
556.2771 Da) at a flow rate of 7.0 μL/min and a concentration of 2 ng/mL every 
10 seconds, with data corrected during acquisition. Data acquisition was 
performed from 0 to 20 minutes of the liquid chromatography separation. 
Duplicate technical analysis was performed in a randomized fashion; with quality 
control samples analyzed every 5 injections. Quality control samples contained 
equal volume aliquots of each sample mixed together. 
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Multivariate statistical analysis of microbial extracts from Micrococcus 
luteus, Escherichia coli, and Bacillus subtilis.  
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Figure A3.1. Principal component analysis of microbial extracts from 
Micrococcus luteus, Escherichia coli, and Bacillus subtilis. Symbols represent 
technical replicates. The clustering of technical replicates indicates instrument 
stability. The separation of groups indicates that the three organisms have 
sufficiently different metabolic profiles that the first two principal components are 
defined by these differences. 
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Figure A2.2. Orthogonal projection to latent structures-discriminant analysis 
(OPLS-DA) scores plot depicting R4 mutant vs. wild type in a binary fashion. 
OPLS-DA defines the first principal component as the eigenvector that with 
maximum eigenvalue of the covariance matrix between the two defined groups 
(R4 and wild type). The orthogonal vector describes the greatest intragroup 
differences.  
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Figure A2.3. Representative S-plot of R4 mutant (-1) vs. wild type (+1). This S-
plot corresponds to Figure A3.2, and is a visualization of loadings contribution. 
The correlation describes how specific to a particular group in the OPLS-DA a 
feature is (represented by a black dot). A correlation of 1 is perfect group 
correlation. The loadings correspond to the contribution of that feature to the first 
principal component of the OPLS-DA. As a result, outliers in quadrant I and III 
correspond to high abundance and exclusive features in the wild type and R4 
mutant extracts, respectively. For all analyses, a correlation cutoff of ≥0.9 was 
used. 
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E. coli B. sub M. lut. 
E. coli 0 46 42 
B. sub 126 0 40 
M. lut. 166 13 0 
 
 
 
Figure A3.4. Left: Feature specificity diagram comparing Bacillus subtilis, 
Escherichia coli, Micrococcusluteus. Pareto scaled OPLS-DA was used, and 
features with a correlation coefficient> 0.9 were considered specific to a group. 
There are 963 total features.Groups were permuted in a binary fashion, with two 
organisms compared against one at a given time. There are 838 shared features. 
Right. Feature specificity matrix comparing Bacillus subtilis, Escherichia coli, 
Micrococcusluteus in a binary fashion. Pareto scaled OPLS-DA was used and a 
correlation coefficient of >0.9 was used as a threshold for feature specific to an 
organism pair. The bottom half of the matrix corresponds to features specific to 
the organism indicated in the first column compared to the organism in the first 
row. The top half of the matrix corresponds to features specific to the organism in 
the first row when compared to the organism in the first column. There are 963 
total features. 
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Structure elucidation of mutaxanthenes 
Feature 1 (Fig. 3B, Table S2) was isolated with UV spectrum showing 
absorption maxima at 225, 252, 279 and 409 nm. The high resolution mass 
spectrum yielded an apparent m/z of 443.101, [M+H]+. Combining mass with 1H 
and 13C NMR spectral data (Table S2) determined molecular formula of 
C22H18O10 with 14 degrees of unsaturation. The 
13C NMR and HMBC spectra 
indicated the presence of 22 carbons including one methyl group, one methoxy, 
two methylene, five methine and thirteen quaternary carbons. The ten olefinic 
carbons and 5 carbonyls accounted for 10 degrees of unsaturaturation 
suggesting the presence of four rings. The 2D NMR spectral data allowed to 
establish partial structures (I - III) (Figure 3.3(A)). The COSY, HSQC and HMBC 
NMR correlations indicated that the aromatic ring of fragment a istrisubstituted 
with the hydroxyl group in C7 position. The chemical shifts of carbons C6 and 
C11 suggested that they are α,β-unsaturated carbonyls in a ring. The HMBC 
correlations from aromatic proton H10 to carbon C11 and from aromatic proton 
H8 to carbon C6 allowed to establish the positions of carbons C6 and C11 in the 
ring and suggested that they are adjacent to the aromatic ring. The structure of 
fragment a was confirmed by the feeding experiment with the 1,2-13C sodium 
acetate where the incorporation pattern allowed to unambiguously establish the 
carbon backbone of I. The partial structure II (Figure 3.3(A)) was determined 
based on 1H and 13C NMR chemical shifts, HMBC and 1,1-ADEQUATE 
correlations and confirmed with data from incorporation of labeled 1,2-13C sodium 
acetate experiment. The HMBC correlations from H12 methylene protons to the 
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quaternary carbons C11a and C12a indicated the position of C12 in the fragment 
II. The 1,1-ADEQUATE experiment and labeled acetate incorporation pattern 
further confirmed that C12 is adjacent to C11a and C12a. The chemical shift of 
methine C1 indicated the presence of neighboring oxygen atom. The HMBC 
correlations from H1 proton to C17 carbon and from H17 protons to C1 carbon 
confirmed the presence of the methoxy group attached to the methine C1. The 
HMBC correlations from proton H1 to carbons C2 and C12a indicated that 
methine C1 is adjacent to C2 and C12a and this was confirmed by 1,1-
ADEQUATE spectral data and labeled acetate incorporation pattern. The 
chemical shift of methine C4a also indicated the presence of neighboring oxygen. 
The HMBC correlations from proton C4a to carbons C4 and C12a suggested that 
they are adjacent and the position of carbon C3 was established based on 
labeled acetate incorporation pattern which indicated that carbons C2 and C3 are 
attached. Furthermore the HMBC correlation from proton H1 to carbon C3 
allowed assembling another ring within fragment II. The crucial HMBC and 1,1-
ADEQUATE correlations from protons H12 to carbon C11a and from proton C4a 
to carbon C5 determined the connectivity between fragments I and II and allowed 
to assemble the last ring which turned out to be unusual xanthene scaffold. 
Finally, the position of carboxylic acid moiety in fragment II was established 
based on HMBC correlations from H12 methylene protons, H4a methine proton 
and H1 methine proton to C16 carbon. The last partial structure III (Figure 
3.3(A)) was determined based on COSY correlations between methyl C15 and 
methylene C14 and HMBC from C14 protons to C13 ketone. Furthermore, the 
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HMBC correlations from C14 methylene protons to C3 quaternary carbon 
allowed assembling fragment II with fragment III and as result we proposed the 
final structure (Figure 3.3(B)). Mutaxanthene B (2) was assigned to the 
molecular formula of C23H20O10 by HR-MS (m/z 457.115, [M + H]
+). Comparison 
of 1H and 13C NMR spectra of compounds 1 and 2 revealed the presence of the 
additional methoxy group (δH 3.96, δC 56.9) which showed the HMBC 
correlations to two olefinic carbons (C7 and C8) in the aromatic ring (Table 
A3.3). The molecular formula of mutaxanthene C (3) was established as 
C21H16O10 by HR-MS of m/z 429.085, [M + H]
+. Comparison of 1H and 13C NMR 
spectra revealed the absence of methylene C14 and significant downfield shift of 
C15 methyl suggesting replacement of ethyl group with methyl group. The HMBC 
correlations to C13 and C3 confirmed the structure of 3 (Table A3.4). 
Mutaxanthene D (4) was assigned to the molecular formula of C22H19NO9. The 
1H and 13C NMR spectra of 1 and 4 were very similar with the most significant 
difference in chemical shift from 208.2 for 1 to 182.5 for 2 for carbon C13 
indicating the replacement of ketone group with amino group in this position 
along with equilibrium shift from endocyclicenol as dominant tautomer for 
compound 1 and ketone as dominant tautomer for compound 4 (Table A3.5). 
The structure of mutaxanthene E (5) was established based on molecular 
formula of C21H17NO9 and comparison of 
1H and 13C NMR spectra of 5 to 
compounds 3 and 4 indicating the presence of amino group in C13 position and 
methyl group adjacent to C13 carbon (Table A3.6).  
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Table A3.2. NMR spectroscopic data for compound 1 in CD3OD. 
 
 
 
Pos. 13C 1H HMBC JCC/Hz 
1 83.3 4.12, 1H, br 2,3,4a,12,12a, 16,17 br 
2 190.2   48.3 
3 109.1   60 
4 190.8   br 
4a 76.3 5.56, 1H, br 1,4,5,12,12a, 16 br 
5 154.3   61.6 
6 183.9   61.6 
6a 114.6   64 
7 162.3   64 
8 124.7 7.0, 1H, d, 8.3 Hz 6, 6a, 7, 10  58.2 
9 137.8 7.43, 1H, br dd, 8Hz 7, 10a 58.2 
10 119.6 7.24, 1H, d, 7.2Hz 6a, 8, 11 62.5 
10a 132.5   62.5 
11 183.3   56.9 
11a 120   56.9 
12 23.1 2.38, 1H br d, 3.08, 1H, br 
d, 19Hz 
1,4a,5,11,11a,12a,16 33.3 
12a 48   33.3 
13 208.2    
14 34.5 2.97, 2H, m 3, 13, 15 35.2 
15 8.3 1.05, 3H, br t, 7.1Hz 13, 14 35.2 
16 172.1    
17 60.9 3.5, 3H, br s 1  
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Table A3.3. NMR spectroscopic data for compound 2 in D2O. 
 
Pos. 13C 1H HMBC 
1 86.0 3.77, 1H, br 2, 3, 4a, 12, 12a, 16, 17 
2 188.6   
3 112.2   
4 189.5   
4a 76.5 5.44, 1H, br 4, 5, 12, 12a, 16 
5 154.5   
6 179.1   
6a 116.9   
7 159.6   
8 118.5 7.23, 1H, d,  6, 6a, 7, 10  
9 136.4 7.52, 1H, brdd,  7, 10a 
10 119.0 7.34, 1H, d,  6a, 8, 11 
10a 133.1   
11 184.8   
11a 117.6   
12 22.4 2.26, 1H br d,2.96, 1H, br d,  1, 4a, 5, 11, 11a, 12a, 16 
12a 48.2   
13 210.0   
14 35.8 2.55, 2H, m 13, 15 
15 8.5 0.89, 3H, br t,  13, 14 
16 176.5   
17 59.8 3.43, 3H, br s 1 
18 56.2 3.83, 3H, s 7, 8 
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Table A3.4. NMR spectroscopic data for compound 3 in CD3OD. 
 
Pos. 13C 1H HMBC 
1 82.9 4.17, 1H, br  
2 -   
3 109.6   
4 -   
4a 76.9 5.55, 1H, br  
5 154.4   
6 178.4   
6a 114.9   
7 162.6   
8 124.5 7.24, 1H, d,  6a, 7, 10  
9 137.7 7.65, 1H, brdd,  7, 10a 
10 119.4 7.56, 1H, d,  6a, 8,11 
10a 132.9   
11 183.4   
11a 119.9   
12 23.0 2.50, 1H br d,3.19, 1H, br d,  1, 4a, 5,6, 11, 11a, 12a, 16 
12a 48.1   
13 203.7   
14 27.4 2.56, 3H, s 3, 13 
15 172.0   
16 60.7 3.57, 3H, br s  
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Table A3.5. NMR spectroscopic data for compound 4 in D2O. 
 
Pos. 13C 1H HMBC JCC/Hz 
1 85.7 3.82, 1H, s 2, 3, 4a, 12, 12a, 16, 17 45.5 
2 192.5   45.5 
3 102.3   61.2 
4 192.2   61.2 
4a 77.2 5.43, 1H, d 1, 4, 5, 12, 12a, 16  
5 153.4   61.0 
6 183.1   61.0 
6a 113.3   64.5 
7 160.0   64.5 
8 123.8 7.0, 1H, d, 8.3 Hz 6, 6a, 7, 10  58.4 
9 137.1 7.43, 1H, dd, 8Hz 7, 10a 58.4 
10 119.2 7.22, 1H, d, 7.2Hz 6a, C8, 11 62.8 
10a 131.1   62.8 
11 183.9   57.6 
11a 119.9   57.6 
12 22.2 2.17, 1H dd,2.94, 1H, 
dd, 19Hz 
1, 4a, 5, 11, 11a, 12a, 16 34.4 
12a 47.3   34.4 
13 182.5   56 
14 29.8 2.83, 2H, dq 3, 13, 15 - 
15 11.3 1.09, 3H, t, 7.1Hz 13, 14 - 
16 175.8    
17 59.9 3.42, 3H, s 1  
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Table A3.6. NMR spectroscopic data for compound 5 in D2O. 
 
Pos. 13C 1H HMBC 
1 85.3 3.83, 1H, s 2, 3, 4a, 12, 12a, 16, 17 
2 192.7   
3 103.3   
4 192.3   
4a 77.4 5.42, 1H, d 1, 4, 5, 12, 12a, 16 
5 153.7   
6 183.3   
6a 113.6   
7 160.2   
8 123.8 7.15, 1H, d, 6, 6a, 7, 10  
9 137.1 7.56, 1H, dd, 7, 10a 
10 119.3 7.43, 1H, d, 6a, 8, 11 
10a 131.4   
11 184.6   
11a 120.0   
12 22.3 2.26, 1H dd,2.95, 1H, dd,  1, 4a, 5, 11, 11a, 12a, 16 
12a 47.6   
13 177.8   
14 24.2 2.41, 3H, s  13, 3 
15 175.9   
16 60.0 3.42, 3H, s 1 
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Figure A3.6. 1H proton NMR of mutaxanthene A (1) in CD3OD. 
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Figure A3.7. 13C carbon NMR of mutaxanthene A (1) in CD3OD. 
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Figure A3.8. 2D COSY NMR of mutaxanthene A (1) in CD3OD. 
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Figure A3.9. 2D HSQC NMR of mutaxanthene A (1) in CD3OD. 
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Figure A3.10. 2D HMBC NMR of mutaxanthene A (1) in CD3OD. 
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Figure A3.11. 2D NOESY NMR of mutaxanthene A (1) in CD3OD. 
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Figure A3.12. 2D 1,1-ADEQUATE NMR of mutaxanthene A (1) in CD3OD. 
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Figure A3.13. 1H proton NMR of mutaxanthene B (2) in D2O. 
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Figure A3.14. 13C carbon NMR of mutaxanthene B (2) in D2O  
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Figure A3.15. 2D COSY NMR of mutaxanthene B (2) in D2O. 
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Figure A3.16. 2D HSQC NMR of mutaxanthene B (2) in D2O. 
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Figure A3.17. 2D HMBC NMR of mutaxanthene B (2) in D2O. 
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Figure A3.18. 1H proton NMR of mutaxanthene C (3) in CD3OD. 
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Figure A3.19. 13C proton NMR of mutaxanthene C (2) in D2O. 
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Figure A3.20. 2D COSY NMR of mutaxanthene C (3) in CD3OD. 
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Figure A3.21. 2D HSQC NMR of mutaxanthene C (3) in CD3OD. 
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Figure A3.22. 2D HMBC NMR of mutaxanthene C (3) in CD3OD. 
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Figure A3.23. 1H proton NMR of mutaxanthene D (4) in D2O. 
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Figure A3.24. 13C proton NMR of mutaxanthene D (4) in D2O. 
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Figure A3.25. 2D COSY NMR of mutaxanthene D (4) in D2O. 
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Figure A3.26. 2D HSQC NMR of mutaxanthene D (4) in D2O. 
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Figure A3.27. 2D HMBC NMR of mutaxanthene D (4) in D2O. 
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Figure A3.28. 2D NOESY NMR of mutaxanthene D (4) in D2O. 
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Figure A3.29. 1H proton NMR of mutaxanthene E (5) 
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Figure A3.30. 2D COSY NMR of mutaxanthene E (5) in D2O. 
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Figure A3.31. 2D HSQC NMR of mutaxanthene E (5) in D2O. 
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Figure A3.32. 2D HMBC NMR of mutaxanthene E (5) in D2O. 
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Figure A3.33. 13C proton NMR of mutaxanthene A (4) enriched with 1,2-13C 
sodium acetate in CD3OD.  
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Figure A3.34. 13C proton NMR of mutaxanthene A (4) enriched with 1,2-13C 
sodium acetate in CD3OD.  
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Figure A3.35. 13C proton NMR of mutaxanthene D (4) enriched with 1,2-13C 
sodium acetate in CD3OD.  
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Figure A3.36. 13C proton NMR of mutaxanthene D (4) enriched with 1,2-13C 
sodium acetate in CD3OD.  
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Table A3.7. Deduced functions of ORFs in the mutaxanthene biosynthetic gene 
cluster 
 
gene 
size 
(aa) 
similar protein 
GeneBank 
accession 
numbers 
Identity(%)/ 
Similarity(%) 
proposed function 
MuxUp4 -577 
SSMG_06347, 
Streptomyces sp. AA4 
ZP_07282307  99/99 ABC transporter 
MuxUp3 -627 
SSMG_06347, 
Streptomyces sp. AA4 
ZP_07282307.1 99/98 ABC transporter  
MuxUp2 254 
SSMG_06348, 
Streptomyces sp. AA4 
ZP_07282308  96/98 ABC transporter 
MuxUp1 247 
SSMG_06349, 
Streptomyces sp. AA4 
ZP_07282309 96/98 ABC transporter 
MuxR2 114 
SSMG_06351, 
Streptomyces sp. AA4 
ZP_07282311 97/96 
PadR 
fam.transcriptional 
repressor 
MuxU1 128 SSMG_06350 ZP_07282310 94/98 hypothetical protein 
MuxU2 91 SSMG_06352 ZP_07282312.1 97/94 hypothetical protein 
MuxP1 332 
AlkNF, Streptomyces 
galilaeus 
BAB72049 69/55 
type II acyl 
transferase (AT) 
MuxP2 -345 
CosE, Streptomyces 
olindensis 
ABC00733 56/69 
type II ketosynthase 
(KS) for starter 
MuxP3 258 
PokC2, Streptomyces 
diastatochromogenes 
ACN64846 78/65 
type II polyketide 
cyclase 
MuxP4 250 
PokT1, Streptomyces 
diastatochromogenes 
ACN64844.1 64/50 
type II 
ketoreductase (KR) 
MuxP5 320 
orf6, Streptomyces 
echinatus 
ABL09954  69/57 
type II 
cyclase/dehydratase 
MuxP6 618 
Sfla_5326,Streptomyces 
flavogriseus 
YP_004926240  60/47 acyl CoA ligase 
MuxO1 412 
Sfla_5326,Streptomyces 
flavogriseus 
YP_004926243.1 70/55 
flavin-dependent 
oxidase 
MuxD1 262 
simA6, Streptomyces 
antibioticus 
AF324838_6  86/75 
type II 
ketoreductase 
MuxP7 -154 
SnoaL_4, uncultured 
bacterium (expressed) 
AEM44306.1 60/51 
type II 
cyclase/dehydratase 
MuxU3 288 none -- -- hypothetical protein 
MuxD2 253 
Strvi_4376, Streptomyces 
violaceusniger Tu 4113 
YP_004814300  61/42 
type II 
ketoreductase (KR) 
 275 
MuxM1 -341 
phzM, Saccharopolyspora 
erythraea 
YP_001106227 57/43 O-methyltransferase 
MuxT4 438 
SAV_5944,Streptomyces 
avermitilis 
NP_827121  63/47 transport efflux 
MuxT5 84 
Sros_2592, 
Streptosporangium roseum 
YP_003338305  72/50 transport efflux 
MuxP8 86 
ChaC, Streptomyces 
chartreusis 
CAH10163  69/51 
type II acyl carrier 
protein (ACP) 
MuxP9 431 
ORF32, uncultured 
bacterium (expressed) 
AEM44309  85/74 
type II beta-ketoacyl 
synthase (KS) 
MuxP10 402 
ORF2, uncultured bacterium 
(expressed) 
AEM44279.1 66/53 
type II beta-ketoacyl 
synthase (KS) 
MuxR3 681 RubS. Streptomyces collinus AAM97369.1 55/41 
SARP type 
transcriptional 
activator  
MuxD3 252 
ORF2, uncultured bacterium 
(expressed) 
AEM44279  66/53 
type II 
ketoreductase (KR) 
MuxO2 511 
ORF20, uncultured 
bacterium (expressed) 
AEM44297  71/61 
flavin-dependent 
oxidase 
MuxM2 335 
SsfM1, Streptomyces sp. 
SF2575 
ADE34508.1 72/89 O-methyltransferase 
MuxO3 -500 
ovmOI, Streptomyces 
antibioticus 
CAG14963.1 63/50 
flavin-dependent 
oxidase 
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Figure A3.37. Mobility separated ramped energy mass spectrum for feature 1, 
Mutaxanthene A. 
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Figure A3.38. Retention time selected drift time chromatograms and extracted 
drift time ion chromatograms for coeluting mutaxanthenes B and C. Using 
mobility separation, fragmentation profiles for each were extracted. 
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Figure A3.39. Mobility separated ramped energy mass spectrum for feature 2, 
Mutaxanthene C. 
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Figure A3.40. Mobility separated ramped energy mass spectrum for feature 3, 
Mutaxanthene B. 
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Figure A3.41. Retention time extracted low energy spectra demonstrating 
Mutaxanthene A adducts. 
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Figure A3.42. Retention time extracted low energy spectra displaying feature 7 
isotopic envelope. 
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Figure A3.43. (Above) Theoretical isotopic profile for [C21H29NO4+H]
+ . (Below) 
Accurate mass isotopic envelope of feature 8, as specified in Table 3.1. 
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Figure A3.44. Mobility separated ramped energy mass spectrum for feature 8. 
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Figure A3.45. (Above) Theoretical isotopic profile for [C21H42N2O4+H]
+ . (Below) 
Accurate mass isotopic envelope of feature 9, as specified in Table 3.1. 
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Figure A3.46. Mobility separated ramped energy mass spectrum for feature 9, 
indicating neutral losses. These neutral losses corroborate the chemical formula 
determination. 
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Figure A3.47. Mobility separated ramped energy mass spectrum for feature 9. 
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Figure A3.48. Mobility separated ramped energy mass spectrum for feature 10.
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Figure A3.49. Mobility separated ramped energy mass spectrum for feature 11, 
indicating proposed fragment identities. 
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Figure A3.50. (Above) Theoretical isotopic profile for [C16H24O5+H]
+ . (Below) 
Accurate mass isotopic envelope of feature 12, as specified in Table 3.1. 
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Figure A3.51. Retention time selected drift time chromatograms and extracted 
drift time ion chromatogram for feature 12. This drift time was used to select the 
proper drift time for high energy data interrogation. 
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Figure A3.52. Mobility separated ramped energy mass spectrum for feature 12.
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Figure A3.53. (Above) Mobility separated ramped energy mass spectrum for 
feature 13, indicating proposed fragment identities. (Bottom) Mobility separated 
MS3 of product ion 136.0626. These fragments further corroborate identification. 
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Figure A3.54. (Above) Mobility separated ramped energy mass spectrum for 
feature 14, indicating proposed fragment identities.  
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Figure A3.55. (Above) Mobility separated ramped energy mass spectrum for 
feature 15, indicating proposed fragment identities. Feature 15 is the result of the 
in-source neutral loss of water. 
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Figure A3.56. (Above) Theoretical isotopic profile for [C12H18N2+H]
+ . (Below) 
Accurate mass isotopic envelope of feature 16, as specified in Table 3.1. 
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Figure A3.57. Mobility separated ramped energy mass spectrum for feature 16. 
The region from 50-190Da is magnified 10x. 
 297 
 
Figure A3.58. (Above) Centroided accurate mass isotopic envelope for feature 
17 . (Below) Continuum accurate mass isotopic envelope of feature 17, as 
specified in Table 3.1. 
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Figure A3.59. Mobility separated ramped energy mass spectrum for feature 17. 
Spectrum is magnified 10x. 
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Figure A3.60. (Above) Mobility separated ramped energy mass spectrum for 
feature 18, indicating proposed fragment identities.  
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Figure A3.61. (Above) Mobility separated ramped energy mass spectrum for 
feature 18 and 19, indicating proposed fragment identities. 
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Figure A3.62. Mobility separated ramped energy mass spectrum for feature 21, 
indicating proposed fragment identities.  
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Figure A3.63. Mobility separated ramped energy mass spectrum for feature 22, 
indicating proposed fragment identities.  
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Figure A3.64. (Above) Theoretical isotopic profile for [C28H46O2+H]
+ . (Below) 
Accurate mass isotopic envelope of feature 23, as specified in Table 3.1. 
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Figure A3.65. Mobility separated ramped energy mass spectrum for feature 23. 
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Figure A3.66. Mobility separated ramped energy mass spectrum for feature 24. 
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Figure A3.67. Mobility separated ramped energy mass spectrum for feature 25 
and 26. 
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Figure A3.68. Mobility separated ramped energy mass spectrum for feature 27.
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Figure A3.69. (Above) Theoretical isotopic profile for [C27H44O2+H]
+ . (Below) 
Accurate mass isotopic envelope of feature 24, as specified in Table 3.1. 
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Figure A3.70. Accurate mass isotopic envelope of feature 25, as specified in 
Table 3.1. 
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Figure A3.71. Accurate mass isotopic envelope of feature 26, as specified in 
Table 1. 
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Figure A3.72. (Above) Theoretical isotopic profile for [C30H50O2+H]
+ . (Below) 
Accurate mass isotopic envelope of feature 27, as specified in Table 1. 
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Figure A3.73. Extracted ion chromatograms for feature 1 w/ ±0.01Da tolerance. 
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Figure A3.74. Extracted ion chromatograms for feature 2 w/ ±0.01Da tolerance. 
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Figure A3.75. Extracted ion chromatograms for feature 3 w/ ±0.01Da tolerance. 
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Figure A3.76. Extracted ion chromatograms for feature 4 w/ ±0.01Da tolerance. 
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Figure A3.77. Extracted ion chromatograms for feature 5 w/ ±0.01Da tolerance. 
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Figure A3.78. Extracted ion chromatograms for feature 6 w/ ±0.01Da tolerance. 
 
 318 
 
 
Figure A3.79. Extracted ion chromatograms for feature 7 w/ ±0.01Da tolerance. 
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Figure A3.80. Extracted ion chromatograms for feature 8 w/ ±0.01Da tolerance. 
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Figure A3.81. Extracted ion chromatograms for feature 9 w/ ±0.01Da tolerance. 
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Figure A3.82. Extracted ion chromatograms for feature 10 w/ ±0.01Da tolerance. 
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Figure A3.83. Extracted ion chromatograms for feature 11 w/ ±0.01Da tolerance. 
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Figure A3.84. Extracted ion chromatograms for feature 12 w/ ±0.01Da tolerance. 
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Figure A3.85. Extracted ion chromatograms for feature 13 w/ ±0.01Da tolerance. 
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Figure A3.86. Extracted ion chromatograms for feature 14 w/ ±0.01Da tolerance. 
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Figure A3.87. Extracted ion chromatograms for feature 15 w/ ±0.01Da tolerance. 
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Figure A3.88. Extracted ion chromatograms for feature 16 w/ ±0.01Da tolerance. 
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Figure A3.89. Extracted ion chromatograms for feature 17 w/ ±0.01Da tolerance. 
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Figure A3.90. Extracted ion chromatograms for feature 18 w/ ±0.01Da tolerance. 
 
 330 
 
 
Figure A3.91. Extracted ion chromatograms for feature 19 w/ ±0.01Da tolerance. 
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Figure A3.92. Extracted ion chromatograms for feature 20 w/ ±0.01Da tolerance. 
 
 332 
 
 
Figure A3.93. Extracted ion chromatograms for feature 21 w/ ±0.01Da tolerance. 
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Figure A3.94. Extracted ion chromatograms for feature 22 w/ ±0.01Da tolerance. 
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Figure A3.95. Extracted ion chromatograms for feature 23 w/ ±0.01Da tolerance. 
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Figure A3.96. Extracted ion chromatograms for feature 24 w/ ±0.01Da tolerance. 
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Figure A3.97. Extracted ion chromatograms for feature 25 w/ ±0.01Da tolerance. 
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Figure A3.98. Extracted ion chromatograms for feature 26 w/ ±0.01Da tolerance. 
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Figure A3.99. Extracted ion chromatograms for feature 27 w/ ±0.01Da tolerance. 
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Table A3.7. Normalized heat map of features described as unique in Figure 
A3.4 when comparing Bacillus subtilus and Micrococcus luteus to Escherichia 
coli extracts using OPLS-DA and extracting features from the generated S-plot 
with correlation coefficients ≥0.9. Features are normalized to maximum intensity 
for that feature. 
 
Feature ID (RT_m/z) B sub  B sub  B sub  E coli E coli E coli M lut M lut M lut 
1.59_136.0628 0.00 0.04 0.07 0.36 1.00 0.87 0.00 0.06 0.03 
1.18_203.0538 0.00 0.22 0.00 1.00 0.71 0.75 0.00 0.01 0.00 
8.87_225.1991 0.00 0.00 0.00 0.86 1.00 0.78 0.00 0.00 0.00 
8.87_226.1249 0.00 0.00 0.00 1.00 0.95 0.88 0.00 0.00 0.00 
6.33_243.0892 0.00 0.16 0.13 0.87 0.78 1.00 0.00 0.00 0.00 
3.58_246.1339 0.00 0.00 0.02 0.68 0.79 1.00 0.00 0.02 0.00 
1.23_258.1102 0.00 0.00 0.00 0.80 1.00 0.76 0.00 0.01 0.01 
3.47_276.1486 0.00 0.00 0.00 0.95 1.00 0.64 0.00 0.00 0.00 
1.16_280.0940 0.00 0.00 0.00 0.61 1.00 0.88 0.00 0.00 0.00 
7.38_364.1685 0.00 0.00 0.00 1.00 0.79 0.52 0.00 0.01 0.00 
8.87_392.1643 0.00 0.00 0.00 0.93 1.00 0.66 0.00 0.00 0.00 
2.45_424.1838 0.00 0.00 0.00 0.74 1.00 0.64 0.00 0.00 0.00 
3.59_438.1989 0.00 0.00 0.00 1.00 0.66 0.87 0.00 0.00 0.00 
10.27_452.2766 0.00 0.00 0.00 0.50 0.81 1.00 0.00 0.00 0.00 
2.41_442.1934 0.00 0.00 0.00 1.00 0.50 0.72 0.00 0.00 0.00 
3.58_456.2096 0.00 0.00 0.01 1.00 0.69 0.88 0.00 0.00 0.00 
10.91_466.2961 0.00 0.00 0.00 0.61 0.62 1.00 0.00 0.00 0.00 
3.40_488.1789 0.00 0.00 0.00 1.00 0.40 0.69 0.02 0.00 0.02 
11.83_494.3263 0.00 0.00 0.00 0.52 0.62 1.00 0.00 0.00 0.00 
5.04_542.3153 0.00 0.00 0.00 1.00 0.91 0.92 0.01 0.00 0.00 
3.37_604.2482 0.00 0.00 0.00 0.91 0.58 1.00 0.00 0.00 0.01 
3.63_600.2512 0.00 0.00 0.00 0.56 0.57 1.00 0.01 0.00 0.02 
1.19_723.1992 0.00 0.00 0.00 0.57 0.98 1.00 0.00 0.00 0.00 
1.22_707.2229 0.00 0.00 0.00 1.00 0.80 0.93 0.00 0.00 0.00 
14.78_742.5100 0.00 0.00 0.01 0.90 0.60 1.00 0.00 0.08 0.00 
11.13_454.2957 0.00 0.00 0.00 0.56 0.91 1.00 0.00 0.00 0.00 
10.68_466.2947 0.00 0.00 0.00 0.55 0.56 1.00 0.00 0.00 0.00 
1.33_428.1800 0.00 0.01 0.00 0.93 0.82 1.00 0.00 0.00 0.00 
7.37_226.1255 0.00 0.00 0.00 0.92 0.94 1.00 0.00 0.00 0.00 
1.21_365.1089 0.00 0.00 0.00 0.77 1.00 0.89 0.00 0.00 0.00 
4.33_260.1502 0.00 0.00 0.00 1.00 0.60 0.86 0.01 0.14 0.06 
1.20_381.0798 0.01 0.00 0.00 1.00 0.83 0.94 0.00 0.00 0.00 
1.13_380.0978 0.01 0.01 0.02 0.78 0.92 1.00 0.00 0.00 0.01 
4.15_260.1506 0.02 0.00 0.00 1.00 0.51 0.99 0.00 0.01 0.00 
3.50_230.1384 0.02 0.07 0.00 0.66 1.00 0.60 0.00 0.03 0.00 
1.23_446.1908 0.03 0.00 0.00 0.99 0.85 1.00 0.00 0.00 0.00 
4.29_447.2276 0.05 0.00 0.00 1.00 0.40 0.96 0.00 0.00 0.00 
3.95_328.1408 0.06 0.09 0.00 0.83 1.00 0.63 0.01 0.07 0.08 
5.25_164.0700 0.11 0.18 0.08 0.88 1.00 0.71 0.45 0.14 0.22 
5.57_277.1177 0.16 0.12 0.11 0.86 0.98 1.00 0.07 0.01 0.12 
6.91_233.0782 0.30 0.27 0.35 1.00 0.98 0.93 0.37 0.45 0.39 
1.32_247.1405 0.38 0.77 1.00 0.04 0.00 0.00 0.67 0.77 0.84 
5.24_374.2291 0.49 0.89 0.96 0.00 0.00 0.00 1.00 0.72 0.91 
6.71_514.3211 0.52 0.77 0.64 0.00 0.00 0.00 1.00 0.65 0.80 
5.31_489.2739 0.55 0.60 0.59 0.00 0.00 0.00 0.85 0.89 1.00 
5.97_441.3089 0.56 0.52 0.53 0.05 0.05 0.02 1.00 0.81 0.86 
6.93_527.2267 0.58 0.76 1.00 0.00 0.00 0.00 0.83 0.78 0.48 
3.65_248.1052 0.62 0.76 0.66 0.00 0.00 0.08 0.89 1.00 0.51 
7.20_340.2507 0.63 0.73 0.89 0.00 0.00 0.00 0.95 0.97 1.00 
8.43_384.2770 0.64 0.47 0.60 0.00 0.00 0.00 0.88 1.00 0.71 
8.74_340.2520 0.66 0.52 0.71 0.00 0.00 0.00 0.86 0.76 1.00 
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8.15_368.2806 0.66 0.47 0.57 0.00 0.00 0.00 0.87 1.00 0.91 
5.48_287.1006 0.69 0.72 1.00 0.00 0.00 0.05 0.77 0.69 0.61 
7.14_120.0804 0.69 0.84 0.88 0.01 0.01 0.02 1.00 0.88 0.81 
8.16_386.2928 0.70 0.70 0.69 0.00 0.00 0.00 0.69 1.00 0.90 
1.26_246.1797 0.70 0.99 0.82 0.02 0.00 0.00 0.89 0.99 1.00 
7.49_358.2600 0.71 0.66 0.72 0.00 0.00 0.00 0.90 0.96 1.00 
6.73_224.1250 0.71 0.83 0.75 0.02 0.00 0.00 1.00 0.67 0.97 
5.17_188.0713 0.72 1.00 0.93 0.00 0.04 0.00 0.77 0.85 0.69 
6.72_406.2313 0.72 0.80 0.81 0.00 0.00 0.00 0.98 0.81 1.00 
1.24_369.1533 0.77 1.00 0.86 0.00 0.00 0.00 0.66 0.71 0.87 
7.59_517.3020 0.77 0.77 0.99 0.00 0.00 0.01 1.00 0.91 0.92 
7.90_328.2507 0.77 0.54 0.61 0.00 0.00 0.00 0.98 1.00 0.75 
1.05_341.1557 0.80 0.90 0.46 0.00 0.00 0.00 0.86 0.75 1.00 
6.97_326.2351 0.81 0.64 0.75 0.00 0.01 0.00 0.87 1.00 1.00 
1.05_323.1483 0.81 0.81 0.88 0.00 0.00 0.00 0.80 1.00 0.79 
1.20_257.1491 0.81 0.44 0.64 0.05 0.04 0.00 0.96 1.00 0.74 
7.13_236.1285 0.81 0.78 0.87 0.01 0.00 0.00 0.80 1.00 0.95 
7.14_396.2770 0.81 0.69 0.85 0.00 0.00 0.00 0.98 1.00 0.79 
7.20_358.2601 0.87 0.65 0.72 0.00 0.00 0.00 0.85 0.92 1.00 
7.59_263.1407 0.87 0.64 0.88 0.00 0.00 0.00 1.00 0.89 0.73 
6.07_159.0926 0.87 0.56 0.85 0.00 0.01 0.00 0.72 1.00 0.56 
6.45_341.1501 0.90 0.63 0.86 0.02 0.02 0.03 0.80 0.99 1.00 
6.94_227.1782 0.90 0.84 1.00 0.00 0.00 0.03 0.75 0.72 0.69 
6.07_299.1768 0.90 0.83 1.00 0.00 0.00 0.00 0.81 0.62 0.67 
6.96_300.1824 0.91 0.63 1.00 0.00 0.00 0.00 0.86 0.89 0.70 
4.93_265.1574 0.92 0.66 0.89 0.01 0.00 0.00 0.86 0.80 1.00 
5.09_245.1881 0.96 0.77 0.82 0.00 0.00 0.00 0.95 1.00 0.99 
6.96_382.2573 0.96 0.78 0.73 0.00 0.00 0.00 0.76 0.96 1.00 
6.08_201.1028 0.97 0.97 1.00 0.00 0.00 0.02 1.00 0.76 0.94 
6.96_282.1702 0.99 0.70 0.94 0.00 0.00 0.00 0.86 0.99 1.00 
7.14_258.1102 1.00 0.62 0.88 0.00 0.00 0.00 0.94 1.00 0.97 
6.08_188.0708 1.00 0.80 0.58 0.01 0.02 0.00 0.54 1.00 0.99 
3.90_186.0783 1.00 0.70 0.58 0.00 0.02 0.00 0.61 0.92 0.84 
3.98_215.1417 1.00 0.60 0.80 0.00 0.00 0.00 0.57 0.88 0.62 
5.42_245.1308 1.00 0.74 0.80 0.00 0.00 0.03 0.68 0.68 0.65 
4.69_302.2081 1.00 0.95 0.90 0.02 0.00 0.00 0.93 0.87 0.75 
6.71_327.0330 1.00 0.72 0.98 0.00 0.01 0.03 0.82 0.87 0.64 
6.68_356.1087 1.00 0.86 0.92 0.00 0.00 0.00 0.95 0.92 0.76 
6.76_393.1819 1.00 0.67 0.89 0.01 0.01 0.02 0.66 0.73 0.77 
5.66_522.2907 1.00 0.62 0.92 0.00 0.00 0.00 0.93 0.98 0.92 
5.40_613.3562 1.00 0.58 0.73 0.00 0.00 0.01 0.86 0.81 0.94 
6.96_913.9555 1.00 0.81 0.92 0.00 0.00 0.00 0.55 0.91 0.98 
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Table A3.8. Normalized heat map of features described as unique in Figure 
A3.4 when comparing Bacillus subtilus and Escherichia coli to Micrococcus 
luteus extracts using OPLS-DA and extracting features from the generated S-plot 
with correlation coefficients ≥0.9. Features are normalized to maximum intensity 
for that feature. 
 
Feature ID (RT_m/z) B sub B sub B sub E coli E coli E coli M lut M lut M lut 
3.85_239.1416 0.00 0.09 0.00 0.00 0.00 0.01 1.00 0.59 0.88 
5.44_316.2237 0.00 0.20 0.00 0.00 0.00 0.03 0.81 1.00 0.63 
1.31_324.1312 0.00 0.10 0.21 0.00 0.00 0.00 0.98 1.00 0.54 
5.57_322.1904 0.00 0.19 0.21 0.00 0.00 0.00 0.62 1.00 0.88 
5.04_334.1767 0.00 0.00 0.00 0.00 0.00 0.50 1.00 0.80 0.77 
5.69_349.7333 0.00 0.08 0.09 0.00 0.00 0.00 1.00 0.78 0.72 
5.31_368.1632 0.00 0.00 0.00 0.30 0.00 0.00 0.73 1.00 0.57 
9.55_400.1299 0.00 0.00 0.00 0.00 0.00 0.00 0.61 1.00 0.45 
5.16_408.2509 0.00 0.00 0.00 0.13 0.00 0.03 0.80 1.00 0.86 
5.02_407.2347 0.00 0.00 0.05 0.00 0.00 0.00 0.69 1.00 0.78 
6.75_431.2681 0.00 0.00 0.31 0.00 0.00 0.00 0.90 0.96 1.00 
5.75_749.3707 0.00 0.24 0.01 0.00 0.00 0.00 1.00 0.97 0.84 
5.88_473.2311 0.01 0.03 0.03 0.00 0.00 0.00 0.96 1.00 0.75 
5.45_764.4128 0.03 0.00 0.02 0.00 0.00 0.00 0.92 1.00 0.87 
6.02_378.2402 0.04 0.36 0.25 0.00 0.00 0.02 1.00 0.73 0.70 
5.58_291.6759 0.06 0.30 0.18 0.00 0.00 0.00 1.00 0.83 0.85 
5.64_507.2827 0.06 0.00 0.16 0.00 0.00 0.01 0.84 0.81 1.00 
10.32_317.2674 0.07 0.03 0.08 0.00 0.00 0.00 1.00 0.97 0.80 
5.06_471.2746 0.10 0.04 0.04 0.00 0.00 0.00 1.00 0.47 0.82 
5.64_360.2149 0.10 0.20 0.21 0.00 0.00 0.14 0.95 1.00 0.87 
10.32_299.2598 0.12 0.05 0.10 0.00 0.00 0.00 1.00 0.63 0.66 
5.18_423.2211 0.14 0.16 0.26 0.00 0.09 0.00 1.00 0.60 0.72 
4.50_493.2325 0.15 0.28 0.28 0.00 0.13 0.00 1.00 0.82 0.86 
5.58_582.3392 0.17 0.00 0.23 0.01 0.00 0.01 1.00 0.69 0.69 
6.17_557.3688 0.18 0.10 0.19 0.00 0.00 0.01 1.00 0.80 0.96 
6.11_734.3731 0.22 0.15 0.07 0.00 0.00 0.00 0.49 1.00 0.79 
4.74_284.1566 0.23 0.38 0.12 0.14 0.19 0.04 0.69 1.00 0.65 
5.88_378.2396 0.23 0.00 0.00 0.06 0.00 0.00 0.59 1.00 0.81 
6.80_857.4155 0.28 0.00 0.26 0.00 0.00 0.00 0.98 0.86 1.00 
8.64_342.2650 0.35 0.00 0.03 0.00 0.00 0.00 0.78 1.00 0.81 
6.15_608.3295 0.39 0.35 0.18 0.00 0.00 0.01 1.00 0.87 0.98 
6.00_288.0498 0.42 0.17 0.15 0.00 0.00 0.00 0.98 1.00 0.61 
6.26_475.2939 0.42 0.09 0.37 0.08 0.00 0.00 0.90 0.90 1.00 
5.50_374.2277 0.45 0.36 0.17 0.00 0.00 0.12 1.00 0.75 0.87 
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Table A3.9. Normalized heat map of features described as unique in Figure 
A3.4 when comparing Bacillus subtilus to Micrococcus luteus and Escherichia 
coli extracts using OPLS-DA and extracting features from the generated S-plot 
with correlation coefficients ≥0.9. Features are normalized to maximum intensity 
for that feature. 
 
Feature ID (RT_m/z) B sub B sub B sub E coli E coli E coli M lut M lut M lut 
4.42_357.1859 0.40 0.32 0.26 1.00 0.67 0.94 0.73 0.84 0.75 
2.31_289.1405 0.62 1.00 0.56 0.02 0.00 0.00 0.33 0.12 0.00 
3.38_271.1408 0.65 1.00 0.51 0.00 0.00 0.00 0.00 0.00 0.29 
4.62_190.0525 0.67 1.00 0.69 0.00 0.00 0.08 0.03 0.24 0.17 
5.71_441.7064 0.71 0.62 1.00 0.32 0.00 0.00 0.00 0.18 0.00 
2.28_259.1292 0.74 1.00 0.59 0.00 0.00 0.05 0.22 0.00 0.08 
4.49_201.1581 0.79 1.00 0.74 0.00 0.00 0.00 0.08 0.14 0.04 
5.68_512.3435 0.88 1.00 0.98 0.00 0.00 0.01 0.02 0.15 0.19 
8.21_272.1420 0.94 0.77 1.00 0.00 0.00 0.00 0.06 0.01 0.02 
1.79_124.0404 1.00 0.85 0.84 0.07 0.10 0.00 0.28 0.50 0.18 
8.29_223.1446 1.00 0.82 0.79 0.00 0.00 0.00 0.03 0.00 0.02 
1.32_221.1124 1.00 0.69 0.94 0.02 0.00 0.00 0.46 0.00 0.08 
6.22_246.1732 1.00 0.80 0.72 0.00 0.00 0.00 0.35 0.31 0.31 
4.78_374.2088 1.00 0.88 0.91 0.00 0.00 0.00 0.42 0.43 0.00 
4.69_431.2509 1.00 0.98 0.57 0.00 0.03 0.00 0.31 0.35 0.10 
 
 343 
Table A3.10. Normalized heat map of features described as unique in Figure 
3.2(B) and (C) when comparing wild type Nocardiopsis sp. FU40 ΔApoS8 to the 
R1 rifampicin resistant mutant extract using OPLS-DA and extracting features 
from the generated S-plot with correlation coefficients ≥0.9. Features are 
normalized to maximum intensity for that feature. 
 
Feature ID (RT_m/z) WT WT R1 R1 
12.03_135.1163 0.00 0.11 0.93 1.00 
12.03_123.1165 0.00 0.00 1.00 0.99 
4.87_118.0679 0.00 0.20 0.64 1.00 
1.50_103.5345 0.00 0.00 1.00 0.69 
13.61_149.0907 0.00 0.00 1.00 0.97 
1.50_165.0624 0.00 0.00 1.00 0.78 
6.56_162.0938 0.00 0.00 0.73 1.00 
4.31_160.1140 0.00 0.00 0.63 1.00 
5.78_170.1204 0.00 0.00 0.80 1.00 
7.08_169.0882 0.00 0.06 1.00 0.83 
2.44_166.0747 0.00 0.20 0.81 1.00 
6.60_180.1017 0.00 0.03 0.76 1.00 
5.02_180.1014 0.00 0.00 0.88 1.00 
10.70_179.1435 0.00 0.00 0.97 1.00 
4.95_177.1399 0.00 0.29 0.67 1.00 
4.39_192.1130 0.00 0.21 0.90 1.00 
9.12_191.0134 0.00 0.00 0.76 1.00 
4.02_198.1143 0.00 0.00 0.71 1.00 
8.84_203.1804 0.00 0.00 0.75 1.00 
6.22_203.0786 0.00 0.10 1.00 1.00 
9.80_203.0277 0.00 0.00 0.70 1.00 
7.49_207.0994 0.00 0.07 0.71 1.00 
1.30_205.9283 0.00 0.00 1.00 1.00 
4.84_205.1323 0.00 0.00 0.68 1.00 
9.81_205.1237 0.00 0.00 0.92 1.00 
10.22_205.1232 0.00 0.00 0.92 1.00 
1.32_211.8786 0.00 0.00 1.00 0.60 
9.81_210.0363 0.00 0.00 0.77 1.00 
5.35_210.0350 0.00 0.00 0.64 1.00 
10.24_222.1533 0.00 0.00 1.00 0.96 
9.81_222.1504 0.00 0.00 0.87 1.00 
8.84_221.1903 0.00 0.00 0.73 1.00 
7.99_225.1125 0.00 0.07 0.95 1.00 
5.48_229.0656 0.00 0.00 0.73 1.00 
4.61_230.0715 0.00 0.38 1.00 0.94 
10.62_236.1643 0.00 0.00 1.00 0.83 
5.11_236.1306 0.00 0.25 1.00 0.86 
8.54_235.1344 0.00 0.00 0.80 1.00 
11.28_233.1548 0.00 0.00 0.95 1.00 
9.80_241.0261 0.00 0.00 0.70 1.00 
11.75_239.1663 0.00 0.01 1.00 0.90 
10.69_238.1826 0.00 0.00 1.00 1.00 
5.81_248.1281 0.00 0.32 0.77 1.00 
11.16_252.0381 0.00 0.00 1.00 0.60 
13.78_251.2405 0.00 0.00 0.48 1.00 
11.26_250.1814 0.00 0.00 1.00 0.91 
4.56_252.0394 0.00 0.18 0.72 1.00 
8.66_252.0394 0.00 0.00 0.47 1.00 
7.48_252.0388 0.00 0.00 1.00 0.65 
6.82_252.0384 0.00 0.00 1.00 0.57 
3.87_257.1146 0.00 0.29 0.97 1.00 
12.02_263.1978 0.00 0.09 0.94 1.00 
1.78_262.1278 0.00 0.00 1.00 0.73 
5.86_262.1048 0.00 0.32 0.66 1.00 
10.71_261.1779 0.00 0.01 0.77 1.00 
10.68_260.1641 0.00 0.00 0.98 1.00 
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5.43_268.0192 0.00 0.12 0.61 1.00 
5.18_266.1406 0.00 0.33 0.76 1.00 
5.27_264.2082 0.00 0.00 0.79 1.00 
5.84_281.1328 0.00 0.00 0.63 1.00 
9.12_279.1585 0.00 0.00 1.00 0.84 
7.18_278.2110 0.00 0.00 0.60 1.00 
13.60_278.2028 0.00 0.00 0.93 1.00 
7.50_283.1523 0.00 0.04 0.65 1.00 
1.73_282.0649 0.00 0.03 1.00 0.92 
7.72_281.1420 0.00 0.00 1.00 0.91 
7.82_294.2085 0.00 0.00 0.75 1.00 
7.15_293.2251 0.00 0.00 0.71 1.00 
3.76_299.1387 0.00 0.05 0.68 1.00 
4.74_298.0969 0.00 0.08 0.90 1.00 
9.60_297.1694 0.00 0.01 0.46 1.00 
7.19_296.2224 0.00 0.00 0.82 1.00 
3.78_300.1386 0.00 0.33 0.74 1.00 
14.29_307.2281 0.00 0.00 1.00 0.82 
8.43_314.1381 0.00 0.29 1.00 0.89 
7.24_312.2197 0.00 0.00 0.98 1.00 
5.82_322.1007 0.00 0.00 0.78 1.00 
1.74_322.0446 0.00 0.03 1.00 0.72 
14.63_321.2420 0.00 0.00 1.00 0.89 
9.13_319.1539 0.00 0.00 1.00 0.68 
6.08_324.1828 0.00 0.42 0.79 1.00 
10.73_340.1475 0.00 0.19 1.00 1.00 
14.63_339.2533 0.00 0.00 1.00 0.90 
14.31_347.2205 0.00 0.00 1.00 0.82 
5.26_354.0787 0.00 0.16 0.69 1.00 
8.24_352.2057 0.00 0.00 1.00 0.84 
6.95_350.2147 0.00 0.05 1.00 0.93 
8.53_359.2035 0.00 0.25 0.80 1.00 
9.80_367.0822 0.00 0.00 0.60 1.00 
6.22_366.2068 0.00 0.36 0.76 1.00 
14.32_379.2817 0.00 0.00 1.00 0.61 
9.80_387.0731 0.00 0.00 0.72 1.00 
6.24_384.2171 0.00 0.00 0.75 1.00 
13.61_399.3201 0.00 0.00 1.00 0.57 
1.49_394.1142 0.00 0.00 1.00 0.58 
14.57_393.2988 0.00 0.00 0.76 1.00 
13.61_407.3140 0.00 0.00 1.00 0.69 
3.75_414.2692 0.00 0.00 0.64 1.00 
9.08_429.0845 0.00 0.00 1.00 0.92 
14.04_428.3345 0.00 0.07 0.79 1.00 
14.04_420.3477 0.00 0.05 0.78 1.00 
6.99_443.3240 0.00 0.12 0.66 1.00 
9.73_443.1014 0.00 0.00 0.83 1.00 
10.02_459.0960 0.00 0.00 0.57 1.00 
11.52_456.3791 0.00 0.00 1.00 0.88 
9.81_454.0847 0.00 0.00 0.86 1.00 
9.78_481.0499 0.00 0.00 1.00 0.98 
6.98_499.2793 0.00 0.00 1.00 0.74 
4.37_494.2617 0.00 0.00 0.82 1.00 
9.09_512.3013 0.00 0.00 0.91 1.00 
13.62_510.2556 0.00 0.03 1.00 0.94 
12.00_515.2832 0.00 0.00 1.00 1.00 
1.76_515.1445 0.00 0.00 0.84 1.00 
1.49_527.1567 0.00 0.00 1.00 0.64 
10.06_526.3139 0.00 0.00 0.84 1.00 
7.20_544.2918 0.00 0.00 1.00 0.66 
12.03_565.3746 0.00 0.04 1.00 0.99 
1.72_551.1035 0.00 0.00 1.00 0.66 
5.52_601.2501 0.00 0.00 0.53 1.00 
1.76_588.1814 0.00 0.00 0.54 1.00 
9.79_576.6021 0.00 0.00 0.60 1.00 
7.01_1221.4414 0.00 0.00 0.67 1.00 
7.00_1216.1209 0.00 0.43 0.97 1.00 
14.64_361.2361 0.00 0.00 1.00 0.86 
7.48_177.0877 0.01 0.00 0.55 1.00 
9.79_218.0234 0.01 0.08 0.72 1.00 
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1.82_228.1004 0.01 0.00 1.00 0.70 
1.29_203.9309 0.01 0.00 1.00 0.96 
1.75_507.1572 0.02 0.00 0.70 1.00 
9.66_279.1583 0.02 0.00 0.72 1.00 
9.78_465.0808 0.02 0.06 0.88 1.00 
9.81_269.0437 0.03 0.00 0.73 1.00 
6.95_368.2220 0.03 0.05 0.97 1.00 
13.79_531.4249 0.03 0.10 0.80 1.00 
16.15_710.1773 0.03 0.01 1.00 0.90 
12.02_205.1953 0.04 0.00 0.94 1.00 
5.43_377.1482 0.04 0.00 0.67 1.00 
14.31_325.2414 0.04 0.03 1.00 0.81 
9.41_281.1770 0.04 0.08 0.81 1.00 
9.67_319.1539 0.04 0.06 1.00 0.93 
6.24_515.2753 0.04 0.02 0.78 1.00 
4.75_136.0625 0.05 0.00 0.68 1.00 
13.79_365.2675 0.05 0.06 1.00 0.67 
8.60_236.1631 0.05 0.11 0.69 1.00 
1.74_150.0789 0.06 0.00 1.00 0.95 
8.53_283.1523 0.06 0.13 0.72 1.00 
9.14_239.1284 0.06 0.06 1.00 0.73 
14.78_323.2583 0.07 0.13 1.00 0.83 
1.73_338.0231 0.07 0.00 1.00 0.66 
8.53_177.0880 0.07 0.07 0.66 1.00 
3.86_150.0940 0.07 0.13 0.61 1.00 
6.95_218.1203 0.07 0.15 0.69 1.00 
8.53_207.1002 0.07 0.09 0.69 1.00 
14.04_295.2283 0.08 0.15 1.00 0.86 
1.70_260.1135 0.10 0.00 1.00 0.70 
7.42_280.1237 0.11 0.31 0.64 1.00 
11.43_466.2973 0.12 0.35 1.00 0.78 
6.27_207.0660 0.12 0.22 0.74 1.00 
7.89_192.1015 0.13 0.22 0.69 1.00 
3.07_230.1126 0.13 0.31 1.00 0.81 
6.41_165.0905 0.13 0.09 0.72 1.00 
8.29_401.1993 0.14 0.00 0.73 1.00 
4.87_329.1844 0.14 0.00 0.72 1.00 
4.88_188.0708 0.15 0.26 0.68 1.00 
14.41_309.2409 0.16 0.29 1.00 0.85 
3.83_198.1623 0.17 0.12 0.62 1.00 
3.85_276.1433 0.18 0.10 0.67 1.00 
7.42_196.0651 0.18 0.09 0.69 1.00 
4.30_310.1305 0.19 0.04 0.73 1.00 
9.47_211.0868 0.19 0.33 0.69 1.00 
5.27_685.1761 0.20 0.00 0.84 1.00 
3.82_230.1126 0.21 0.13 0.61 1.00 
13.84_397.2963 0.22 0.00 1.00 0.86 
8.08_219.1411 0.22 0.32 0.75 1.00 
6.78_176.0714 0.22 0.37 0.69 1.00 
16.18_335.9929 0.28 0.00 0.83 1.00 
13.50_409.7445 0.30 0.38 0.84 1.00 
6.15_485.2027 0.37 0.39 0.67 1.00 
12.62_416.2462 0.37 0.45 1.00 0.88 
9.69_220.1127 0.40 0.47 0.98 1.00 
16.15_481.1090 0.42 0.00 0.89 1.00 
14.82_332.2940 0.43 0.28 1.00 0.85 
4.29_244.1199 0.45 0.46 0.78 1.00 
5.16_210.1137 0.45 0.44 0.70 1.00 
12.40_251.2372 0.47 0.00 1.00 0.98 
11.97_299.2600 0.49 0.61 1.00 0.91 
10.60_346.3091 0.51 1.00 0.00 0.00 
10.40_371.3275 0.52 1.00 0.00 0.00 
10.70_288.2557 0.52 1.00 0.00 0.00 
6.40_439.1986 0.52 0.52 0.90 1.00 
9.48_225.1993 0.53 1.00 0.01 0.02 
6.81_807.1918 0.54 1.00 0.00 0.00 
4.26_669.2631 0.56 1.00 0.00 0.00 
11.80_235.1712 0.56 1.00 0.00 0.00 
4.09_573.1785 0.58 1.00 0.00 0.00 
4.37_663.2850 0.59 1.00 0.00 0.00 
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5.20_239.1759 0.62 1.00 0.10 0.12 
4.64_412.2067 0.62 1.00 0.00 0.14 
6.19_181.1351 0.63 1.00 0.05 0.05 
1.50_432.0982 0.66 1.00 0.13 0.00 
4.27_647.2871 0.67 1.00 0.04 0.00 
1.50_448.0831 0.67 1.00 0.14 0.00 
11.44_223.2060 0.67 1.00 0.00 0.00 
7.62_970.6124 0.70 1.00 0.00 0.00 
6.85_824.9348 0.70 1.00 0.00 0.00 
16.15_442.8736 0.71 1.00 0.00 0.00 
7.07_184.1710 0.72 1.00 0.00 0.00 
4.37_150.0945 0.72 1.00 0.00 0.00 
3.89_518.1743 0.73 1.00 0.03 0.00 
11.18_473.3585 0.75 1.00 0.52 0.41 
1.53_143.0837 0.76 1.00 0.00 0.00 
12.74_443.3505 0.77 1.00 0.00 0.07 
12.98_282.2118 0.82 1.00 0.00 0.14 
3.86_242.1126 0.82 0.90 1.00 1.00 
9.26_219.1735 0.88 1.00 0.00 0.00 
4.50_359.1197 0.89 1.00 0.24 0.28 
1.49_594.1582 0.91 1.00 0.66 0.45 
15.94_338.3442 0.91 1.00 0.78 0.80 
13.48_341.2200 0.91 1.00 0.00 0.00 
13.49_295.2258 0.91 1.00 0.14 0.08 
1.47_508.0657 0.91 1.00 0.47 0.19 
1.50_260.0296 0.92 1.00 0.12 0.06 
1.47_748.1127 0.94 1.00 0.66 0.51 
12.73_320.2010 0.94 1.00 0.00 0.30 
1.48_481.1031 0.96 1.00 0.70 0.43 
4.49_225.1597 0.97 1.00 0.20 0.23 
13.95_270.2746 1.00 1.00 0.52 0.66 
3.99_164.0936 1.00 0.90 0.39 0.60 
1.50_230.0720 1.00 0.75 0.52 0.27 
9.27_240.2315 1.00 0.88 0.17 0.15 
10.39_268.2627 1.00 0.83 0.00 0.00 
6.59_273.1670 1.00 0.84 0.00 0.21 
13.97_282.2786 1.00 0.85 0.67 0.58 
3.80_288.1929 1.00 0.87 0.00 0.00 
11.44_291.1951 1.00 0.75 0.00 0.00 
11.33_299.2599 1.00 0.77 0.00 0.00 
15.49_338.3442 1.00 0.86 0.18 0.00 
1.55_385.5441 1.00 0.65 0.22 0.05 
1.50_401.0693 1.00 0.93 0.73 0.51 
12.86_485.3471 1.00 0.86 0.66 0.44 
13.92_641.5490 1.00 0.85 0.00 0.00 
4.37_685.2548 1.00 0.86 0.00 0.30 
7.66_916.7249 1.00 0.76 0.00 0.00 
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Table A3.11. Normalized heat map of features described as unique in Figure 
3.2(B) and (C) when comparing wild type Nocardiopsis sp. FU40 ΔApoS8 to the 
R2 rifampicin resistant mutant extract using OPLS-DA and extracting features 
from the generated S-plot with correlation coefficients ≥0.9. Features are 
normalized to maximum intensity for that feature. 
 
Feature ID (RT_m/z) WT WT R2 R2 
12.03_135.1163 0.00 0.31 0.69 1.00 
12.03_123.1165 0.00 0.00 1.00 0.65 
4.87_118.0679 0.00 0.18 1.00 1.00 
12.03_149.1327 0.00 0.00 1.00 0.61 
13.61_149.0907 0.00 0.00 1.00 0.91 
1.50_165.0624 0.00 0.00 1.00 0.98 
10.69_163.6058 0.00 0.00 1.00 0.67 
6.56_162.0938 0.00 0.00 0.66 1.00 
5.78_170.1204 0.00 0.00 1.00 1.00 
7.08_169.0882 0.00 0.01 0.62 1.00 
6.60_180.1017 0.00 0.03 1.00 0.91 
5.02_180.1014 0.00 0.00 1.00 0.86 
4.95_177.1399 0.00 0.38 1.00 0.94 
4.39_192.1130 0.00 0.26 0.80 1.00 
9.26_191.1250 0.00 0.00 1.00 0.74 
9.12_191.0134 0.00 0.00 1.00 0.88 
6.97_190.1257 0.00 0.00 1.00 0.80 
4.14_186.1168 0.00 0.00 0.95 1.00 
9.08_196.0187 0.00 0.00 1.00 0.68 
8.84_203.1804 0.00 0.00 1.00 0.90 
8.12_203.1781 0.00 0.00 1.00 0.94 
9.08_203.0278 0.00 0.00 1.00 0.72 
9.80_203.0277 0.00 0.00 1.00 0.72 
9.42_202.0393 0.00 0.00 0.75 1.00 
4.35_209.0956 0.00 0.00 0.82 1.00 
5.44_208.0539 0.00 0.01 1.00 0.97 
7.49_207.0994 0.00 0.10 1.00 0.75 
1.30_205.9283 0.00 0.00 1.00 1.00 
4.84_205.1323 0.00 0.00 1.00 0.91 
1.32_211.8786 0.00 0.00 1.00 0.98 
9.25_211.0284 0.00 0.04 1.00 0.81 
8.31_210.0369 0.00 0.00 1.00 0.59 
9.81_210.0363 0.00 0.00 1.00 0.76 
9.07_210.0305 0.00 0.00 1.00 0.86 
9.41_219.0312 0.00 0.00 1.00 0.77 
9.03_217.0413 0.00 0.00 1.00 0.82 
16.16_223.9875 0.00 0.00 1.00 0.84 
8.84_221.1903 0.00 0.00 1.00 0.93 
6.51_220.1710 0.00 0.07 0.97 1.00 
5.15_226.5984 0.00 0.03 1.00 0.86 
7.35_225.1140 0.00 0.00 1.00 0.89 
7.99_225.1125 0.00 0.02 1.00 0.94 
9.04_225.0298 0.00 0.01 1.00 0.79 
9.77_224.0325 0.00 0.00 1.00 0.83 
5.48_229.0656 0.00 0.00 0.97 1.00 
5.11_227.1386 0.00 0.00 1.00 0.99 
9.19_230.0719 0.00 0.00 1.00 0.69 
9.82_230.0718 0.00 0.03 0.79 1.00 
8.41_230.0715 0.00 0.00 1.00 0.90 
10.62_236.1643 0.00 0.00 1.00 0.82 
5.11_236.1306 0.00 0.17 1.00 0.92 
8.54_235.1344 0.00 0.00 1.00 0.88 
9.80_241.0261 0.00 0.00 1.00 0.85 
8.82_241.0249 0.00 0.00 0.72 1.00 
5.81_248.1281 0.00 0.36 0.99 1.00 
9.03_248.0351 0.00 0.00 1.00 0.83 
8.44_247.1345 0.00 0.00 0.75 1.00 
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4.04_247.1287 0.00 0.00 1.00 0.88 
7.33_247.0943 0.00 0.11 1.00 0.94 
9.07_246.5440 0.00 0.00 1.00 0.83 
5.04_244.1219 0.00 0.00 1.00 0.91 
11.26_250.1814 0.00 0.00 1.00 0.82 
4.94_250.1290 0.00 0.00 1.00 0.93 
8.52_250.0297 0.00 0.00 1.00 0.94 
4.31_249.0807 0.00 0.00 1.00 0.87 
8.16_249.0423 0.00 0.00 1.00 0.80 
4.56_252.0394 0.00 0.13 0.90 1.00 
6.01_252.0391 0.00 0.00 1.00 0.84 
6.82_252.0384 0.00 0.00 1.00 0.82 
6.23_258.1449 0.00 0.00 1.00 0.86 
6.94_256.2241 0.00 0.00 1.00 0.89 
4.75_255.5956 0.00 0.28 1.00 0.83 
6.97_254.2139 0.00 0.00 1.00 0.86 
9.81_253.5524 0.00 0.01 1.00 0.86 
4.75_263.0841 0.00 0.16 1.00 0.81 
1.78_262.1278 0.00 0.00 1.00 0.73 
9.91_261.5430 0.00 0.00 0.52 1.00 
5.01_261.1438 0.00 0.06 1.00 0.94 
9.03_260.5527 0.00 0.00 1.00 0.64 
8.32_268.0180 0.00 0.00 1.00 0.94 
10.77_267.1616 0.00 0.06 0.55 1.00 
5.18_266.1406 0.00 0.37 1.00 0.82 
5.27_264.2082 0.00 0.00 1.00 0.80 
7.49_268.0200 0.00 0.00 1.00 0.68 
9.67_268.0195 0.00 0.00 1.00 0.74 
7.61_273.1085 0.00 0.00 1.00 0.84 
5.84_281.1328 0.00 0.00 1.00 0.97 
7.18_278.2110 0.00 0.00 1.00 0.88 
6.07_276.1943 0.00 0.00 1.00 0.79 
5.71_286.2118 0.00 0.00 1.00 0.83 
7.19_284.2219 0.00 0.00 0.86 1.00 
12.79_284.1681 0.00 0.05 1.00 0.98 
7.50_283.1523 0.00 0.05 1.00 0.92 
1.73_282.0649 0.00 0.03 1.00 0.94 
7.72_281.1420 0.00 0.00 0.83 1.00 
3.93_291.1653 0.00 0.00 1.00 0.83 
9.72_290.1445 0.00 0.00 0.99 1.00 
7.06_287.2336 0.00 0.00 0.93 1.00 
5.22_295.1312 0.00 0.03 0.87 1.00 
6.82_294.2084 0.00 0.00 1.00 0.82 
7.15_293.2251 0.00 0.00 1.00 0.65 
4.87_293.1612 0.00 0.35 1.00 0.91 
6.49_292.1923 0.00 0.01 0.96 1.00 
3.76_299.1387 0.00 0.00 0.54 1.00 
2.95_299.1385 0.00 0.00 1.00 0.90 
12.77_298.1902 0.00 0.00 0.95 1.00 
4.74_298.0969 0.00 0.06 0.99 1.00 
7.19_296.2224 0.00 0.00 1.00 0.92 
5.83_303.1558 0.00 0.04 0.65 1.00 
7.70_303.1206 0.00 0.04 1.00 0.99 
3.78_300.1386 0.00 0.05 1.00 0.78 
12.02_309.1921 0.00 0.06 1.00 0.80 
6.00_308.2238 0.00 0.00 1.00 0.83 
8.43_314.1381 0.00 0.21 1.00 0.60 
6.06_312.2197 0.00 0.00 0.92 1.00 
6.84_312.2197 0.00 0.00 1.00 0.91 
7.24_312.2197 0.00 0.00 1.00 0.81 
9.72_312.1580 0.00 0.00 1.00 0.77 
10.59_311.1859 0.00 0.00 1.00 0.72 
9.79_311.0549 0.00 0.00 1.00 0.92 
7.47_310.2026 0.00 0.00 0.84 1.00 
5.82_322.1007 0.00 0.00 1.00 0.87 
1.74_322.0446 0.00 0.03 1.00 0.96 
9.13_319.1539 0.00 0.00 1.00 0.83 
6.92_318.2094 0.00 0.00 1.00 0.93 
6.00_328.7423 0.00 0.13 1.00 0.93 
5.91_328.5999 0.00 0.00 1.00 0.92 
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6.01_326.2353 0.00 0.00 0.95 1.00 
4.97_326.0999 0.00 0.34 1.00 0.77 
6.08_324.1828 0.00 0.23 1.00 0.93 
6.31_335.7452 0.00 0.00 1.00 0.80 
6.62_334.2005 0.00 0.00 1.00 0.80 
9.73_334.1684 0.00 0.00 1.00 0.77 
8.76_329.1942 0.00 0.19 0.99 1.00 
12.72_342.2152 0.00 0.10 1.00 0.86 
5.99_338.1374 0.00 0.00 0.88 1.00 
9.08_348.2310 0.00 0.00 1.00 0.77 
6.22_346.2031 0.00 0.00 0.71 1.00 
7.48_345.1875 0.00 0.00 1.00 0.85 
7.37_344.2218 0.00 0.00 1.00 0.84 
9.69_356.1867 0.00 0.00 1.00 0.85 
5.26_354.0787 0.00 0.28 0.97 1.00 
8.24_352.2057 0.00 0.00 1.00 0.88 
12.66_364.2323 0.00 0.28 1.00 0.74 
6.67_362.2335 0.00 0.00 0.97 1.00 
6.51_360.2165 0.00 0.00 1.00 0.89 
8.53_359.2035 0.00 0.18 1.00 0.87 
8.77_368.2219 0.00 0.00 1.00 0.92 
7.52_368.2211 0.00 0.00 1.00 0.87 
9.80_367.0822 0.00 0.00 1.00 0.96 
10.08_366.2455 0.00 0.00 1.00 0.72 
9.04_366.2404 0.00 0.00 1.00 0.83 
6.22_366.2068 0.00 0.12 0.76 1.00 
5.64_366.2063 0.00 0.00 0.91 1.00 
8.47_382.2398 0.00 0.00 1.00 0.75 
9.68_378.2012 0.00 0.00 1.00 0.72 
7.43_374.2181 0.00 0.00 0.61 1.00 
7.83_387.1861 0.00 0.00 1.00 0.94 
9.80_387.0731 0.00 0.00 1.00 0.86 
6.88_386.2329 0.00 0.01 1.00 0.90 
6.24_384.2171 0.00 0.00 1.00 0.85 
8.63_398.2317 0.00 0.00 1.00 1.00 
1.49_394.1142 0.00 0.00 1.00 0.92 
12.60_408.2538 0.00 0.15 1.00 0.67 
7.68_401.3048 0.00 0.00 1.00 0.86 
9.40_418.0851 0.00 0.00 1.00 0.97 
8.66_429.0854 0.00 0.00 1.00 0.77 
9.08_429.0845 0.00 0.00 1.00 0.82 
4.02_423.1940 0.00 0.00 0.98 1.00 
1.48_431.0890 0.00 0.45 1.00 0.91 
9.07_451.0615 0.00 0.00 1.00 0.97 
9.09_448.0576 0.00 0.00 1.00 0.71 
6.99_443.3240 0.00 0.08 1.00 0.95 
9.73_443.1014 0.00 0.00 1.00 0.87 
8.33_443.0954 0.00 0.00 1.00 0.90 
6.90_461.2902 0.00 0.00 1.00 0.96 
5.90_459.3212 0.00 0.13 1.00 0.76 
10.02_459.0960 0.00 0.00 1.00 0.77 
9.03_457.1145 0.00 0.00 1.00 0.79 
8.67_457.1133 0.00 0.00 1.00 0.95 
11.52_456.3791 0.00 0.00 0.70 1.00 
6.21_455.1906 0.00 0.19 1.00 0.85 
9.81_454.0847 0.00 0.00 1.00 0.88 
9.05_454.0819 0.00 0.00 1.00 0.72 
5.01_452.1838 0.00 0.00 0.99 1.00 
6.42_472.2832 0.00 0.00 0.56 1.00 
6.46_471.2466 0.00 0.01 1.00 0.90 
10.02_470.0758 0.00 0.00 1.00 0.82 
9.02_468.1011 0.00 0.00 1.00 0.83 
8.31_465.0807 0.00 0.00 1.00 0.79 
8.82_465.0807 0.00 0.00 1.00 0.70 
9.79_462.0710 0.00 0.00 1.00 0.81 
9.04_462.0699 0.00 0.00 1.00 0.73 
9.78_481.0499 0.00 0.00 0.74 1.00 
9.02_479.0963 0.00 0.00 1.00 0.88 
10.01_478.0692 0.00 0.00 1.00 0.66 
4.15_476.2404 0.00 0.00 1.00 0.84 
 350 
9.02_476.0877 0.00 0.00 1.00 0.79 
7.51_499.2782 0.00 0.06 1.00 0.92 
9.02_495.0687 0.00 0.00 1.00 0.95 
4.37_494.2617 0.00 0.00 0.50 1.00 
9.74_493.2809 0.00 0.01 1.00 0.93 
5.37_493.1709 0.00 0.00 1.00 0.80 
9.79_513.1525 0.00 0.00 1.00 0.62 
6.65_512.8485 0.00 0.00 0.95 1.00 
5.76_512.6875 0.00 0.00 1.00 1.00 
9.09_512.3013 0.00 0.00 1.00 0.82 
13.62_510.2556 0.00 0.37 1.00 0.85 
5.65_504.2609 0.00 0.00 1.00 0.99 
5.64_515.2738 0.00 0.00 1.00 0.91 
9.71_537.3041 0.00 0.00 0.95 1.00 
10.06_526.3139 0.00 0.00 1.00 0.86 
7.21_526.2839 0.00 0.02 0.97 1.00 
7.20_544.2918 0.00 0.00 1.00 0.93 
7.57_542.3960 0.00 0.15 1.00 0.65 
12.03_565.3746 0.00 0.08 0.73 1.00 
7.14_560.1805 0.00 0.00 0.75 1.00 
6.90_555.3068 0.00 0.00 1.00 0.92 
5.52_601.2501 0.00 0.00 1.00 0.87 
9.02_590.6205 0.00 0.00 1.00 0.79 
9.74_581.3322 0.00 0.00 0.96 1.00 
9.79_576.6021 0.00 0.00 0.82 1.00 
9.06_576.6005 0.00 0.00 0.97 1.00 
1.25_639.8836 0.00 0.00 1.00 0.83 
12.72_634.4531 0.00 0.00 1.00 0.73 
9.71_625.3598 0.00 0.00 1.00 0.84 
9.73_669.3835 0.00 0.00 1.00 0.90 
9.02_704.1451 0.00 0.00 1.00 0.61 
9.03_696.1548 0.00 0.00 1.00 0.81 
9.71_694.1152 0.00 0.00 0.77 1.00 
9.03_690.1259 0.00 0.00 1.00 0.54 
9.79_683.1204 0.00 0.00 1.00 0.77 
9.06_676.1101 0.00 0.00 1.00 0.87 
9.74_713.4076 0.00 0.00 0.65 1.00 
9.78_885.1896 0.00 0.00 1.00 0.69 
9.07_879.1306 0.00 0.00 0.96 1.00 
9.02_935.1961 0.00 0.00 1.00 0.77 
7.20_920.0962 0.00 0.00 0.77 1.00 
7.21_916.0943 0.00 0.00 0.54 1.00 
9.80_907.1678 0.00 0.00 1.00 0.88 
9.04_907.1662 0.00 0.00 1.00 0.53 
7.65_1000.0444 0.00 0.00 0.87 1.00 
7.63_942.9948 0.00 0.00 1.00 0.83 
7.01_1221.4414 0.00 0.00 0.92 1.00 
6.97_357.2762 0.00 0.00 1.00 0.85 
9.79_218.0234 0.00 0.01 1.00 0.89 
7.07_184.1710 0.00 0.00 1.00 0.83 
9.78_465.0808 0.00 0.01 1.00 0.94 
8.21_315.2621 0.00 0.01 1.00 0.83 
8.21_212.2021 0.00 0.00 1.00 0.84 
5.66_384.2168 0.00 0.00 1.00 0.87 
9.79_1349.2480 0.01 0.00 1.00 0.88 
9.27_343.2981 0.01 0.03 1.00 0.92 
8.34_150.0928 0.01 0.09 0.90 1.00 
10.70_288.2557 0.01 0.01 1.00 0.74 
1.64_174.0879 0.01 0.00 1.00 1.00 
6.76_310.2021 0.01 0.00 1.00 1.00 
1.82_228.1004 0.01 0.00 1.00 0.82 
6.06_294.2084 0.01 0.00 1.00 0.80 
6.24_515.2753 0.01 0.00 1.00 0.97 
8.74_542.3146 0.01 0.00 0.89 1.00 
1.29_203.9309 0.01 0.00 0.96 1.00 
1.64_246.1172 0.01 0.00 1.00 0.96 
9.71_757.4327 0.01 0.00 0.92 1.00 
6.65_282.2073 0.02 0.11 1.00 0.75 
7.48_177.0877 0.02 0.00 1.00 0.86 
1.75_507.1572 0.02 0.00 1.00 0.62 
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8.10_301.1534 0.02 0.10 1.00 0.95 
8.29_401.1993 0.03 0.00 1.00 0.82 
4.82_393.2208 0.03 0.00 1.00 0.74 
16.15_710.1773 0.03 0.01 0.61 1.00 
1.53_143.0837 0.04 0.05 0.82 1.00 
9.27_240.2315 0.04 0.03 1.00 0.81 
5.43_377.1482 0.04 0.00 1.00 0.99 
12.62_416.2462 0.04 0.05 1.00 0.74 
3.22_235.1201 0.05 0.00 0.91 1.00 
7.06_325.1861 0.05 0.31 1.00 0.78 
9.66_279.1583 0.06 0.00 1.00 0.80 
12.02_205.1953 0.07 0.00 1.00 0.62 
9.14_239.1284 0.07 0.06 1.00 0.88 
1.74_150.0789 0.07 0.00 1.00 0.87 
4.75_136.0625 0.07 0.00 0.85 1.00 
1.73_338.0231 0.07 0.00 0.97 1.00 
6.39_336.2172 0.08 0.06 1.00 0.68 
12.57_815.5173 0.08 0.25 1.00 0.86 
10.40_371.3275 0.08 0.15 1.00 0.80 
12.73_328.1928 0.08 0.00 1.00 0.86 
6.72_1450.6973 0.08 0.02 0.72 1.00 
8.53_283.1523 0.08 0.18 0.82 1.00 
1.70_260.1135 0.08 0.00 1.00 0.97 
6.66_264.1980 0.08 0.04 1.00 0.88 
6.95_218.1203 0.09 0.19 1.00 0.87 
12.66_372.2164 0.10 0.24 1.00 0.80 
12.70_350.2054 0.10 0.19 1.00 0.86 
16.22_252.0441 0.11 0.19 0.60 1.00 
1.77_218.1042 0.11 0.03 1.00 1.00 
3.86_150.0940 0.11 0.21 1.00 0.92 
7.25_371.1508 0.12 0.00 1.00 0.87 
6.71_1160.7578 0.12 0.00 0.81 1.00 
12.78_306.1796 0.13 0.22 1.00 0.89 
12.63_394.2284 0.13 0.10 1.00 0.73 
7.06_221.1900 0.14 0.44 1.00 0.97 
7.62_970.6124 0.15 0.21 0.74 1.00 
8.53_207.1002 0.15 0.19 0.85 1.00 
7.42_280.1237 0.15 0.42 1.00 0.93 
12.55_438.2596 0.16 0.26 1.00 0.68 
3.80_288.1929 0.17 0.15 1.00 0.93 
12.73_320.2010 0.17 0.18 1.00 0.90 
12.62_787.4580 0.18 0.31 1.00 0.92 
7.06_203.1787 0.19 0.35 1.00 0.91 
8.53_177.0880 0.19 0.18 1.00 0.85 
10.98_442.3651 0.20 0.16 1.00 0.77 
4.88_188.0708 0.20 0.35 1.00 0.92 
12.70_699.4109 0.20 0.23 1.00 0.96 
6.41_165.0905 0.21 0.14 0.89 1.00 
6.06_203.1781 0.21 0.37 1.00 0.92 
4.87_329.1844 0.22 0.00 1.00 0.87 
16.18_335.9929 0.22 0.00 0.66 1.00 
12.78_611.3565 0.22 0.25 1.00 0.98 
1.51_393.5330 0.23 0.58 1.00 0.98 
5.84_299.0939 0.23 0.11 0.69 1.00 
12.61_771.4862 0.24 0.30 1.00 0.83 
12.73_655.3845 0.24 0.29 1.00 1.00 
4.31_265.0552 0.24 0.00 1.00 0.82 
12.67_743.4367 0.24 0.27 1.00 0.95 
12.70_683.4373 0.24 0.32 1.00 0.83 
5.97_286.6247 0.24 0.04 0.82 1.00 
12.79_595.3829 0.25 0.34 1.00 0.84 
12.67_727.4605 0.25 0.34 1.00 0.81 
2.84_200.1047 0.25 0.00 1.00 0.99 
12.74_639.4067 0.26 0.31 1.00 0.84 
6.95_368.2220 0.27 0.47 1.00 0.85 
12.86_523.3040 0.27 0.18 0.94 1.00 
12.80_567.3292 0.27 0.32 0.97 1.00 
3.85_276.1433 0.28 0.16 0.98 1.00 
1.65_159.0768 0.28 0.00 0.65 1.00 
12.86_507.3281 0.28 0.43 1.00 0.74 
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4.30_310.1305 0.28 0.06 1.00 0.96 
4.12_413.1243 0.32 0.58 1.00 0.99 
7.91_389.2523 0.33 0.15 1.00 0.93 
3.83_198.1623 0.33 0.23 1.00 0.89 
7.65_970.5389 0.33 0.00 1.00 0.95 
12.82_551.3593 0.34 0.50 0.86 1.00 
12.87_262.1528 0.35 0.15 1.00 0.94 
6.78_176.0714 0.36 0.62 1.00 0.87 
12.70_678.4764 0.37 0.21 1.00 0.72 
12.86_502.3745 0.37 0.45 1.00 0.72 
12.86_463.2998 0.37 0.49 1.00 0.79 
3.76_347.1589 0.38 0.00 1.00 0.75 
12.56_441.2657 0.39 0.56 0.84 1.00 
6.73_1160.5609 0.39 0.00 0.82 1.00 
12.67_722.5060 0.41 0.20 1.00 0.73 
5.61_343.2002 0.43 0.10 1.00 0.85 
4.29_244.1199 0.47 0.49 0.93 1.00 
4.00_320.1711 0.49 0.06 1.00 0.99 
14.78_323.2583 0.50 1.00 0.00 0.03 
13.49_420.3478 0.51 1.00 0.01 0.00 
10.60_346.3091 0.51 1.00 0.00 0.00 
13.00_413.3095 0.52 1.00 0.05 0.00 
5.16_210.1137 0.52 0.51 0.96 1.00 
9.48_225.1993 0.53 1.00 0.01 0.00 
6.81_807.1918 0.54 1.00 0.00 0.00 
6.15_485.2027 0.55 0.59 1.00 0.88 
7.42_196.0651 0.55 0.29 1.00 0.92 
4.26_669.2631 0.56 1.00 0.00 0.00 
11.80_235.1712 0.56 1.00 0.04 0.00 
10.15_739.4618 0.56 1.00 0.03 0.02 
14.41_309.2409 0.56 1.00 0.04 0.03 
10.53_531.4000 0.57 1.00 0.00 0.00 
4.86_372.1909 0.57 0.29 1.00 0.89 
12.97_407.3144 0.58 1.00 0.01 0.00 
12.98_399.3242 0.58 1.00 0.01 0.00 
4.09_573.1785 0.58 1.00 0.00 0.00 
3.79_359.1699 0.59 0.29 1.00 0.92 
4.64_137.0376 0.59 0.61 1.00 0.87 
4.37_663.2850 0.59 1.00 0.05 0.00 
13.98_433.3418 0.61 1.00 0.01 0.00 
4.64_412.2067 0.62 1.00 0.10 0.08 
6.19_181.1351 0.63 1.00 0.00 0.07 
10.97_401.2525 0.63 1.00 0.00 0.00 
11.58_415.2745 0.65 1.00 0.00 0.00 
12.62_273.1378 0.66 1.00 0.00 0.00 
12.97_290.7254 0.66 1.00 0.15 0.05 
4.27_647.2871 0.67 1.00 0.01 0.06 
11.44_223.2060 0.67 1.00 0.00 0.00 
8.08_219.1411 0.68 1.00 0.36 0.28 
6.40_263.1761 0.70 0.75 1.00 0.88 
6.85_824.9348 0.70 1.00 0.19 0.00 
4.81_506.2950 0.71 1.00 0.39 0.33 
16.15_442.8736 0.71 1.00 0.15 0.06 
4.40_158.0302 0.72 0.53 0.99 1.00 
4.34_266.1408 0.72 0.56 0.98 1.00 
4.37_150.0945 0.72 1.00 0.00 0.00 
5.94_213.1018 0.73 0.55 0.97 1.00 
3.89_518.1743 0.73 1.00 0.00 0.00 
11.18_473.3585 0.75 1.00 0.02 0.02 
16.18_214.9181 0.76 1.00 0.43 0.27 
12.74_443.3505 0.77 1.00 0.00 0.00 
12.97_547.4060 0.77 1.00 0.07 0.00 
13.86_425.2896 0.78 1.00 0.22 0.14 
5.26_147.0936 0.79 1.00 0.33 0.30 
13.50_409.7445 0.80 1.00 0.34 0.09 
4.28_227.1066 0.80 1.00 0.59 0.57 
11.97_299.2600 0.80 1.00 0.00 0.00 
13.50_524.2740 0.81 1.00 0.22 0.15 
15.06_413.2647 0.81 1.00 0.27 0.14 
4.55_279.1361 0.81 1.00 0.65 0.60 
 353 
1.50_710.1736 0.81 0.82 0.96 1.00 
11.84_443.3878 0.82 1.00 0.09 0.06 
11.03_354.1608 0.82 1.00 0.11 0.09 
11.28_440.3462 0.82 1.00 0.00 0.00 
12.98_282.2118 0.82 1.00 0.00 0.00 
13.79_365.2675 0.84 1.00 0.00 0.00 
9.69_220.1127 0.87 1.00 0.19 0.44 
10.38_401.3397 0.88 1.00 0.18 0.13 
9.26_219.1735 0.88 1.00 0.00 0.00 
14.79_310.3109 0.90 1.00 0.55 0.67 
15.94_338.3442 0.91 1.00 0.44 0.37 
13.48_341.2200 0.91 1.00 0.34 0.19 
13.49_295.2258 0.91 1.00 0.00 0.00 
1.47_508.0657 0.91 1.00 0.76 0.71 
1.47_748.1127 0.94 1.00 0.84 0.83 
4.58_336.1924 0.95 1.00 0.68 0.54 
1.48_481.1031 0.96 1.00 0.73 0.71 
4.49_225.1597 0.97 1.00 0.52 0.50 
13.95_270.2746 1.00 1.00 0.33 0.27 
6.34_150.0787 1.00 0.95 0.88 0.81 
10.36_211.6353 1.00 0.89 0.20 0.00 
3.82_209.1275 1.00 0.90 0.72 0.65 
11.31_225.6512 1.00 0.95 0.17 0.00 
11.44_291.1951 1.00 0.75 0.00 0.00 
11.33_299.2599 1.00 0.77 0.00 0.00 
5.53_306.1782 1.00 0.69 0.37 0.26 
12.62_313.2746 1.00 0.83 0.00 0.00 
14.31_325.2414 1.00 0.74 0.00 0.08 
14.82_332.2940 1.00 0.65 0.00 0.10 
15.49_338.3442 1.00 0.86 0.00 0.00 
4.26_356.1796 1.00 0.84 0.64 0.56 
15.92_360.3229 1.00 0.71 0.26 0.20 
13.48_397.3392 1.00 0.75 0.00 0.00 
10.78_415.3581 1.00 0.61 0.18 0.15 
13.95_411.3586 1.00 0.78 0.00 0.00 
13.27_419.3131 1.00 0.81 0.00 0.00 
10.77_434.3251 1.00 0.58 0.21 0.00 
12.97_555.3910 1.00 0.94 0.19 0.09 
13.92_641.5490 1.00 0.85 0.00 0.00 
4.37_685.2548 1.00 0.86 0.20 0.23 
6.87_807.0837 1.00 0.57 0.00 0.00 
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Table A3.12. Normalized heat map of features described as unique in Figure 
3.2(B) and (C) when comparing wild type Nocardiopsis sp. FU40 ΔApoS8 to the 
R2 rifampicin resistant mutant extract using OPLS-DA and extracting features 
from the generated S-plot with correlation coefficients ≥0.9. Features are 
normalized to maximum intensity for that feature. 
 
Feature ID (RT_m/z) WT WT R3 R3 
12.03_135.1163 0.00 0.13 1.00 0.81 
1.52_129.5659 0.00 0.00 1.00 0.65 
12.03_123.1165 0.00 0.00 1.00 0.81 
4.87_118.0679 0.00 0.13 0.60 1.00 
4.95_114.0908 0.00 0.00 0.84 1.00 
1.50_165.0624 0.00 0.00 1.00 0.83 
6.56_162.0938 0.00 0.00 1.00 0.86 
4.31_160.1140 0.00 0.00 1.00 0.88 
5.78_170.1204 0.00 0.00 1.00 0.92 
7.08_169.0882 0.00 0.02 0.64 1.00 
2.44_166.0747 0.00 0.12 1.00 0.85 
6.60_180.1017 0.00 0.02 1.00 0.77 
4.95_177.1399 0.00 0.43 1.00 0.94 
9.12_191.0134 0.00 0.00 1.00 0.78 
6.97_190.1257 0.00 0.00 1.00 0.82 
4.99_198.1134 0.00 0.00 0.68 1.00 
9.08_196.0187 0.00 0.00 1.00 0.99 
8.84_203.1804 0.00 0.00 1.00 0.93 
9.08_203.0278 0.00 0.00 0.89 1.00 
9.80_203.0277 0.00 0.00 1.00 0.82 
9.42_202.0393 0.00 0.00 1.00 0.87 
4.35_209.0956 0.00 0.00 0.65 1.00 
4.54_208.1355 0.00 0.00 0.95 1.00 
5.44_208.0539 0.00 0.00 0.95 1.00 
7.49_207.0994 0.00 0.07 1.00 0.63 
1.30_205.9283 0.00 0.00 1.00 0.75 
4.84_205.1323 0.00 0.00 1.00 0.94 
8.67_212.0251 0.00 0.00 1.00 0.87 
1.32_211.8786 0.00 0.00 1.00 0.84 
9.81_210.0363 0.00 0.00 0.85 1.00 
9.07_210.0305 0.00 0.00 0.58 1.00 
9.41_219.0312 0.00 0.00 0.69 1.00 
3.69_218.1136 0.00 0.30 1.00 0.83 
8.67_218.0490 0.00 0.00 0.92 1.00 
9.03_217.0413 0.00 0.00 1.00 0.99 
8.84_221.1903 0.00 0.00 1.00 0.85 
6.51_220.1710 0.00 0.03 0.59 1.00 
4.58_226.1445 0.00 0.00 0.91 1.00 
5.11_226.1427 0.00 0.03 0.67 1.00 
9.04_225.0298 0.00 0.01 1.00 0.97 
9.77_224.0325 0.00 0.00 0.95 1.00 
5.11_227.1386 0.00 0.00 0.91 1.00 
9.82_230.0718 0.00 0.04 1.00 1.00 
6.24_230.0717 0.00 0.34 1.00 0.88 
8.41_230.0715 0.00 0.00 1.00 0.75 
5.11_236.1306 0.00 0.12 0.68 1.00 
4.89_235.1441 0.00 0.00 1.00 0.98 
9.80_241.0261 0.00 0.00 1.00 0.63 
5.81_248.1281 0.00 0.25 0.76 1.00 
9.03_248.0351 0.00 0.00 1.00 0.51 
4.04_247.1287 0.00 0.00 1.00 0.91 
5.04_244.1219 0.00 0.00 0.87 1.00 
2.62_252.0382 0.00 0.29 0.96 1.00 
11.26_250.1814 0.00 0.00 1.00 0.73 
14.09_252.0478 0.00 0.00 0.56 1.00 
8.66_252.0394 0.00 0.00 0.67 1.00 
12.02_263.1978 0.00 0.10 1.00 0.79 
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1.78_262.1278 0.00 0.00 0.87 1.00 
5.86_262.1048 0.00 0.26 0.68 1.00 
10.71_261.1779 0.00 0.03 1.00 0.87 
5.01_261.1438 0.00 0.03 1.00 0.79 
5.43_268.0192 0.00 0.06 1.00 0.52 
8.32_268.0180 0.00 0.00 0.97 1.00 
10.77_267.1616 0.00 0.12 1.00 0.81 
2.47_276.1033 0.00 0.00 0.81 1.00 
9.12_279.1585 0.00 0.00 1.00 0.94 
7.18_278.2110 0.00 0.00 1.00 0.97 
7.19_284.2219 0.00 0.00 0.95 1.00 
7.50_283.1523 0.00 0.05 1.00 0.81 
9.01_283.1521 0.00 0.13 0.70 1.00 
1.73_282.0649 0.00 0.03 0.98 1.00 
7.72_281.1420 0.00 0.00 0.95 1.00 
5.22_295.1312 0.00 0.02 1.00 0.82 
7.82_294.2085 0.00 0.00 1.00 0.80 
6.82_294.2084 0.00 0.00 0.68 1.00 
7.15_293.2251 0.00 0.00 1.00 0.96 
4.87_293.1612 0.00 0.25 0.79 1.00 
3.76_299.1387 0.00 0.00 1.00 0.57 
4.74_298.0969 0.00 0.07 1.00 0.85 
9.60_297.1694 0.00 0.01 1.00 0.84 
7.19_296.2224 0.00 0.00 0.97 1.00 
3.78_300.1386 0.00 0.03 1.00 0.68 
12.02_309.1921 0.00 0.03 1.00 0.66 
6.00_308.2238 0.00 0.00 1.00 0.97 
6.06_312.2197 0.00 0.00 1.00 0.87 
6.84_312.2197 0.00 0.00 0.95 1.00 
7.24_312.2197 0.00 0.00 0.96 1.00 
9.79_311.0549 0.00 0.00 0.75 1.00 
1.74_322.0446 0.00 0.02 0.91 1.00 
9.13_319.1539 0.00 0.00 1.00 0.92 
6.92_318.2094 0.00 0.00 1.00 0.85 
6.00_328.7423 0.00 0.09 1.00 0.56 
5.91_328.5999 0.00 0.00 0.62 1.00 
7.34_326.2353 0.00 0.00 1.00 0.89 
6.01_326.2353 0.00 0.00 1.00 0.87 
4.97_326.0999 0.00 0.27 1.00 0.90 
12.03_325.1706 0.00 0.00 1.00 0.66 
6.08_324.1828 0.00 0.23 0.81 1.00 
6.62_334.2005 0.00 0.00 1.00 1.00 
8.76_329.1942 0.00 0.09 0.92 1.00 
5.84_341.1007 0.00 0.00 0.85 1.00 
7.48_345.1875 0.00 0.00 0.89 1.00 
7.37_344.2218 0.00 0.00 1.00 0.75 
6.06_359.1205 0.00 0.00 0.58 1.00 
8.24_352.2057 0.00 0.00 0.71 1.00 
4.01_351.5992 0.00 0.00 0.81 1.00 
6.67_362.2335 0.00 0.00 0.99 1.00 
6.51_360.2165 0.00 0.00 1.00 0.75 
8.53_359.2035 0.00 0.12 1.00 0.70 
8.77_368.2219 0.00 0.00 1.00 0.66 
6.02_368.2219 0.00 0.07 0.95 1.00 
7.52_368.2211 0.00 0.00 1.00 0.73 
9.80_367.0822 0.00 0.00 1.00 0.99 
9.04_366.2404 0.00 0.00 1.00 0.66 
5.64_366.2063 0.00 0.00 0.75 1.00 
9.80_387.0731 0.00 0.00 0.98 1.00 
6.88_386.2329 0.00 0.00 1.00 0.76 
6.89_384.2172 0.00 0.00 0.86 1.00 
6.24_384.2171 0.00 0.00 0.54 1.00 
8.63_398.2317 0.00 0.00 0.97 1.00 
1.49_394.1142 0.00 0.00 0.53 1.00 
8.66_429.0854 0.00 0.00 0.94 1.00 
9.08_429.0845 0.00 0.00 1.00 0.92 
9.42_432.0873 0.00 0.00 1.00 1.00 
9.07_451.0615 0.00 0.00 1.00 0.69 
9.09_448.0576 0.00 0.00 1.00 0.66 
6.99_443.3240 0.00 0.06 1.00 0.61 
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9.73_443.1014 0.00 0.00 1.00 0.99 
8.33_443.0954 0.00 0.00 1.00 0.82 
6.90_461.2902 0.00 0.00 0.96 1.00 
5.90_459.3212 0.00 0.09 1.00 0.68 
10.02_459.0960 0.00 0.00 1.00 0.76 
9.03_457.1145 0.00 0.00 1.00 0.91 
8.67_457.1133 0.00 0.00 1.00 0.75 
11.52_456.3791 0.00 0.00 1.00 0.50 
6.21_455.1906 0.00 0.16 0.99 1.00 
9.81_454.0847 0.00 0.00 1.00 0.70 
6.46_471.2466 0.00 0.01 1.00 0.67 
9.02_468.1011 0.00 0.00 1.00 0.61 
9.08_467.0388 0.00 0.00 1.00 0.68 
9.79_462.0710 0.00 0.00 1.00 0.67 
9.78_481.0499 0.00 0.00 0.57 1.00 
9.02_479.0963 0.00 0.00 1.00 0.84 
10.01_478.0692 0.00 0.00 1.00 0.76 
4.15_476.2404 0.00 0.00 1.00 0.80 
9.02_476.0877 0.00 0.00 1.00 0.78 
6.98_499.2793 0.00 0.00 1.00 0.62 
7.51_499.2782 0.00 0.05 0.81 1.00 
9.02_495.0687 0.00 0.00 1.00 0.61 
4.37_494.2617 0.00 0.00 0.98 1.00 
5.37_493.1709 0.00 0.00 0.71 1.00 
9.79_513.1525 0.00 0.00 1.00 0.59 
9.09_512.3013 0.00 0.00 1.00 0.54 
5.65_504.2609 0.00 0.00 0.83 1.00 
5.64_515.2738 0.00 0.01 1.00 0.79 
10.06_526.3139 0.00 0.00 1.00 0.57 
7.21_526.2839 0.00 0.02 1.00 0.98 
5.90_546.1391 0.00 0.00 0.76 1.00 
7.20_544.2918 0.00 0.00 1.00 0.69 
7.57_542.3960 0.00 0.09 1.00 0.59 
9.00_540.1495 0.00 0.00 1.00 0.72 
6.63_570.3104 0.00 0.00 1.00 0.84 
12.03_565.3746 0.00 0.04 1.00 0.90 
6.90_555.3068 0.00 0.00 1.00 0.77 
5.52_601.2501 0.00 0.00 0.95 1.00 
9.79_576.6021 0.00 0.00 1.00 0.56 
1.25_639.8836 0.00 0.00 1.00 0.72 
9.07_662.0928 0.00 0.00 1.00 0.90 
9.02_704.1451 0.00 0.00 1.00 0.95 
9.79_683.1204 0.00 0.00 1.00 0.66 
9.06_676.1101 0.00 0.00 1.00 1.00 
9.78_885.1896 0.00 0.00 1.00 0.56 
7.60_846.3434 0.00 0.00 0.75 1.00 
9.02_935.1961 0.00 0.00 1.00 0.55 
9.80_907.1678 0.00 0.00 1.00 0.66 
7.69_1031.1674 0.00 0.09 0.61 1.00 
7.63_942.9948 0.00 0.00 0.57 1.00 
7.01_1221.4414 0.00 0.00 1.00 0.76 
9.79_218.0234 0.00 0.01 1.00 0.86 
9.78_465.0808 0.00 0.01 1.00 0.81 
8.74_542.3146 0.00 0.00 0.66 1.00 
9.79_1349.2480 0.00 0.00 1.00 0.51 
8.34_150.0928 0.00 0.07 1.00 0.93 
1.64_174.0879 0.01 0.00 0.88 1.00 
9.81_269.0437 0.01 0.00 0.62 1.00 
6.76_310.2021 0.01 0.00 1.00 0.84 
1.82_228.1004 0.01 0.00 0.88 1.00 
5.66_384.2168 0.01 0.00 1.00 0.77 
6.06_294.2084 0.01 0.00 0.81 1.00 
1.29_203.9309 0.01 0.00 1.00 0.80 
1.64_246.1172 0.01 0.00 1.00 0.94 
6.24_515.2753 0.01 0.01 0.93 1.00 
7.48_177.0877 0.02 0.00 0.94 1.00 
8.10_301.1534 0.02 0.07 1.00 0.75 
1.53_143.0837 0.03 0.03 0.93 1.00 
1.75_507.1572 0.03 0.00 0.68 1.00 
3.22_235.1201 0.03 0.00 1.00 0.87 
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16.15_710.1773 0.03 0.01 0.77 1.00 
12.02_205.1953 0.04 0.00 1.00 0.79 
5.43_377.1482 0.05 0.00 1.00 0.86 
1.73_338.0231 0.05 0.00 0.98 1.00 
7.06_325.1861 0.05 0.29 1.00 0.91 
8.29_401.1993 0.05 0.00 1.00 0.92 
4.37_326.1802 0.05 0.32 0.66 1.00 
6.39_336.2172 0.05 0.04 1.00 0.91 
9.66_279.1583 0.06 0.00 0.69 1.00 
6.66_264.1980 0.06 0.03 0.66 1.00 
3.07_230.1126 0.06 0.15 0.85 1.00 
1.77_218.1042 0.06 0.02 1.00 0.83 
9.67_319.1539 0.07 0.09 0.83 1.00 
4.75_136.0625 0.07 0.00 1.00 0.84 
8.53_283.1523 0.07 0.14 1.00 0.90 
7.62_970.6124 0.07 0.10 0.54 1.00 
1.74_150.0789 0.07 0.00 1.00 0.81 
1.70_260.1135 0.07 0.00 1.00 0.93 
6.95_218.1203 0.08 0.16 1.00 0.83 
9.14_239.1284 0.10 0.09 1.00 0.62 
16.24_268.0194 0.10 0.20 0.72 1.00 
8.53_207.1002 0.10 0.12 0.61 1.00 
3.83_292.1654 0.11 0.00 0.56 1.00 
6.72_1450.6973 0.12 0.03 1.00 0.69 
3.80_288.1929 0.12 0.11 0.88 1.00 
3.86_150.0940 0.13 0.23 1.00 0.92 
1.65_159.0768 0.13 0.00 0.83 1.00 
6.95_368.2220 0.13 0.22 1.00 0.95 
7.06_221.1900 0.13 0.39 1.00 0.74 
8.53_177.0880 0.13 0.13 1.00 0.98 
7.25_371.1508 0.13 0.00 0.58 1.00 
10.52_673.3745 0.14 0.22 1.00 0.70 
16.22_252.0441 0.14 0.25 0.77 1.00 
7.42_280.1237 0.16 0.43 1.00 0.84 
1.76_596.1679 0.16 0.00 0.74 1.00 
13.77_459.1339 0.16 0.35 0.67 1.00 
6.71_1160.7578 0.17 0.00 1.00 0.69 
7.06_203.1787 0.17 0.33 1.00 0.91 
5.97_286.6247 0.18 0.03 1.00 1.00 
3.82_230.1126 0.20 0.12 0.78 1.00 
6.41_165.0905 0.21 0.14 1.00 0.85 
4.87_329.1844 0.22 0.00 1.00 0.97 
4.31_265.0552 0.23 0.00 0.85 1.00 
4.88_188.0708 0.23 0.40 0.92 1.00 
9.41_281.1770 0.26 0.48 1.00 0.84 
3.85_276.1433 0.26 0.15 1.00 0.83 
4.30_284.1098 0.27 0.08 0.68 1.00 
4.30_310.1305 0.28 0.06 0.94 1.00 
4.12_413.1243 0.28 0.50 0.76 1.00 
16.18_335.9929 0.28 0.00 1.00 0.67 
6.06_203.1781 0.29 0.51 1.00 0.99 
5.11_307.1591 0.31 0.00 0.74 1.00 
4.81_464.2611 0.34 0.41 1.00 0.92 
3.76_347.1589 0.38 0.00 1.00 0.78 
6.78_176.0714 0.39 0.66 1.00 0.96 
3.80_194.0821 0.43 0.00 0.92 1.00 
4.29_244.1199 0.44 0.45 1.00 0.93 
4.64_137.0376 0.44 0.45 1.00 0.86 
5.61_343.2002 0.49 0.11 1.00 0.96 
4.86_372.1909 0.49 0.25 1.00 0.86 
12.43_386.2820 0.50 1.00 0.00 0.00 
3.79_359.1699 0.51 0.25 1.00 0.93 
10.60_346.3091 0.51 1.00 0.00 0.00 
9.48_225.1993 0.53 1.00 0.01 0.01 
6.81_807.1918 0.54 1.00 0.00 0.00 
6.15_485.2027 0.55 0.59 0.86 1.00 
4.26_669.2631 0.56 1.00 0.00 0.00 
11.80_235.1712 0.56 1.00 0.00 0.00 
10.15_739.4618 0.56 1.00 0.03 0.02 
14.41_309.2409 0.56 1.00 0.00 0.09 
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6.27_207.0660 0.57 1.00 0.00 0.00 
10.53_531.4000 0.57 1.00 0.00 0.00 
12.97_407.3144 0.58 1.00 0.05 0.02 
12.98_399.3242 0.58 1.00 0.05 0.02 
7.42_196.0651 0.59 0.30 0.97 1.00 
4.37_663.2850 0.59 1.00 0.05 0.03 
13.98_433.3418 0.61 1.00 0.00 0.00 
6.90_166.0720 0.61 1.00 0.00 0.00 
4.64_412.2067 0.62 1.00 0.00 0.06 
6.19_181.1351 0.63 1.00 0.03 0.00 
10.97_401.2525 0.63 1.00 0.00 0.00 
11.58_415.2745 0.65 1.00 0.00 0.00 
12.62_273.1378 0.66 1.00 0.00 0.00 
12.86_507.3281 0.66 1.00 0.20 0.14 
12.97_290.7254 0.66 1.00 0.31 0.16 
4.27_647.2871 0.67 1.00 0.02 0.01 
12.82_551.3593 0.67 1.00 0.21 0.16 
11.44_223.2060 0.67 1.00 0.00 0.00 
8.08_219.1411 0.68 1.00 0.14 0.17 
12.56_441.2657 0.70 1.00 0.28 0.26 
6.40_263.1761 0.70 0.75 1.00 0.89 
6.85_824.9348 0.70 1.00 0.00 0.00 
4.81_506.2950 0.71 1.00 0.12 0.10 
16.15_442.8736 0.71 1.00 0.00 0.00 
7.07_184.1710 0.72 1.00 0.00 0.00 
4.37_150.0945 0.72 1.00 0.00 0.00 
12.79_595.3829 0.73 1.00 0.25 0.17 
3.89_518.1743 0.73 1.00 0.03 0.00 
12.67_727.4605 0.74 1.00 0.33 0.21 
11.18_473.3585 0.75 1.00 0.02 0.00 
12.70_683.4373 0.77 1.00 0.28 0.21 
12.86_463.2998 0.77 1.00 0.07 0.18 
12.74_443.3505 0.77 1.00 0.00 0.00 
12.97_547.4060 0.77 1.00 0.00 0.04 
13.86_425.2896 0.78 1.00 0.27 0.23 
1.50_401.0693 0.79 0.73 0.95 1.00 
5.26_147.0936 0.79 1.00 0.29 0.30 
3.75_267.1417 0.80 1.00 0.58 0.43 
12.61_771.4862 0.80 1.00 0.32 0.24 
11.97_299.2600 0.80 1.00 0.00 0.00 
15.06_413.2647 0.81 1.00 0.27 0.26 
12.86_502.3745 0.82 1.00 0.18 0.12 
11.84_443.3878 0.82 1.00 0.09 0.04 
11.03_354.1608 0.82 1.00 0.05 0.05 
11.28_440.3462 0.82 1.00 0.00 0.00 
12.98_282.2118 0.82 1.00 0.00 0.00 
12.73_655.3845 0.83 1.00 0.00 0.22 
12.74_639.4067 0.83 1.00 0.31 0.22 
13.79_365.2675 0.84 1.00 0.00 0.00 
12.80_567.3292 0.85 1.00 0.30 0.19 
12.83_546.4021 0.86 1.00 0.19 0.13 
10.38_401.3397 0.88 1.00 0.24 0.16 
9.26_219.1735 0.88 1.00 0.00 0.00 
12.67_743.4367 0.88 1.00 0.37 0.24 
4.50_359.1197 0.89 1.00 0.63 0.50 
12.70_699.4109 0.89 1.00 0.20 0.00 
5.43_241.1546 0.91 0.93 0.98 1.00 
12.78_611.3565 0.91 1.00 0.33 0.07 
15.94_338.3442 0.91 1.00 0.41 0.39 
13.49_295.2258 0.91 1.00 0.04 0.02 
12.73_320.2010 0.94 1.00 0.00 0.20 
1.48_481.1031 0.96 1.00 0.88 0.83 
4.49_225.1597 0.97 1.00 0.45 0.40 
12.89_441.3208 0.99 1.00 0.15 0.13 
12.78_590.4295 1.00 1.00 0.20 0.14 
13.95_270.2746 1.00 1.00 0.35 0.33 
3.99_164.0936 1.00 0.90 0.63 0.69 
10.36_211.6353 1.00 0.89 0.25 0.00 
3.82_209.1275 1.00 0.90 0.51 0.39 
11.31_225.6512 1.00 0.95 0.00 0.00 
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9.27_240.2315 1.00 0.88 0.16 0.16 
10.39_268.2627 1.00 0.83 0.00 0.03 
6.59_273.1670 1.00 0.84 0.66 0.53 
11.44_291.1951 1.00 0.75 0.00 0.00 
11.33_299.2599 1.00 0.77 0.00 0.00 
12.62_313.2746 1.00 0.83 0.01 0.00 
14.31_325.2414 1.00 0.74 0.00 0.00 
14.82_332.2940 1.00 0.65 0.16 0.00 
15.49_338.3442 1.00 0.86 0.00 0.06 
4.26_356.1796 1.00 0.84 0.59 0.52 
15.92_360.3229 1.00 0.71 0.32 0.13 
13.48_397.3392 1.00 0.75 0.00 0.00 
10.78_415.3581 1.00 0.61 0.22 0.15 
13.95_411.3586 1.00 0.78 0.00 0.00 
13.27_419.3131 1.00 0.81 0.00 0.00 
10.77_434.3251 1.00 0.58 0.18 0.00 
12.86_485.3471 1.00 0.86 0.13 0.09 
12.86_523.3040 1.00 0.66 0.25 0.24 
12.81_529.3766 1.00 0.77 0.13 0.12 
12.97_555.3910 1.00 0.94 0.00 0.12 
12.79_573.4039 1.00 0.73 0.11 0.15 
12.75_617.4294 1.00 0.84 0.16 0.15 
13.92_641.5490 1.00 0.85 0.00 0.00 
4.37_685.2548 1.00 0.86 0.00 0.00 
12.67_705.4810 1.00 0.93 0.25 0.15 
6.87_807.0837 1.00 0.57 0.00 0.00 
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Table A3.13. Normalized heat map of features described as unique in Figure 
3.2(B) and (C) when comparing wild type Nocardiopsis sp. FU40 ΔApoS8 to the 
R4 rifampicin resistant mutant extract using OPLS-DA and extracting features 
from the generated S-plot with correlation coefficients ≥0.9. Features are 
normalized to maximum intensity for that feature. 
 
Feature ID (RT_m/z) WT WT R4 R4 
1.51_137.5554 0.00 0.00 1.00 0.52 
1.52_129.5659 0.00 0.00 1.00 0.52 
1.50_103.5345 0.00 0.00 0.50 1.00 
13.61_149.0907 0.00 0.00 1.00 0.75 
6.56_162.0938 0.00 0.00 0.80 1.00 
4.31_160.1140 0.00 0.00 0.67 1.00 
5.78_170.1204 0.00 0.00 0.64 1.00 
6.60_180.1017 0.00 0.03 0.58 1.00 
5.02_180.1014 0.00 0.00 0.58 1.00 
9.12_191.0134 0.00 0.00 0.60 1.00 
4.14_186.1168 0.00 0.00 0.93 1.00 
9.08_196.0187 0.00 0.00 0.79 1.00 
8.68_204.0325 0.00 0.00 0.72 1.00 
9.08_203.0278 0.00 0.00 0.76 1.00 
9.42_202.0393 0.00 0.00 0.68 1.00 
1.42_201.0074 0.00 0.00 0.79 1.00 
4.35_209.0956 0.00 0.00 0.51 1.00 
4.54_208.1355 0.00 0.00 0.90 1.00 
5.44_208.0539 0.00 0.00 0.78 1.00 
7.49_207.0994 0.00 0.11 0.55 1.00 
1.30_205.9283 0.00 0.00 0.53 1.00 
4.84_205.1323 0.00 0.00 0.86 1.00 
8.67_212.0251 0.00 0.00 0.63 1.00 
1.49_211.0584 0.00 0.19 0.65 1.00 
9.25_211.0284 0.00 0.01 1.00 0.92 
8.31_210.0369 0.00 0.00 0.81 1.00 
9.81_210.0363 0.00 0.00 1.00 0.66 
9.07_210.0305 0.00 0.00 0.77 1.00 
9.41_219.0312 0.00 0.00 1.00 0.86 
8.67_218.0490 0.00 0.00 0.82 1.00 
9.03_217.0413 0.00 0.00 0.70 1.00 
2.51_216.0981 0.00 0.02 0.49 1.00 
16.16_223.9875 0.00 0.00 0.90 1.00 
6.51_220.1710 0.00 0.04 1.00 0.99 
4.58_226.1445 0.00 0.00 1.00 0.82 
5.11_226.1427 0.00 0.02 0.53 1.00 
8.67_226.0395 0.00 0.00 0.61 1.00 
9.04_225.0298 0.00 0.01 0.74 1.00 
9.77_224.0325 0.00 0.00 0.63 1.00 
5.11_227.1386 0.00 0.00 0.56 1.00 
9.19_230.0719 0.00 0.00 1.00 0.54 
9.82_230.0718 0.00 0.03 0.91 1.00 
8.41_230.0715 0.00 0.00 0.96 1.00 
10.62_236.1643 0.00 0.00 1.00 0.76 
5.11_236.1306 0.00 0.18 0.96 1.00 
4.89_235.1441 0.00 0.00 0.93 1.00 
8.54_235.1344 0.00 0.00 0.60 1.00 
9.80_241.0261 0.00 0.00 1.00 0.78 
8.82_241.0249 0.00 0.00 1.00 0.94 
4.13_237.1268 0.00 0.35 1.00 0.96 
5.81_248.1281 0.00 0.35 1.00 0.99 
9.03_248.0351 0.00 0.00 0.80 1.00 
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4.04_247.1287 0.00 0.00 0.50 1.00 
9.07_246.5440 0.00 0.00 0.71 1.00 
5.63_245.1880 0.00 0.00 1.00 0.83 
5.04_244.1219 0.00 0.00 0.85 1.00 
4.70_243.1326 0.00 0.00 0.55 1.00 
8.52_250.0297 0.00 0.00 0.76 1.00 
4.31_249.0807 0.00 0.00 0.72 1.00 
8.08_252.0397 0.00 0.00 1.00 0.84 
4.56_252.0394 0.00 0.16 1.00 0.63 
8.66_252.0394 0.00 0.00 1.00 0.58 
6.82_252.0384 0.00 0.00 0.83 1.00 
6.23_258.1449 0.00 0.00 1.00 0.75 
9.81_253.5524 0.00 0.02 0.91 1.00 
1.78_262.1278 0.00 0.00 0.75 1.00 
5.86_262.1048 0.00 0.41 0.85 1.00 
9.91_261.5430 0.00 0.00 1.00 0.65 
5.01_261.1438 0.00 0.08 0.80 1.00 
9.03_260.5527 0.00 0.00 0.72 1.00 
8.32_268.0180 0.00 0.00 1.00 0.55 
10.77_267.1616 0.00 0.02 1.00 1.00 
5.27_264.2082 0.00 0.00 0.79 1.00 
9.67_268.0195 0.00 0.00 1.00 0.94 
2.47_276.1033 0.00 0.00 0.83 1.00 
9.12_279.1585 0.00 0.00 0.56 1.00 
7.18_278.2110 0.00 0.00 0.62 1.00 
6.07_276.1943 0.00 0.00 0.57 1.00 
5.71_286.2118 0.00 0.00 0.84 1.00 
7.19_284.2219 0.00 0.00 0.63 1.00 
12.79_284.1681 0.00 0.22 1.00 0.68 
7.50_283.1523 0.00 0.06 0.78 1.00 
1.73_282.0649 0.00 0.03 0.61 1.00 
5.22_295.1312 0.00 0.05 0.70 1.00 
7.48_294.2085 0.00 0.00 1.00 0.58 
7.82_294.2085 0.00 0.00 0.56 1.00 
6.82_294.2084 0.00 0.00 0.63 1.00 
7.15_293.2251 0.00 0.00 0.92 1.00 
4.87_293.1612 0.00 0.39 1.00 0.83 
6.49_292.1923 0.00 0.01 0.80 1.00 
3.76_299.1387 0.00 0.08 0.64 1.00 
7.73_298.2024 0.00 0.00 0.60 1.00 
4.74_298.0969 0.00 0.05 0.68 1.00 
9.60_297.1694 0.00 0.01 0.61 1.00 
7.19_296.2224 0.00 0.00 0.58 1.00 
6.00_308.2238 0.00 0.00 0.64 1.00 
6.92_313.1550 0.00 0.00 0.55 1.00 
6.06_312.2197 0.00 0.00 0.84 1.00 
6.84_312.2197 0.00 0.00 0.52 1.00 
7.24_312.2197 0.00 0.00 0.62 1.00 
10.59_311.1859 0.00 0.00 0.65 1.00 
9.79_311.0549 0.00 0.00 0.57 1.00 
7.47_310.2026 0.00 0.00 1.00 0.56 
5.82_322.1007 0.00 0.00 0.89 1.00 
1.74_322.0446 0.00 0.03 0.90 1.00 
3.86_320.0995 0.00 0.00 0.64 1.00 
9.13_319.1539 0.00 0.00 0.60 1.00 
6.92_318.2094 0.00 0.00 0.76 1.00 
5.91_328.5999 0.00 0.00 0.65 1.00 
7.34_326.2353 0.00 0.00 0.58 1.00 
6.01_326.2353 0.00 0.00 0.79 1.00 
4.97_326.0999 0.00 0.23 0.83 1.00 
6.08_324.1828 0.00 0.09 0.64 1.00 
6.31_335.7452 0.00 0.00 1.00 0.52 
6.62_334.2005 0.00 0.00 0.50 1.00 
5.84_341.1007 0.00 0.00 0.59 1.00 
5.99_338.1374 0.00 0.00 1.00 0.77 
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6.22_346.2031 0.00 0.00 1.00 0.86 
7.48_345.1875 0.00 0.00 0.84 1.00 
7.37_344.2218 0.00 0.00 0.66 1.00 
5.26_354.0787 0.00 0.32 1.00 0.94 
8.24_352.2057 0.00 0.00 0.54 1.00 
6.67_362.2335 0.00 0.00 1.00 0.86 
6.51_360.2165 0.00 0.00 1.00 0.81 
8.53_359.2035 0.00 0.11 0.90 1.00 
8.77_368.2219 0.00 0.00 0.73 1.00 
6.02_368.2219 0.00 0.04 0.72 1.00 
7.52_368.2211 0.00 0.00 0.90 1.00 
9.80_367.0822 0.00 0.00 0.66 1.00 
5.64_366.2063 0.00 0.00 0.71 1.00 
8.47_382.2398 0.00 0.00 0.89 1.00 
7.30_389.1593 0.00 0.00 1.00 0.89 
9.80_387.0731 0.00 0.00 0.56 1.00 
6.88_386.2329 0.00 0.00 0.66 1.00 
6.24_384.2171 0.00 0.00 0.70 1.00 
8.63_398.2317 0.00 0.00 0.65 1.00 
1.49_394.1142 0.00 0.00 0.61 1.00 
9.40_418.0851 0.00 0.00 0.59 1.00 
8.66_429.0854 0.00 0.00 0.56 1.00 
9.08_429.0845 0.00 0.00 0.57 1.00 
4.02_423.1940 0.00 0.00 0.61 1.00 
9.15_440.0708 0.00 0.00 0.59 1.00 
9.42_432.0873 0.00 0.00 0.65 1.00 
1.48_431.0890 0.00 0.41 0.98 1.00 
9.09_448.0576 0.00 0.00 0.61 1.00 
9.73_443.1014 0.00 0.00 0.82 1.00 
8.33_443.0954 0.00 0.00 0.93 1.00 
8.80_443.0945 0.00 0.00 0.61 1.00 
6.90_461.2902 0.00 0.00 0.90 1.00 
10.02_459.0960 0.00 0.00 0.58 1.00 
9.03_457.1145 0.00 0.00 0.60 1.00 
8.67_457.1133 0.00 0.00 0.66 1.00 
6.21_455.1906 0.00 0.16 0.86 1.00 
9.81_454.0847 0.00 0.00 0.78 1.00 
9.05_454.0819 0.00 0.00 0.57 1.00 
6.42_472.2832 0.00 0.00 0.75 1.00 
6.46_471.2466 0.00 0.01 0.64 1.00 
10.02_470.0758 0.00 0.00 0.62 1.00 
9.02_468.1011 0.00 0.00 0.58 1.00 
9.08_467.0388 0.00 0.00 0.79 1.00 
8.31_465.0807 0.00 0.00 0.70 1.00 
8.82_465.0807 0.00 0.00 0.67 1.00 
9.79_462.0710 0.00 0.00 0.72 1.00 
9.04_462.0699 0.00 0.00 0.61 1.00 
7.03_483.0939 0.00 0.00 0.72 1.00 
9.78_481.0499 0.00 0.00 1.00 0.75 
9.02_479.0963 0.00 0.00 0.62 1.00 
10.01_478.0692 0.00 0.00 0.53 1.00 
4.15_476.2404 0.00 0.00 0.56 1.00 
9.02_476.0877 0.00 0.00 0.55 1.00 
7.06_475.1057 0.00 0.00 0.61 1.00 
9.02_495.0687 0.00 0.00 0.70 1.00 
4.37_494.2617 0.00 0.00 0.68 1.00 
5.37_493.1709 0.00 0.00 1.00 0.69 
9.79_513.1525 0.00 0.00 0.48 1.00 
5.64_515.2738 0.00 0.01 0.65 1.00 
1.76_515.1445 0.00 0.00 0.74 1.00 
10.06_526.3139 0.00 0.00 1.00 0.54 
7.21_526.2839 0.00 0.06 0.58 1.00 
7.20_544.2918 0.00 0.00 0.61 1.00 
9.00_540.1495 0.00 0.00 0.63 1.00 
6.63_570.3104 0.00 0.00 0.91 1.00 
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9.67_563.3802 0.00 0.00 0.59 1.00 
9.08_562.5875 0.00 0.00 0.62 1.00 
7.14_560.1805 0.00 0.00 0.64 1.00 
6.90_555.3068 0.00 0.00 0.53 1.00 
1.72_551.1035 0.00 0.00 0.96 1.00 
5.52_601.2501 0.00 0.00 0.73 1.00 
9.02_590.6205 0.00 0.00 0.63 1.00 
9.79_576.6021 0.00 0.00 1.00 0.60 
9.06_576.6005 0.00 0.00 0.60 1.00 
1.25_639.8836 0.00 0.00 0.63 1.00 
9.07_662.0928 0.00 0.00 0.48 1.00 
9.02_704.1451 0.00 0.00 0.54 1.00 
9.03_696.1548 0.00 0.00 0.49 1.00 
9.71_694.1152 0.00 0.00 0.66 1.00 
9.03_690.1259 0.00 0.00 0.54 1.00 
9.79_683.1204 0.00 0.00 1.00 0.68 
9.06_676.1101 0.00 0.00 0.53 1.00 
9.41_675.1324 0.00 0.00 0.54 1.00 
9.78_885.1896 0.00 0.00 0.47 1.00 
9.07_879.1306 0.00 0.00 0.69 1.00 
7.69_868.6024 0.00 0.00 1.00 0.57 
9.02_935.1961 0.00 0.00 0.53 1.00 
7.21_916.0943 0.00 0.00 1.00 0.78 
9.80_907.1678 0.00 0.00 0.82 1.00 
9.04_907.1662 0.00 0.00 0.51 1.00 
9.41_904.1590 0.00 0.00 0.53 1.00 
7.67_1031.2480 0.00 0.14 0.97 1.00 
7.69_1031.1674 0.00 0.10 1.00 0.91 
7.67_1031.0798 0.00 0.00 0.91 1.00 
7.69_1000.1273 0.00 0.00 0.49 1.00 
7.65_1000.0444 0.00 0.00 0.92 1.00 
7.63_942.9948 0.00 0.00 1.00 0.90 
7.01_1221.4414 0.00 0.00 0.55 1.00 
9.41_1125.2062 0.00 0.00 0.48 1.00 
9.78_465.0808 0.00 0.00 0.87 1.00 
9.79_1349.2480 0.00 0.00 0.51 1.00 
6.06_294.2084 0.00 0.00 0.59 1.00 
9.81_269.0437 0.00 0.00 0.61 1.00 
8.34_150.0928 0.00 0.07 0.56 1.00 
6.65_282.2073 0.01 0.04 0.76 1.00 
6.76_310.2021 0.01 0.00 1.00 0.90 
8.74_542.3146 0.01 0.00 1.00 0.73 
1.75_507.1572 0.01 0.00 0.69 1.00 
1.29_203.9309 0.01 0.00 0.50 1.00 
5.66_384.2168 0.01 0.00 0.71 1.00 
1.64_246.1172 0.02 0.00 0.74 1.00 
7.48_177.0877 0.02 0.00 0.60 1.00 
1.64_174.0879 0.02 0.01 1.00 0.56 
6.66_264.1980 0.03 0.01 0.63 1.00 
8.10_301.1534 0.03 0.11 0.90 1.00 
5.43_377.1482 0.03 0.00 0.68 1.00 
16.15_710.1773 0.04 0.01 0.70 1.00 
9.14_239.1284 0.04 0.04 0.59 1.00 
6.24_515.2753 0.04 0.02 0.84 1.00 
9.66_279.1583 0.05 0.00 0.65 1.00 
9.67_319.1539 0.05 0.06 0.64 1.00 
1.74_150.0789 0.05 0.00 0.59 1.00 
3.22_235.1201 0.05 0.00 1.00 0.67 
6.95_368.2220 0.05 0.09 1.00 0.59 
8.53_283.1523 0.05 0.12 0.85 1.00 
8.29_401.1993 0.06 0.00 0.56 1.00 
3.07_230.1126 0.06 0.14 0.82 1.00 
4.75_136.0625 0.06 0.00 0.78 1.00 
1.73_338.0231 0.06 0.00 0.84 1.00 
1.70_260.1135 0.08 0.00 0.75 1.00 
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8.53_207.1002 0.09 0.11 0.81 1.00 
6.95_218.1203 0.09 0.18 0.63 1.00 
8.53_177.0880 0.09 0.09 0.84 1.00 
7.25_371.1508 0.09 0.00 0.67 1.00 
9.41_281.1770 0.10 0.19 0.65 1.00 
10.52_673.3745 0.12 0.19 0.63 1.00 
10.18_621.4210 0.13 0.00 0.59 1.00 
3.86_150.0940 0.14 0.25 0.68 1.00 
3.83_198.1623 0.14 0.10 0.57 1.00 
1.77_218.1042 0.14 0.03 0.70 1.00 
3.80_288.1929 0.15 0.13 1.00 0.77 
6.41_165.0905 0.17 0.11 0.78 1.00 
3.86_338.1113 0.19 0.00 0.65 1.00 
4.31_265.0552 0.19 0.00 0.80 1.00 
1.65_159.0768 0.21 0.00 1.00 0.65 
1.73_288.1454 0.21 0.00 0.85 1.00 
5.97_286.6247 0.22 0.04 1.00 0.66 
4.30_478.1379 0.22 0.05 0.76 1.00 
3.85_276.1433 0.22 0.13 0.58 1.00 
4.87_329.1844 0.23 0.00 0.80 1.00 
7.91_389.2523 0.23 0.10 0.63 1.00 
7.89_192.1015 0.23 0.40 0.74 1.00 
6.72_1450.6973 0.25 0.06 0.68 1.00 
3.76_347.1589 0.28 0.00 0.76 1.00 
16.18_335.9929 0.29 0.00 0.69 1.00 
1.60_229.1318 0.29 0.06 0.78 1.00 
4.30_310.1305 0.29 0.06 0.71 1.00 
5.97_278.6345 0.30 0.08 1.00 0.95 
9.11_505.3321 0.33 0.00 0.70 1.00 
9.47_211.0868 0.34 0.59 1.00 0.98 
3.82_230.1126 0.34 0.22 1.00 0.80 
4.00_320.1711 0.43 0.05 0.99 1.00 
5.11_307.1591 0.44 0.00 1.00 0.92 
4.81_464.2611 0.44 0.52 1.00 0.80 
4.86_372.1909 0.49 0.25 0.81 1.00 
10.60_346.3091 0.51 1.00 0.00 0.00 
10.40_371.3275 0.52 1.00 0.00 0.00 
10.70_288.2557 0.52 1.00 0.00 0.00 
4.64_137.0376 0.53 0.55 0.84 1.00 
9.48_225.1993 0.53 1.00 0.01 0.02 
7.06_203.1787 0.53 1.00 0.01 0.00 
4.26_669.2631 0.56 1.00 0.00 0.00 
11.80_235.1712 0.56 1.00 0.00 0.04 
10.15_739.4618 0.56 1.00 0.06 0.05 
14.41_309.2409 0.56 1.00 0.14 0.13 
10.53_531.4000 0.57 1.00 0.00 0.00 
12.97_407.3144 0.58 1.00 0.20 0.09 
12.98_399.3242 0.58 1.00 0.19 0.09 
4.09_573.1785 0.58 1.00 0.00 0.00 
4.37_663.2850 0.59 1.00 0.01 0.00 
5.45_144.0814 0.60 1.00 0.13 0.21 
13.98_433.3418 0.61 1.00 0.02 0.01 
4.64_412.2067 0.62 1.00 0.08 0.10 
6.19_181.1351 0.63 1.00 0.09 0.11 
10.97_401.2525 0.63 1.00 0.00 0.00 
11.58_415.2745 0.65 1.00 0.00 0.00 
12.62_273.1378 0.66 1.00 0.00 0.00 
12.86_507.3281 0.66 1.00 0.37 0.22 
4.27_647.2871 0.67 1.00 0.00 0.01 
12.82_551.3593 0.67 1.00 0.38 0.32 
11.44_223.2060 0.67 1.00 0.00 0.00 
8.08_219.1411 0.68 1.00 0.00 0.00 
12.56_441.2657 0.70 1.00 0.24 0.35 
6.85_824.9348 0.70 1.00 0.00 0.00 
4.81_506.2950 0.71 1.00 0.24 0.26 
 365 
16.15_442.8736 0.71 1.00 0.00 0.00 
7.07_184.1710 0.72 1.00 0.00 0.00 
4.37_150.0945 0.72 1.00 0.00 0.00 
12.79_595.3829 0.73 1.00 0.46 0.37 
12.67_727.4605 0.74 1.00 0.22 0.33 
11.18_473.3585 0.75 1.00 0.04 0.01 
4.34_266.1408 0.75 0.59 0.98 1.00 
12.70_683.4373 0.77 1.00 0.48 0.36 
12.86_463.2998 0.77 1.00 0.48 0.31 
12.74_443.3505 0.77 1.00 0.00 0.00 
12.97_547.4060 0.77 1.00 0.38 0.19 
13.86_425.2896 0.78 1.00 0.30 0.28 
5.26_147.0936 0.79 1.00 0.25 0.37 
12.61_771.4862 0.80 1.00 0.47 0.38 
11.97_299.2600 0.80 1.00 0.00 0.00 
12.86_502.3745 0.82 1.00 0.34 0.33 
11.84_443.3878 0.82 1.00 0.09 0.05 
11.03_354.1608 0.82 1.00 0.00 0.04 
11.28_440.3462 0.82 1.00 0.00 0.00 
12.98_282.2118 0.82 1.00 0.14 0.03 
12.73_655.3845 0.83 1.00 0.56 0.44 
12.74_639.4067 0.83 1.00 0.51 0.39 
13.79_365.2675 0.84 1.00 0.05 0.00 
12.80_567.3292 0.85 1.00 0.55 0.36 
12.83_546.4021 0.86 1.00 0.00 0.24 
5.16_237.1592 0.87 1.00 0.21 0.29 
10.38_401.3397 0.88 1.00 0.50 0.32 
9.26_219.1735 0.88 1.00 0.00 0.00 
12.67_743.4367 0.88 1.00 0.54 0.53 
4.50_359.1197 0.89 1.00 0.00 0.00 
14.79_310.3109 0.90 1.00 0.51 0.53 
12.78_611.3565 0.91 1.00 0.63 0.53 
15.94_338.3442 0.91 1.00 0.32 0.34 
13.49_295.2258 0.91 1.00 0.08 0.03 
1.47_508.0657 0.91 1.00 0.60 0.39 
1.50_260.0296 0.92 1.00 0.58 0.26 
1.47_748.1127 0.94 1.00 0.76 0.59 
4.29_244.1199 0.97 1.00 0.42 0.49 
4.49_225.1597 0.97 1.00 0.49 0.50 
12.89_441.3208 0.99 1.00 0.40 0.25 
12.78_590.4295 1.00 1.00 0.40 0.33 
13.95_270.2746 1.00 1.00 0.31 0.41 
3.99_164.0936 1.00 0.90 0.41 0.45 
10.36_211.6353 1.00 0.89 0.60 0.50 
11.31_225.6512 1.00 0.95 0.26 0.18 
9.27_240.2315 1.00 0.88 0.00 0.11 
4.59_251.1399 1.00 0.99 0.81 0.84 
10.39_268.2627 1.00 0.83 0.00 0.00 
11.44_291.1951 1.00 0.75 0.00 0.00 
11.33_299.2599 1.00 0.77 0.00 0.00 
12.62_313.2746 1.00 0.83 0.00 0.00 
14.31_325.2414 1.00 0.74 0.00 0.00 
14.82_332.2940 1.00 0.65 0.00 0.20 
4.25_343.1235 1.00 0.70 0.01 0.00 
15.49_338.3442 1.00 0.86 0.00 0.03 
4.42_351.1212 1.00 0.79 0.09 0.14 
4.39_362.1069 1.00 0.88 0.00 0.08 
15.92_360.3229 1.00 0.71 0.22 0.13 
13.48_397.3392 1.00 0.75 0.00 0.01 
10.78_415.3581 1.00 0.61 0.36 0.19 
13.95_411.3586 1.00 0.78 0.00 0.00 
13.27_419.3131 1.00 0.81 0.00 0.00 
12.86_485.3471 1.00 0.86 0.31 0.23 
1.45_519.0543 1.00 0.72 0.41 0.18 
12.81_529.3766 1.00 0.77 0.31 0.19 
 366 
12.97_555.3910 1.00 0.94 0.56 0.33 
12.79_573.4039 1.00 0.73 0.29 0.21 
12.75_617.4294 1.00 0.84 0.00 0.25 
13.92_641.5490 1.00 0.85 0.00 0.00 
4.37_685.2548 1.00 0.86 0.00 0.00 
12.67_705.4810 1.00 0.93 0.15 0.26 
6.87_807.0837 1.00 0.57 0.08 0.00 
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Table A3.14. Normalized heat map of features described as unique in Figure 
3.2(B) and (C) when comparing wild type Nocardiopsis sp. FU40 ΔApoS8 to the 
R5 rifampicin resistant mutant extract using OPLS-DA and extracting features 
from the generated S-plot with correlation coefficients ≥0.9. Features are 
normalized to maximum intensity for that feature. 
 
Feature ID (RT_m/z) WT WT R5 R5 
12.03_135.1163 0.00 0.07 1.00 0.65 
12.03_123.1165 0.00 0.00 1.00 0.99 
1.50_103.5345 0.00 0.00 1.00 0.70 
6.56_162.0938 0.00 0.00 1.00 0.88 
16.16_174.0876 0.00 0.00 0.70 1.00 
5.78_170.1204 0.00 0.00 1.00 0.77 
7.08_169.0882 0.00 0.02 1.00 0.84 
6.60_180.1017 0.00 0.01 0.84 1.00 
5.02_180.1014 0.00 0.00 1.00 0.74 
4.95_177.1399 0.00 0.21 0.98 1.00 
4.39_192.1130 0.00 0.14 1.00 0.80 
9.12_191.0134 0.00 0.00 0.93 1.00 
4.14_186.1168 0.00 0.00 1.00 0.54 
9.08_196.0187 0.00 0.00 1.00 0.74 
8.84_203.1804 0.00 0.00 1.00 0.91 
8.12_203.1781 0.00 0.00 0.96 1.00 
9.08_203.0278 0.00 0.00 0.99 1.00 
9.80_203.0277 0.00 0.00 1.00 0.84 
9.42_202.0393 0.00 0.00 1.00 0.83 
5.44_208.0539 0.00 0.01 0.66 1.00 
7.49_207.0994 0.00 0.05 1.00 0.74 
1.30_205.9283 0.00 0.00 1.00 0.91 
4.84_205.1323 0.00 0.00 1.00 0.96 
1.32_211.8786 0.00 0.00 0.81 1.00 
1.49_211.0584 0.00 0.15 0.98 1.00 
9.81_210.0363 0.00 0.00 1.00 0.85 
9.07_210.0305 0.00 0.00 1.00 0.67 
9.41_219.0312 0.00 0.00 0.67 1.00 
3.69_218.1136 0.00 0.32 1.00 0.78 
8.84_221.1903 0.00 0.00 1.00 0.98 
7.35_225.1140 0.00 0.00 0.67 1.00 
7.99_225.1125 0.00 0.03 1.00 0.60 
7.49_230.0712 0.00 0.00 0.82 1.00 
5.48_229.0656 0.00 0.00 1.00 0.91 
9.82_230.0718 0.00 0.09 1.00 0.74 
5.11_236.1306 0.00 0.13 1.00 0.67 
4.89_235.1441 0.00 0.00 1.00 0.71 
8.54_235.1344 0.00 0.00 0.83 1.00 
4.13_237.1268 0.00 0.17 1.00 0.82 
7.33_247.0943 0.00 0.25 1.00 0.90 
5.04_244.1219 0.00 0.00 1.00 0.62 
4.31_249.0807 0.00 0.00 0.96 1.00 
8.08_252.0397 0.00 0.00 1.00 0.86 
4.56_252.0394 0.00 0.21 0.86 1.00 
6.01_252.0391 0.00 0.00 1.00 0.87 
5.12_252.0389 0.00 0.00 0.90 1.00 
7.48_252.0388 0.00 0.00 1.00 0.91 
6.23_258.1449 0.00 0.00 1.00 0.57 
12.02_263.1978 0.00 0.03 1.00 0.93 
1.78_262.1278 0.00 0.00 0.63 1.00 
5.86_262.1048 0.00 0.17 1.00 0.77 
5.01_261.1438 0.00 0.03 0.85 1.00 
7.18_278.2110 0.00 0.00 1.00 0.75 
6.07_276.1943 0.00 0.00 0.85 1.00 
7.50_283.1523 0.00 0.03 0.83 1.00 
7.72_281.1420 0.00 0.00 0.90 1.00 
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5.22_295.1312 0.00 0.01 0.56 1.00 
7.48_294.2085 0.00 0.00 0.58 1.00 
7.82_294.2085 0.00 0.00 1.00 1.00 
1.50_294.0959 0.00 0.44 1.00 0.85 
7.15_293.2251 0.00 0.00 1.00 0.51 
4.87_293.1612 0.00 0.19 0.73 1.00 
7.73_298.2024 0.00 0.00 0.75 1.00 
7.19_296.2224 0.00 0.00 1.00 0.93 
5.83_303.1558 0.00 0.01 1.00 0.88 
7.70_303.1206 0.00 0.09 1.00 0.65 
3.78_300.1386 0.00 0.03 1.00 0.51 
12.02_309.1921 0.00 0.01 0.89 1.00 
6.00_308.2238 0.00 0.00 1.00 0.86 
6.84_312.2197 0.00 0.00 1.00 0.97 
7.24_312.2197 0.00 0.00 1.00 0.93 
7.47_310.2026 0.00 0.00 0.99 1.00 
1.74_322.0446 0.00 0.03 0.56 1.00 
6.92_318.2094 0.00 0.00 0.58 1.00 
7.34_326.2353 0.00 0.00 0.84 1.00 
6.01_326.2353 0.00 0.00 0.99 1.00 
12.03_325.1706 0.00 0.00 1.00 0.93 
6.08_324.1828 0.00 0.31 0.99 1.00 
5.99_338.1374 0.00 0.00 0.92 1.00 
6.07_337.1394 0.00 0.03 0.55 1.00 
10.06_348.2310 0.00 0.00 0.79 1.00 
5.19_344.6196 0.00 0.23 0.89 1.00 
6.06_359.1205 0.00 0.00 0.98 1.00 
5.26_354.0787 0.00 0.13 0.78 1.00 
8.24_352.2057 0.00 0.00 0.92 1.00 
4.01_351.5992 0.00 0.00 0.64 1.00 
6.51_360.2165 0.00 0.00 0.56 1.00 
8.77_368.2219 0.00 0.00 0.60 1.00 
7.52_368.2211 0.00 0.00 1.00 0.74 
7.83_387.1861 0.00 0.00 1.00 0.55 
6.88_386.2329 0.00 0.02 0.60 1.00 
6.89_384.2172 0.00 0.01 1.00 0.84 
6.24_384.2171 0.00 0.00 1.00 0.64 
1.49_394.1142 0.00 0.00 1.00 0.99 
3.74_416.1928 0.00 0.01 1.00 0.70 
3.75_414.2692 0.00 0.00 1.00 0.76 
8.66_429.0854 0.00 0.00 0.93 1.00 
9.08_429.0845 0.00 0.00 0.52 1.00 
9.07_451.0615 0.00 0.00 1.00 0.76 
9.09_448.0576 0.00 0.00 1.00 0.77 
9.73_443.1014 0.00 0.00 0.77 1.00 
8.33_443.0954 0.00 0.00 0.81 1.00 
5.90_459.3212 0.00 0.02 0.69 1.00 
9.03_457.1145 0.00 0.01 0.76 1.00 
8.67_457.1133 0.00 0.00 1.00 0.97 
11.52_456.3791 0.00 0.00 0.86 1.00 
6.21_455.1906 0.00 0.11 1.00 0.75 
9.81_454.0847 0.00 0.00 0.67 1.00 
9.05_454.0819 0.00 0.00 0.79 1.00 
6.42_472.2832 0.00 0.00 1.00 0.67 
9.08_467.0388 0.00 0.00 0.94 1.00 
8.82_465.0807 0.00 0.00 1.00 0.90 
9.79_462.0710 0.00 0.00 0.79 1.00 
9.04_462.0699 0.00 0.00 1.00 0.86 
9.78_481.0499 0.00 0.00 1.00 1.00 
4.15_476.2404 0.00 0.00 1.00 0.57 
7.51_499.2782 0.00 0.02 0.93 1.00 
5.37_493.1709 0.00 0.00 1.00 0.81 
6.65_512.8485 0.00 0.00 1.00 0.82 
5.65_504.2609 0.00 0.00 1.00 0.90 
5.64_515.2738 0.00 0.03 1.00 1.00 
1.76_515.1445 0.00 0.00 1.00 0.96 
10.06_526.3139 0.00 0.00 0.60 1.00 
7.21_526.2839 0.00 0.06 1.00 0.82 
6.79_549.3505 0.00 0.00 1.00 0.52 
7.20_544.2918 0.00 0.00 0.56 1.00 
 369 
7.57_542.3960 0.00 0.01 1.00 0.67 
6.63_570.3104 0.00 0.00 1.00 0.87 
12.03_565.3746 0.00 0.00 1.00 0.87 
9.67_563.3802 0.00 0.00 1.00 0.88 
6.90_555.3068 0.00 0.00 0.84 1.00 
5.52_601.2501 0.00 0.00 1.00 0.77 
9.79_576.6021 0.00 0.00 0.51 1.00 
9.06_576.6005 0.00 0.00 0.51 1.00 
1.25_639.8836 0.00 0.00 1.00 0.75 
6.02_637.3187 0.00 0.00 1.00 0.97 
5.79_646.1977 0.00 0.00 0.82 1.00 
9.79_683.1204 0.00 0.00 0.81 1.00 
9.80_907.1678 0.00 0.00 0.84 1.00 
7.01_1221.4414 0.00 0.00 0.65 1.00 
7.00_1216.1209 0.00 0.37 0.79 1.00 
9.79_218.0234 0.00 0.02 0.98 1.00 
8.34_150.0928 0.00 0.04 0.66 1.00 
9.78_465.0808 0.00 0.01 1.00 0.94 
6.76_310.2021 0.01 0.00 1.00 0.98 
7.48_177.0877 0.01 0.00 1.00 0.72 
8.10_301.1534 0.01 0.03 1.00 0.87 
1.75_507.1572 0.01 0.00 0.61 1.00 
1.82_228.1004 0.01 0.00 0.88 1.00 
6.06_294.2084 0.02 0.00 1.00 0.70 
6.24_515.2753 0.02 0.01 0.83 1.00 
8.74_542.3146 0.02 0.00 0.73 1.00 
7.06_325.1861 0.02 0.14 1.00 0.86 
6.65_282.2073 0.03 0.15 1.00 0.69 
5.43_377.1482 0.03 0.00 1.00 0.87 
8.29_401.1993 0.03 0.00 0.83 1.00 
1.64_174.0879 0.03 0.02 0.97 1.00 
4.75_136.0625 0.03 0.00 1.00 0.69 
9.66_279.1583 0.04 0.00 1.00 0.61 
1.53_143.0837 0.04 0.05 1.00 0.81 
5.66_384.2168 0.04 0.00 1.00 0.86 
6.95_218.1203 0.04 0.09 0.92 1.00 
3.22_235.1201 0.05 0.00 1.00 0.97 
1.73_338.0231 0.05 0.00 1.00 0.76 
7.06_221.1900 0.06 0.17 0.71 1.00 
7.42_280.1237 0.06 0.16 0.65 1.00 
8.53_283.1523 0.06 0.13 0.91 1.00 
3.86_150.0940 0.06 0.11 1.00 0.97 
6.66_264.1980 0.06 0.03 1.00 0.75 
8.53_177.0880 0.06 0.06 1.00 0.58 
7.80_291.1290 0.06 0.23 1.00 0.93 
10.52_673.3745 0.07 0.10 0.94 1.00 
8.53_207.1002 0.07 0.08 1.00 0.70 
3.75_289.1389 0.07 0.31 1.00 0.93 
9.67_319.1539 0.07 0.10 0.74 1.00 
1.77_218.1042 0.07 0.02 1.00 0.92 
3.83_198.1623 0.08 0.06 0.84 1.00 
4.88_188.0708 0.08 0.14 1.00 0.91 
7.06_203.1787 0.08 0.15 1.00 0.89 
4.37_326.1802 0.08 0.50 1.00 0.91 
6.72_1450.6973 0.09 0.02 1.00 0.94 
6.06_203.1781 0.10 0.18 1.00 0.98 
4.30_310.1305 0.11 0.02 1.00 0.55 
4.87_329.1844 0.12 0.00 1.00 0.85 
6.41_165.0905 0.14 0.09 1.00 0.83 
9.47_211.0868 0.15 0.25 1.00 0.91 
9.14_239.1284 0.16 0.15 1.00 0.77 
5.27_685.1761 0.17 0.00 1.00 0.82 
5.83_325.1311 0.17 0.00 1.00 0.98 
4.26_450.2439 0.19 0.01 0.78 1.00 
1.65_159.0768 0.19 0.00 0.78 1.00 
7.89_192.1015 0.20 0.35 1.00 0.96 
16.18_335.9929 0.22 0.00 0.93 1.00 
4.30_284.1098 0.24 0.07 1.00 0.94 
5.20_239.1759 0.24 0.39 1.00 0.97 
3.85_258.1333 0.24 0.00 1.00 0.62 
 370 
4.86_372.1909 0.25 0.13 1.00 0.74 
6.60_152.1087 0.25 0.46 1.00 0.93 
4.63_149.1104 0.26 0.41 1.00 0.94 
5.34_191.1575 0.26 0.37 1.00 0.71 
5.19_249.1604 0.27 0.43 1.00 0.87 
1.73_288.1454 0.27 0.00 1.00 0.81 
4.00_320.1711 0.28 0.03 1.00 0.79 
3.80_194.0821 0.29 0.00 1.00 0.95 
9.41_281.1770 0.29 0.54 0.95 1.00 
7.15_504.8508 0.30 0.59 1.00 0.91 
16.22_252.0441 0.30 0.53 1.00 0.96 
6.74_1160.9454 0.31 0.26 0.83 1.00 
4.34_266.1408 0.31 0.24 1.00 0.72 
5.00_152.1079 0.33 0.50 1.00 0.84 
6.78_176.0714 0.33 0.56 1.00 0.97 
6.62_297.1617 0.33 0.59 1.00 0.88 
5.16_237.1592 0.33 0.38 1.00 0.79 
16.15_365.1085 0.34 0.00 1.00 0.82 
3.82_230.1126 0.34 0.21 1.00 0.74 
8.22_220.1332 0.34 0.49 0.95 1.00 
4.53_236.1764 0.34 0.44 1.00 0.95 
5.78_164.0706 0.34 0.46 0.98 1.00 
4.77_179.0472 0.34 0.62 1.00 1.00 
4.64_137.0376 0.35 0.36 0.95 1.00 
4.40_158.0302 0.36 0.27 1.00 0.94 
5.71_249.1598 0.38 0.52 1.00 0.89 
6.15_485.2027 0.38 0.41 1.00 0.84 
5.81_605.2195 0.39 0.55 1.00 0.88 
4.70_221.1315 0.39 0.58 0.99 1.00 
3.81_136.0628 0.40 0.64 1.00 0.86 
4.16_256.1718 0.40 0.55 1.00 0.87 
4.66_304.1776 0.42 0.62 1.00 0.90 
5.16_210.1137 0.43 0.42 1.00 0.82 
16.17_188.9130 0.43 0.00 1.00 0.88 
16.18_204.8884 0.44 0.00 0.99 1.00 
4.67_270.1917 0.44 0.60 1.00 0.97 
3.94_254.1629 0.45 0.17 1.00 0.90 
6.34_469.2088 0.49 0.63 1.00 0.87 
4.39_362.1069 0.49 0.43 0.99 1.00 
6.23_251.1781 0.49 0.54 1.00 0.87 
12.43_386.2820 0.50 1.00 0.00 0.00 
14.78_323.2583 0.50 1.00 0.00 0.00 
13.49_420.3478 0.51 1.00 0.00 0.00 
10.60_346.3091 0.51 1.00 0.00 0.00 
13.00_413.3095 0.52 1.00 0.00 0.00 
10.40_371.3275 0.52 1.00 0.00 0.03 
10.70_288.2557 0.52 1.00 0.00 0.00 
9.48_225.1993 0.53 1.00 0.00 0.02 
6.81_807.1918 0.54 1.00 0.00 0.00 
13.53_339.2529 0.55 1.00 0.00 0.00 
4.26_669.2631 0.56 1.00 0.00 0.13 
11.80_235.1712 0.56 1.00 0.06 0.07 
10.15_739.4618 0.56 1.00 0.06 0.04 
14.41_309.2409 0.56 1.00 0.00 0.00 
12.99_526.2341 0.56 1.00 0.00 0.06 
10.53_531.4000 0.57 1.00 0.00 0.00 
4.81_415.2090 0.57 0.40 1.00 0.89 
12.97_407.3144 0.58 1.00 0.00 0.00 
6.02_274.1066 0.58 0.40 1.00 0.86 
12.98_399.3242 0.58 1.00 0.00 0.00 
4.09_573.1785 0.58 1.00 0.00 0.00 
12.98_510.2581 0.59 1.00 0.00 0.11 
4.37_663.2850 0.59 1.00 0.00 0.20 
4.59_251.1399 0.60 0.60 1.00 0.90 
13.98_433.3418 0.61 1.00 0.00 0.00 
6.90_166.0720 0.61 1.00 0.00 0.00 
4.64_412.2067 0.62 1.00 0.00 0.16 
6.19_181.1351 0.63 1.00 0.00 0.07 
10.97_401.2525 0.63 1.00 0.08 0.08 
16.14_274.0340 0.63 0.45 1.00 0.97 
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11.58_415.2745 0.65 1.00 0.00 0.00 
12.62_273.1378 0.66 1.00 0.00 0.00 
12.86_507.3281 0.66 1.00 0.21 0.02 
12.97_290.7254 0.66 1.00 0.00 0.00 
4.27_647.2871 0.67 1.00 0.00 0.14 
11.44_223.2060 0.67 1.00 0.00 0.00 
8.08_219.1411 0.68 1.00 0.22 0.18 
4.44_178.1088 0.70 0.60 0.99 1.00 
6.85_824.9348 0.70 1.00 0.00 0.00 
4.37_150.0945 0.72 1.00 0.00 0.00 
3.89_518.1743 0.73 1.00 0.00 0.00 
11.18_473.3585 0.75 1.00 0.00 0.03 
12.86_463.2998 0.77 1.00 0.00 0.08 
12.74_443.3505 0.77 1.00 0.00 0.01 
12.97_547.4060 0.77 1.00 0.00 0.00 
13.86_425.2896 0.78 1.00 0.48 0.46 
13.50_409.7445 0.80 1.00 0.00 0.04 
4.28_227.1066 0.80 1.00 0.41 0.47 
12.61_771.4862 0.80 1.00 0.00 0.37 
11.97_299.2600 0.80 1.00 0.03 0.00 
13.50_524.2740 0.81 1.00 0.01 0.10 
15.06_413.2647 0.81 1.00 0.42 0.42 
12.86_502.3745 0.82 1.00 0.36 0.00 
11.84_443.3878 0.82 1.00 0.06 0.06 
11.03_354.1608 0.82 1.00 0.00 0.03 
11.28_440.3462 0.82 1.00 0.00 0.00 
12.98_282.2118 0.82 1.00 0.00 0.00 
13.79_365.2675 0.84 1.00 0.00 0.00 
12.80_567.3292 0.85 1.00 0.00 0.00 
10.38_401.3397 0.88 1.00 0.29 0.27 
14.79_310.3109 0.90 1.00 0.18 0.00 
12.78_611.3565 0.91 1.00 0.21 0.57 
13.48_341.2200 0.91 1.00 0.00 0.20 
13.49_295.2258 0.91 1.00 0.00 0.00 
1.50_260.0296 0.92 1.00 0.30 0.47 
4.49_225.1597 0.97 1.00 0.51 0.49 
12.89_441.3208 0.99 1.00 0.46 0.31 
12.78_590.4295 1.00 1.00 0.25 0.00 
3.99_164.0936 1.00 0.90 0.58 0.61 
10.36_211.6353 1.00 0.89 0.00 0.34 
11.31_225.6512 1.00 0.95 0.00 0.00 
5.40_230.0720 1.00 0.81 0.58 0.47 
9.27_240.2315 1.00 0.88 0.25 0.00 
10.39_268.2627 1.00 0.83 0.00 0.00 
12.97_278.2028 1.00 0.62 0.00 0.04 
11.44_291.1951 1.00 0.75 0.00 0.00 
11.33_299.2599 1.00 0.77 0.00 0.00 
12.62_313.2746 1.00 0.83 0.00 0.00 
14.31_325.2414 1.00 0.74 0.00 0.00 
14.82_332.2940 1.00 0.65 0.27 0.10 
15.49_338.3442 1.00 0.86 0.00 0.03 
15.92_360.3229 1.00 0.71 0.37 0.20 
13.48_397.3392 1.00 0.75 0.00 0.00 
10.78_415.3581 1.00 0.61 0.20 0.19 
13.95_411.3586 1.00 0.78 0.00 0.00 
13.27_419.3131 1.00 0.81 0.00 0.00 
10.77_434.3251 1.00 0.58 0.00 0.16 
10.98_442.3651 1.00 0.78 0.00 0.00 
12.86_485.3471 1.00 0.86 0.19 0.41 
12.81_529.3766 1.00 0.77 0.00 0.31 
12.97_555.3910 1.00 0.94 0.00 0.00 
12.75_617.4294 1.00 0.84 0.20 0.41 
13.92_641.5490 1.00 0.85 0.00 0.00 
12.67_705.4810 1.00 0.93 0.15 0.50 
6.87_807.0837 1.00 0.57 0.19 0.00 
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Table A3.15. Normalized heat map of features described as unique in Figure 
3.2(B) and (C) when comparing wild type Nocardiopsis sp. FU40 ΔApoS8 to the 
S1 streptomycin resistant mutant extract using OPLS-DA and extracting features 
from the generated S-plot with correlation coefficients ≥0.9. Features are 
normalized to maximum intensity for that feature. 
 
Feature ID (RT_m/z) WT WT S1 S1 
12.03_135.1163 0.00 0.04 0.67 1.00 
12.03_123.1165 0.00 0.00 0.66 1.00 
4.95_114.0908 0.00 0.00 0.50 1.00 
1.50_103.5345 0.00 0.00 0.76 1.00 
12.03_149.1327 0.00 0.00 0.66 1.00 
13.61_149.0907 0.00 0.00 0.87 1.00 
6.56_162.0938 0.00 0.00 1.00 0.94 
5.78_170.1204 0.00 0.00 0.73 1.00 
4.29_169.0959 0.00 0.00 1.00 0.76 
2.44_166.0747 0.00 0.13 0.99 1.00 
6.60_180.1017 0.00 0.03 0.85 1.00 
9.12_191.0134 0.00 0.00 0.60 1.00 
4.14_186.1168 0.00 0.00 1.00 0.79 
4.02_198.1143 0.00 0.00 0.72 1.00 
8.84_203.1804 0.00 0.00 0.69 1.00 
6.22_203.0786 0.00 0.03 0.84 1.00 
7.49_207.0994 0.00 0.08 0.88 1.00 
1.30_205.9283 0.00 0.00 0.73 1.00 
4.84_205.1323 0.00 0.00 0.53 1.00 
10.22_205.1232 0.00 0.00 0.91 1.00 
1.32_211.8786 0.00 0.00 0.85 1.00 
9.81_210.0363 0.00 0.00 0.51 1.00 
9.03_217.0413 0.00 0.00 1.00 0.82 
16.16_223.9875 0.00 0.00 0.92 1.00 
10.24_222.1533 0.00 0.06 0.72 1.00 
8.84_221.1903 0.00 0.00 0.78 1.00 
5.48_229.0656 0.00 0.00 0.78 1.00 
5.11_236.1306 0.00 0.14 0.83 1.00 
8.54_235.1344 0.00 0.00 0.81 1.00 
11.28_233.1548 0.00 0.01 0.51 1.00 
11.16_252.0381 0.00 0.00 0.52 1.00 
13.78_251.2405 0.00 0.00 0.96 1.00 
11.26_250.1814 0.00 0.00 0.78 1.00 
8.08_252.0397 0.00 0.00 1.00 0.65 
4.56_252.0394 0.00 0.17 0.90 1.00 
5.12_252.0389 0.00 0.00 0.91 1.00 
7.48_252.0388 0.00 0.00 0.98 1.00 
12.02_263.1978 0.00 0.03 0.71 1.00 
5.86_262.1048 0.00 0.37 0.81 1.00 
10.71_261.1779 0.00 0.01 0.72 1.00 
11.95_266.1298 0.00 0.00 0.66 1.00 
5.27_264.2082 0.00 0.00 1.00 0.99 
7.50_283.1523 0.00 0.06 0.95 1.00 
9.01_283.1521 0.00 0.09 0.88 1.00 
1.73_282.0649 0.00 0.03 0.80 1.00 
7.15_293.2251 0.00 0.00 0.75 1.00 
4.87_293.1612 0.00 0.33 0.74 1.00 
6.49_292.1923 0.00 0.14 1.00 0.82 
3.78_300.1386 0.00 0.42 0.90 1.00 
12.02_309.1921 0.00 0.01 0.61 1.00 
14.29_307.2281 0.00 0.00 0.89 1.00 
1.74_322.0446 0.00 0.03 0.45 1.00 
14.63_321.2420 0.00 0.00 1.00 0.91 
12.03_325.1706 0.00 0.00 0.66 1.00 
13.85_333.2427 0.00 0.00 1.00 0.79 
10.73_340.1475 0.00 0.10 0.81 1.00 
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14.63_339.2533 0.00 0.00 1.00 0.75 
15.50_349.2615 0.00 0.00 1.00 0.89 
14.31_347.2205 0.00 0.00 0.78 1.00 
7.48_345.1875 0.00 0.00 1.00 0.94 
4.01_351.5992 0.00 0.00 1.00 0.79 
6.95_350.2147 0.00 0.02 1.00 1.00 
12.59_361.1697 0.00 0.15 1.00 0.92 
6.51_360.2165 0.00 0.00 0.52 1.00 
7.52_368.2211 0.00 0.00 0.58 1.00 
9.80_367.0822 0.00 0.00 0.51 1.00 
14.32_379.2817 0.00 0.00 1.00 0.80 
7.43_374.2181 0.00 0.00 0.76 1.00 
6.24_384.2171 0.00 0.00 0.66 1.00 
13.61_399.3201 0.00 0.00 1.00 0.94 
1.49_394.1142 0.00 0.00 0.48 1.00 
14.57_393.2988 0.00 0.00 1.00 0.89 
14.04_420.3477 0.00 0.07 0.68 1.00 
8.04_432.2606 0.00 0.00 1.00 0.83 
9.03_457.1145 0.00 0.15 0.53 1.00 
11.52_456.3791 0.00 0.00 0.46 1.00 
6.21_455.1906 0.00 0.17 0.88 1.00 
11.66_454.2954 0.00 0.23 1.00 0.89 
9.81_454.0847 0.00 0.00 0.43 1.00 
9.79_462.0710 0.00 0.00 0.51 1.00 
9.78_481.0499 0.00 0.00 0.49 1.00 
7.51_499.2782 0.00 0.06 0.86 1.00 
4.37_494.2617 0.00 0.00 0.75 1.00 
8.58_490.2972 0.00 0.00 0.67 1.00 
12.00_515.2832 0.00 0.00 0.84 1.00 
1.76_515.1445 0.00 0.00 0.63 1.00 
9.11_548.3433 0.00 0.06 0.65 1.00 
12.03_565.3746 0.00 0.00 0.77 1.00 
6.90_555.3068 0.00 0.00 0.91 1.00 
12.03_549.4012 0.00 0.00 0.74 1.00 
9.02_549.3610 0.00 0.02 1.00 0.81 
5.52_601.2501 0.00 0.00 0.82 1.00 
7.20_920.0962 0.00 0.00 1.00 0.74 
7.21_916.0943 0.00 0.00 1.00 0.92 
7.01_1221.4414 0.00 0.00 1.00 0.93 
8.34_150.0928 0.00 0.06 0.69 1.00 
14.64_361.2361 0.01 0.00 1.00 0.90 
7.48_177.0877 0.01 0.00 0.82 1.00 
6.95_368.2220 0.01 0.02 0.86 1.00 
8.10_301.1534 0.01 0.05 0.53 1.00 
8.54_447.2904 0.02 0.13 0.57 1.00 
3.22_235.1201 0.02 0.00 0.84 1.00 
12.02_205.1953 0.02 0.00 0.72 1.00 
10.18_621.4210 0.02 0.00 0.53 1.00 
1.29_203.9309 0.02 0.00 0.65 1.00 
13.79_365.2675 0.02 0.02 1.00 0.93 
14.31_335.2563 0.03 0.00 1.00 0.60 
11.43_466.2973 0.03 0.08 0.95 1.00 
6.92_332.1986 0.03 0.01 1.00 0.97 
6.24_515.2753 0.03 0.01 1.00 0.83 
1.75_507.1572 0.04 0.00 0.92 1.00 
9.11_505.3321 0.05 0.00 0.63 1.00 
8.52_491.3179 0.06 0.00 0.63 1.00 
1.74_150.0789 0.06 0.00 0.64 1.00 
3.07_230.1126 0.06 0.15 0.84 1.00 
13.79_531.4249 0.06 0.19 0.69 1.00 
9.78_465.0808 0.06 0.18 0.55 1.00 
1.73_338.0231 0.06 0.00 1.00 0.95 
8.53_177.0880 0.07 0.06 0.73 1.00 
10.52_673.3745 0.07 0.11 0.49 1.00 
12.39_279.1366 0.07 0.19 0.99 1.00 
3.86_150.0940 0.08 0.14 0.60 1.00 
8.53_283.1523 0.08 0.17 1.00 0.96 
8.53_207.1002 0.08 0.10 0.84 1.00 
5.97_286.6247 0.09 0.01 0.94 1.00 
7.95_433.2783 0.09 0.24 0.65 1.00 
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11.73_360.1653 0.10 0.23 0.78 1.00 
6.95_218.1203 0.10 0.21 0.61 1.00 
14.78_323.2583 0.11 0.21 1.00 0.83 
11.33_299.2599 0.11 0.08 0.97 1.00 
5.43_377.1482 0.11 0.00 0.63 1.00 
12.40_251.2372 0.11 0.00 0.94 1.00 
11.73_352.1729 0.11 0.48 1.00 1.00 
11.97_299.2600 0.11 0.14 0.67 1.00 
13.53_339.2529 0.12 0.21 1.00 0.85 
1.82_228.1004 0.13 0.01 0.57 1.00 
7.42_280.1237 0.13 0.36 0.64 1.00 
7.89_192.1015 0.13 0.23 0.88 1.00 
5.97_278.6345 0.14 0.03 1.00 0.88 
6.41_165.0905 0.15 0.10 0.89 1.00 
14.31_325.2414 0.16 0.12 1.00 0.87 
7.91_389.2523 0.17 0.08 0.64 1.00 
14.04_295.2283 0.17 0.32 1.00 0.95 
4.87_329.1844 0.18 0.00 0.68 1.00 
12.39_401.2333 0.19 0.47 1.00 0.96 
12.62_313.2746 0.19 0.16 0.89 1.00 
4.31_265.0552 0.20 0.00 0.73 1.00 
7.06_203.1787 0.21 0.38 0.66 1.00 
12.62_273.1378 0.21 0.32 0.83 1.00 
6.06_203.1781 0.22 0.39 0.71 1.00 
6.87_807.0837 0.22 0.13 1.00 0.80 
9.69_220.1127 0.23 0.26 0.73 1.00 
4.30_310.1305 0.23 0.05 0.75 1.00 
4.75_136.0625 0.24 0.00 1.00 0.85 
1.73_288.1454 0.24 0.00 0.71 1.00 
3.82_230.1126 0.25 0.15 0.71 1.00 
3.83_198.1623 0.25 0.18 0.77 1.00 
14.41_309.2409 0.26 0.46 1.00 0.94 
3.85_276.1433 0.28 0.16 0.76 1.00 
5.96_534.2942 0.32 0.07 1.00 0.95 
16.18_335.9929 0.33 0.00 0.68 1.00 
4.88_188.0708 0.34 0.58 0.80 1.00 
5.61_343.2002 0.35 0.08 0.67 1.00 
13.84_397.2963 0.38 0.00 1.00 0.82 
12.70_699.4109 0.39 0.43 0.78 1.00 
12.62_787.4580 0.39 0.66 0.91 1.00 
14.79_310.3109 0.41 0.46 1.00 0.78 
12.78_611.3565 0.43 0.47 0.73 1.00 
3.80_194.0821 0.43 0.00 0.97 1.00 
12.86_523.3040 0.43 0.29 0.94 1.00 
12.63_394.2284 0.47 0.36 1.00 0.93 
12.67_743.4367 0.48 0.54 0.81 1.00 
12.73_655.3845 0.48 0.58 0.85 1.00 
13.50_409.7445 0.48 0.60 0.84 1.00 
12.74_639.4067 0.48 0.58 0.77 1.00 
15.06_413.2647 0.49 0.60 1.00 0.85 
12.61_771.4862 0.49 0.62 0.80 1.00 
6.15_485.2027 0.50 0.53 0.75 1.00 
12.86_463.2998 0.50 0.66 1.00 0.99 
10.60_346.3091 0.51 1.00 0.00 0.00 
9.48_225.1993 0.53 1.00 0.02 0.02 
5.18_364.0987 0.54 1.00 0.07 0.07 
12.78_590.4295 0.55 0.56 0.90 1.00 
4.26_669.2631 0.56 1.00 0.00 0.00 
11.80_235.1712 0.56 1.00 0.00 0.05 
3.80_119.0369 0.56 1.00 0.11 0.00 
12.83_546.4021 0.58 0.67 0.85 1.00 
1.28_188.9112 0.59 1.00 0.24 0.00 
4.37_663.2850 0.59 1.00 0.01 0.00 
13.92_641.5490 0.61 0.52 1.00 0.83 
12.70_678.4764 0.61 0.35 0.93 1.00 
6.90_166.0720 0.61 1.00 0.00 0.00 
4.64_412.2067 0.62 1.00 0.00 0.11 
5.19_249.1604 0.63 1.00 0.20 0.27 
6.19_181.1351 0.63 1.00 0.03 0.00 
6.39_336.2172 0.66 0.54 1.00 0.89 
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4.27_647.2871 0.67 1.00 0.00 0.00 
11.44_223.2060 0.67 1.00 0.00 0.00 
8.08_219.1411 0.68 1.00 0.00 0.10 
1.28_172.9358 0.69 1.00 0.28 0.39 
7.62_970.6124 0.70 1.00 0.10 0.00 
4.81_506.2950 0.71 1.00 0.29 0.33 
4.37_150.0945 0.72 1.00 0.00 0.00 
3.89_518.1743 0.73 1.00 0.00 0.02 
11.18_473.3585 0.75 1.00 0.29 0.35 
12.89_441.3208 0.75 0.76 0.92 1.00 
12.74_443.3505 0.77 1.00 0.00 0.03 
4.28_227.1066 0.80 1.00 0.35 0.50 
4.55_279.1361 0.81 1.00 0.47 0.53 
11.28_440.3462 0.82 1.00 0.55 0.36 
12.98_282.2118 0.82 1.00 0.21 0.15 
4.27_302.2070 0.86 1.00 0.70 0.59 
5.16_237.1592 0.87 1.00 0.36 0.32 
9.26_219.1735 0.88 1.00 0.00 0.00 
4.50_359.1197 0.89 1.00 0.00 0.00 
10.84_227.1557 0.90 1.00 0.15 0.00 
13.49_295.2258 0.91 1.00 0.22 0.18 
1.47_508.0657 0.91 1.00 0.40 0.00 
1.50_260.0296 0.92 1.00 0.05 0.14 
1.47_748.1127 0.94 1.00 0.61 0.76 
4.58_336.1924 0.95 1.00 0.76 0.57 
1.48_481.1031 0.96 1.00 0.62 0.69 
4.29_244.1199 0.97 1.00 0.28 0.00 
4.49_225.1597 0.97 1.00 0.12 0.18 
1.50_710.1736 0.99 1.00 0.73 0.82 
13.95_270.2746 1.00 1.00 0.34 0.39 
4.44_178.1088 1.00 0.86 0.33 0.50 
3.80_288.1929 1.00 0.87 0.00 0.00 
11.44_291.1951 1.00 0.75 0.00 0.00 
4.25_343.1235 1.00 0.70 0.08 0.00 
15.49_338.3442 1.00 0.86 0.00 0.00 
4.26_356.1796 1.00 0.84 0.42 0.58 
4.42_351.1212 1.00 0.79 0.18 0.20 
4.39_362.1069 1.00 0.88 0.18 0.00 
1.55_385.5441 1.00 0.65 0.12 0.00 
13.95_411.3586 1.00 0.78 0.60 0.53 
10.98_442.3651 1.00 0.78 0.12 0.33 
4.37_685.2548 1.00 0.86 0.00 0.00 
7.66_916.7249 1.00 0.76 0.00 0.00 
7.00_916.3325 1.00 0.59 0.07 0.17 
7.00_913.0933 1.00 0.71 0.00 0.10 
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Table A3.16. Normalized heat map of features described as unique in Figure 
3.2(B) and (C) when comparing wild type Nocardiopsis sp. FU40 ΔApoS8 to the 
S2 streptomycin resistant mutant extract using OPLS-DA and extracting features 
from the generated S-plot with correlation coefficients ≥0.9. Features are 
normalized to maximum intensity for that feature. 
 
Feature ID (RT_m/z) WT WT S2 S2 
12.03_135.1163 0.00 0.07 1.00 0.69 
12.03_123.1165 0.00 0.00 1.00 0.72 
1.50_103.5345 0.00 0.00 1.00 0.81 
12.03_149.1327 0.00 0.00 1.00 0.70 
13.61_149.0907 0.00 0.00 0.76 1.00 
1.50_165.0624 0.00 0.00 1.00 0.85 
6.56_162.0938 0.00 0.00 0.58 1.00 
2.01_158.0950 0.00 0.30 1.00 0.88 
5.78_170.1204 0.00 0.00 1.00 0.91 
4.29_169.0959 0.00 0.00 0.66 1.00 
6.60_180.1017 0.00 0.02 0.99 1.00 
5.02_180.1014 0.00 0.00 0.91 1.00 
10.70_179.1435 0.00 0.00 1.00 0.66 
4.95_177.1399 0.00 0.28 1.00 0.96 
4.39_192.1130 0.00 0.30 1.00 0.94 
9.12_191.0134 0.00 0.00 1.00 0.84 
4.02_198.1143 0.00 0.00 0.95 1.00 
4.99_198.1134 0.00 0.00 0.76 1.00 
9.08_196.0187 0.00 0.00 0.55 1.00 
8.84_203.1804 0.00 0.00 1.00 0.82 
8.12_203.1781 0.00 0.00 1.00 0.78 
9.08_203.0278 0.00 0.00 1.00 0.72 
9.80_203.0277 0.00 0.00 1.00 0.86 
4.35_209.0956 0.00 0.00 1.00 0.91 
5.44_208.0539 0.00 0.00 1.00 0.80 
7.49_207.0994 0.00 0.12 1.00 0.85 
1.30_205.9283 0.00 0.00 1.00 0.96 
4.84_205.1323 0.00 0.00 1.00 0.98 
1.32_211.8786 0.00 0.00 1.00 0.91 
1.49_211.0584 0.00 0.24 1.00 0.85 
9.81_210.0363 0.00 0.00 1.00 0.77 
9.41_219.0312 0.00 0.00 1.00 0.70 
9.03_217.0413 0.00 0.00 1.00 0.90 
1.85_216.1242 0.00 0.05 0.98 1.00 
16.16_223.9875 0.00 0.00 0.63 1.00 
10.24_222.1533 0.00 0.08 1.00 0.70 
9.81_222.1504 0.00 0.05 1.00 0.80 
8.84_221.1903 0.00 0.00 1.00 0.79 
9.04_225.0298 0.00 0.04 1.00 0.86 
9.77_224.0325 0.00 0.00 1.00 0.80 
5.48_229.0656 0.00 0.00 1.00 0.94 
9.19_230.0719 0.00 0.00 1.00 0.98 
9.82_230.0718 0.00 0.05 0.84 1.00 
8.41_230.0715 0.00 0.00 1.00 0.63 
10.62_236.1643 0.00 0.00 0.93 1.00 
5.11_236.1306 0.00 0.13 0.79 1.00 
8.54_235.1344 0.00 0.00 1.00 0.69 
9.80_241.0261 0.00 0.00 1.00 0.91 
10.69_238.1826 0.00 0.00 1.00 0.65 
4.13_237.1268 0.00 0.31 1.00 0.81 
5.81_248.1281 0.00 0.27 1.00 0.85 
9.03_248.0351 0.00 0.00 0.80 1.00 
8.44_247.1345 0.00 0.00 1.00 0.95 
4.04_247.1287 0.00 0.00 0.74 1.00 
9.07_246.5440 0.00 0.00 1.00 0.75 
5.04_244.1219 0.00 0.00 1.00 0.94 
4.31_249.0807 0.00 0.00 1.00 0.87 
8.08_252.0397 0.00 0.00 0.91 1.00 
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9.63_252.0395 0.00 0.00 0.88 1.00 
8.66_252.0394 0.00 0.00 1.00 0.55 
5.12_252.0389 0.00 0.00 0.55 1.00 
7.48_252.0388 0.00 0.00 0.79 1.00 
6.23_258.1449 0.00 0.00 1.00 0.69 
3.87_257.1146 0.00 0.30 1.00 0.95 
9.81_253.5524 0.00 0.03 1.00 0.97 
12.02_263.1978 0.00 0.08 1.00 0.84 
1.78_262.1278 0.00 0.00 0.96 1.00 
5.86_262.1048 0.00 0.27 0.97 1.00 
5.01_261.1438 0.00 0.06 0.77 1.00 
9.03_260.5527 0.00 0.00 0.94 1.00 
10.52_268.0194 0.00 0.21 0.89 1.00 
5.43_268.0192 0.00 0.06 0.96 1.00 
6.28_268.0191 0.00 0.10 1.00 0.96 
8.32_268.0180 0.00 0.00 1.00 0.55 
5.18_266.1406 0.00 0.27 1.00 0.91 
5.27_264.2082 0.00 0.00 1.00 0.88 
7.49_268.0200 0.00 0.00 0.51 1.00 
4.60_268.0196 0.00 0.00 1.00 0.82 
11.39_268.0195 0.00 0.00 0.93 1.00 
5.84_281.1328 0.00 0.00 0.91 1.00 
9.12_279.1585 0.00 0.00 1.00 0.67 
7.18_278.2110 0.00 0.00 1.00 0.80 
6.07_276.1943 0.00 0.00 1.00 0.97 
4.52_276.1726 0.00 0.00 0.97 1.00 
5.71_286.2118 0.00 0.00 1.00 0.70 
7.19_284.2219 0.00 0.00 1.00 0.68 
7.50_283.1523 0.00 0.05 1.00 0.74 
1.73_282.0649 0.00 0.02 1.00 0.87 
7.72_281.1420 0.00 0.00 1.00 0.80 
5.22_295.1312 0.00 0.04 1.00 0.81 
7.82_294.2085 0.00 0.00 1.00 0.84 
6.82_294.2084 0.00 0.00 1.00 0.56 
3.86_294.1559 0.00 0.40 1.00 0.86 
7.15_293.2251 0.00 0.00 1.00 0.67 
4.87_293.1612 0.00 0.22 0.87 1.00 
6.49_292.1923 0.00 0.03 0.65 1.00 
3.76_299.1387 0.00 0.00 1.00 0.71 
7.73_298.2024 0.00 0.00 1.00 0.87 
4.74_298.0969 0.00 0.06 1.00 0.84 
9.60_297.1694 0.00 0.00 1.00 0.64 
7.19_296.2224 0.00 0.00 1.00 0.89 
5.83_303.1558 0.00 0.01 0.95 1.00 
3.78_300.1386 0.00 0.04 1.00 0.81 
12.02_309.1921 0.00 0.02 1.00 0.90 
6.00_308.2238 0.00 0.00 1.00 0.92 
6.06_312.2197 0.00 0.00 0.99 1.00 
6.84_312.2197 0.00 0.00 1.00 0.78 
7.24_312.2197 0.00 0.00 1.00 0.70 
10.59_311.1859 0.00 0.00 1.00 0.67 
7.47_310.2026 0.00 0.00 0.97 1.00 
5.82_322.1007 0.00 0.00 1.00 0.89 
1.74_322.0446 0.00 0.02 1.00 0.91 
14.63_321.2420 0.00 0.00 0.64 1.00 
9.13_319.1539 0.00 0.00 1.00 0.71 
6.92_318.2094 0.00 0.00 0.94 1.00 
6.00_328.7423 0.00 0.24 1.00 0.83 
7.34_326.2353 0.00 0.00 1.00 0.84 
12.03_325.1706 0.00 0.00 1.00 0.92 
6.08_324.1828 0.00 0.30 1.00 0.84 
6.31_335.7452 0.00 0.00 1.00 0.82 
6.62_334.2005 0.00 0.00 0.51 1.00 
8.76_329.1942 0.00 0.10 1.00 0.76 
5.84_341.1007 0.00 0.00 1.00 0.86 
14.63_339.2533 0.00 0.00 1.00 0.89 
7.48_345.1875 0.00 0.00 1.00 0.78 
5.26_354.0787 0.00 0.16 0.98 1.00 
8.24_352.2057 0.00 0.00 1.00 0.96 
4.01_351.5992 0.00 0.00 1.00 0.87 
 378 
6.95_350.2147 0.00 0.10 1.00 0.72 
6.51_360.2165 0.00 0.00 1.00 0.82 
8.53_359.2035 0.00 0.09 1.00 0.74 
7.52_368.2211 0.00 0.00 0.92 1.00 
9.80_367.0822 0.00 0.00 1.00 0.84 
10.08_366.2455 0.00 0.00 1.00 0.73 
6.22_366.2068 0.00 0.15 1.00 0.92 
5.64_366.2063 0.00 0.00 0.75 1.00 
7.83_387.1861 0.00 0.00 1.00 0.96 
9.80_387.0731 0.00 0.00 1.00 0.77 
6.88_386.2329 0.00 0.03 0.95 1.00 
6.24_384.2171 0.00 0.00 1.00 0.96 
8.63_398.2317 0.00 0.00 1.00 0.69 
9.08_429.0845 0.00 0.00 1.00 0.75 
7.98_431.2698 0.00 0.05 1.00 0.80 
9.07_451.0615 0.00 0.00 1.00 0.78 
6.99_443.3240 0.00 0.06 1.00 0.92 
9.73_443.1014 0.00 0.00 1.00 0.83 
6.90_461.2902 0.00 0.00 0.88 1.00 
5.90_459.3212 0.00 0.14 1.00 0.88 
10.02_459.0960 0.00 0.00 1.00 0.67 
9.03_457.1145 0.00 0.01 1.00 0.77 
11.52_456.3791 0.00 0.00 1.00 0.64 
6.21_455.1906 0.00 0.15 1.00 0.82 
9.81_454.0847 0.00 0.00 1.00 0.73 
9.79_462.0710 0.00 0.00 1.00 0.67 
9.78_481.0499 0.00 0.00 1.00 0.79 
9.02_479.0963 0.00 0.00 1.00 0.87 
4.15_476.2404 0.00 0.00 1.00 0.74 
6.98_499.2793 0.00 0.00 1.00 0.75 
7.51_499.2782 0.00 0.04 1.00 0.91 
9.02_495.0687 0.00 0.00 1.00 0.78 
5.37_493.1709 0.00 0.00 1.00 0.85 
9.09_512.3013 0.00 0.00 1.00 0.78 
13.62_510.2556 0.00 0.28 1.00 0.73 
5.65_504.2609 0.00 0.00 1.00 0.98 
5.64_515.2738 0.00 0.01 1.00 0.74 
6.62_515.2737 0.00 0.00 0.86 1.00 
1.76_515.1445 0.00 0.00 0.92 1.00 
10.06_526.3139 0.00 0.00 1.00 0.65 
7.21_526.2839 0.00 0.03 0.97 1.00 
6.79_549.3505 0.00 0.00 1.00 0.60 
7.20_544.2918 0.00 0.00 1.00 0.85 
7.57_542.3960 0.00 0.20 1.00 0.78 
12.03_565.3746 0.00 0.02 1.00 0.85 
7.14_560.1805 0.00 0.00 0.76 1.00 
6.90_555.3068 0.00 0.00 1.00 0.82 
1.72_551.1035 0.00 0.00 1.00 0.87 
12.03_549.4012 0.00 0.00 1.00 0.84 
5.52_601.2501 0.00 0.00 0.60 1.00 
1.25_639.8836 0.00 0.00 1.00 0.61 
6.02_637.3187 0.00 0.00 1.00 0.84 
9.79_683.1204 0.00 0.00 1.00 0.51 
7.60_846.3434 0.00 0.00 1.00 0.91 
7.20_920.0962 0.00 0.00 0.89 1.00 
7.21_916.0943 0.00 0.00 0.86 1.00 
9.80_907.1678 0.00 0.00 1.00 0.79 
7.67_1031.2480 0.00 0.22 1.00 0.77 
7.69_1031.1674 0.00 0.27 1.00 0.93 
7.67_1031.0798 0.00 0.00 1.00 0.59 
7.63_970.6960 0.00 0.00 1.00 0.53 
7.01_1221.4414 0.00 0.00 1.00 0.93 
7.00_1216.1209 0.00 0.36 1.00 0.85 
7.70_1064.5448 0.00 0.13 0.60 1.00 
8.34_150.0928 0.00 0.03 1.00 0.86 
9.79_218.0234 0.00 0.02 0.96 1.00 
1.64_174.0879 0.00 0.00 0.59 1.00 
9.78_465.0808 0.01 0.02 1.00 0.61 
6.76_310.2021 0.01 0.00 0.99 1.00 
6.24_515.2753 0.01 0.00 1.00 0.79 
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1.82_228.1004 0.01 0.00 0.89 1.00 
1.29_203.9309 0.01 0.00 1.00 0.90 
8.10_301.1534 0.01 0.04 1.00 0.77 
5.66_384.2168 0.01 0.00 1.00 0.96 
1.64_246.1172 0.01 0.00 0.93 1.00 
3.22_235.1201 0.01 0.00 0.84 1.00 
9.81_269.0437 0.02 0.00 1.00 0.73 
6.06_294.2084 0.02 0.00 1.00 0.78 
7.48_177.0877 0.02 0.00 1.00 0.89 
9.66_279.1583 0.02 0.00 1.00 0.69 
8.74_542.3146 0.02 0.00 0.90 1.00 
12.02_205.1953 0.02 0.00 1.00 0.71 
9.14_239.1284 0.03 0.02 1.00 0.75 
5.43_377.1482 0.03 0.00 1.00 0.74 
9.67_319.1539 0.03 0.05 0.64 1.00 
1.73_338.0231 0.04 0.00 1.00 0.99 
7.06_325.1861 0.04 0.23 1.00 1.00 
8.53_283.1523 0.04 0.09 0.88 1.00 
1.74_150.0789 0.04 0.00 1.00 0.77 
6.95_218.1203 0.05 0.10 1.00 0.90 
6.95_368.2220 0.05 0.09 1.00 0.76 
3.07_230.1126 0.05 0.12 0.96 1.00 
10.52_673.3745 0.06 0.10 1.00 0.69 
1.70_260.1135 0.06 0.00 0.91 1.00 
7.42_280.1237 0.07 0.19 1.00 0.88 
4.75_136.0625 0.07 0.00 0.80 1.00 
10.98_442.3651 0.07 0.05 1.00 0.65 
4.61_247.1287 0.07 0.00 0.81 1.00 
3.83_198.1623 0.07 0.05 1.00 0.89 
3.86_150.0940 0.07 0.13 1.00 0.90 
1.76_596.1679 0.07 0.00 0.64 1.00 
4.37_326.1802 0.07 0.44 0.97 1.00 
8.53_207.1002 0.07 0.09 0.97 1.00 
5.97_286.6247 0.08 0.01 0.84 1.00 
8.53_177.0880 0.08 0.07 1.00 0.95 
7.80_291.1290 0.08 0.30 1.00 0.91 
14.64_361.2361 0.09 0.00 0.95 1.00 
5.84_299.0939 0.11 0.05 0.99 1.00 
7.25_371.1508 0.11 0.00 0.89 1.00 
5.83_325.1311 0.12 0.00 0.92 1.00 
9.41_281.1770 0.13 0.24 1.00 0.77 
7.06_221.1900 0.13 0.40 1.00 0.79 
6.41_165.0905 0.14 0.09 1.00 0.72 
1.65_159.0768 0.16 0.00 0.75 1.00 
9.79_1349.2480 0.16 0.00 0.89 1.00 
4.87_329.1844 0.17 0.00 1.00 0.86 
4.30_310.1305 0.17 0.04 1.00 0.86 
3.85_276.1433 0.17 0.10 1.00 0.86 
6.71_1160.7578 0.17 0.00 1.00 0.77 
7.06_203.1787 0.17 0.32 1.00 0.90 
6.06_203.1781 0.18 0.32 1.00 0.79 
1.78_217.1296 0.18 0.37 0.78 1.00 
9.47_211.0868 0.18 0.32 1.00 0.72 
1.73_288.1454 0.20 0.00 1.00 0.86 
4.31_265.0552 0.20 0.00 1.00 0.92 
4.81_464.2611 0.21 0.25 1.00 0.82 
8.29_401.1993 0.21 0.00 1.00 0.92 
3.82_230.1126 0.22 0.14 0.93 1.00 
4.30_478.1379 0.23 0.05 1.00 0.89 
5.81_222.1598 0.24 0.46 1.00 0.85 
16.18_335.9929 0.24 0.00 1.00 0.83 
4.12_413.1243 0.25 0.45 1.00 0.89 
7.42_196.0651 0.25 0.13 1.00 0.87 
4.09_573.1785 0.27 0.46 1.00 0.90 
6.39_336.2172 0.28 0.23 1.00 0.95 
4.88_188.0708 0.29 0.50 0.99 1.00 
12.62_416.2462 0.30 0.36 1.00 0.90 
4.26_450.2439 0.30 0.01 1.00 0.92 
4.86_372.1909 0.30 0.16 1.00 0.91 
6.27_207.0660 0.32 0.57 1.00 1.00 
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4.64_137.0376 0.33 0.34 1.00 0.98 
5.27_685.1761 0.33 0.00 1.00 0.89 
3.80_194.0821 0.34 0.00 0.77 1.00 
5.96_534.2942 0.35 0.08 1.00 0.90 
16.15_459.1339 0.35 0.00 0.74 1.00 
5.81_605.2195 0.36 0.51 1.00 0.81 
4.63_149.1104 0.38 0.61 1.00 0.89 
6.78_176.0714 0.38 0.65 1.00 0.93 
5.16_210.1137 0.40 0.39 1.00 0.83 
8.22_220.1332 0.40 0.59 1.00 0.81 
5.34_191.1575 0.44 0.63 1.00 0.90 
4.32_308.1712 0.46 0.16 1.00 0.89 
4.34_266.1408 0.46 0.36 0.90 1.00 
12.43_386.2820 0.50 1.00 0.00 0.00 
13.49_420.3478 0.51 1.00 0.03 0.04 
10.60_346.3091 0.51 1.00 0.00 0.00 
3.93_438.1964 0.51 0.19 1.00 0.89 
13.00_413.3095 0.52 1.00 0.06 0.04 
10.40_371.3275 0.52 1.00 0.00 0.00 
6.40_263.1761 0.53 0.57 1.00 0.92 
9.48_225.1993 0.53 1.00 0.02 0.01 
6.81_807.1918 0.54 1.00 0.00 0.00 
4.40_158.0302 0.54 0.40 1.00 0.88 
13.53_339.2529 0.55 1.00 0.00 0.00 
4.26_669.2631 0.56 1.00 0.00 0.00 
11.80_235.1712 0.56 1.00 0.07 0.00 
10.15_739.4618 0.56 1.00 0.01 0.02 
14.41_309.2409 0.56 1.00 0.05 0.17 
6.15_485.2027 0.57 0.61 1.00 0.81 
10.53_531.4000 0.57 1.00 0.00 0.00 
1.94_252.0411 0.57 0.43 0.95 1.00 
12.97_407.3144 0.58 1.00 0.04 0.03 
12.98_399.3242 0.58 1.00 0.05 0.03 
4.37_663.2850 0.59 1.00 0.00 0.00 
4.29_244.1199 0.61 0.63 1.00 0.87 
13.98_433.3418 0.61 1.00 0.00 0.00 
6.90_166.0720 0.61 1.00 0.00 0.00 
5.20_239.1759 0.62 1.00 0.23 0.19 
4.64_412.2067 0.62 1.00 0.13 0.12 
3.86_242.1126 0.63 0.68 0.91 1.00 
6.19_181.1351 0.63 1.00 0.06 0.06 
10.97_401.2525 0.63 1.00 0.12 0.04 
3.87_166.0522 0.65 0.38 0.96 1.00 
6.40_439.1986 0.65 0.65 1.00 0.84 
11.58_415.2745 0.65 1.00 0.02 0.00 
12.62_273.1378 0.66 1.00 0.00 0.00 
12.86_507.3281 0.66 1.00 0.29 0.25 
12.97_290.7254 0.66 1.00 0.31 0.24 
4.27_647.2871 0.67 1.00 0.01 0.01 
12.82_551.3593 0.67 1.00 0.37 0.26 
11.44_223.2060 0.67 1.00 0.00 0.00 
5.72_240.1231 0.68 0.47 0.88 1.00 
6.85_824.9348 0.70 1.00 0.00 0.00 
4.81_506.2950 0.71 1.00 0.10 0.00 
16.15_442.8736 0.71 1.00 0.00 0.00 
4.50_359.1197 0.71 0.79 0.97 1.00 
7.07_184.1710 0.72 1.00 0.00 0.00 
4.37_150.0945 0.72 1.00 0.00 0.00 
12.79_595.3829 0.73 1.00 0.43 0.35 
3.89_518.1743 0.73 1.00 0.05 0.00 
12.67_727.4605 0.74 1.00 0.45 0.40 
4.81_415.2090 0.74 0.52 1.00 0.95 
11.18_473.3585 0.75 1.00 0.00 0.01 
3.75_245.1607 0.75 1.00 0.13 0.15 
6.23_251.1781 0.76 0.84 1.00 0.94 
5.43_241.1546 0.76 0.78 0.98 1.00 
12.70_683.4373 0.77 1.00 0.52 0.40 
12.86_463.2998 0.77 1.00 0.00 0.23 
12.74_443.3505 0.77 1.00 0.01 0.02 
6.34_150.0787 0.77 0.73 0.91 1.00 
 381 
12.97_547.4060 0.77 1.00 0.10 0.13 
13.86_425.2896 0.78 1.00 0.32 0.26 
5.26_147.0936 0.79 1.00 0.38 0.32 
11.97_299.2600 0.80 1.00 0.00 0.00 
13.50_524.2740 0.81 1.00 0.54 0.42 
15.06_413.2647 0.81 1.00 0.09 0.34 
12.86_502.3745 0.82 1.00 0.52 0.35 
11.84_443.3878 0.82 1.00 0.21 0.13 
11.03_354.1608 0.82 1.00 0.10 0.10 
11.28_440.3462 0.82 1.00 0.00 0.00 
12.98_282.2118 0.82 1.00 0.00 0.04 
12.73_655.3845 0.83 1.00 0.22 0.42 
12.74_639.4067 0.83 1.00 0.46 0.40 
13.79_365.2675 0.84 1.00 0.00 0.00 
12.80_567.3292 0.85 1.00 0.00 0.37 
12.83_546.4021 0.86 1.00 0.46 0.30 
10.38_401.3397 0.88 1.00 0.29 0.21 
9.26_219.1735 0.88 1.00 0.00 0.00 
12.67_743.4367 0.88 1.00 0.59 0.51 
12.70_699.4109 0.89 1.00 0.34 0.24 
14.79_310.3109 0.90 1.00 0.67 0.66 
12.78_611.3565 0.91 1.00 0.19 0.49 
15.94_338.3442 0.91 1.00 0.59 0.48 
13.49_295.2258 0.91 1.00 0.01 0.00 
1.47_508.0657 0.91 1.00 0.44 0.17 
12.73_320.2010 0.94 1.00 0.13 0.00 
4.49_225.1597 0.97 1.00 0.36 0.32 
12.89_441.3208 0.99 1.00 0.38 0.19 
12.78_590.4295 1.00 1.00 0.58 0.46 
10.36_211.6353 1.00 0.89 0.31 0.00 
3.82_209.1275 1.00 0.90 0.62 0.56 
11.31_225.6512 1.00 0.95 0.38 0.31 
9.27_240.2315 1.00 0.88 0.10 0.00 
10.39_268.2627 1.00 0.83 0.00 0.00 
6.59_273.1670 1.00 0.84 0.62 0.67 
11.44_291.1951 1.00 0.75 0.00 0.00 
11.33_299.2599 1.00 0.77 0.00 0.00 
12.62_313.2746 1.00 0.83 0.00 0.00 
14.82_332.2940 1.00 0.65 0.21 0.23 
4.25_343.1235 1.00 0.70 0.34 0.08 
15.49_338.3442 1.00 0.86 0.00 0.00 
15.92_360.3229 1.00 0.71 0.09 0.32 
13.48_397.3392 1.00 0.75 0.00 0.00 
10.78_415.3581 1.00 0.61 0.11 0.22 
13.95_411.3586 1.00 0.78 0.01 0.02 
13.27_419.3131 1.00 0.81 0.00 0.00 
12.86_485.3471 1.00 0.86 0.32 0.24 
12.81_529.3766 1.00 0.77 0.35 0.14 
12.97_555.3910 1.00 0.94 0.00 0.23 
12.79_573.4039 1.00 0.73 0.34 0.24 
12.75_617.4294 1.00 0.84 0.39 0.25 
13.92_641.5490 1.00 0.85 0.00 0.00 
4.37_685.2548 1.00 0.86 0.00 0.00 
12.67_705.4810 1.00 0.93 0.57 0.33 
6.87_807.0837 1.00 0.57 0.11 0.00 
 
 382 
Table A3.17. Normalized heat map of features described as unique in Figure 
3.2(B) and (C) when comparing wild type Nocardiopsis sp. FU40 ΔApoS8 to the 
S3 streptomycin resistant mutant extract using OPLS-DA and extracting features 
from the generated S-plot with correlation coefficients ≥0.9. Features are 
normalized to maximum intensity for that feature. 
 
Feature ID (RT_m/z) WT WT S3 S3 
12.03_135.1163 0.00 0.05 0.98 1.00 
12.03_123.1165 0.00 0.00 0.93 1.00 
4.87_118.0679 0.00 0.14 0.81 1.00 
12.03_149.1327 0.00 0.00 0.98 1.00 
6.56_162.0938 0.00 0.00 0.88 1.00 
2.01_158.0950 0.00 0.27 1.00 0.67 
5.78_170.1204 0.00 0.00 1.00 0.97 
7.08_169.0882 0.00 0.01 1.00 0.70 
2.44_166.0747 0.00 0.10 0.94 1.00 
6.60_180.1017 0.00 0.02 1.00 0.98 
5.02_180.1014 0.00 0.00 0.66 1.00 
4.95_177.1399 0.00 0.31 0.92 1.00 
4.39_192.1130 0.00 0.16 1.00 0.98 
9.12_191.0134 0.00 0.00 0.83 1.00 
4.14_186.1168 0.00 0.00 1.00 0.60 
4.02_198.1143 0.00 0.00 1.00 0.96 
4.99_198.1134 0.00 0.00 1.00 0.97 
9.08_196.0187 0.00 0.00 1.00 0.97 
8.84_203.1804 0.00 0.00 0.96 1.00 
8.12_203.1781 0.00 0.00 0.97 1.00 
9.08_203.0278 0.00 0.00 1.00 0.98 
9.80_203.0277 0.00 0.00 0.95 1.00 
1.42_201.0074 0.00 0.00 0.99 1.00 
4.35_209.0956 0.00 0.00 0.86 1.00 
4.54_208.1355 0.00 0.00 0.72 1.00 
5.44_208.0539 0.00 0.00 1.00 0.76 
7.49_207.0994 0.00 0.08 1.00 0.83 
1.30_205.9283 0.00 0.00 1.00 0.94 
4.84_205.1323 0.00 0.00 0.92 1.00 
9.81_205.1237 0.00 0.00 1.00 1.00 
10.22_205.1232 0.00 0.00 1.00 0.51 
1.32_211.8786 0.00 0.00 0.80 1.00 
1.49_211.0584 0.00 0.18 0.74 1.00 
9.81_210.0363 0.00 0.00 0.94 1.00 
9.07_210.0305 0.00 0.00 0.76 1.00 
9.41_219.0312 0.00 0.00 0.99 1.00 
3.69_218.1136 0.00 0.39 1.00 0.78 
9.03_217.0413 0.00 0.00 1.00 1.00 
8.84_221.1903 0.00 0.00 1.00 0.98 
6.51_220.1710 0.00 0.13 1.00 0.86 
5.15_226.5984 0.00 0.08 1.00 0.85 
7.35_225.1140 0.00 0.00 1.00 0.73 
7.99_225.1125 0.00 0.02 1.00 0.97 
9.04_225.0298 0.00 0.02 0.93 1.00 
9.77_224.0325 0.00 0.00 1.00 0.92 
5.48_229.0656 0.00 0.00 0.97 1.00 
4.02_228.1701 0.00 0.00 0.91 1.00 
9.82_230.0718 0.00 0.04 1.00 0.58 
8.41_230.0715 0.00 0.00 1.00 0.50 
5.11_236.1306 0.00 0.16 0.98 1.00 
8.54_235.1344 0.00 0.00 1.00 0.92 
9.80_241.0261 0.00 0.00 1.00 0.99 
8.82_241.0249 0.00 0.00 1.00 0.85 
10.69_238.1826 0.00 0.00 1.00 0.74 
5.81_248.1281 0.00 0.23 1.00 0.85 
9.03_248.0351 0.00 0.00 1.00 0.90 
4.04_247.1287 0.00 0.00 1.00 0.99 
 383 
7.33_247.0943 0.00 0.18 0.96 1.00 
9.07_246.5440 0.00 0.00 1.00 0.72 
5.04_244.1219 0.00 0.00 0.84 1.00 
4.31_249.0807 0.00 0.00 1.00 0.94 
4.56_252.0394 0.00 0.11 1.00 0.57 
6.01_252.0391 0.00 0.00 0.63 1.00 
7.48_252.0388 0.00 0.00 0.92 1.00 
3.87_257.1146 0.00 0.33 0.88 1.00 
9.81_253.5524 0.00 0.03 0.89 1.00 
12.02_263.1978 0.00 0.03 0.87 1.00 
1.78_262.1278 0.00 0.00 1.00 0.89 
5.86_262.1048 0.00 0.27 1.00 0.82 
10.71_261.1779 0.00 0.01 0.79 1.00 
5.01_261.1438 0.00 0.03 0.99 1.00 
9.03_260.5527 0.00 0.00 1.00 0.75 
10.68_260.1641 0.00 0.00 0.98 1.00 
6.81_268.0194 0.00 0.00 1.00 0.67 
5.18_266.1406 0.00 0.25 0.71 1.00 
5.27_264.2082 0.00 0.00 1.00 0.83 
9.67_268.0195 0.00 0.00 0.87 1.00 
5.84_281.1328 0.00 0.00 1.00 0.78 
7.18_278.2110 0.00 0.00 0.93 1.00 
6.07_276.1943 0.00 0.00 0.64 1.00 
5.71_286.2118 0.00 0.00 1.00 0.93 
9.01_283.1521 0.00 0.07 0.97 1.00 
1.73_282.0649 0.00 0.02 0.91 1.00 
7.72_281.1420 0.00 0.00 1.00 0.72 
5.10_288.1525 0.00 0.05 0.97 1.00 
5.22_295.1312 0.00 0.01 1.00 0.86 
7.82_294.2085 0.00 0.00 0.89 1.00 
4.87_293.1612 0.00 0.29 0.69 1.00 
6.49_292.1923 0.00 0.02 1.00 0.68 
3.76_299.1387 0.00 0.00 0.70 1.00 
2.95_299.1385 0.00 0.00 0.87 1.00 
4.74_298.0969 0.00 0.08 1.00 0.91 
9.60_297.1694 0.00 0.01 1.00 1.00 
7.19_296.2224 0.00 0.00 0.83 1.00 
5.83_303.1558 0.00 0.01 1.00 0.98 
7.70_303.1206 0.00 0.05 1.00 0.73 
12.02_309.1921 0.00 0.01 0.91 1.00 
3.90_307.1446 0.00 0.00 0.93 1.00 
6.84_312.2197 0.00 0.00 0.85 1.00 
10.59_311.1859 0.00 0.00 0.51 1.00 
9.79_311.0549 0.00 0.00 0.82 1.00 
7.47_310.2026 0.00 0.00 0.81 1.00 
1.74_322.0446 0.00 0.02 0.94 1.00 
9.13_319.1539 0.00 0.00 0.82 1.00 
6.92_318.2094 0.00 0.00 1.00 0.98 
6.00_328.7423 0.00 0.09 1.00 0.83 
5.91_328.5999 0.00 0.00 0.60 1.00 
7.34_326.2353 0.00 0.00 0.84 1.00 
6.01_326.2353 0.00 0.00 0.99 1.00 
4.97_326.0999 0.00 0.15 0.94 1.00 
12.03_325.1706 0.00 0.00 0.99 1.00 
6.31_335.7452 0.00 0.00 1.00 0.77 
5.84_341.1007 0.00 0.00 0.99 1.00 
6.07_337.1394 0.00 0.03 0.91 1.00 
10.06_348.2310 0.00 0.00 1.00 0.76 
7.48_345.1875 0.00 0.00 0.73 1.00 
5.19_344.6196 0.00 0.04 1.00 0.77 
7.37_344.2218 0.00 0.00 0.93 1.00 
6.06_359.1205 0.00 0.00 1.00 0.82 
4.84_357.1855 0.00 0.16 1.00 0.72 
5.26_354.0787 0.00 0.16 1.00 0.97 
8.24_352.2057 0.00 0.00 0.60 1.00 
6.67_362.2335 0.00 0.00 0.62 1.00 
6.51_360.2165 0.00 0.00 0.89 1.00 
8.53_359.2035 0.00 0.09 1.00 0.90 
8.77_368.2219 0.00 0.00 1.00 0.67 
7.52_368.2211 0.00 0.00 0.98 1.00 
 384 
9.80_367.0822 0.00 0.00 0.75 1.00 
5.64_366.2063 0.00 0.00 0.90 1.00 
7.43_374.2181 0.00 0.00 0.95 1.00 
7.83_387.1861 0.00 0.00 0.93 1.00 
9.80_387.0731 0.00 0.00 0.74 1.00 
6.89_384.2172 0.00 0.01 1.00 0.92 
6.24_384.2171 0.00 0.00 0.93 1.00 
8.63_398.2317 0.00 0.00 1.00 0.84 
1.49_394.1142 0.00 0.00 1.00 0.97 
9.40_418.0851 0.00 0.00 0.88 1.00 
3.74_416.1928 0.00 0.04 0.77 1.00 
8.66_429.0854 0.00 0.00 0.91 1.00 
9.08_429.0845 0.00 0.00 0.97 1.00 
8.04_432.2606 0.00 0.00 1.00 0.95 
1.48_431.0890 0.00 0.37 1.00 0.90 
9.07_451.0615 0.00 0.00 0.86 1.00 
6.99_443.3240 0.00 0.08 0.84 1.00 
9.73_443.1014 0.00 0.00 0.96 1.00 
8.33_443.0954 0.00 0.00 1.00 0.99 
8.80_443.0945 0.00 0.00 0.88 1.00 
6.90_461.2902 0.00 0.00 1.00 0.96 
5.90_459.3212 0.00 0.03 1.00 0.95 
10.02_459.0960 0.00 0.00 1.00 0.98 
9.03_457.1145 0.00 0.01 0.92 1.00 
8.67_457.1133 0.00 0.00 0.94 1.00 
11.52_456.3791 0.00 0.00 1.00 0.93 
6.21_455.1906 0.00 0.15 0.85 1.00 
9.81_454.0847 0.00 0.00 0.86 1.00 
9.05_454.0819 0.00 0.00 0.97 1.00 
6.42_472.2832 0.00 0.00 1.00 0.99 
6.46_471.2466 0.00 0.03 1.00 0.83 
9.02_468.1011 0.00 0.00 0.91 1.00 
8.82_465.0807 0.00 0.00 0.68 1.00 
9.79_462.0710 0.00 0.00 0.98 1.00 
9.78_481.0499 0.00 0.00 0.92 1.00 
4.15_476.2404 0.00 0.00 1.00 0.83 
9.02_476.0877 0.00 0.00 1.00 0.85 
7.51_499.2782 0.00 0.06 1.00 0.94 
9.02_495.0687 0.00 0.00 1.00 0.99 
4.37_494.2617 0.00 0.00 0.98 1.00 
5.37_493.1709 0.00 0.00 0.91 1.00 
1.49_491.1254 0.00 0.17 1.00 0.74 
8.58_490.2972 0.00 0.00 0.89 1.00 
9.79_513.1525 0.00 0.00 0.94 1.00 
6.65_512.8485 0.00 0.00 1.00 0.95 
9.09_512.3013 0.00 0.00 0.90 1.00 
5.65_504.2609 0.00 0.00 1.00 0.55 
5.64_515.2738 0.00 0.02 1.00 0.90 
1.76_515.1445 0.00 0.00 0.74 1.00 
10.06_526.3139 0.00 0.00 0.69 1.00 
7.21_526.2839 0.00 0.08 1.00 1.00 
6.79_549.3505 0.00 0.00 1.00 0.90 
9.11_548.3433 0.00 0.02 0.83 1.00 
7.20_544.2918 0.00 0.00 1.00 0.71 
7.57_542.3960 0.00 0.34 0.86 1.00 
12.03_565.3746 0.00 0.00 0.94 1.00 
9.67_563.3802 0.00 0.00 0.86 1.00 
6.90_555.3068 0.00 0.00 1.00 0.95 
12.03_549.4012 0.00 0.00 1.00 0.93 
9.02_549.3610 0.00 0.01 0.84 1.00 
5.52_601.2501 0.00 0.00 1.00 0.97 
9.79_576.6021 0.00 0.00 1.00 0.96 
9.06_576.6005 0.00 0.00 1.00 0.87 
1.25_639.8836 0.00 0.00 1.00 0.94 
9.79_683.1204 0.00 0.00 1.00 0.92 
9.78_885.1896 0.00 0.00 0.66 1.00 
7.69_868.6024 0.00 0.00 1.00 0.84 
7.60_846.3434 0.00 0.00 1.00 0.50 
7.20_920.0962 0.00 0.00 1.00 0.94 
9.80_907.1678 0.00 0.00 0.83 1.00 
 385 
7.69_1031.1674 0.00 0.20 1.00 0.90 
7.65_1000.0444 0.00 0.00 0.89 1.00 
7.63_970.6960 0.00 0.00 0.61 1.00 
7.63_942.9948 0.00 0.00 0.74 1.00 
7.01_1221.4414 0.00 0.00 1.00 0.56 
7.00_1216.1209 0.00 0.29 1.00 0.68 
9.79_218.0234 0.00 0.02 0.79 1.00 
8.34_150.0928 0.00 0.04 0.96 1.00 
9.78_465.0808 0.00 0.01 1.00 0.99 
6.76_310.2021 0.00 0.00 1.00 0.93 
1.64_174.0879 0.01 0.00 1.00 0.96 
10.18_621.4210 0.01 0.00 0.87 1.00 
8.54_447.2904 0.01 0.05 0.90 1.00 
1.82_228.1004 0.01 0.00 1.00 0.93 
9.81_269.0437 0.01 0.00 0.81 1.00 
1.29_203.9309 0.01 0.00 0.92 1.00 
1.64_246.1172 0.01 0.00 0.98 1.00 
8.10_301.1534 0.01 0.05 1.00 0.98 
7.48_177.0877 0.02 0.00 1.00 0.83 
12.02_205.1953 0.02 0.00 0.96 1.00 
8.74_542.3146 0.02 0.00 1.00 0.68 
9.11_505.3321 0.02 0.00 0.91 1.00 
3.22_235.1201 0.02 0.00 1.00 0.97 
9.79_1349.2480 0.02 0.00 0.88 1.00 
5.66_384.2168 0.02 0.00 1.00 0.89 
8.52_491.3179 0.02 0.00 0.86 1.00 
6.24_515.2753 0.02 0.01 1.00 0.79 
4.82_393.2208 0.02 0.00 1.00 0.79 
6.06_294.2084 0.02 0.00 0.89 1.00 
8.29_401.1993 0.02 0.00 0.89 1.00 
7.06_325.1861 0.02 0.14 1.00 0.99 
10.18_223.2085 0.03 0.21 1.00 1.00 
1.73_338.0231 0.04 0.00 1.00 0.98 
6.65_282.2073 0.04 0.24 0.85 1.00 
7.95_433.2783 0.04 0.10 0.90 1.00 
5.43_377.1482 0.04 0.00 0.94 1.00 
3.07_230.1126 0.05 0.12 1.00 0.79 
16.15_710.1773 0.05 0.01 1.00 0.97 
1.74_150.0789 0.05 0.00 0.87 1.00 
1.70_260.1135 0.05 0.00 0.92 1.00 
9.66_279.1583 0.06 0.00 0.85 1.00 
6.95_218.1203 0.06 0.12 0.96 1.00 
8.53_283.1523 0.06 0.14 0.91 1.00 
7.06_221.1900 0.07 0.20 1.00 0.99 
5.84_299.0939 0.07 0.03 1.00 0.95 
8.53_207.1002 0.07 0.09 0.86 1.00 
4.37_326.1802 0.07 0.42 1.00 0.93 
8.53_177.0880 0.07 0.07 0.81 1.00 
6.71_1160.7578 0.07 0.00 1.00 0.97 
3.86_150.0940 0.08 0.14 0.97 1.00 
5.83_325.1311 0.08 0.00 1.00 0.92 
7.06_203.1787 0.08 0.15 0.98 1.00 
9.67_319.1539 0.09 0.12 1.00 0.64 
4.75_136.0625 0.09 0.00 0.92 1.00 
3.83_198.1623 0.10 0.07 0.94 1.00 
7.42_280.1237 0.11 0.29 0.92 1.00 
5.97_286.6247 0.11 0.02 1.00 0.82 
6.06_203.1781 0.11 0.19 0.86 1.00 
3.80_288.1929 0.11 0.10 0.95 1.00 
7.91_389.2523 0.12 0.05 0.86 1.00 
1.65_159.0768 0.12 0.00 0.96 1.00 
9.14_239.1284 0.12 0.11 0.89 1.00 
1.73_288.1454 0.14 0.00 1.00 0.56 
5.97_278.6345 0.14 0.04 1.00 0.88 
5.11_231.1676 0.14 0.51 0.95 1.00 
4.88_188.0708 0.15 0.26 0.80 1.00 
6.39_336.2172 0.16 0.13 1.00 0.85 
6.41_165.0905 0.17 0.11 0.94 1.00 
3.85_276.1433 0.19 0.11 0.93 1.00 
4.30_310.1305 0.19 0.04 0.95 1.00 
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6.66_264.1980 0.19 0.08 1.00 0.84 
3.82_230.1126 0.20 0.12 0.86 1.00 
4.87_329.1844 0.20 0.00 0.89 1.00 
4.31_265.0552 0.20 0.00 1.00 0.82 
4.64_137.0376 0.21 0.22 1.00 0.97 
4.30_478.1379 0.22 0.05 1.00 0.75 
7.25_371.1508 0.22 0.00 1.00 0.88 
4.12_413.1243 0.24 0.43 1.00 0.82 
4.77_179.0472 0.28 0.51 0.90 1.00 
7.64_999.9779 0.28 0.00 0.74 1.00 
5.27_685.1761 0.29 0.00 1.00 0.91 
4.81_464.2611 0.29 0.34 0.99 1.00 
16.18_335.9929 0.30 0.00 1.00 0.84 
4.86_372.1909 0.30 0.15 1.00 0.91 
7.42_196.0651 0.33 0.17 0.85 1.00 
9.41_281.1770 0.34 0.65 0.93 1.00 
9.47_211.0868 0.34 0.60 0.93 1.00 
5.11_307.1591 0.35 0.00 0.97 1.00 
5.61_343.2002 0.37 0.08 0.90 1.00 
3.80_194.0821 0.38 0.00 0.91 1.00 
4.63_149.1104 0.40 0.65 0.88 1.00 
12.62_416.2462 0.42 0.52 1.00 0.94 
5.16_210.1137 0.44 0.44 0.96 1.00 
3.85_258.1333 0.45 0.00 1.00 0.98 
4.34_266.1408 0.46 0.36 0.98 1.00 
5.34_191.1575 0.48 0.68 0.90 1.00 
7.29_331.2114 0.50 0.72 0.94 1.00 
12.43_386.2820 0.50 1.00 0.00 0.00 
4.32_308.1712 0.50 0.18 1.00 0.91 
14.78_323.2583 0.50 1.00 0.00 0.00 
13.49_420.3478 0.51 1.00 0.00 0.00 
10.60_346.3091 0.51 1.00 0.00 0.00 
3.94_180.0961 0.51 0.23 0.88 1.00 
13.00_413.3095 0.52 1.00 0.00 0.00 
10.40_371.3275 0.52 1.00 0.04 0.00 
9.48_225.1993 0.53 1.00 0.01 0.01 
14.04_295.2283 0.54 1.00 0.00 0.00 
6.81_807.1918 0.54 1.00 0.00 0.00 
3.86_242.1126 0.55 0.60 0.90 1.00 
13.53_339.2529 0.55 1.00 0.00 0.00 
4.26_669.2631 0.56 1.00 0.00 0.00 
11.80_235.1712 0.56 1.00 0.00 0.00 
10.15_739.4618 0.56 1.00 0.00 0.00 
14.41_309.2409 0.56 1.00 0.00 0.00 
12.99_526.2341 0.56 1.00 0.08 0.03 
10.53_531.4000 0.57 1.00 0.00 0.00 
4.29_244.1199 0.57 0.59 1.00 0.98 
4.40_158.0302 0.57 0.42 0.92 1.00 
12.97_407.3144 0.58 1.00 0.00 0.00 
12.98_399.3242 0.58 1.00 0.00 0.00 
12.98_510.2581 0.59 1.00 0.12 0.00 
6.40_263.1761 0.59 0.63 0.89 1.00 
4.37_663.2850 0.59 1.00 0.00 0.00 
13.98_433.3418 0.61 1.00 0.00 0.00 
6.90_166.0720 0.61 1.00 0.00 0.00 
5.72_240.1231 0.62 0.43 1.00 0.88 
4.64_412.2067 0.62 1.00 0.11 0.05 
6.19_181.1351 0.63 1.00 0.00 0.00 
4.39_362.1069 0.63 0.55 1.00 0.89 
10.97_401.2525 0.63 1.00 0.00 0.00 
4.50_359.1197 0.64 0.72 1.00 0.99 
6.15_485.2027 0.65 0.69 0.91 1.00 
11.58_415.2745 0.65 1.00 0.00 0.00 
12.62_273.1378 0.66 1.00 0.00 0.00 
12.86_507.3281 0.66 1.00 0.29 0.26 
12.97_290.7254 0.66 1.00 0.05 0.00 
4.27_647.2871 0.67 1.00 0.04 0.00 
12.82_551.3593 0.67 1.00 0.23 0.23 
1.49_594.1582 0.67 0.74 1.00 0.92 
11.44_223.2060 0.67 1.00 0.00 0.00 
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1.50_401.0693 0.67 0.62 1.00 0.90 
6.40_439.1986 0.68 0.69 0.94 1.00 
12.56_441.2657 0.70 1.00 0.37 0.29 
4.59_251.1399 0.70 0.70 1.00 0.86 
6.85_824.9348 0.70 1.00 0.00 0.00 
16.15_442.8736 0.71 1.00 0.00 0.00 
7.07_184.1710 0.72 1.00 0.00 0.00 
4.37_150.0945 0.72 1.00 0.00 0.00 
12.79_595.3829 0.73 1.00 0.32 0.31 
13.98_292.2624 0.73 1.00 0.22 0.21 
3.89_518.1743 0.73 1.00 0.00 0.05 
12.67_727.4605 0.74 1.00 0.37 0.34 
11.18_473.3585 0.75 1.00 0.01 0.01 
6.23_251.1781 0.75 0.82 0.94 1.00 
12.70_683.4373 0.77 1.00 0.38 0.38 
12.86_463.2998 0.77 1.00 0.31 0.00 
12.74_443.3505 0.77 1.00 0.00 0.00 
10.84_227.1557 0.77 0.85 1.00 0.99 
12.97_547.4060 0.77 1.00 0.13 0.08 
13.86_425.2896 0.78 1.00 0.17 0.23 
5.26_147.0936 0.79 1.00 0.28 0.35 
13.50_409.7445 0.80 1.00 0.06 0.00 
12.61_771.4862 0.80 1.00 0.38 0.00 
11.97_299.2600 0.80 1.00 0.00 0.00 
13.50_524.2740 0.81 1.00 0.10 0.04 
15.06_413.2647 0.81 1.00 0.19 0.19 
12.86_502.3745 0.82 1.00 0.28 0.00 
11.84_443.3878 0.82 1.00 0.03 0.00 
11.03_354.1608 0.82 1.00 0.00 0.02 
11.28_440.3462 0.82 1.00 0.00 0.00 
12.98_282.2118 0.82 1.00 0.00 0.00 
12.73_655.3845 0.83 1.00 0.53 0.47 
12.74_639.4067 0.83 1.00 0.44 0.40 
13.79_365.2675 0.84 1.00 0.00 0.00 
12.80_567.3292 0.85 1.00 0.45 0.00 
12.83_546.4021 0.86 1.00 0.28 0.12 
10.38_401.3397 0.88 1.00 0.18 0.19 
12.67_743.4367 0.88 1.00 0.53 0.47 
12.70_699.4109 0.89 1.00 0.61 0.62 
14.79_310.3109 0.90 1.00 0.57 0.67 
12.78_611.3565 0.91 1.00 0.53 0.41 
15.94_338.3442 0.91 1.00 0.41 0.48 
13.48_341.2200 0.91 1.00 0.17 0.00 
13.49_295.2258 0.91 1.00 0.00 0.00 
1.47_508.0657 0.91 1.00 0.73 0.79 
12.73_320.2010 0.94 1.00 0.52 0.24 
4.49_225.1597 0.97 1.00 0.26 0.27 
12.89_441.3208 0.99 1.00 0.18 0.20 
12.78_590.4295 1.00 1.00 0.38 0.36 
13.95_270.2746 1.00 1.00 0.40 0.47 
10.36_211.6353 1.00 0.89 0.22 0.26 
3.82_209.1275 1.00 0.90 0.55 0.58 
11.31_225.6512 1.00 0.95 0.00 0.00 
9.27_240.2315 1.00 0.88 0.00 0.00 
10.39_268.2627 1.00 0.83 0.00 0.00 
12.97_278.2028 1.00 0.62 0.09 0.02 
11.44_291.1951 1.00 0.75 0.00 0.00 
11.33_299.2599 1.00 0.77 0.00 0.00 
12.62_313.2746 1.00 0.83 0.00 0.00 
14.31_325.2414 1.00 0.74 0.00 0.00 
14.82_332.2940 1.00 0.65 0.11 0.00 
15.49_338.3442 1.00 0.86 0.00 0.23 
15.92_360.3229 1.00 0.71 0.26 0.32 
13.48_397.3392 1.00 0.75 0.00 0.00 
10.78_415.3581 1.00 0.61 0.14 0.15 
13.95_411.3586 1.00 0.78 0.00 0.00 
13.27_419.3131 1.00 0.81 0.00 0.00 
10.77_434.3251 1.00 0.58 0.00 0.00 
12.86_485.3471 1.00 0.86 0.14 0.29 
12.81_529.3766 1.00 0.77 0.39 0.00 
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12.97_555.3910 1.00 0.94 0.14 0.00 
12.79_573.4039 1.00 0.73 0.21 0.24 
12.75_617.4294 1.00 0.84 0.10 0.27 
13.92_641.5490 1.00 0.85 0.00 0.00 
4.37_685.2548 1.00 0.86 0.42 0.21 
6.87_807.0837 1.00 0.57 0.00 0.00 
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Table A3.18. Normalized heat map of features described as unique in Figure 
3.2(B) and (C) when comparing wild type Nocardiopsis sp. FU40 ΔApoS8 to the 
S4 streptomycin resistant mutant extract using OPLS-DA and extracting features 
from the generated S-plot with correlation coefficients ≥0.9. Features are 
normalized to maximum intensity for that feature. 
 
Feature ID (RT_m/z) WT WT S4 S4 
1.50_165.0624 0.00 0.00 1.00 1.00 
6.56_162.0938 0.00 0.00 0.63 1.00 
5.78_170.1204 0.00 0.00 0.55 1.00 
5.02_180.1014 0.00 0.00 0.73 1.00 
4.95_177.1399 0.00 0.17 0.57 1.00 
4.14_186.1168 0.00 0.00 1.00 0.70 
4.02_198.1143 0.00 0.00 0.81 1.00 
9.08_196.0187 0.00 0.00 0.85 1.00 
9.80_203.0277 0.00 0.00 0.57 1.00 
7.49_207.0994 0.00 0.05 0.62 1.00 
4.84_205.1323 0.00 0.00 0.63 1.00 
5.48_229.0656 0.00 0.00 0.51 1.00 
4.61_230.0715 0.00 0.18 0.90 1.00 
4.27_237.0717 0.00 0.26 1.00 0.73 
9.80_241.0261 0.00 0.00 1.00 0.67 
5.81_248.1281 0.00 0.15 0.83 1.00 
5.04_244.1219 0.00 0.00 1.00 0.60 
13.78_251.2405 0.00 0.00 0.96 1.00 
4.31_249.0807 0.00 0.00 0.78 1.00 
8.08_252.0397 0.00 0.00 0.67 1.00 
6.01_252.0391 0.00 0.00 0.93 1.00 
1.78_262.1278 0.00 0.00 0.87 1.00 
5.01_261.1438 0.00 0.17 0.72 1.00 
5.18_266.1406 0.00 0.19 1.00 0.90 
11.95_266.1298 0.00 0.00 0.74 1.00 
7.50_283.1523 0.00 0.03 0.63 1.00 
1.73_282.0649 0.00 0.01 0.67 1.00 
4.87_293.1612 0.00 0.11 1.00 0.86 
4.74_298.0969 0.00 0.15 1.00 0.99 
6.00_308.2238 0.00 0.00 1.00 0.90 
5.82_322.1007 0.00 0.00 1.00 0.69 
1.74_322.0446 0.00 0.01 0.99 1.00 
8.76_329.1942 0.00 0.14 1.00 1.00 
10.73_340.1475 0.00 0.10 0.65 1.00 
14.63_339.2533 0.00 0.00 1.00 0.84 
6.07_337.1394 0.00 0.13 0.86 1.00 
5.19_344.6196 0.00 0.07 1.00 0.85 
5.26_354.0787 0.00 0.14 1.00 0.98 
4.01_351.5992 0.00 0.00 0.59 1.00 
8.53_359.2035 0.00 0.10 0.54 1.00 
5.64_366.2063 0.00 0.00 1.00 0.72 
1.49_394.1142 0.00 0.00 0.78 1.00 
14.04_420.3477 0.00 0.23 1.00 0.79 
11.52_456.3791 0.00 0.00 1.00 0.97 
6.21_455.1906 0.00 0.09 0.55 1.00 
6.98_499.2793 0.00 0.00 0.78 1.00 
5.64_515.2738 0.00 0.02 0.68 1.00 
1.49_527.1567 0.00 0.00 1.00 0.53 
5.52_601.2501 0.00 0.00 0.57 1.00 
1.25_639.8836 0.00 0.00 0.78 1.00 
12.72_634.4531 0.00 0.00 1.00 0.79 
7.21_916.0943 0.00 0.00 0.69 1.00 
3.22_235.1201 0.01 0.00 1.00 0.79 
16.15_710.1773 0.02 0.00 0.84 1.00 
1.73_338.0231 0.02 0.00 0.93 1.00 
1.74_150.0789 0.03 0.00 0.67 1.00 
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3.86_150.0940 0.04 0.07 0.64 1.00 
5.43_377.1482 0.04 0.00 0.57 1.00 
6.24_515.2753 0.05 0.02 0.69 1.00 
1.82_228.1004 0.05 0.01 1.00 0.68 
1.70_260.1135 0.05 0.00 1.00 0.98 
4.87_329.1844 0.07 0.00 0.55 1.00 
11.79_304.1184 0.08 0.42 0.97 1.00 
6.41_165.0905 0.08 0.05 0.87 1.00 
11.43_466.2973 0.09 0.27 0.98 1.00 
4.30_310.1305 0.10 0.02 0.65 1.00 
6.89_843.7588 0.11 0.00 1.00 0.69 
15.37_230.0721 0.11 0.37 1.00 0.84 
16.24_268.0194 0.11 0.22 1.00 0.94 
3.83_198.1623 0.12 0.09 0.63 1.00 
16.22_252.0441 0.13 0.23 1.00 0.71 
4.30_478.1379 0.14 0.03 0.79 1.00 
5.27_685.1761 0.17 0.00 0.60 1.00 
4.12_413.1243 0.18 0.31 0.99 1.00 
4.34_266.1408 0.21 0.16 1.00 0.65 
5.16_210.1137 0.22 0.21 0.63 1.00 
3.85_276.1433 0.22 0.13 1.00 0.99 
3.80_194.0821 0.23 0.00 1.00 0.91 
4.26_450.2439 0.24 0.01 0.78 1.00 
13.79_365.2675 0.25 0.29 1.00 0.85 
4.38_242.1131 0.26 0.47 1.00 0.76 
5.61_343.2002 0.26 0.06 0.84 1.00 
16.15_365.1085 0.28 0.00 0.67 1.00 
12.73_328.1928 0.28 0.00 0.76 1.00 
3.85_258.1333 0.28 0.00 0.69 1.00 
5.71_249.1598 0.29 0.40 0.83 1.00 
4.32_308.1712 0.29 0.10 1.00 0.79 
4.88_188.0708 0.29 0.50 0.78 1.00 
4.70_221.1315 0.31 0.45 0.74 1.00 
1.50_423.1007 0.33 0.49 1.00 0.76 
4.86_372.1909 0.35 0.18 0.71 1.00 
4.59_251.1399 0.38 0.37 1.00 0.91 
3.82_209.1275 0.38 0.34 0.91 1.00 
6.10_320.1966 0.40 0.00 0.77 1.00 
6.34_150.0787 0.41 0.39 0.71 1.00 
4.60_303.1563 0.43 0.30 1.00 0.71 
6.02_274.1066 0.44 0.31 0.85 1.00 
12.43_386.2820 0.50 1.00 0.00 0.00 
13.97_282.2786 0.50 0.43 0.75 1.00 
13.49_420.3478 0.51 1.00 0.04 0.02 
10.60_346.3091 0.51 1.00 0.00 0.00 
3.86_242.1126 0.51 0.56 0.78 1.00 
10.70_288.2557 0.52 1.00 0.00 0.00 
3.94_180.0961 0.53 0.24 0.94 1.00 
9.48_225.1993 0.53 1.00 0.01 0.00 
13.53_339.2529 0.55 1.00 0.00 0.00 
4.26_669.2631 0.56 1.00 0.00 0.01 
11.80_235.1712 0.56 1.00 0.02 0.10 
3.80_119.0369 0.56 1.00 0.14 0.00 
10.15_739.4618 0.56 1.00 0.03 0.04 
10.53_531.4000 0.57 1.00 0.00 0.00 
6.95_368.2220 0.57 1.00 0.00 0.00 
12.97_407.3144 0.58 1.00 0.13 0.08 
12.98_399.3242 0.58 1.00 0.13 0.08 
4.09_573.1785 0.58 1.00 0.00 0.00 
4.37_663.2850 0.59 1.00 0.00 0.00 
3.79_359.1699 0.60 0.30 1.00 0.89 
13.98_433.3418 0.61 1.00 0.00 0.02 
6.90_166.0720 0.61 1.00 0.00 0.00 
4.64_412.2067 0.62 1.00 0.22 0.25 
6.19_181.1351 0.63 1.00 0.00 0.00 
11.58_415.2745 0.65 1.00 0.06 0.12 
4.27_647.2871 0.67 1.00 0.05 0.09 
11.44_223.2060 0.67 1.00 0.00 0.00 
1.48_497.0811 0.68 0.39 1.00 0.99 
8.08_219.1411 0.68 1.00 0.00 0.00 
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7.62_970.6124 0.70 1.00 0.00 0.00 
4.81_506.2950 0.71 1.00 0.00 0.00 
16.15_442.8736 0.71 1.00 0.00 0.00 
7.07_184.1710 0.72 1.00 0.38 0.28 
4.37_150.0945 0.72 1.00 0.00 0.01 
3.89_518.1743 0.73 1.00 0.05 0.01 
11.18_473.3585 0.75 1.00 0.03 0.02 
12.74_443.3505 0.77 1.00 0.00 0.00 
12.97_547.4060 0.77 1.00 0.34 0.23 
15.06_413.2647 0.81 1.00 0.59 0.55 
11.84_443.3878 0.82 1.00 0.04 0.04 
11.03_354.1608 0.82 1.00 0.00 0.00 
11.28_440.3462 0.82 1.00 0.00 0.00 
12.98_282.2118 0.82 1.00 0.07 0.00 
5.16_237.1592 0.87 1.00 0.00 0.00 
10.38_401.3397 0.88 1.00 0.18 0.23 
9.26_219.1735 0.88 1.00 0.00 0.00 
13.49_295.2258 0.91 1.00 0.00 0.00 
4.49_225.1597 0.97 1.00 0.18 0.14 
5.94_213.1018 1.00 0.76 0.00 0.00 
10.36_211.6353 1.00 0.89 0.06 0.01 
11.31_225.6512 1.00 0.95 0.00 0.00 
9.27_240.2315 1.00 0.88 0.16 0.50 
10.39_268.2627 1.00 0.83 0.00 0.07 
6.59_273.1670 1.00 0.84 0.46 0.23 
11.44_291.1951 1.00 0.75 0.00 0.00 
12.62_313.2746 1.00 0.83 0.43 0.46 
6.39_336.2172 1.00 0.82 0.00 0.00 
14.82_332.2940 1.00 0.65 0.08 0.00 
15.49_338.3442 1.00 0.86 0.10 0.00 
13.48_397.3392 1.00 0.75 0.00 0.00 
10.78_415.3581 1.00 0.61 0.24 0.18 
13.95_411.3586 1.00 0.78 0.06 0.08 
13.27_419.3131 1.00 0.81 0.00 0.00 
10.77_434.3251 1.00 0.58 0.00 0.00 
10.98_442.3651 1.00 0.78 0.16 0.14 
12.97_555.3910 1.00 0.94 0.52 0.61 
13.92_641.5490 1.00 0.85 0.00 0.00 
4.37_685.2548 1.00 0.86 0.10 0.00 
7.66_916.7249 1.00 0.76 0.00 0.26 
7.00_916.3325 1.00 0.59 0.00 0.00 
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Table A3.19. Normalized heat map of features described as unique in Figure 
3.2(B) and (C) when comparing wild type Nocardiopsis sp. FU40 ΔApoS8 to the 
S5 streptomycin resistant mutant extract using OPLS-DA and extracting features 
from the generated S-plot with correlation coefficients ≥0.9. Features are 
normalized to maximum intensity for that feature. 
 
Feature ID (RT_m/z) WT WT S5 S5 
12.03_135.1163 0.00 0.04 0.79 1.00 
12.03_123.1165 0.00 0.00 0.84 1.00 
4.95_114.0908 0.00 0.00 0.96 1.00 
1.50_103.5345 0.00 0.00 0.92 1.00 
12.03_149.1327 0.00 0.00 0.88 1.00 
1.50_165.0624 0.00 0.00 1.00 0.96 
6.56_162.0938 0.00 0.00 0.82 1.00 
16.16_174.0876 0.00 0.00 0.60 1.00 
5.78_170.1204 0.00 0.00 0.97 1.00 
2.44_166.0747 0.00 0.24 1.00 0.91 
6.60_180.1017 0.00 0.01 0.89 1.00 
5.02_180.1014 0.00 0.00 0.90 1.00 
4.95_177.1399 0.00 0.27 0.99 1.00 
9.26_191.1250 0.00 0.00 0.89 1.00 
9.12_191.0134 0.00 0.00 0.88 1.00 
4.14_186.1168 0.00 0.00 0.81 1.00 
4.02_198.1143 0.00 0.00 1.00 0.61 
8.84_203.1804 0.00 0.00 0.85 1.00 
8.12_203.1781 0.00 0.00 0.96 1.00 
6.22_203.0786 0.00 0.02 1.00 0.92 
9.80_203.0277 0.00 0.00 0.93 1.00 
7.49_207.0994 0.00 0.06 0.86 1.00 
1.30_205.9283 0.00 0.00 1.00 0.89 
4.84_205.1323 0.00 0.00 1.00 0.89 
1.32_211.8786 0.00 0.00 1.00 0.92 
1.49_211.0584 0.00 0.25 1.00 0.88 
9.81_210.0363 0.00 0.00 1.00 0.65 
9.41_219.0312 0.00 0.00 1.00 0.77 
8.84_221.1903 0.00 0.00 0.98 1.00 
4.61_230.0715 0.00 0.25 1.00 0.81 
10.62_236.1643 0.00 0.00 1.00 0.97 
5.11_236.1306 0.00 0.11 0.88 1.00 
8.54_235.1344 0.00 0.00 0.96 1.00 
7.38_246.1513 0.00 0.00 0.62 1.00 
2.62_252.0382 0.00 0.47 0.96 1.00 
4.31_249.0807 0.00 0.00 0.73 1.00 
10.50_252.0400 0.00 0.11 0.52 1.00 
8.08_252.0397 0.00 0.00 1.00 0.97 
4.56_252.0394 0.00 0.09 0.81 1.00 
6.01_252.0391 0.00 0.00 0.56 1.00 
7.48_252.0388 0.00 0.00 0.82 1.00 
3.58_252.0387 0.00 0.35 1.00 1.00 
3.87_257.1146 0.00 0.34 0.72 1.00 
9.81_253.5524 0.00 0.12 1.00 0.57 
12.02_263.1978 0.00 0.03 0.93 1.00 
1.78_262.1278 0.00 0.00 0.74 1.00 
5.86_262.1048 0.00 0.22 0.91 1.00 
10.71_261.1779 0.00 0.01 0.90 1.00 
5.01_261.1438 0.00 0.16 1.00 0.98 
9.03_260.5527 0.00 0.00 1.00 0.76 
6.81_268.0194 0.00 0.00 0.64 1.00 
6.28_268.0191 0.00 0.13 1.00 0.72 
10.77_267.1616 0.00 0.05 0.99 1.00 
5.18_266.1406 0.00 0.28 1.00 0.89 
5.27_264.2082 0.00 0.00 0.97 1.00 
4.60_268.0196 0.00 0.00 0.83 1.00 
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9.12_279.1585 0.00 0.00 0.54 1.00 
7.18_278.2110 0.00 0.00 0.79 1.00 
6.07_276.1943 0.00 0.00 1.00 0.74 
7.50_283.1523 0.00 0.03 0.93 1.00 
1.73_282.0649 0.00 0.01 0.74 1.00 
7.72_281.1420 0.00 0.00 1.00 0.98 
3.86_294.1559 0.00 0.44 0.98 1.00 
7.15_293.2251 0.00 0.00 0.69 1.00 
4.87_293.1612 0.00 0.19 1.00 0.61 
6.49_292.1923 0.00 0.03 0.89 1.00 
3.76_299.1387 0.00 0.04 0.68 1.00 
7.73_298.2024 0.00 0.00 0.88 1.00 
4.74_298.0969 0.00 0.09 1.00 0.92 
9.60_297.1694 0.00 0.01 1.00 1.00 
7.19_296.2224 0.00 0.00 0.85 1.00 
12.02_309.1921 0.00 0.01 0.90 1.00 
6.00_308.2238 0.00 0.00 1.00 0.57 
6.06_312.2197 0.00 0.00 1.00 0.83 
7.24_312.2197 0.00 0.00 0.97 1.00 
10.59_311.1859 0.00 0.00 0.80 1.00 
5.82_322.1007 0.00 0.00 1.00 0.99 
1.74_322.0446 0.00 0.01 0.78 1.00 
9.13_319.1539 0.00 0.00 0.91 1.00 
6.92_318.2094 0.00 0.00 1.00 0.94 
12.03_325.1706 0.00 0.00 0.84 1.00 
8.76_329.1942 0.00 0.09 0.81 1.00 
10.73_340.1475 0.00 0.14 1.00 0.71 
5.99_338.1374 0.00 0.00 1.00 0.97 
6.22_346.2031 0.00 0.00 0.95 1.00 
7.48_345.1875 0.00 0.00 1.00 0.72 
7.37_344.2218 0.00 0.00 0.73 1.00 
5.26_354.0787 0.00 0.18 0.81 1.00 
4.01_351.5992 0.00 0.00 1.00 0.57 
6.67_362.2335 0.00 0.00 1.00 0.74 
6.51_360.2165 0.00 0.00 0.96 1.00 
8.53_359.2035 0.00 0.13 1.00 0.80 
7.52_368.2211 0.00 0.00 0.71 1.00 
9.80_367.0822 0.00 0.00 1.00 1.00 
7.83_387.1861 0.00 0.00 1.00 1.00 
9.80_387.0731 0.00 0.00 0.59 1.00 
6.24_384.2171 0.00 0.00 0.71 1.00 
1.49_394.1142 0.00 0.00 0.69 1.00 
9.08_429.0845 0.00 0.00 1.00 0.88 
4.02_423.1940 0.00 0.00 0.75 1.00 
7.98_431.2698 0.00 0.06 0.90 1.00 
1.48_431.0890 0.00 0.30 0.88 1.00 
9.07_451.0615 0.00 0.00 0.68 1.00 
6.99_443.3240 0.00 0.23 0.87 1.00 
9.73_443.1014 0.00 0.00 1.00 0.95 
10.02_459.0960 0.00 0.00 0.87 1.00 
9.03_457.1145 0.00 0.02 0.69 1.00 
6.21_455.1906 0.00 0.09 0.66 1.00 
6.46_471.2466 0.00 0.03 0.93 1.00 
9.79_462.0710 0.00 0.00 0.89 1.00 
9.78_481.0499 0.00 0.00 0.92 1.00 
9.02_479.0963 0.00 0.00 0.83 1.00 
7.51_499.2782 0.00 0.02 1.00 0.97 
4.37_494.2617 0.00 0.00 0.78 1.00 
1.49_527.1567 0.00 0.00 0.55 1.00 
7.21_526.2839 0.00 0.15 0.70 1.00 
7.20_544.2918 0.00 0.00 1.00 0.80 
12.03_549.4012 0.00 0.00 0.87 1.00 
5.52_601.2501 0.00 0.00 0.86 1.00 
5.18_599.2879 0.00 0.00 1.00 0.78 
1.76_588.1814 0.00 0.00 0.69 1.00 
1.25_639.8836 0.00 0.00 1.00 0.77 
9.79_683.1204 0.00 0.00 1.00 0.63 
9.80_907.1678 0.00 0.00 1.00 1.00 
7.62_891.8938 0.00 0.00 1.00 0.76 
8.34_150.0928 0.00 0.05 1.00 0.94 
 394 
9.79_218.0234 0.01 0.05 0.92 1.00 
6.24_515.2753 0.01 0.00 0.77 1.00 
1.29_203.9309 0.01 0.00 1.00 0.72 
7.48_177.0877 0.01 0.00 0.69 1.00 
8.10_301.1534 0.01 0.03 0.81 1.00 
5.66_384.2168 0.01 0.00 0.81 1.00 
12.02_205.1953 0.01 0.00 0.84 1.00 
9.78_465.0808 0.02 0.04 0.81 1.00 
6.76_310.2021 0.02 0.00 0.93 1.00 
8.29_401.1993 0.02 0.00 0.93 1.00 
6.06_294.2084 0.02 0.00 0.75 1.00 
3.22_235.1201 0.03 0.00 1.00 0.84 
16.15_710.1773 0.03 0.01 1.00 0.97 
9.66_279.1583 0.03 0.00 0.73 1.00 
1.73_338.0231 0.04 0.00 0.82 1.00 
1.74_150.0789 0.04 0.00 1.00 0.99 
10.18_223.2085 0.04 0.25 1.00 0.79 
3.07_230.1126 0.05 0.11 0.79 1.00 
5.97_286.6247 0.05 0.01 0.92 1.00 
8.53_283.1523 0.05 0.10 0.92 1.00 
4.37_326.1802 0.05 0.29 0.77 1.00 
6.95_218.1203 0.05 0.10 0.89 1.00 
9.14_239.1284 0.05 0.05 1.00 0.70 
7.42_280.1237 0.06 0.16 0.95 1.00 
8.53_177.0880 0.06 0.06 0.72 1.00 
3.86_150.0940 0.06 0.11 0.92 1.00 
10.52_673.3745 0.06 0.09 0.87 1.00 
8.53_207.1002 0.06 0.07 0.84 1.00 
5.43_377.1482 0.06 0.00 0.86 1.00 
5.97_278.6345 0.06 0.02 1.00 0.96 
4.75_136.0625 0.07 0.00 0.66 1.00 
1.53_143.0837 0.08 0.10 0.93 1.00 
6.72_1450.6973 0.08 0.02 1.00 0.92 
6.41_165.0905 0.09 0.06 0.83 1.00 
1.77_218.1042 0.09 0.02 0.92 1.00 
7.89_192.1015 0.10 0.17 0.80 1.00 
7.42_196.0651 0.10 0.05 0.58 1.00 
7.06_221.1900 0.12 0.36 1.00 0.97 
15.37_230.0721 0.12 0.40 0.82 1.00 
4.30_478.1379 0.13 0.03 0.66 1.00 
9.47_211.0868 0.13 0.23 0.82 1.00 
3.83_198.1623 0.13 0.09 0.86 1.00 
4.87_329.1844 0.13 0.00 0.95 1.00 
3.82_230.1126 0.14 0.09 0.81 1.00 
6.06_203.1781 0.15 0.26 0.83 1.00 
7.06_203.1787 0.15 0.28 0.88 1.00 
4.30_310.1305 0.15 0.03 0.80 1.00 
3.85_276.1433 0.16 0.09 0.78 1.00 
6.73_1161.1593 0.16 0.04 0.85 1.00 
5.96_534.2942 0.16 0.04 0.97 1.00 
6.78_176.0714 0.17 0.28 0.81 1.00 
6.71_1160.7578 0.17 0.00 1.00 0.86 
9.41_281.1770 0.19 0.36 0.99 1.00 
6.73_1160.5609 0.20 0.00 1.00 1.00 
1.60_229.1318 0.21 0.04 0.91 1.00 
5.27_685.1761 0.22 0.00 0.72 1.00 
4.88_188.0708 0.23 0.39 0.94 1.00 
5.61_343.2002 0.23 0.05 0.84 1.00 
4.81_464.2611 0.24 0.29 0.94 1.00 
3.80_194.0821 0.26 0.00 0.66 1.00 
9.11_505.3321 0.27 0.00 0.93 1.00 
16.22_252.0441 0.28 0.50 0.80 1.00 
5.81_605.2195 0.28 0.40 0.77 1.00 
16.18_335.9929 0.28 0.00 0.95 1.00 
4.32_308.1712 0.29 0.11 0.73 1.00 
4.26_450.2439 0.31 0.02 0.69 1.00 
6.60_152.1087 0.31 0.58 0.95 1.00 
6.74_1160.9454 0.32 0.26 1.00 0.79 
4.63_149.1104 0.32 0.51 0.98 1.00 
5.34_191.1575 0.32 0.46 0.91 1.00 
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4.86_372.1909 0.32 0.17 0.79 1.00 
4.00_320.1711 0.33 0.04 0.80 1.00 
5.16_210.1137 0.33 0.33 0.91 1.00 
6.10_320.1966 0.33 0.00 0.70 1.00 
1.49_365.1079 0.35 0.48 0.78 1.00 
16.15_481.1090 0.35 0.00 0.73 1.00 
6.15_485.2027 0.36 0.38 0.68 1.00 
7.25_371.1508 0.36 0.00 1.00 0.98 
6.40_263.1761 0.36 0.38 0.81 1.00 
3.85_258.1333 0.36 0.00 0.73 1.00 
4.53_236.1764 0.37 0.48 0.94 1.00 
7.29_331.2114 0.38 0.55 0.91 1.00 
5.78_164.0706 0.39 0.52 1.00 0.96 
8.22_220.1332 0.39 0.57 0.94 1.00 
3.75_267.1417 0.40 0.50 0.78 1.00 
9.69_220.1127 0.41 0.48 1.00 0.98 
5.71_249.1598 0.41 0.57 0.84 1.00 
4.40_158.0302 0.42 0.31 1.00 0.98 
5.20_239.1759 0.42 0.69 0.98 1.00 
4.67_270.1917 0.43 0.59 0.81 1.00 
3.79_359.1699 0.45 0.22 0.72 1.00 
4.34_266.1408 0.45 0.35 0.75 1.00 
3.94_254.1629 0.45 0.17 0.91 1.00 
4.70_221.1315 0.45 0.67 0.96 1.00 
4.16_256.1718 0.46 0.62 0.88 1.00 
12.73_328.1928 0.46 0.00 0.98 1.00 
6.40_439.1986 0.47 0.47 0.81 1.00 
8.66_655.2795 0.48 1.00 0.00 0.00 
6.23_251.1781 0.49 0.54 0.87 1.00 
3.93_438.1964 0.49 0.18 0.91 1.00 
1.48_610.1314 0.50 0.23 0.82 1.00 
10.60_346.3091 0.51 1.00 0.00 0.00 
3.86_242.1126 0.51 0.56 0.83 1.00 
10.40_371.3275 0.52 1.00 0.02 0.02 
9.48_225.1993 0.53 1.00 0.02 0.02 
1.50_401.0693 0.54 0.50 1.00 0.98 
4.26_669.2631 0.56 1.00 0.00 0.08 
11.80_235.1712 0.56 1.00 0.00 0.09 
10.15_739.4618 0.56 1.00 0.11 0.07 
5.72_240.1231 0.56 0.39 0.89 1.00 
10.53_531.4000 0.57 1.00 0.00 0.00 
4.37_663.2850 0.59 1.00 0.00 0.00 
12.63_394.2284 0.59 0.45 1.00 0.87 
6.59_273.1670 0.60 0.51 0.84 1.00 
13.48_341.2200 0.60 0.66 1.00 0.86 
13.98_433.3418 0.61 1.00 0.05 0.00 
5.43_241.1546 0.61 0.63 0.93 1.00 
4.64_412.2067 0.62 1.00 0.15 0.20 
6.19_181.1351 0.63 1.00 0.08 0.10 
10.97_401.2525 0.63 1.00 0.08 0.21 
4.64_137.0376 0.64 0.67 0.83 1.00 
3.99_164.0936 0.65 0.59 0.89 1.00 
11.58_415.2745 0.65 1.00 0.07 0.02 
12.62_273.1378 0.66 1.00 0.00 0.00 
4.27_647.2871 0.67 1.00 0.09 0.00 
11.44_223.2060 0.67 1.00 0.00 0.00 
8.08_219.1411 0.68 1.00 0.30 0.24 
6.85_824.9348 0.70 1.00 0.00 0.23 
16.15_442.8736 0.71 1.00 0.00 0.00 
7.07_184.1710 0.72 1.00 0.00 0.00 
4.37_150.0945 0.72 1.00 0.00 0.00 
3.89_518.1743 0.73 1.00 0.06 0.00 
11.18_473.3585 0.75 1.00 0.08 0.04 
12.74_443.3505 0.77 1.00 0.01 0.00 
1.50_230.0720 0.77 0.58 1.00 0.98 
11.97_299.2600 0.80 1.00 0.31 0.21 
15.06_413.2647 0.81 1.00 0.42 0.57 
11.84_443.3878 0.82 1.00 0.11 0.06 
11.03_354.1608 0.82 1.00 0.09 0.25 
11.28_440.3462 0.82 1.00 0.00 0.00 
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12.98_282.2118 0.82 1.00 0.15 0.10 
5.16_237.1592 0.87 1.00 0.66 0.73 
10.38_401.3397 0.88 1.00 0.27 0.16 
9.26_219.1735 0.88 1.00 0.00 0.00 
4.50_359.1197 0.89 1.00 0.00 0.00 
15.94_338.3442 0.91 1.00 0.74 0.68 
13.49_295.2258 0.91 1.00 0.06 0.00 
1.47_508.0657 0.91 1.00 0.37 0.00 
4.49_225.1597 0.97 1.00 0.54 0.56 
12.89_441.3208 0.99 1.00 0.49 0.58 
10.36_211.6353 1.00 0.89 0.03 0.00 
11.31_225.6512 1.00 0.95 0.00 0.00 
9.27_240.2315 1.00 0.88 0.00 0.00 
10.39_268.2627 1.00 0.83 0.00 0.00 
11.44_291.1951 1.00 0.75 0.00 0.00 
12.62_313.2746 1.00 0.83 0.12 0.11 
14.31_325.2414 1.00 0.74 0.00 0.00 
15.49_338.3442 1.00 0.86 0.00 0.00 
13.48_397.3392 1.00 0.75 0.00 0.00 
13.95_411.3586 1.00 0.78 0.06 0.00 
13.27_419.3131 1.00 0.81 0.00 0.00 
10.98_442.3651 1.00 0.78 0.00 0.29 
12.97_555.3910 1.00 0.94 0.77 0.59 
12.75_617.4294 1.00 0.84 0.36 0.00 
13.92_641.5490 1.00 0.85 0.00 0.00 
4.37_685.2548 1.00 0.86 0.12 0.23 
7.00_916.3325 1.00 0.59 0.00 0.00 
 
 397 
Table A3.20. Normalized heat map of features described as unique in Figure 
3.2(B) and (C) when comparing wild type Nocardiopsis sp. FU40 ΔApoS8 to the 
S6 streptomycin resistant mutant extract using OPLS-DA and extracting features 
from the generated S-plot with correlation coefficients ≥0.9. Features are 
normalized to maximum intensity for that feature. 
 
Feature ID (RT_m/z) WT WT S6 S6 
12.03_135.1163 0.00 0.04 0.52 1.00 
12.03_123.1165 0.00 0.00 0.83 1.00 
1.50_103.5345 0.00 0.00 0.90 1.00 
12.03_149.1327 0.00 0.00 0.77 1.00 
13.61_149.0907 0.00 0.00 1.00 0.65 
1.50_165.0624 0.00 0.00 0.96 1.00 
6.56_162.0938 0.00 0.00 0.91 1.00 
4.31_160.1140 0.00 0.00 0.71 1.00 
16.16_174.0876 0.00 0.00 0.77 1.00 
5.78_170.1204 0.00 0.00 0.84 1.00 
7.08_169.0882 0.00 0.05 0.72 1.00 
6.60_180.1017 0.00 0.02 1.00 0.97 
5.02_180.1014 0.00 0.00 0.73 1.00 
10.70_179.1435 0.00 0.00 1.00 0.89 
4.95_177.1399 0.00 0.17 0.64 1.00 
4.39_192.1130 0.00 0.27 0.80 1.00 
9.12_191.0134 0.00 0.00 0.86 1.00 
4.14_186.1168 0.00 0.00 0.86 1.00 
4.02_198.1143 0.00 0.00 0.97 1.00 
9.08_196.0187 0.00 0.00 0.64 1.00 
8.84_203.1804 0.00 0.00 0.95 1.00 
8.12_203.1781 0.00 0.00 0.91 1.00 
6.22_203.0786 0.00 0.08 1.00 0.92 
9.08_203.0278 0.00 0.00 0.77 1.00 
9.80_203.0277 0.00 0.00 0.61 1.00 
9.42_202.0393 0.00 0.00 0.61 1.00 
5.44_208.0539 0.00 0.01 0.91 1.00 
7.49_207.0994 0.00 0.07 0.89 1.00 
1.30_205.9283 0.00 0.00 0.96 1.00 
4.84_205.1323 0.00 0.00 0.62 1.00 
10.22_205.1232 0.00 0.00 0.61 1.00 
8.67_212.0251 0.00 0.00 1.00 0.81 
1.32_211.8786 0.00 0.00 0.94 1.00 
1.49_211.0584 0.00 0.14 0.92 1.00 
9.81_210.0363 0.00 0.00 0.60 1.00 
5.35_210.0350 0.00 0.00 0.84 1.00 
9.41_219.0312 0.00 0.00 0.93 1.00 
10.24_222.1533 0.00 0.14 1.00 0.98 
8.84_221.1903 0.00 0.00 1.00 0.94 
6.51_220.1710 0.00 0.04 1.00 0.60 
8.67_226.0395 0.00 0.00 1.00 0.94 
7.99_225.1125 0.00 0.09 0.76 1.00 
9.04_225.0298 0.00 0.02 0.56 1.00 
9.77_224.0325 0.00 0.00 0.95 1.00 
5.48_229.0656 0.00 0.00 0.95 1.00 
9.82_230.0718 0.00 0.05 1.00 0.75 
5.11_236.1306 0.00 0.11 0.76 1.00 
9.80_241.0261 0.00 0.00 1.00 0.83 
8.82_241.0249 0.00 0.00 0.97 1.00 
5.04_244.1219 0.00 0.00 0.71 1.00 
11.26_250.1814 0.00 0.00 1.00 0.69 
8.08_252.0397 0.00 0.00 1.00 0.69 
9.63_252.0395 0.00 0.00 0.48 1.00 
6.01_252.0391 0.00 0.00 0.79 1.00 
5.12_252.0389 0.00 0.00 1.00 0.84 
7.48_252.0388 0.00 0.00 0.62 1.00 
3.87_257.1146 0.00 0.30 0.82 1.00 
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12.02_263.1978 0.00 0.03 0.77 1.00 
1.78_262.1278 0.00 0.00 0.86 1.00 
5.86_262.1048 0.00 0.22 0.90 1.00 
10.71_261.1779 0.00 0.00 0.71 1.00 
5.01_261.1438 0.00 0.12 0.78 1.00 
10.77_267.1616 0.00 0.21 0.58 1.00 
5.18_266.1406 0.00 0.18 0.78 1.00 
5.27_264.2082 0.00 0.00 1.00 0.78 
7.18_278.2110 0.00 0.00 0.83 1.00 
6.07_276.1943 0.00 0.00 0.83 1.00 
12.79_284.1681 0.00 0.20 0.88 1.00 
7.50_283.1523 0.00 0.05 1.00 0.82 
1.73_282.0649 0.00 0.01 0.63 1.00 
7.82_294.2085 0.00 0.00 1.00 1.00 
4.87_293.1612 0.00 0.21 0.98 1.00 
6.49_292.1923 0.00 0.03 1.00 0.96 
4.74_298.0969 0.00 0.07 1.00 0.84 
9.60_297.1694 0.00 0.05 0.66 1.00 
7.19_296.2224 0.00 0.00 0.94 1.00 
3.78_300.1386 0.00 0.10 0.69 1.00 
12.02_309.1921 0.00 0.01 0.99 1.00 
6.00_308.2238 0.00 0.00 0.80 1.00 
6.06_312.2197 0.00 0.00 1.00 0.91 
6.84_312.2197 0.00 0.00 0.91 1.00 
7.24_312.2197 0.00 0.00 1.00 0.78 
5.82_322.1007 0.00 0.00 1.00 0.98 
6.92_318.2094 0.00 0.00 1.00 0.76 
7.34_326.2353 0.00 0.00 1.00 0.82 
6.01_326.2353 0.00 0.00 0.80 1.00 
12.03_325.1706 0.00 0.00 0.78 1.00 
8.76_329.1942 0.00 0.06 0.98 1.00 
5.84_341.1007 0.00 0.00 1.00 0.70 
5.19_344.6196 0.00 0.18 0.77 1.00 
7.37_344.2218 0.00 0.00 0.98 1.00 
5.26_354.0787 0.00 0.13 1.00 0.83 
8.24_352.2057 0.00 0.00 0.91 1.00 
4.01_351.5992 0.00 0.00 1.00 1.00 
6.67_362.2335 0.00 0.00 0.67 1.00 
6.51_360.2165 0.00 0.00 1.00 0.75 
9.80_367.0822 0.00 0.00 0.61 1.00 
9.80_387.0731 0.00 0.00 0.64 1.00 
6.88_386.2329 0.00 0.01 1.00 0.82 
6.89_384.2172 0.00 0.00 0.57 1.00 
6.24_384.2171 0.00 0.00 0.92 1.00 
8.63_398.2317 0.00 0.00 0.87 1.00 
1.49_394.1142 0.00 0.00 0.83 1.00 
3.74_416.1928 0.00 0.07 0.72 1.00 
9.08_429.0845 0.00 0.00 1.00 0.92 
4.02_423.1940 0.00 0.00 0.55 1.00 
9.07_451.0615 0.00 0.00 0.78 1.00 
6.99_443.3240 0.00 0.15 1.00 0.61 
9.73_443.1014 0.00 0.00 1.00 0.99 
8.80_443.0945 0.00 0.00 0.95 1.00 
10.02_459.0960 0.00 0.00 1.00 0.93 
9.03_457.1145 0.00 0.01 1.00 0.98 
6.21_455.1906 0.00 0.10 0.95 1.00 
9.81_454.0847 0.00 0.00 0.80 1.00 
9.05_454.0819 0.00 0.00 1.00 0.98 
6.46_471.2466 0.00 0.01 0.76 1.00 
8.82_465.0807 0.00 0.00 0.84 1.00 
9.79_462.0710 0.00 0.00 0.68 1.00 
9.04_462.0699 0.00 0.00 0.59 1.00 
9.78_481.0499 0.00 0.00 0.87 1.00 
9.02_479.0963 0.00 0.00 0.79 1.00 
7.37_478.2069 0.00 0.12 0.69 1.00 
4.15_476.2404 0.00 0.00 1.00 0.96 
7.51_499.2782 0.00 0.05 1.00 0.83 
8.58_490.2972 0.00 0.00 1.00 0.76 
9.79_513.1525 0.00 0.00 0.79 1.00 
5.64_515.2738 0.00 0.01 0.57 1.00 
 399 
6.62_515.2737 0.00 0.00 1.00 0.61 
1.76_515.1445 0.00 0.00 0.60 1.00 
7.21_526.2839 0.00 0.02 1.00 0.95 
7.20_544.2918 0.00 0.00 1.00 0.68 
6.63_570.3104 0.00 0.00 0.95 1.00 
12.03_565.3746 0.00 0.00 0.96 1.00 
9.67_563.3802 0.00 0.00 0.86 1.00 
6.90_555.3068 0.00 0.00 0.84 1.00 
1.72_551.1035 0.00 0.00 0.72 1.00 
12.03_549.4012 0.00 0.00 1.00 0.86 
9.02_590.6205 0.00 0.00 0.87 1.00 
9.79_576.6021 0.00 0.00 0.77 1.00 
1.25_639.8836 0.00 0.00 0.63 1.00 
12.72_634.4531 0.00 0.00 1.00 0.53 
9.79_683.1204 0.00 0.00 0.84 1.00 
7.20_920.0962 0.00 0.00 1.00 0.83 
9.80_907.1678 0.00 0.00 1.00 1.00 
7.01_1221.4414 0.00 0.00 0.91 1.00 
9.79_218.0234 0.00 0.01 0.64 1.00 
8.34_150.0928 0.00 0.03 0.85 1.00 
9.78_465.0808 0.00 0.01 0.78 1.00 
9.81_269.0437 0.00 0.00 0.57 1.00 
6.76_310.2021 0.00 0.00 0.99 1.00 
6.24_515.2753 0.01 0.00 1.00 0.78 
8.10_301.1534 0.01 0.03 1.00 0.92 
5.66_384.2168 0.01 0.00 0.95 1.00 
1.29_203.9309 0.01 0.00 0.99 1.00 
7.48_177.0877 0.01 0.00 0.81 1.00 
8.74_542.3146 0.01 0.00 1.00 0.77 
12.02_205.1953 0.01 0.00 0.89 1.00 
3.22_235.1201 0.02 0.00 0.59 1.00 
6.65_282.2073 0.02 0.11 1.00 0.97 
16.15_710.1773 0.02 0.01 1.00 0.63 
5.43_377.1482 0.02 0.00 0.85 1.00 
8.54_447.2904 0.02 0.21 1.00 1.00 
1.74_150.0789 0.03 0.00 0.69 1.00 
8.53_177.0880 0.03 0.03 0.81 1.00 
4.75_136.0625 0.03 0.00 0.83 1.00 
8.53_283.1523 0.03 0.07 1.00 0.92 
6.95_218.1203 0.03 0.07 0.71 1.00 
8.53_207.1002 0.04 0.04 0.97 1.00 
9.79_1349.2480 0.04 0.00 0.82 1.00 
7.06_325.1861 0.04 0.21 1.00 0.95 
1.73_338.0231 0.04 0.00 1.00 0.98 
3.86_150.0940 0.04 0.08 0.83 1.00 
10.52_673.3745 0.05 0.08 0.97 1.00 
3.07_230.1126 0.06 0.14 1.00 0.79 
1.70_260.1135 0.06 0.00 0.83 1.00 
1.82_228.1004 0.06 0.01 0.92 1.00 
10.18_223.2085 0.06 0.39 1.00 0.81 
1.53_143.0837 0.07 0.09 0.75 1.00 
7.42_196.0651 0.07 0.04 0.55 1.00 
4.82_393.2208 0.07 0.00 1.00 0.93 
6.66_264.1980 0.08 0.03 0.99 1.00 
6.41_165.0905 0.08 0.06 0.80 1.00 
7.42_280.1237 0.09 0.26 1.00 0.96 
4.87_329.1844 0.10 0.00 0.91 1.00 
5.27_685.1761 0.10 0.00 0.77 1.00 
6.78_176.0714 0.11 0.18 0.79 1.00 
7.06_221.1900 0.11 0.34 0.90 1.00 
7.89_192.1015 0.11 0.20 0.74 1.00 
5.97_286.6247 0.12 0.02 0.83 1.00 
4.30_310.1305 0.12 0.03 0.95 1.00 
7.06_203.1787 0.12 0.23 0.87 1.00 
5.97_278.6345 0.12 0.03 0.61 1.00 
6.06_203.1781 0.13 0.22 0.92 1.00 
1.77_218.1042 0.13 0.03 0.92 1.00 
9.47_211.0868 0.13 0.23 0.78 1.00 
16.18_335.9929 0.14 0.00 1.00 0.75 
5.81_605.2195 0.14 0.20 0.97 1.00 
 400 
3.82_230.1126 0.16 0.10 1.00 0.92 
4.63_149.1104 0.21 0.35 0.81 1.00 
4.88_188.0708 0.22 0.37 1.00 1.00 
7.29_331.2114 0.22 0.32 0.81 1.00 
4.31_265.0552 0.22 0.00 0.66 1.00 
1.60_229.1318 0.23 0.05 0.90 1.00 
8.29_401.1993 0.24 0.00 0.86 1.00 
1.73_288.1454 0.24 0.00 1.00 0.94 
5.81_222.1598 0.25 0.48 0.91 1.00 
6.60_152.1087 0.26 0.47 0.83 1.00 
4.64_137.0376 0.26 0.27 0.75 1.00 
16.15_365.1085 0.28 0.00 1.00 0.86 
6.15_485.2027 0.29 0.31 0.98 1.00 
4.77_179.0472 0.29 0.54 0.96 1.00 
6.34_150.0787 0.31 0.29 0.81 1.00 
4.34_266.1408 0.31 0.24 0.72 1.00 
16.18_204.8884 0.32 0.00 1.00 0.98 
8.22_220.1332 0.33 0.49 0.84 1.00 
5.78_164.0706 0.34 0.46 0.95 1.00 
6.62_297.1617 0.34 0.61 0.90 1.00 
5.71_249.1598 0.35 0.49 0.88 1.00 
4.40_158.0302 0.36 0.26 0.83 1.00 
4.70_268.1679 0.36 0.65 1.00 0.99 
3.80_288.1929 0.37 0.32 1.00 0.77 
4.67_270.1917 0.38 0.52 0.97 1.00 
4.16_256.1718 0.38 0.51 0.99 1.00 
4.00_320.1711 0.38 0.04 1.00 0.73 
3.94_254.1629 0.39 0.15 1.00 0.94 
6.34_469.2088 0.39 0.51 1.00 0.92 
5.16_210.1137 0.41 0.40 0.80 1.00 
16.17_188.9130 0.42 0.00 1.00 1.00 
6.23_251.1781 0.42 0.46 0.81 1.00 
6.40_263.1761 0.43 0.46 0.91 1.00 
3.75_267.1417 0.44 0.55 0.98 1.00 
6.10_320.1966 0.44 0.00 0.94 1.00 
3.82_209.1275 0.44 0.40 0.78 1.00 
4.66_304.1776 0.45 0.67 1.00 0.97 
6.40_439.1986 0.46 0.46 1.00 1.00 
11.27_448.3444 0.48 1.00 0.00 0.00 
12.43_386.2820 0.50 1.00 0.00 0.00 
3.75_245.1607 0.50 0.67 1.00 0.91 
16.14_274.0340 0.51 0.36 1.00 0.77 
10.60_346.3091 0.51 1.00 0.00 0.00 
10.40_371.3275 0.52 1.00 0.00 0.00 
10.70_288.2557 0.52 1.00 0.00 0.00 
3.86_242.1126 0.52 0.57 0.82 1.00 
9.48_225.1993 0.53 1.00 0.00 0.02 
3.94_180.0961 0.54 0.24 0.90 1.00 
6.74_1160.9454 0.54 0.45 0.89 1.00 
3.79_359.1699 0.55 0.27 0.90 1.00 
13.53_339.2529 0.55 1.00 0.00 0.00 
7.22_541.3491 0.56 1.00 0.00 0.10 
4.26_669.2631 0.56 1.00 0.00 0.00 
11.80_235.1712 0.56 1.00 0.06 0.07 
10.15_739.4618 0.56 1.00 0.08 0.07 
14.41_309.2409 0.56 1.00 0.22 0.09 
5.95_273.1788 0.56 1.00 0.23 0.00 
10.53_531.4000 0.57 1.00 0.00 0.00 
4.59_251.1399 0.57 0.57 0.85 1.00 
12.97_407.3144 0.58 1.00 0.24 0.02 
5.72_240.1231 0.58 0.40 0.95 1.00 
6.02_274.1066 0.58 0.40 0.86 1.00 
12.98_399.3242 0.58 1.00 0.22 0.02 
4.37_663.2850 0.59 1.00 0.00 0.00 
13.98_433.3418 0.61 1.00 0.04 0.00 
6.90_166.0720 0.61 1.00 0.00 0.00 
5.20_239.1759 0.62 1.00 0.25 0.31 
9.69_220.1127 0.62 0.72 0.88 1.00 
4.64_412.2067 0.62 1.00 0.07 0.20 
6.19_181.1351 0.63 1.00 0.06 0.11 
 401 
10.97_401.2525 0.63 1.00 0.00 0.09 
11.58_415.2745 0.65 1.00 0.00 0.03 
12.62_273.1378 0.66 1.00 0.00 0.00 
4.27_647.2871 0.67 1.00 0.00 0.07 
1.50_448.0831 0.67 1.00 0.19 0.00 
11.44_223.2060 0.67 1.00 0.00 0.00 
1.50_423.1007 0.67 1.00 0.00 0.20 
8.08_219.1411 0.68 1.00 0.00 0.00 
4.81_415.2090 0.69 0.48 0.91 1.00 
16.15_442.8736 0.71 1.00 0.00 0.00 
7.07_184.1710 0.72 1.00 0.00 0.00 
4.37_150.0945 0.72 1.00 0.00 0.00 
3.89_518.1743 0.73 1.00 0.00 0.02 
11.18_473.3585 0.75 1.00 0.04 0.02 
12.86_463.2998 0.77 1.00 0.31 0.33 
12.74_443.3505 0.77 1.00 0.00 0.00 
12.97_547.4060 0.77 1.00 0.46 0.06 
13.86_425.2896 0.78 1.00 0.55 0.40 
11.97_299.2600 0.80 1.00 0.05 0.00 
15.06_413.2647 0.81 1.00 0.53 0.42 
11.84_443.3878 0.82 1.00 0.14 0.07 
11.03_354.1608 0.82 1.00 0.06 0.05 
11.28_440.3462 0.82 1.00 0.00 0.00 
12.98_282.2118 0.82 1.00 0.00 0.00 
13.79_365.2675 0.84 1.00 0.00 0.00 
4.81_464.2611 0.84 1.00 0.48 0.21 
12.83_546.4021 0.86 1.00 0.71 0.59 
10.38_401.3397 0.88 1.00 0.41 0.26 
9.26_219.1735 0.88 1.00 0.00 0.00 
10.84_227.1557 0.90 1.00 0.62 0.43 
15.94_338.3442 0.91 1.00 0.58 0.52 
13.49_295.2258 0.91 1.00 0.05 0.01 
1.47_508.0657 0.91 1.00 0.53 0.67 
1.50_260.0296 0.92 1.00 0.28 0.12 
12.73_320.2010 0.94 1.00 0.00 0.37 
4.49_225.1597 0.97 1.00 0.22 0.24 
5.43_241.1546 0.98 1.00 0.00 0.00 
12.89_441.3208 0.99 1.00 0.65 0.48 
3.99_164.0936 1.00 0.90 0.67 0.59 
1.64_174.0879 1.00 0.59 0.00 0.00 
5.94_213.1018 1.00 0.76 0.00 0.00 
10.36_211.6353 1.00 0.89 0.00 0.00 
11.31_225.6512 1.00 0.95 0.03 0.00 
9.27_240.2315 1.00 0.88 0.00 0.30 
10.39_268.2627 1.00 0.83 0.00 0.00 
11.44_291.1951 1.00 0.75 0.00 0.00 
11.33_299.2599 1.00 0.77 0.00 0.00 
12.62_313.2746 1.00 0.83 0.00 0.00 
14.31_325.2414 1.00 0.74 0.00 0.24 
4.25_343.1235 1.00 0.70 0.00 0.00 
15.49_338.3442 1.00 0.86 0.00 0.00 
13.48_397.3392 1.00 0.75 0.03 0.00 
13.95_411.3586 1.00 0.78 0.06 0.00 
13.27_419.3131 1.00 0.81 0.00 0.00 
10.77_434.3251 1.00 0.58 0.00 0.00 
12.86_485.3471 1.00 0.86 0.57 0.49 
1.61_539.0459 1.00 0.57 0.00 0.00 
13.92_641.5490 1.00 0.85 0.00 0.00 
4.37_685.2548 1.00 0.86 0.00 0.00 
7.66_916.7249 1.00 0.76 0.00 0.25 
 402 
Table A3.21. Normalized heat map of features described as unique in Figure 
3.3(A) when comparing wild type Nocardiopsis sp. FU40 ΔApoS8 and S5 
streptomycin resistant mutant to the R4 rifampicin resistant mutant extract using 
OPLS-DA and extracting features from the generated S-plot with correlation 
coefficients ≥0.9. Features are normalized to maximum intensity for that feature. 
 
Feature ID (RT_m/z) WT WT R4 R4 S5 S5 
1.51_137.5554 0.00 0.00 1.00 0.52 0.00 0.00 
1.52_129.5659 0.00 0.00 1.00 0.52 0.00 0.00 
4.95_114.0908 0.00 0.00 0.45 1.00 0.12 0.13 
4.31_160.1140 0.00 0.00 0.67 1.00 0.00 0.00 
9.08_196.0187 0.00 0.00 0.79 1.00 0.00 0.00 
8.68_204.0325 0.00 0.00 0.72 1.00 0.00 0.00 
9.08_203.0278 0.00 0.00 0.76 1.00 0.00 0.05 
9.42_202.0393 0.00 0.00 0.68 1.00 0.00 0.00 
1.42_201.0074 0.00 0.00 0.79 1.00 0.00 0.00 
4.54_208.1355 0.00 0.00 0.90 1.00 0.02 0.00 
8.67_212.0251 0.00 0.00 0.63 1.00 0.00 0.01 
9.25_211.0284 0.00 0.01 1.00 0.92 0.00 0.00 
8.31_210.0369 0.00 0.00 0.81 1.00 0.00 0.00 
9.81_210.0363 0.00 0.00 1.00 0.66 0.23 0.15 
9.07_210.0305 0.00 0.00 0.77 1.00 0.00 0.00 
9.41_219.0312 0.00 0.00 1.00 0.86 0.04 0.03 
8.67_218.0490 0.00 0.00 0.82 1.00 0.00 0.00 
9.03_217.0413 0.00 0.00 0.70 1.00 0.05 0.02 
2.51_216.0981 0.00 0.02 0.49 1.00 0.05 0.08 
16.16_223.9875 0.00 0.00 0.90 1.00 0.00 0.00 
6.51_220.1710 0.00 0.04 1.00 0.99 0.00 0.00 
4.58_226.1445 0.00 0.00 1.00 0.82 0.00 0.00 
5.11_226.1427 0.00 0.02 0.53 1.00 0.00 0.00 
8.67_226.0395 0.00 0.00 0.61 1.00 0.15 0.00 
9.04_225.0298 0.00 0.01 0.74 1.00 0.04 0.00 
9.77_224.0325 0.00 0.00 0.63 1.00 0.32 0.09 
5.11_227.1386 0.00 0.00 0.56 1.00 0.00 0.00 
9.19_230.0719 0.00 0.00 1.00 0.54 0.00 0.00 
9.82_230.0718 0.00 0.03 0.91 1.00 0.16 0.50 
4.89_235.1441 0.00 0.00 0.93 1.00 0.00 0.00 
9.80_241.0261 0.00 0.00 1.00 0.78 0.00 0.09 
8.82_241.0249 0.00 0.00 1.00 0.94 0.00 0.00 
9.03_248.0351 0.00 0.00 0.80 1.00 0.00 0.00 
4.04_247.1287 0.00 0.00 0.50 1.00 0.00 0.05 
9.07_246.5440 0.00 0.00 0.71 1.00 0.03 0.01 
5.63_245.1880 0.00 0.00 1.00 0.83 0.00 0.00 
5.04_244.1219 0.00 0.00 0.85 1.00 0.13 0.00 
4.70_243.1326 0.00 0.00 0.55 1.00 0.00 0.10 
8.52_250.0297 0.00 0.00 0.76 1.00 0.00 0.00 
9.81_253.5524 0.00 0.02 0.91 1.00 0.13 0.07 
9.91_261.5430 0.00 0.00 1.00 0.65 0.00 0.00 
9.03_260.5527 0.00 0.00 0.72 1.00 0.05 0.04 
10.77_267.1616 0.00 0.02 1.00 1.00 0.31 0.32 
9.67_268.0195 0.00 0.00 1.00 0.94 0.49 0.00 
7.18_278.2110 0.00 0.00 0.62 1.00 0.05 0.06 
6.07_276.1943 0.00 0.00 0.57 1.00 0.19 0.14 
5.71_286.2118 0.00 0.00 0.84 1.00 0.08 0.32 
7.19_284.2219 0.00 0.00 0.63 1.00 0.00 0.08 
5.22_295.1312 0.00 0.05 0.70 1.00 0.10 0.00 
7.48_294.2085 0.00 0.00 1.00 0.58 0.00 0.03 
7.82_294.2085 0.00 0.00 0.56 1.00 0.00 0.08 
6.82_294.2084 0.00 0.00 0.63 1.00 0.18 0.00 
7.73_298.2024 0.00 0.00 0.60 1.00 0.09 0.10 
7.19_296.2224 0.00 0.00 0.58 1.00 0.05 0.06 
6.00_308.2238 0.00 0.00 0.64 1.00 0.07 0.04 
6.92_313.1550 0.00 0.00 0.55 1.00 0.09 0.00 
6.06_312.2197 0.00 0.00 0.84 1.00 0.10 0.09 
 403 
6.84_312.2197 0.00 0.00 0.52 1.00 0.06 0.00 
9.79_311.0549 0.00 0.00 0.57 1.00 0.00 0.22 
3.86_320.0995 0.00 0.00 0.64 1.00 0.00 0.01 
6.92_318.2094 0.00 0.00 0.76 1.00 0.11 0.10 
5.91_328.5999 0.00 0.00 0.65 1.00 0.06 0.00 
7.34_326.2353 0.00 0.00 0.58 1.00 0.03 0.06 
6.01_326.2353 0.00 0.00 0.79 1.00 0.12 0.03 
4.97_326.0999 0.00 0.23 0.83 1.00 0.00 0.00 
6.08_324.1828 0.00 0.09 0.64 1.00 0.08 0.21 
6.62_334.2005 0.00 0.00 0.50 1.00 0.00 0.00 
5.84_341.1007 0.00 0.00 0.59 1.00 0.00 0.00 
6.22_346.2031 0.00 0.00 1.00 0.86 0.26 0.27 
7.37_344.2218 0.00 0.00 0.66 1.00 0.03 0.04 
8.24_352.2057 0.00 0.00 0.54 1.00 0.07 0.00 
6.67_362.2335 0.00 0.00 1.00 0.86 0.07 0.05 
6.51_360.2165 0.00 0.00 1.00 0.81 0.20 0.21 
8.77_368.2219 0.00 0.00 0.73 1.00 0.09 0.00 
6.02_368.2219 0.00 0.04 0.72 1.00 0.00 0.00 
9.80_367.0822 0.00 0.00 0.66 1.00 0.13 0.13 
5.64_366.2063 0.00 0.00 0.71 1.00 0.00 0.00 
8.47_382.2398 0.00 0.00 0.89 1.00 0.05 0.00 
7.30_389.1593 0.00 0.00 1.00 0.89 0.16 0.00 
9.80_387.0731 0.00 0.00 0.56 1.00 0.08 0.13 
6.88_386.2329 0.00 0.00 0.66 1.00 0.11 0.00 
8.63_398.2317 0.00 0.00 0.65 1.00 0.00 0.00 
9.40_418.0851 0.00 0.00 0.59 1.00 0.00 0.00 
8.66_429.0854 0.00 0.00 0.56 1.00 0.00 0.00 
9.08_429.0845 0.00 0.00 0.57 1.00 0.02 0.02 
9.15_440.0708 0.00 0.00 0.59 1.00 0.00 0.00 
9.42_432.0873 0.00 0.00 0.65 1.00 0.00 0.00 
9.09_448.0576 0.00 0.00 0.61 1.00 0.00 0.00 
9.73_443.1014 0.00 0.00 0.82 1.00 0.06 0.06 
8.33_443.0954 0.00 0.00 0.93 1.00 0.03 0.00 
8.80_443.0945 0.00 0.00 0.61 1.00 0.00 0.00 
6.90_461.2902 0.00 0.00 0.90 1.00 0.29 0.00 
10.02_459.0960 0.00 0.00 0.58 1.00 0.07 0.09 
9.03_457.1145 0.00 0.00 0.60 1.00 0.03 0.04 
8.67_457.1133 0.00 0.00 0.66 1.00 0.00 0.00 
3.92_456.2075 0.00 0.32 0.61 1.00 0.00 0.00 
9.81_454.0847 0.00 0.00 0.78 1.00 0.00 0.03 
9.05_454.0819 0.00 0.00 0.57 1.00 0.00 0.00 
6.42_472.2832 0.00 0.00 0.75 1.00 0.00 0.02 
6.46_471.2466 0.00 0.01 0.64 1.00 0.19 0.21 
10.02_470.0758 0.00 0.00 0.62 1.00 0.00 0.00 
9.02_468.1011 0.00 0.00 0.58 1.00 0.00 0.00 
9.08_467.0388 0.00 0.00 0.79 1.00 0.00 0.00 
8.31_465.0807 0.00 0.00 0.70 1.00 0.00 0.00 
8.82_465.0807 0.00 0.00 0.67 1.00 0.00 0.00 
9.79_462.0710 0.00 0.00 0.72 1.00 0.03 0.03 
9.04_462.0699 0.00 0.00 0.61 1.00 0.00 0.00 
7.03_483.0939 0.00 0.00 0.72 1.00 0.00 0.00 
9.78_481.0499 0.00 0.00 1.00 0.75 0.07 0.08 
9.02_479.0963 0.00 0.00 0.62 1.00 0.04 0.04 
10.01_478.0692 0.00 0.00 0.53 1.00 0.00 0.00 
4.15_476.2404 0.00 0.00 0.56 1.00 0.00 0.03 
9.02_476.0877 0.00 0.00 0.55 1.00 0.00 0.00 
7.06_475.1057 0.00 0.00 0.61 1.00 0.00 0.01 
9.02_495.0687 0.00 0.00 0.70 1.00 0.00 0.03 
5.37_493.1709 0.00 0.00 1.00 0.69 0.00 0.14 
9.79_513.1525 0.00 0.00 0.48 1.00 0.00 0.00 
1.76_515.1445 0.00 0.00 0.74 1.00 0.00 0.00 
10.06_526.3139 0.00 0.00 1.00 0.54 0.02 0.00 
7.20_544.2918 0.00 0.00 0.61 1.00 0.20 0.16 
9.00_540.1495 0.00 0.00 0.63 1.00 0.00 0.00 
6.63_570.3104 0.00 0.00 0.91 1.00 0.00 0.00 
9.08_562.5875 0.00 0.00 0.62 1.00 0.00 0.00 
7.14_560.1805 0.00 0.00 0.64 1.00 0.13 0.00 
9.02_590.6205 0.00 0.00 0.63 1.00 0.00 0.00 
9.79_576.6021 0.00 0.00 1.00 0.60 0.03 0.00 
9.06_576.6005 0.00 0.00 0.60 1.00 0.00 0.00 
 404 
9.07_662.0928 0.00 0.00 0.48 1.00 0.00 0.00 
9.02_704.1451 0.00 0.00 0.54 1.00 0.00 0.00 
9.03_696.1548 0.00 0.00 0.49 1.00 0.00 0.00 
9.71_694.1152 0.00 0.00 0.66 1.00 0.00 0.00 
9.03_690.1259 0.00 0.00 0.54 1.00 0.00 0.00 
9.79_683.1204 0.00 0.00 1.00 0.68 0.00 0.00 
9.06_676.1101 0.00 0.00 0.53 1.00 0.00 0.00 
9.41_675.1324 0.00 0.00 0.54 1.00 0.00 0.00 
9.78_885.1896 0.00 0.00 0.47 1.00 0.00 0.00 
9.07_879.1306 0.00 0.00 0.69 1.00 0.00 0.00 
9.02_935.1961 0.00 0.00 0.53 1.00 0.00 0.00 
7.21_916.0943 0.00 0.00 1.00 0.78 0.13 0.00 
9.80_907.1678 0.00 0.00 0.82 1.00 0.01 0.01 
9.04_907.1662 0.00 0.00 0.51 1.00 0.02 0.00 
9.41_904.1590 0.00 0.00 0.53 1.00 0.00 0.00 
7.67_1031.2480 0.00 0.14 0.97 1.00 0.47 0.00 
7.69_1031.1674 0.00 0.10 1.00 0.91 0.13 0.22 
7.67_1031.0798 0.00 0.00 0.91 1.00 0.00 0.00 
7.69_1000.1273 0.00 0.00 0.49 1.00 0.00 0.07 
7.63_942.9948 0.00 0.00 1.00 0.90 0.00 0.00 
7.01_1221.4414 0.00 0.00 0.55 1.00 0.00 0.00 
9.41_1125.2062 0.00 0.00 0.48 1.00 0.00 0.00 
9.78_465.0808 0.00 0.00 0.87 1.00 0.09 0.11 
9.79_1349.2480 0.00 0.00 0.51 1.00 0.00 0.00 
6.06_294.2084 0.00 0.00 0.59 1.00 0.11 0.14 
9.81_269.0437 0.00 0.00 0.61 1.00 0.17 0.00 
6.65_282.2073 0.01 0.04 0.76 1.00 0.00 0.14 
8.74_542.3146 0.01 0.00 1.00 0.73 0.00 0.00 
1.64_246.1172 0.02 0.00 0.74 1.00 0.19 0.00 
1.64_174.0879 0.02 0.01 1.00 0.56 0.12 0.01 
6.66_264.1980 0.03 0.01 0.63 1.00 0.00 0.02 
1.70_260.1135 0.08 0.00 0.75 1.00 0.49 0.00 
7.25_371.1508 0.09 0.00 0.67 1.00 0.26 0.25 
10.18_621.4210 0.13 0.00 0.59 1.00 0.00 0.00 
3.80_288.1929 0.15 0.13 1.00 0.77 0.13 0.00 
3.86_338.1113 0.19 0.00 0.65 1.00 0.00 0.18 
7.91_389.2523 0.23 0.10 0.63 1.00 0.34 0.00 
4.39_362.1069 0.62 0.54 0.00 0.05 0.64 1.00 
12.61_771.4862 0.68 0.85 0.40 0.33 0.86 1.00 
12.67_727.4605 0.69 0.94 0.21 0.30 0.86 1.00 
12.79_595.3829 0.73 1.00 0.46 0.37 0.79 0.83 
12.70_683.4373 0.77 1.00 0.48 0.36 0.89 0.90 
12.78_590.4295 0.78 0.78 0.32 0.26 0.79 1.00 
12.73_655.3845 0.83 1.00 0.56 0.44 0.82 1.00 
12.80_567.3292 0.85 1.00 0.55 0.36 0.75 0.92 
14.79_310.3109 0.85 0.95 0.48 0.50 0.72 1.00 
12.83_546.4021 0.86 1.00 0.00 0.24 0.76 0.84 
5.16_237.1592 0.87 1.00 0.21 0.29 0.66 0.73 
15.94_338.3442 0.91 1.00 0.32 0.34 0.74 0.68 
11.33_299.2599 1.00 0.77 0.00 0.00 0.69 0.51 
4.42_351.1212 1.00 0.79 0.09 0.14 0.79 0.66 
15.92_360.3229 1.00 0.71 0.22 0.13 0.66 0.88 
 
 405 
Table A3.22. Normalized heat map of features described as unique in Figure 
3.3(A) when comparing wild type Nocardiopsis sp. FU40 ΔApoS8 and R4 
rifampicin resistant mutant to the S5 streptomycin resistant mutant extract using 
OPLS-DA and extracting features from the generated S-plot with correlation 
coefficients ≥0.9. Features are normalized to maximum intensity for that feature. 
 
Feature ID (RT_m/z) WT WT R4 R4 S5 S5 
12.03_135.1163 0.00 0.04 0.00 0.00 0.79 1.00 
12.03_123.1165 0.00 0.00 0.00 0.00 0.84 1.00 
12.03_149.1327 0.00 0.00 0.00 0.00 0.88 1.00 
6.56_162.0938 0.00 0.00 0.28 0.35 0.82 1.00 
16.16_174.0876 0.00 0.00 0.00 0.00 0.60 1.00 
6.60_180.1017 0.00 0.01 0.23 0.40 0.89 1.00 
8.84_203.1804 0.00 0.00 0.00 0.00 0.85 1.00 
8.12_203.1781 0.00 0.00 0.00 0.00 0.96 1.00 
6.22_203.0786 0.00 0.02 0.00 0.00 1.00 0.92 
7.49_207.0994 0.00 0.06 0.28 0.52 0.86 1.00 
8.84_221.1903 0.00 0.00 0.00 0.00 0.98 1.00 
10.62_236.1643 0.00 0.00 0.39 0.30 1.00 0.97 
8.54_235.1344 0.00 0.00 0.30 0.51 0.96 1.00 
7.38_246.1513 0.00 0.00 0.00 0.00 0.62 1.00 
3.58_252.0387 0.00 0.35 0.11 0.52 1.00 1.00 
12.02_263.1978 0.00 0.03 0.00 0.00 0.93 1.00 
10.71_261.1779 0.00 0.01 0.00 0.00 0.90 1.00 
6.28_268.0191 0.00 0.13 0.17 0.16 1.00 0.72 
5.27_264.2082 0.00 0.00 0.36 0.46 0.97 1.00 
4.60_268.0196 0.00 0.00 0.44 0.18 0.83 1.00 
7.15_293.2251 0.00 0.00 0.27 0.29 0.69 1.00 
12.02_309.1921 0.00 0.01 0.00 0.00 0.90 1.00 
12.03_325.1706 0.00 0.00 0.00 0.00 0.84 1.00 
10.73_340.1475 0.00 0.14 0.00 0.00 1.00 0.71 
5.99_338.1374 0.00 0.00 0.30 0.24 1.00 0.97 
4.01_351.5992 0.00 0.00 0.00 0.00 1.00 0.57 
7.52_368.2211 0.00 0.00 0.31 0.34 0.71 1.00 
7.83_387.1861 0.00 0.00 0.50 0.00 1.00 1.00 
6.24_384.2171 0.00 0.00 0.07 0.11 0.71 1.00 
7.98_431.2698 0.00 0.06 0.00 0.11 0.90 1.00 
6.99_443.3240 0.00 0.23 0.00 0.00 0.87 1.00 
7.51_499.2782 0.00 0.02 0.07 0.49 1.00 0.97 
4.37_494.2617 0.00 0.00 0.06 0.09 0.78 1.00 
7.57_542.3960 0.00 0.42 0.00 0.00 0.79 1.00 
12.03_549.4012 0.00 0.00 0.00 0.00 0.87 1.00 
5.18_599.2879 0.00 0.00 0.00 0.00 1.00 0.78 
6.02_637.3187 0.00 0.00 0.00 0.00 0.38 1.00 
6.24_515.2753 0.01 0.00 0.15 0.18 0.77 1.00 
8.10_301.1534 0.01 0.03 0.28 0.31 0.81 1.00 
12.02_205.1953 0.01 0.00 0.00 0.00 0.84 1.00 
8.29_401.1993 0.02 0.00 0.20 0.36 0.93 1.00 
10.18_223.2085 0.04 0.25 0.00 0.00 1.00 0.79 
5.97_286.6247 0.05 0.01 0.21 0.14 0.92 1.00 
7.42_280.1237 0.06 0.16 0.21 0.37 0.95 1.00 
3.86_150.0940 0.06 0.11 0.29 0.43 0.92 1.00 
10.52_673.3745 0.06 0.09 0.32 0.51 0.87 1.00 
5.97_278.6345 0.06 0.02 0.21 0.20 1.00 0.96 
6.72_1450.6973 0.08 0.02 0.22 0.32 1.00 0.92 
7.89_192.1015 0.10 0.17 0.31 0.42 0.80 1.00 
7.42_196.0651 0.10 0.05 0.11 0.19 0.58 1.00 
7.06_221.1900 0.12 0.36 0.01 0.00 1.00 0.97 
15.37_230.0721 0.12 0.40 0.20 0.45 0.82 1.00 
9.47_211.0868 0.13 0.23 0.39 0.38 0.82 1.00 
3.82_230.1126 0.14 0.09 0.41 0.33 0.81 1.00 
6.06_203.1781 0.15 0.26 0.00 0.13 0.83 1.00 
7.06_203.1787 0.15 0.28 0.00 0.00 0.88 1.00 
 406 
6.73_1161.1593 0.16 0.04 0.12 0.07 0.85 1.00 
5.96_534.2942 0.16 0.04 0.16 0.16 0.97 1.00 
6.71_1160.7578 0.17 0.00 0.31 0.00 1.00 0.86 
6.73_1160.5609 0.20 0.00 0.05 0.17 1.00 1.00 
5.61_343.2002 0.23 0.05 0.22 0.32 0.84 1.00 
4.81_464.2611 0.24 0.29 0.55 0.44 0.94 1.00 
5.81_605.2195 0.28 0.40 0.38 0.62 0.77 1.00 
4.32_308.1712 0.29 0.11 0.32 0.50 0.73 1.00 
6.74_1160.9454 0.32 0.26 0.22 0.14 1.00 0.79 
4.63_149.1104 0.32 0.51 0.38 0.66 0.98 1.00 
5.34_191.1575 0.32 0.46 0.31 0.56 0.91 1.00 
1.49_365.1079 0.35 0.48 0.31 0.35 0.78 1.00 
6.40_263.1761 0.36 0.38 0.37 0.56 0.81 1.00 
13.98_292.2624 0.36 0.49 0.29 0.40 0.66 1.00 
4.53_236.1764 0.37 0.48 0.36 0.57 0.94 1.00 
5.78_164.0706 0.39 0.52 0.39 0.60 1.00 0.96 
8.22_220.1332 0.39 0.57 0.44 0.73 0.94 1.00 
3.75_267.1417 0.40 0.50 0.35 0.62 0.78 1.00 
9.69_220.1127 0.41 0.48 0.29 0.00 1.00 0.98 
5.71_249.1598 0.41 0.57 0.38 0.61 0.84 1.00 
4.67_270.1917 0.43 0.59 0.44 0.57 0.81 1.00 
4.70_221.1315 0.45 0.67 0.43 0.63 0.96 1.00 
6.23_251.1781 0.49 0.54 0.37 0.61 0.87 1.00 
1.50_401.0693 0.54 0.50 0.60 0.33 1.00 0.98 
5.72_240.1231 0.56 0.39 0.47 0.51 0.89 1.00 
6.59_273.1670 0.60 0.51 0.53 0.67 0.84 1.00 
5.43_241.1546 0.61 0.63 0.59 0.79 0.93 1.00 
7.00_916.3325 1.00 0.59 0.55 0.66 0.00 0.00 
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Table A3.23. Normalized heat map of features described as unique in Figure 
3.3(A) when comparing wild type Nocardiopsis sp. FU40 ΔApoS8 to the R4 
rifampicin resistant and S5 streptomycin resistant mutant extracts using OPLS-
DA and extracting features from the generated S-plot with correlation coefficients 
≥0.9. Features are normalized to maximum intensity for that feature. 
 
Feature ID (RT_m/z) WT WT R4 R4 S5 S5 
1.50_103.5345 0.00 0.00 0.50 1.00 0.83 0.90 
4.14_186.1168 0.00 0.00 0.76 0.81 0.81 1.00 
4.84_205.1323 0.00 0.00 0.74 0.86 1.00 0.89 
1.32_211.8786 0.00 0.00 0.42 0.94 1.00 0.92 
1.49_211.0584 0.00 0.19 0.65 1.00 0.77 0.68 
5.11_236.1306 0.00 0.11 0.59 0.61 0.88 1.00 
8.08_252.0397 0.00 0.00 0.72 0.60 1.00 0.97 
1.78_262.1278 0.00 0.00 0.61 0.81 0.74 1.00 
9.60_297.1694 0.00 0.01 0.61 1.00 0.71 0.71 
5.82_322.1007 0.00 0.00 0.87 0.97 1.00 0.99 
9.13_319.1539 0.00 0.00 0.60 1.00 0.63 0.70 
7.48_345.1875 0.00 0.00 0.77 0.91 1.00 0.72 
8.53_359.2035 0.00 0.11 0.90 1.00 0.78 0.62 
1.49_394.1142 0.00 0.00 0.61 1.00 0.63 0.92 
4.02_423.1940 0.00 0.00 0.53 0.86 0.75 1.00 
1.48_431.0890 0.00 0.30 0.72 0.73 0.88 1.00 
5.52_601.2501 0.00 0.00 0.53 0.73 0.86 1.00 
1.25_639.8836 0.00 0.00 0.48 0.77 1.00 0.77 
5.66_384.2168 0.01 0.00 0.45 0.64 0.81 1.00 
16.15_710.1773 0.03 0.01 0.60 0.86 1.00 0.97 
9.66_279.1583 0.03 0.00 0.46 0.71 0.73 1.00 
5.43_377.1482 0.03 0.00 0.68 1.00 0.50 0.58 
1.73_338.0231 0.04 0.00 0.50 0.59 0.82 1.00 
9.14_239.1284 0.04 0.04 0.59 1.00 0.80 0.56 
1.74_150.0789 0.04 0.00 0.47 0.80 1.00 0.99 
3.07_230.1126 0.05 0.11 0.65 0.79 0.79 1.00 
8.53_283.1523 0.05 0.10 0.73 0.86 0.92 1.00 
8.53_177.0880 0.06 0.06 0.53 0.63 0.72 1.00 
4.75_136.0625 0.06 0.00 0.78 1.00 0.56 0.85 
8.53_207.1002 0.06 0.07 0.56 0.69 0.84 1.00 
3.83_198.1623 0.13 0.09 0.54 0.95 0.86 1.00 
1.73_288.1454 0.16 0.00 0.62 0.73 1.00 0.56 
1.60_229.1318 0.21 0.04 0.54 0.70 0.91 1.00 
9.11_505.3321 0.27 0.00 0.59 0.84 0.93 1.00 
16.18_335.9929 0.28 0.00 0.67 0.98 0.95 1.00 
4.00_320.1711 0.33 0.04 0.76 0.77 0.80 1.00 
12.11_316.2860 0.41 1.00 0.00 0.01 0.00 0.00 
11.78_354.1615 0.44 1.00 0.00 0.00 0.00 0.00 
11.49_251.2052 0.45 1.00 0.00 0.00 0.00 0.00 
11.27_448.3444 0.48 1.00 0.09 0.00 0.00 0.00 
12.43_386.2820 0.50 1.00 0.15 0.00 0.18 0.00 
10.60_346.3091 0.51 1.00 0.00 0.00 0.00 0.00 
10.40_371.3275 0.52 1.00 0.00 0.00 0.02 0.02 
10.70_288.2557 0.52 1.00 0.00 0.00 0.00 0.20 
9.48_225.1993 0.53 1.00 0.01 0.02 0.02 0.02 
4.26_669.2631 0.56 1.00 0.00 0.00 0.00 0.08 
11.80_235.1712 0.56 1.00 0.00 0.04 0.00 0.09 
10.15_739.4618 0.56 1.00 0.06 0.05 0.11 0.07 
14.41_309.2409 0.56 1.00 0.14 0.13 0.32 0.23 
10.53_531.4000 0.57 1.00 0.00 0.00 0.00 0.00 
12.97_407.3144 0.58 1.00 0.20 0.09 0.30 0.12 
12.98_399.3242 0.58 1.00 0.19 0.09 0.31 0.12 
4.37_663.2850 0.59 1.00 0.01 0.00 0.00 0.00 
13.98_433.3418 0.61 1.00 0.02 0.01 0.05 0.00 
4.64_412.2067 0.62 1.00 0.08 0.10 0.15 0.20 
6.19_181.1351 0.63 1.00 0.09 0.11 0.08 0.10 
 408 
10.97_401.2525 0.63 1.00 0.00 0.00 0.08 0.21 
11.58_415.2745 0.65 1.00 0.00 0.00 0.07 0.02 
12.62_273.1378 0.66 1.00 0.00 0.00 0.00 0.00 
4.27_647.2871 0.67 1.00 0.00 0.01 0.09 0.00 
11.44_223.2060 0.67 1.00 0.00 0.00 0.00 0.00 
8.08_219.1411 0.68 1.00 0.00 0.00 0.30 0.24 
6.85_824.9348 0.70 1.00 0.00 0.00 0.00 0.23 
16.15_442.8736 0.71 1.00 0.00 0.00 0.00 0.00 
7.07_184.1710 0.72 1.00 0.00 0.00 0.00 0.00 
4.37_150.0945 0.72 1.00 0.00 0.00 0.00 0.00 
11.18_473.3585 0.75 1.00 0.04 0.01 0.08 0.04 
12.74_443.3505 0.77 1.00 0.00 0.00 0.01 0.00 
11.97_299.2600 0.80 1.00 0.00 0.00 0.31 0.21 
11.84_443.3878 0.82 1.00 0.09 0.05 0.11 0.06 
11.03_354.1608 0.82 1.00 0.00 0.04 0.09 0.25 
11.28_440.3462 0.82 1.00 0.00 0.00 0.00 0.00 
12.98_282.2118 0.82 1.00 0.14 0.03 0.15 0.10 
10.38_401.3397 0.88 1.00 0.50 0.32 0.27 0.16 
9.26_219.1735 0.88 1.00 0.00 0.00 0.00 0.00 
4.50_359.1197 0.89 1.00 0.00 0.00 0.00 0.00 
13.49_295.2258 0.91 1.00 0.08 0.03 0.06 0.00 
4.49_225.1597 0.97 1.00 0.49 0.50 0.54 0.56 
12.89_441.3208 0.99 1.00 0.40 0.25 0.49 0.58 
11.31_225.6512 1.00 0.95 0.26 0.18 0.00 0.00 
9.27_240.2315 1.00 0.88 0.00 0.11 0.00 0.00 
10.39_268.2627 1.00 0.83 0.00 0.00 0.00 0.00 
11.44_291.1951 1.00 0.75 0.00 0.00 0.00 0.00 
12.62_313.2746 1.00 0.83 0.00 0.00 0.12 0.11 
14.31_325.2414 1.00 0.74 0.00 0.00 0.00 0.00 
15.49_338.3442 1.00 0.86 0.00 0.03 0.00 0.00 
13.48_397.3392 1.00 0.75 0.00 0.01 0.00 0.00 
13.95_411.3586 1.00 0.78 0.00 0.00 0.06 0.00 
13.27_419.3131 1.00 0.81 0.00 0.00 0.00 0.00 
12.75_617.4294 1.00 0.84 0.00 0.25 0.36 0.00 
13.92_641.5490 1.00 0.85 0.00 0.00 0.00 0.00 
4.37_685.2548 1.00 0.86 0.00 0.00 0.12 0.23 
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SUPPORTING INFORMATION FOR CHAPTER 4 
 410 
 
 
Figure A4.1. Density map for Figure 4.2(B). Color indicates the density of 
features per node. These features are then summed to determine the node 
intensity. 
 411 
 
 
Figure A4.2. Orthogonal partial least square-discriminant analysis comparing 
cocaine experienced (-1) to cocaine naïve (+1) rat sera profiles. 
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Table A4.1. Region “a” statistical summary. 
 
Blue Non-addicted averages Addicted averages Naïve averages Experienced averages 
 
6200.54 8959.59 3002.5 6200.54 
  10163.6 7979.64 2892.6 10163.6 
  8724.59 11042.4 2606.9 8724.59 
  7838.07 8700.31 2218.3 7838.07 
  9355.55 8140.3 2057.7 9355.55 
  5919.37 8945.93 2298.2 5919.37 
  8781.63   2461 8781.63 
  5323.97   2551.5 5323.97 
  6343.24   2704.5 6343.24 
  6202.28     6202.28 
        8959.59 
        7979.64 
        11042.4 
        8700.31 
        8140.3 
        8945.93 
Kruskal-Wallace One-way ANOVA 
SUMMARY 
Groups Count Sum Average Variance 
Column 1 10 74852.9 7485.286 2859614 
Column 2 6 53768.1 8961.355 1207373 
Column 3 9 22793.3 2532.586 96271.43 
Column 4 16 128621 8038.812 2662921 
ANOVA 
H=22.02 df=3 Non-addicted Addicted Naïve Experienced 
p<0.0001 Mean Ranks for Sample 22.7 30.2 5 25.5 
Post hoc test: Bonferroni-Holm 
Group 1 Group 2 Critical P Significant? 
Addicted average Naïve average 0.008333 3.25E-10 Yes 
Naïve average Experienced average 0.01 8.69E-10 Yes 
Non-addicted average Naïve average 0.0125 1.28E-07 Yes 
Non-addicted average Addicted average 0.016667 0.078596 No 
Addicted average Experienced average 0.025 0.218321 No 
Non-addicted average Experienced average 0.05 0.414697 No 
Test for Equal Variance 
F DFn DFd P 
 
6.716522861 3 37 0.000987 FAIL-equal variance cannot be 
assumed 
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Table A4.2. Region “b” statistical summary. 
Gray Non-addicted averages Addicted averages Naïve averages Experienced averages 
 
2170.11 1016.38 245.32 2170.11 
 
2101.32 692.3 327.03 2101.32 
 
1542.41 782.36 331.68 1542.41 
 
843.41 879.43 400.34 843.41 
 
748.87 879.85 338.84 748.87 
 
814.03 1082.14 439.14 814.03 
 
737.19 
 
401.79 737.19 
 
704.62 
 
476.22 704.62 
 
593.51 
 
515.46 593.51 
 
620.41 
  
620.41 
    
1016.38 
    
692.3 
    
782.36 
    
879.43 
    
879.85 
    
1082.14 
ANOVA: Single Factor 
SUMMARY 
      
Groups Count Sum Average Variance 
  
Column 1 10 10875.9 1087.588 376374.2 
  
Column 2 6 5332.46 888.7433 20753.32 
  
Column 3 9 3475.82 386.2022 7077.63 
  
Column 4 16 16208.3 1013.021 242627.1 
  
ANOVA 
      
Source of 
Variation 
SS df MS F P-value F crit 
Between 
Groups 
2908170 3 969389.9 4.990485 0.00525 4.3595 
Within 
Groups 
7187162 37 194247.6 
   
Total 10095332 40 
    
Post hoc test: Bonferroni-Holm 
Group 1 Group 2 Critical P Significant? 
Addicted average Naïve average 0.008333 1.02E-06 Yes 
Naïve average Experienced average 0.01 0.001037 Yes 
Non-addicted average Naïve average 0.0125 0.003471 Yes 
Non-addicted average Addicted average 0.016667 0.453466 No 
Addicted average Experienced average 0.025 0.555188 No 
Non-addicted average Experienced average 0.05 0.735433 No 
Test for Equal Variance 
F DFn DFd P   
2.31283416 3 37 0.091936 
PASS - equal variance may 
be assumed (p > 0.05).  
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Table A4.3. Region “c” statistical summary. 
Green Non-addicted averages 
Addicted 
averages 
Naïve averages 
Experienced 
averages 
 
1878.46 2836.05 504.97 1878.46 
  1469.38 3042.55 448.33 1469.38 
  1993.71 2200.57 345.58 1993.71 
  2543.64 1483.77 251.39 2543.64 
  1045.84 1382.98 293.38 1045.84 
  8985.16 726.63 296.93 8985.16 
  6632.13   263.09 6632.13 
  7836.09   405.93 7836.09 
  7118.23   333.42 7118.23 
  6014.89     6014.89 
        2836.05 
        3042.55 
        2200.57 
        1483.77 
        1382.98 
        726.63 
Kruskal-Wallace one-way ANOVA 
SUMMARY 
Groups Count Sum Average Variance 
Column 1 10 45517.5 4551.753 9223617 
Column 2 6 11672.6 1945.425 815385.2 
Column 3 9 3143.02 349.2244 7550.15 
Column 4 16 57190.1 3574.38 7504202 
ANOVA 
H=21.83 df=3 Non-addicted Addicted Naïve Experienced 
p<0.0001 Mean Ranks for Sample 28.1 21.2 5 25.5 
Post hoc test: Bonferroni-Holm  
Group 1 Group 2 Critical P Significant? 
Addicted average Naïve average 0.008333 0.000128 Yes 
Naïve average Experienced average 0.01 0.000688 Yes 
Non-addicted average Naïve average 0.0125 0.001938 Yes 
Non-addicted average Addicted average 0.016667 0.062533 No 
Addicted average Experienced average 0.025 0.174181 No 
Non-addicted average Experienced average 0.05 0.404085 No 
Test for Equal Variance 
F DFn DFd P 
 
11.32572354 3 37 2.05E-05 FAIL-equal variance cannot be 
assumed 
 415 
Table A4.4. Region “d” statistical summary. 
Purple Non-addicted averages Addicted averages Naïve averages Experienced averages 
 
1961.77 1068.04 564.75 1961.77 
  1714.38 1373.17 459.78 1714.38 
  1701.73 1044.29 582.72 1701.73 
  1803.42 1004.43 388.91 1803.42 
  3796.06 1516.42 345.29 3796.06 
  964.43 1350.24 536.04 964.43 
  841.67   772.68 841.67 
  1642.09   675.7 1642.09 
  1295.13   673.84 1295.13 
  1657.07     1657.07 
        1068.04 
        1373.17 
        1044.29 
        1004.43 
        1516.42 
        1350.24 
ANOVA: Single Factor 
SUMMARY             
Groups Count Sum Average Variance     
Column 1 10 17377.8 1737.775 656170.8     
Column 2 6 7356.59 1226.098 45700.29     
Column 3 9 4999.71 555.5233 19740.94     
Column 4 16 24734.3 1545.896 474389.1     
ANOVA             
Source of 
Variation 
SS df MS F P-value F crit 
Between 
Groups 
7871591 3 2623864 7.240781 0.00061 4.3595 
Within 
Groups 
13407803 37 362373.1       
Total 21279394 40         
Post hoc test: Bonferroni-Holm 
Group 1 Group 2 Critical P Significant? 
Addicted average Naïve average 0.008333 5.35E-06 Yes 
Naïve average Experienced average 0.01 0.00032 Yes 
Non-addicted average Naïve average 0.0125 0.000476 Yes 
Non-addicted average Addicted average 0.016667 0.156613 No 
Addicted average Experienced average 0.025 0.283378 No 
Non-addicted average Experienced average 0.05 0.524272 No 
Test for Equal Variance 
F DFn DFd P 
 
2.801616821 3 37 0.053266 
PASS - equal variance may 
be assumed (p > 0.05). 
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Table A4.5. Region “e” statistical summary. 
Red Non-addicted averages Addicted averages Naïve averages Experienced averages 
 
411.94 655.04 174.65 411.94 
  386.85 238.99 176.65 386.85 
  1046.58 487.88 209.55 1046.58 
  889.8 897.8 155.11 889.8 
  1555.52 652.19 151.64 1555.52 
  494.63 1134.66 158.86 494.63 
  581.41   384.33 581.41 
  878.57   344.2 878.57 
  417.64   345.88 417.64 
  723.63     723.63 
        655.04 
        238.99 
        487.88 
        897.8 
        652.19 
        1134.66 
ANOVA: Single Factor 
SUMMARY             
Groups Count Sum Average Variance     
Column 1 10 7386.57 738.657 135840.8     
Column 2 6 4066.56 677.76 97383.75     
Column 3 9 2100.87 233.43 9164.929     
Column 4 16 11453.1 715.8206 114892.8     
ANOVA 
H=18.9 df=3 Non-addicted Addicted Naïve Experienced 
p<0.0001 Mean Ranks for Sample 25.5 25 5.7 25.3 
Post hoc test: Bonferroni-Holm 
Group 1 Group 2 Critical P Significant? 
Addicted average Naïve average 0.008333 0.000395 Yes 
Naïve average Experienced average 0.01 0.000963 Yes 
Non-addicted average Naïve average 0.0125 0.001348 Yes 
Non-addicted average Addicted average 0.016667 0.740765 No 
Addicted average Experienced average 0.025 0.813415 No 
Non-addicted average Experienced average 0.05 0.872901 No 
Test for Equal Variance 
F DFn DFd P 
 
5.963301904 3 37 0.002013 
FAIL - equal variance cannot 
be assumed. 
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Table A4.6. Region “f” statistical summary. 
White Non-addicted averages Addicted averages Naïve averages Experienced averages 
 
1950.42 1520.41 470.8 1950.42 
 
786.35 2827.55 511.69 786.35 
 
915.45 2014.75 446.62 915.45 
 
1068.64 2372.6 359.06 1068.64 
 
2538.34 3169.89 414.26 2538.34 
 
1199.5 2626.97 294.02 1199.5 
 
694.17 
 
408.2 694.17 
 
1263.33 
 
300.77 1263.33 
 
1087.39 
 
318.73 1087.39 
 
728.13 
  
728.13 
    
1520.41 
    
2827.55 
    
2014.75 
    
2372.6 
    
3169.89 
    
2626.97 
Kruskal-Wallis One-way ANOVA 
SUMMARY 
Groups Count Sum Average Variance     
Column 1 10 12231.7 1223.172 345940.3     
Column 2 6 14532.2 2422.028 349396.1     
Column 3 9 3524.15 391.5722 6081.414     
Column 4 16 26763.9 1672.743 683343.6     
ANOVA 
H=25.6 
df=3 
 
Non-
addicted 
Addicted Naïve Experienced 
p<0.0001 
Mean Ranks for 
Sample 
20.3 34.2 5 25.5 
Post hoc test: Bonferroni-Holm 
Group 1 Group 2 Critical P Significant? 
Addicted average Naïve average 0.008333 1.18E-07 Yes 
Naïve average Experienced average 0.01 0.000128 Yes 
Non-addicted average Naïve average 0.0125 0.000606 Yes 
Non-addicted average Addicted average 0.016667 0.00148 Yes 
Addicted average Experienced average 0.025 0.05688 No 
Non-addicted average Experienced average 0.05 0.148061 No 
Test for Equal Variance 
F DFn DFd P   
10.23623293 3 37 4.79E-05 
FAIL - equal variance cannot 
be assumed. 
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Table S4.7. Features within region extracted from the S-plot in Figure 4.4(B). 
Included are the retention time, mass, loadings and correlation coefficients, 
averages for each group, factor of change with uncertainty, in addition to the 
regional location in the MEDI heat map in Figure 4.4(C). 
 
Retention 
Time 
Mass p[1]P p(corr)[1]P 
Experienced 
Average 
Naïve 
Average 
Factor of 
Change 
Uncertainty Region 
11.76 130.066 -0.077 -0.730 60.693 4.294 14.1 5.121 blue 
12.87 614.174 -0.046 -0.584 25.551 0.000 -3.4E+07 10000 green 
12.83 616.179 -0.186 -0.689 354.740 0.000 10000 10000 blue 
13.22 158.154 -0.056 -0.576 51.840 13.964 3.7 0.709 blue 
10.19 162.056 -0.051 -0.739 26.495 1.509 17.6 12.02 purple 
9.92 182.192 -0.198 -0.811 475.820 139.393 3.4 0.274 blue 
10.82 185.116 -0.066 -0.633 64.801 17.044 3.8 0.653 blue 
10.46 186.223 -0.031 -0.577 16.783 5.390 3.1 0.819 red 
11.78 190.086 -0.059 -0.720 35.808 1.642 21.8 14.47 blue 
9.09 201.072 -0.057 -0.670 47.493 13.496 3.5 0.548 grey 
1.2 203.054 -0.049 -0.636 31.450 4.884 6.4 1.842 white 
9.98 211.143 -0.056 -0.583 39.752 2.159 18.4 8.956 blue 
9.6 215.125 -0.078 -0.615 96.993 29.218 3.3 0.497 blue 
11.94 223.066 -0.042 -0.628 25.111 5.240 4.8 1.275 white 
12.62 225.110 -0.065 -0.591 54.029 3.078 17.6 7.917 green 
9.85 229.069 -0.084 -0.549 139.021 49.404 2.8 0.44 blue 
10.53 229.142 -0.182 -0.709 418.809 97.261 4.3 0.527 blue 
10.77 243.104 -0.065 -0.643 46.404 0.571 81.3 89.034 blue 
10.85 257.136 -0.055 -0.602 48.442 14.323 3.4 0.556 blue 
12.63 261.109 -0.100 -0.575 165.129 44.117 3.7 0.613 blue 
9.55 269.129 -0.050 -0.704 35.318 9.933 3.6 0.595 purple 
10.34 273.168 -0.069 -0.577 97.670 39.432 2.5 0.327 blue 
9.09 279.688 -0.044 -0.571 33.130 10.547 3.1 0.667 blue 
9.22 305.159 -0.032 -0.555 16.740 3.643 4.6 1.467 green 
10.19 308.091 -0.049 -0.659 27.579 2.347 11.8 5.586 blue 
9.49 338.087 -0.053 -0.598 32.848 0.000 -2.4E+07 10000 blue 
9.74 340.104 -0.049 -0.630 29.279 2.385 12.3 6.83 blue 
10.55 361.138 -0.049 -0.609 54.713 27.654 2 0.225 blue 
9.48 371.227 -0.052 -0.606 41.785 10.601 3.9 0.875 purple 
10.71 383.113 -0.042 -0.556 21.828 0.000 10000 10000 white 
10.58 392.138 -0.046 -0.594 30.563 5.803 5.3 1.534 green 
9.54 399.625 -0.037 -0.610 15.955 0.000 10000 10000 red 
9.6 406.164 -0.046 -0.600 27.037 1.929 14 7.712 green 
12.18 430.296 -0.067 -0.712 44.363 0.000 -4.2E+07 10000 green 
9.96 431.090 -0.046 -0.728 19.933 0.000 -4E+07 10000 green 
9.58 432.280 -0.048 -0.680 33.715 10.099 3.3 0.601 gray 
12.18 448.306 -0.050 -0.626 29.513 1.137 26 20.871 green 
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12.19 466.318 -0.067 -0.556 58.968 2.487 23.7 11.808 green 
14.09 500.277 -0.063 -0.577 48.380 1.157 41.8 33.792 blue 
9.72 520.313 -0.069 -0.854 51.818 12.795 4 0.548 blue 
14.11 542.327 -0.045 -0.582 24.440 0.000 -3.2E+07 10000 white 
9.86 547.334 -0.031 -0.558 18.339 6.459 2.8 0.559 purple 
9.93 608.387 -0.034 -0.680 18.797 7.236 2.6 0.481 purple 
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